
<html lang="en"     class="pb-page"  data-request-id="9265a300-631a-4296-8ddf-7d01b803f8e3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm400266t;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-11;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors" /></meta><meta name="dc.Creator" content="Jun  Liang" /></meta><meta name="dc.Creator" content="Anne  van Abbema" /></meta><meta name="dc.Creator" content="Mercedesz  Balazs" /></meta><meta name="dc.Creator" content="Kathy  Barrett" /></meta><meta name="dc.Creator" content="Leo  Berezhkovsky" /></meta><meta name="dc.Creator" content="Wade  Blair" /></meta><meta name="dc.Creator" content="Christine  Chang" /></meta><meta name="dc.Creator" content="Donnie  Delarosa" /></meta><meta name="dc.Creator" content="Jason  DeVoss" /></meta><meta name="dc.Creator" content="Jim  Driscoll" /></meta><meta name="dc.Creator" content="Charles  Eigenbrot" /></meta><meta name="dc.Creator" content="Nico  Ghilardi" /></meta><meta name="dc.Creator" content="Paul  Gibbons" /></meta><meta name="dc.Creator" content="Jason  Halladay" /></meta><meta name="dc.Creator" content="Adam  Johnson" /></meta><meta name="dc.Creator" content="Pawan Bir  Kohli" /></meta><meta name="dc.Creator" content="Yingjie  Lai" /></meta><meta name="dc.Creator" content="Yanzhou  Liu" /></meta><meta name="dc.Creator" content="Joseph  Lyssikatos" /></meta><meta name="dc.Creator" content="Priscilla  Mantik" /></meta><meta name="dc.Creator" content="Kapil  Menghrajani" /></meta><meta name="dc.Creator" content="Jeremy  Murray" /></meta><meta name="dc.Creator" content="Ivan  Peng" /></meta><meta name="dc.Creator" content="Amy  Sambrone" /></meta><meta name="dc.Creator" content="Steven  Shia" /></meta><meta name="dc.Creator" content="Young  Shin" /></meta><meta name="dc.Creator" content="Jan  Smith" /></meta><meta name="dc.Creator" content="Sue  Sohn" /></meta><meta name="dc.Creator" content="Vickie  Tsui" /></meta><meta name="dc.Creator" content="Mark  Ultsch" /></meta><meta name="dc.Creator" content="Lawren C.  Wu" /></meta><meta name="dc.Creator" content="Yisong  Xiao" /></meta><meta name="dc.Creator" content="Wenqian  Yang" /></meta><meta name="dc.Creator" content="Judy  Young" /></meta><meta name="dc.Creator" content="Birong  Zhang" /></meta><meta name="dc.Creator" content="Bing-yan  Zhu" /></meta><meta name="dc.Creator" content="Steven  Magnuson" /></meta><meta name="dc.Description" content="Herein we report our lead optimization effort to identify potent, selective, and orally bioavailable TYK2 inhibitors, starting with lead molecule 3. We used structure-based design to discover 2,6-d..." /></meta><meta name="Description" content="Herein we report our lead optimization effort to identify potent, selective, and orally bioavailable TYK2 inhibitors, starting with lead molecule 3. We used structure-based design to discover 2,6-d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 29, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400266t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400266t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400266t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400266t" /></link>
        
    
    

<title>Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400266t" /></meta><meta property="og:title" content="Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0015.jpeg" /></meta><meta property="og:description" content="Herein we report our lead optimization effort to identify potent, selective, and orally bioavailable TYK2 inhibitors, starting with lead molecule 3. We used structure-based design to discover 2,6-dichloro-4-cyanophenyl and (1R,2R)-2-fluorocyclopropylamide modifications, each of which exhibited improved TYK2 potency and JAK1 and JAK2 selectivity relative to 3. Further optimization eventually led to compound 37 that showed good TYK2 enzyme and interleukin-12 (IL-12) cell potency, as well as acceptable cellular JAK1 and JAK2 selectivity and excellent oral exposure in mice. When tested in a mouse IL-12 PK/PD model, compound 37 showed statistically significant knockdown of cytokine interferon-γ (IFNγ), suggesting that selective inhibition of TYK2 kinase activity might be sufficient to block the IL-12 pathway in vivo." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Herein we report our lead optimization effort to identify potent, selective, and orally bioavailable TYK2 inhibitors, starting with lead molecule 3. We used structure-based design to discover 2,6-dichloro-4-cyanophenyl and (1R,2R)-2-fluorocyclopropylamide modifications, each of which exhibited improved TYK2 potency and JAK1 and JAK2 selectivity relative to 3. Further optimization eventually led to compound 37 that showed good TYK2 enzyme and interleukin-12 (IL-12) cell potency, as well as acceptable cellular JAK1 and JAK2 selectivity and excellent oral exposure in mice. When tested in a mouse IL-12 PK/PD model, compound 37 showed statistically significant knockdown of cytokine interferon-γ (IFNγ), suggesting that selective inhibition of TYK2 kinase activity might be sufficient to block the IL-12 pathway in vivo." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0015.jpeg" /></meta><meta name="twitter:title" content="Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400266t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400266t">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400266t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400266t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400266t&amp;href=/doi/10.1021/jm400266t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4521-4536</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400257a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400268b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Liang">Jun Liang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++van+Abbema">Anne van Abbema</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mercedesz++Balazs">Mercedesz Balazs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Barrett">Kathy Barrett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leo++Berezhkovsky">Leo Berezhkovsky</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wade++Blair">Wade Blair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Chang">Christine Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donnie++Delarosa">Donnie Delarosa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++DeVoss">Jason DeVoss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Driscoll">Jim Driscoll</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Eigenbrot">Charles Eigenbrot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nico++Ghilardi">Nico Ghilardi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gibbons">Paul Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Halladay">Jason Halladay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Johnson">Adam Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawan+Bir++Kohli">Pawan Bir Kohli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingjie++Lai">Yingjie Lai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanzhou++Liu">Yanzhou Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Lyssikatos">Joseph Lyssikatos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Priscilla++Mantik">Priscilla Mantik</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kapil++Menghrajani">Kapil Menghrajani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Murray">Jeremy Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ivan++Peng">Ivan Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy++Sambrone">Amy Sambrone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Shia">Steven Shia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Young++Shin">Young Shin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Smith">Jan Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sue++Sohn">Sue Sohn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vickie++Tsui">Vickie Tsui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Ultsch">Mark Ultsch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawren+C.++Wu">Lawren C. Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yisong++Xiao">Yisong Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenqian++Yang">Wenqian Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>×</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judy++Young">Judy Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Birong++Zhang">Birong Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bing-yan++Zhu">Bing-yan Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Magnuson">Steven Magnuson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of <sup>†</sup>Discovery Chemistry, <sup>‡</sup>Biochemical and Cellular Pharmacology, <sup>§</sup>Drug Metabolism and Pharmacokinetics, <sup>∥</sup>Immunology, <sup>⊥</sup>Formulation, <sup>#</sup>Structural Biology, and <sup>∞</sup>Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">×</span> <span class="aff-text">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech Park, Shanghai, 201203, P. R. China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">○</span> <span class="aff-text">WuXi AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, 200131, P. R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-467-3567,. E-mail: <a href="/cdn-cgi/l/email-protection#96fafff7f8f1b8fce3f8d6f1f3f8f3b8f5f9fb"><span class="__cf_email__" data-cfemail="dcb0b5bdb2bbf2b6a9b29cbbb9b2b9f2bfb3b1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400266t&amp;href=/doi/10.1021%2Fjm400266t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4521–4536</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 14, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 February 2013</li><li><span class="item_label"><b>Published</b> online</span>29 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400266t" title="DOI URL">https://doi.org/10.1021/jm400266t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4521%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJun%2BLiang%252C%2BAnne%2Bvan%2BAbbema%252C%2BMercedesz%2BBalazs%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D11%26contentID%3Djm400266t%26title%3DLead%2BOptimization%2Bof%2Ba%2B4-Aminopyridine%2BBenzamide%2BScaffold%2BTo%2BIdentify%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BTYK2%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4536%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400266t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5106</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400266t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;van Abbema&quot;},{&quot;first_name&quot;:&quot;Mercedesz&quot;,&quot;last_name&quot;:&quot;Balazs&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Barrett&quot;},{&quot;first_name&quot;:&quot;Leo&quot;,&quot;last_name&quot;:&quot;Berezhkovsky&quot;},{&quot;first_name&quot;:&quot;Wade&quot;,&quot;last_name&quot;:&quot;Blair&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Donnie&quot;,&quot;last_name&quot;:&quot;Delarosa&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;DeVoss&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Driscoll&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Eigenbrot&quot;},{&quot;first_name&quot;:&quot;Nico&quot;,&quot;last_name&quot;:&quot;Ghilardi&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gibbons&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Halladay&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Pawan&quot;,&quot;last_name&quot;:&quot;Bir Kohli&quot;},{&quot;first_name&quot;:&quot;Yingjie&quot;,&quot;last_name&quot;:&quot;Lai&quot;},{&quot;first_name&quot;:&quot;Yanzhou&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Lyssikatos&quot;},{&quot;first_name&quot;:&quot;Priscilla&quot;,&quot;last_name&quot;:&quot;Mantik&quot;},{&quot;first_name&quot;:&quot;Kapil&quot;,&quot;last_name&quot;:&quot;Menghrajani&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Ivan&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;Sambrone&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Shia&quot;},{&quot;first_name&quot;:&quot;Young&quot;,&quot;last_name&quot;:&quot;Shin&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Sue&quot;,&quot;last_name&quot;:&quot;Sohn&quot;},{&quot;first_name&quot;:&quot;Vickie&quot;,&quot;last_name&quot;:&quot;Tsui&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Ultsch&quot;},{&quot;first_name&quot;:&quot;Lawren&quot;,&quot;last_name&quot;:&quot;C. Wu&quot;},{&quot;first_name&quot;:&quot;Yisong&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Wenqian&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Judy&quot;,&quot;last_name&quot;:&quot;Young&quot;},{&quot;first_name&quot;:&quot;Birong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Bing-yan&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Magnuson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4521-4536&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400266t&quot;},&quot;abstract&quot;:&quot;Herein we report our lead optimization effort to identify potent, selective, and orally bioavailable TYK2 inhibitors, starting with lead molecule 3. We used structure-based design to discover 2,6-dichloro-4-cyanophenyl and (1R,2R)-2-fluorocyclopropylamide modifications, each of which exhibited improved TYK2 potency and JAK1 and JAK2 selectivity relative to 3. Further optimization eventually led to compound 37 that showed good TYK2 enzyme and interleukin-12 (IL-12) cell potency, as well as acceptable cellular JAK1 and JAK2 selectivity and excellent oral exposure in mice. When tested in a mouse IL-12 PK/PD model, compound 37 showed statistically significant knockdown of cytokine interferon-γ (IFNγ), suggesting that selective inhibition of TYK2 kinase activity might be sufficient to block the IL-12 pathway in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400266t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400266t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400266t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400266t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400266t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400266t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400266t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400266t&amp;href=/doi/10.1021/jm400266t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400266t" /></input><a href="/doi/pdf/10.1021/jm400266t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400266t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400266t%26sid%3Dliteratum%253Aachs%26pmid%3D23668484%26genre%3Darticle%26aulast%3DLiang%26date%3D2013%26atitle%3DLead%2BOptimization%2Bof%2Ba%2B4-Aminopyridine%2BBenzamide%2BScaffold%2BTo%2BIdentify%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BTYK2%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D11%26spage%3D4521%26epage%3D4536%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/11" title="Go to Volume 56, Issue 11"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jmcmar.2013.56.issue-11/production/jmcmar.2013.56.issue-11.largecover.jpg" alt="Go to Volume 56, Issue 11"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we report our lead optimization effort to identify potent, selective, and orally bioavailable TYK2 inhibitors, starting with lead molecule <b>3</b>. We used structure-based design to discover 2,6-dichloro-4-cyanophenyl and (1<i>R</i>,2<i>R</i>)-2-fluorocyclopropylamide modifications, each of which exhibited improved TYK2 potency and JAK1 and JAK2 selectivity relative to <b>3</b>. Further optimization eventually led to compound <b>37</b> that showed good TYK2 enzyme and interleukin-12 (IL-12) cell potency, as well as acceptable cellular JAK1 and JAK2 selectivity and excellent oral exposure in mice. When tested in a mouse IL-12 PK/PD model, compound <b>37</b> showed statistically significant knockdown of cytokine interferon-γ (IFNγ), suggesting that selective inhibition of TYK2 kinase activity might be sufficient to block the IL-12 pathway in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GI1">4GI1</a> for <b>19</b> complexed with TYK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ2">4GJ2</a> for <b>23</b> complexed with TYK2, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ3">4GJ3</a> for <b>35</b> complexed with TYK2.</p></div><div class="extra-info-sec articleNote"><h4><span>●</span> Author Present Address</h4><p class="last">A.v.A: Department of Cell Biology, Novartis, Emeryville, California.</p></div><div class="extra-info-sec articleNote"><h4><span>△</span> Author Present Address</h4><p class="last">W.B: Department of Infectious Disease, MedImmune, Gaithersburg, Maryland.</p></div><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">J.D.: Department of Phamcokinetics, Theravance, South San Francisco, California.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Psoriasis and inflammatory bowel diseases (IBD), which include Crohn’s disease and ulcerative colitis, are both chronic inflammatory disorders of epithelial cells triggered by an overly activated immune system.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Psoriasis is a chronic skin disease characterized by red and scaly skin plaques, which is estimated to affect ∼2% of the general population.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In its moderate to severe form where topical application of corticosteroid is no longer effective, psoriasis can present a substantial burden on the well-being of patients.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> IBD is a chronic inflammation of epithelial cells lining the gastrointestinal tract and colon that affects approximately 1.4 million patients in United States alone.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recent approvals of several antitumor necrosis factor (anti-TNF) antibodies represent a major step forward in terms of treatment options for IBD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> However, it is reported that one-third of IBD patients do not respond to anti-TNF therapy. For those who do respond initially, loss of response occurs in 23–46% of patients annually, most often because of development of antidrug antibodies.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Therefore, significant unmet medical needs still exist for both psoriasis and IBD.</div><div class="NLM_p">Although clinically distinct, psoriasis and IBD were reported to be associated in some patient populations and show overlapping genetic predispositions, suggesting a shared etiological basis.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Extensive research confirmed that aberrant T cells and their associated extracellular signaling molecules called cytokines play significant roles in the pathogenesis of both diseases.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Of particular importance are T helper type 1 (Th1) and T helper type 17 (Th17) cells. Th1 cells produce cytokine IFNγ, which in turn stimulates innate and T cell-mediated immune response.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Overstimulated Th1 cells, however, cause tissue damage and result in chronic inflammation. The more recently discovered Th17 cells, which secrete cytokine IL-17, have been quickly recognized as key players in many autoimmune diseases including psoriasis and IBD.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Th1 and Th17 cell differentiations are driven by IL-12 and IL-23, respectively.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Both IL-12 and IL-23 are heterodimeric proteins that share a common subunit designated p40. The receptor for IL-12 consists of two subunits IL-12Rβ1 and IL-12Rβ2,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> whereas the receptor for IL-23 shares the IL-12Rβ1 subunit and has a unique subunit called IL-23R.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The IL-12 and IL-23 receptors lack intrinsic enzymatic activity. Instead, IL-12Rβ1 is known to be constitutively associated with the TYK2 enzyme,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> while IL-12Rβ2 and IL-23R are constitutively associated with the JAK2 enzyme.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Both TYK2 and JAK2 belong to the Janus family of tyrosine kinases (JAK) which also includes JAK1<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and JAK3.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">In multiple studies with psoriatic patients, significant elevation of IL-12 and IL-23 was observed in lesional skin compared to normal skin.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Consistent with this observation, IL-12 and IL-23 expression decreased after psoriatic treatment.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Similar results were observed in studies in animal models of psoriasis. Transgenic mice that overexpressed the p40 subunit or nontransgenic mice injected with recombinant IL-23 developed inflammatory skin disease, showing comparable phenotype to psoriatic patients.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Inhibition of both IL-12 and IL-23 pathways by anti-p40 antibodies proved to be therapeutically beneficial in both animal models,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> as well as in patients.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Ustekinumab, an anti-p40 antibody, was recently approved by the FDA for treating psoriasis.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Human genetics studies, especially the recent genome-wide association study, have identified a strong association of IL-23R and IL-12B (encoding the p40 subunit) polymorphisms with IBD.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Once again, studies with transgenic mice provided further evidence for the importance of the IL-12 and IL-23 pathways in IBD. In well-established T-cell-mediated colitis models, p40 knockout mice were protected from development of intestinal inflammation.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Finally, the anti-p40 antibody ustekinumab also showed indications of efficacy in certain patients with Crohn’s disease.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">We were attracted to the opportunity of blocking the IL-12 and IL-23 signaling pathways in vivo by an orally bioavailable small molecule that inhibits the kinase activity of TYK2 or JAK2 or both. From the outset, however, we believed that inhibition of the JAK2 kinase activity might be highly problematic. JAK2 is associated with signaling of several hematopoietic growth factors, including the erythropoietin (EPO) receptor.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> JAK2 deficiency is embryonically lethal in mice,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and its inhibition leads to anemia in humans.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A couple of reports, however, suggested that inhibition of the TYK2 enzyme alone might be tolerated and sufficient to block IL-12 and IL-23 signaling in vivo. TYK2-deficient mice were viable with no gross abnormal phenotype and showed severely impaired signaling and biological response to IL-12 and IL-23 while displaying marked resistance to development of skin inflammation and experimental colitis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A human patient carrying a TYK2-inactivating mutation was also reported<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and was clinically diagnosed with hyper-IgE syndromes (HIES). Consistent with observations with the TYK2-deficient mice, the human patient’s T cells showed almost complete defects in IL-12 and IL-23 signaling, with apparently normal embryogenesis, postnatal growth, and hematopoiesis. Therefore, we were cautiously optimistic that inhibiting the TYK2 kinase activity, while sparing JAK2, might be adequate to block IL-12 and IL-23 signaling in vivo. On the basis of safety considerations, we decided to target a JAK2 selectivity criterion of at least 10-fold in cell-based assays. We have previously shown that the predominant drivers of the IL-12 and EPO pathways are TYK2 and JAK2, respectively.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Thus, cellular assays with pSTAT4 and pSTAT5 as proximal readouts of these respective pathways were established to assess TYK2 and JAK2 inhibitions in cells.</div><div class="NLM_p">Required JAK1 and JAK3 selectivity was more difficult to define at the beginning of our program. JAK1 is essential for signaling of a wide variety of physiologically important cytokines such as IL-6, and its deficiency is perinatally lethal in mice.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> JAK3 expression is mostly restricted to hematopoietic cells and is known to be exclusively associated with the γ common (γ<sub>c</sub>) receptor of type I cytokines.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Inactivating mutation or deletion of JAK3 gene in humans results in severe combined immunodeficiency (SCID).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Despite the deleterious phenotypes of JAK1- and JAK3-deficient mice and humans, JAK kinases inhibitors, most notably tofacitinib (<b>1</b>)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and ruxolitinib (<b>2</b>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> are reported to be tolerated at efficacious doses during clinical trials at concentrations that only partially inhibit the activity of JAK1 and JAK3. In order to test our hypothesis with a TYK2-selective inhibitor, we decided to tentatively target the JAK1- and JAK3-selectivity criteria of at least 10-fold as measured in cell-based assays as well.</div><div class="NLM_p">Given the high degree of sequence homology between the JAK family kinases, especially in the ATP binding site where our ATP-competitive inhibitors reside, it was recognized that achieving a high degree of TYK2 selectivity vs other JAKs represented a significant challenge.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> To the best of our knowledge, we are not aware of any published report of selective TYK2 inhibitors except several recent patent applications that appeared after completion of our work.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Toward our goal of discovering potent and selective TYK2 inhibitors, we had identified, through a hit to lead campaign following a high throughput screen, a 4-aminopyridine benzamide lead <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) with many attractive properties.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In biochemical assays, compound <b>3</b> showed moderate potency inhibiting the TYK2 enzyme, with modest biochemical selectivity against JAK2 and JAK1 and good selectivity against JAK3.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biochemical and cell-based assay data of <b>1</b>, <b>2</b>, and <b>3</b>. <sup><i>a</i></sup>Biochemical assays. <sup><i>b</i></sup>Arithmetic mean of at least four separate runs (<i>n</i> ≥ 4). On average, the coefficients of variation were less than 0.3 times the mean for biochemical assays. <sup><i>c</i></sup>Cell-based assays. Arithmetic mean of at least four separate runs (<i>n</i> ≥ 4). On average, the coefficients of variation were less than 0.5 times the mean for cell-based assays. <sup><i>d</i></sup>Cell-based assay of TYK2 inhibition. <sup><i>e</i></sup>Cell-based assay of JAK1 inhibition. <sup><i>f</i></sup>Cell-based assay of JAK2 inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In cell-based assays,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><b>3</b> demonstrated reasonable potency in blocking the IL-12 pathway (IL-12 pSTAT4 EC<sub>50</sub> = 380 nM) while displaying less activity in the EPO (JAK2) and IL-6 (JAK1) pathways. Even though the biochemical and cellular potency as well as JAK1 and JAK2 selectivity required improvement, compound <b>3</b> represented an important milestone for our program, demonstrating that despite the high sequence homology of ATP-binding pockets between TYK2 and other JAK isoforms, reasonably selective TYK2 inhibitors could be identified. In terms of physiochemical properties, lipophilicy for <b>3</b> was somewhat high with measured LogD of 3.4 at pH 7.4.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> We intended to improve potency and selectivity of our analogues without further increase in lipophilicity. In mice, compound <b>3</b> exhibited relatively high clearance (65 mL/min/kg) when dosed intravenously (iv 1 mg/kg) and exhibited modest oral exposure (AUC = 2.6 μM·h at po 5 mg/kg) despite excellent cell permeability (MDCK A/B <i>P</i><sub>app</sub> = 30 × 10<sup>–6</sup> cm/s) and aqueous solubility (170 μg/mL at pH 7.4). These results suggested that oral exposure in mice for compound <b>3</b> might be limited by first-pass metabolism. Since our IL-12 PK/PD experiments would be conducted in mice, it was important to achieve good oral exposure in mice while maintaining low predicted clearance in other species. Herein we describe in detail our lead optimization efforts of compound <b>3</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To enable design of more potent and selective TYK2 inhibitors, we obtained cocrystal structures of lead molecule <b>3</b> with the JH1 domain of the TYK2 and JAK2 enzymes at 2.0 and 2.4 Å resolution, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Significant difference in P-loop conformation was noted between the two enzymes: in the crystal structure of <b>3</b> with the TYK2 enzyme, the P-loop reached down toward the C-terminal lobe, and as a result, the 4-position of the phenyl group is only 3.6 Å from the backbone carbonyl of Glu905 on the tip of the P-loop. On the contrary, the P-loop in the JAK2 enzyme was significantly more “open”. We envisioned that introduction of hydrogen bond (H-bond) donor at the C4-position on phenyl might lead to favorable and specific H-bond interaction with the carbonyl of Glu905 on the TYK2 P-loop, resulting in improved potency and possibly selectivity. It also seemed plausible that substitution at the C4-position of the phenyl ring might force the P-loop to move up<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> so that the C4-substituent could interact with a very polar region containing charged residues such as Arg1027. A second region to potentially capitalize on is where the cyclopropylamide group was bound, for which there is a residue difference between the TYK2 and JAK2 enzymes. In the TYK2 enzyme, this residue is a positively charged arginine (Arg901), while it is a neutral glutamine (Gln853) in JAK2. Even though both residues are on the protein surface and solvent-exposed, we were eager to determine if this difference could be exploited to improve the JAK2 selectivity of our analogues. Initial modeling suggested that substitution at the C2-position of the cyclopropylamide group could provide a vector to access this region.</div><div class="NLM_p">We started SAR exploration by first focusing on modifications at the C4-position of the 2,6-dichlorophenyl group in compound <b>3</b>. In addition to the structural rationale outlined above, incubation of compound <b>3</b> with human liver microsomes showed formation of two major metabolites resulting from hydrolysis of the cyclopropylamide and oxidation on the 2,6-dichlorophenyl ring, respectively. Metasite<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (Molecular Discovery) analysis predicted that the phenyl C4-position was likely the site of this oxidative metabolic transformation. Therefore, introduction of a functional group, preferably a polar and electron-withdrawing one, might be a viable approach to block such metabolism while simultaneously lowering the associated LogD. Previous structure–activity relationship (SAR) of 4-aminopyridine benzamides from a library of commercially available 2-chlorobenzoic acids had demonstrated that small groups were tolerated at the C4-position of the phenyl ring,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> so all indications pointed to this being an important region to explore.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of the TYK2 and JAK2 crystal structures with compound <b>3</b> (TYK2 sandy brown, JAK2 blue), highlighting the different P-loop conformations between the TYK2 and JAK2 enzymes and the residue difference (Arg901 vs Gln853) in the area where cyclopropylamide group was bound. The resolutions of the X-ray structures are 2.0 Å (TYK2) and 2.4 Å (JAK2), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Representative analogues from the C4-position SAR and their biological data are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Enzyme data were used to calculate the biochemical JAK1 and JAK2 indexes, defined as (JAK1 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>) and (JAK2 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>), respectively. For analogues that showed TYK2 enzyme <i>K</i><sub>i</sub> < 5.0 nM, cellular inhibitory activities (EC<sub>50</sub>) of the IL-12, IL-6, and EPO pathways using pSTAT4, pSTAT3, and pSTAT5 readouts, respectively, were also measured. The cell potency data were then used to calculate the associated cell JAK1 and JAK2 indexes, defined as (IL-6 pSTAT3 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>) and (EPO pSTAT5 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>), respectively.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Modifications at C4-Position on the Phenyl Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Biochemical assays. Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3). On average, the coefficients of variation were less than 0.3 times the mean for biochemical assays.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">(JAK1 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">(JAK2 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Cell-based assay of TYK2 inhibition. Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3). On average, the coefficients of variation were less than 0.5 times the mean for cell-based assays.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">(IL-6 pSTAT3 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">(EPO pSTAT5 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>).</p></div></div><div></div></div><div class="NLM_p">Among compounds with an H-bond donor directly connected to the phenyl ring (compounds <b>4</b>–<b>7</b>), aniline analogue <b>4</b> was found to be the most potent TYK2 inhibitor, with slightly better JAK1 and JAK2 indexes than <b>3</b>. Phenol <b>7</b> was also well-tolerated. When the phenol was converted to a methyl ether (compound <b>8</b>), a slight loss of potency was observed. Given the potential liabilities of both phenol and aniline, we investigated whether benzyl alcohols or benzylamines, with the H-bond donor removed one atom from the ring, would be suitable replacements. Primary, secondary, tertiary, and propargylic alcohols (compounds <b>9</b>–<b>12</b>) were introduced at the C4-position. None, however, was as potent as the phenol analogue <b>7</b>. We also systematically examined primary, secondary, and tertiary benzylamines (compounds <b>13</b>–<b>16</b>). Likely protonated at physiological pH, the amino groups could not only serve as H-bond donors but also result in significantly lowered lipophilicity. Disappointingly, biochemical data showed that all the benzylamino analogues were less potent than the aniline analogue <b>4</b>.</div><div class="NLM_p">Among other functional groups surveyed at the C4-position, nitrile <b>19</b> stood out because of its improved TYK2 <i>K</i><sub>i</sub> (1.8 vs 4.8 nM for <b>3</b>) and slightly better biochemical JAK1 and JAK2 indexes. Nitrile isostere-acetylene <b>20</b> was approximately 4-fold less potent against TYK2 than nitrile <b>19</b>. Heterocycles, in the form of pyrazole and triazole, were also evaluated at the C4-position. Pyrazole <b>21</b> was tolerated, although with poor JAK1 and JAK2 selectivities as measured in both biochemical and cellular assays. On the other hand, loss of TYK2 inhibitory activity was noted for triazole <b>22</b>. Additionally, aqueous solubility at pH 7.4 for both <b>21</b> and <b>22</b> was poor (1 and 2 μg/mL, respectively), possibly because of the addition of one more aromatic ring.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Further exploration of heterocycles at the C4-position was not pursued.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of compound <b>19</b> in complex with the TYK2 enzyme. The resolution of the X-ray structure is 2.3 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The SAR described above is consistent with the design hypothesis that an H-bond donor such as a primary amino group in compound <b>4</b> could have a favorable interaction with the TYK2 enzyme. What we had not predicted, however, was that compound <b>19</b> with a C4-nitrile, typically an H-bond acceptor, would also show improved TYK2 potency. To understand the interaction of nitrile <b>19</b> with the TYK2 enzyme, we obtained a cocrystal structure at 2.3 Å resolution (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The distance between the nitrile nitrogen and the Arg1027 NH is 3.5 Å, slightly outside the range of a reasonable H-bond but not excluding the possibility of a long-range electrostatic interaction. Instead, what we noticed was that the P-loop conformation was almost identical to that observed in the TYK2 cocrystal structure with compound <b>3</b>. The carbonyl oxygen of Glu905 on the P-loop is 3.2 Å away from the carbon of the nitrile group and likely makes an orthogonal multipolar interaction. This less conventional type of interaction has been observed in the Cambridge small-molecule database (CSD)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and is visually identified by Proasis<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (Desert Scientific Software) to be a favorable interaction. We supplemented these empirical observations using <i>ab initio</i> calculations of a model system, restraining the distance and angles between the carbonyl and the nitrile carbon atom, and also found this to be an energetically favorable interaction (details in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). One may argue that the potency boost stemmed instead from a nonclassical H-bond between C5-hydrogen of the phenyl and the backbone carbonyl of Glu905, but even though this C5···O distance is 3.4 Å, the angle was not ideal. From an SAR standpoint, the carbon of the C4-nitrile and the nitrogen of the C4-aniline occupied similar space. Both substitutions provided potency gain relative to the C4-hydrogen, with the C4-aniline being approximately 2-fold more potent than the C4-nitrile, supporting our interpretation that the C═O···CN is a favorable polar interaction but is not as strong as an H-bond.</div><div class="NLM_p">It is remarkable that the P-loop maintained its “closed down” conformation in the cocrystal structures with compounds <b>3</b> and <b>19</b>, leading us to hypothesize that the TYK2 P-loop is relatively rigid. We believe that the observed TYK2 potency SAR in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> could be rationalized by the “inflexible” P-loop hypothesis. Larger substitutions at the C4-position were tolerated but did not lead to improved potency as designed likely because any favorable interactions to the TYK2 enzyme that such groups facilitated were offset by the energy cost of moving the P-loop. By contrast, aniline <b>4</b> could be readily modeled using the TYK2 bound crystal structure of compound <b>3</b>:<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> the primary amino group could be accommodated at the 4-position with no movement, and thus no entropic cost, of the P-loop while making a favorable H-bond with the carbonyl of Glu905. This hypothesis could also explain the improved JAK2 index for analogues <b>4</b> and <b>19</b> as the result of better TYK2 enzyme potency, due to favorable H-bond or orthogonal multipolar interaction with the adjacent P-loop in TYK2. Such interaction is likely absent with a more “open” JAK2 P-loop. This difference in P-loop conformations between the TYK2 and JAK2 enzymes had been reported previously with other classes of JAK inhibitors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">Despite its better biochemical potency, aniline <b>4</b> was less potent in the IL-12 cell assay than nitrile <b>19</b> (pSTAT4 EC<sub>50</sub> of 248 vs 157 nM). It was encouraging that for both analogues <b>4</b> and <b>19</b>, the slightly improved biochemical JAK1 and JAK2 indexes translated into slightly better cellular JAK1 and JAK2 indexes than lead molecule <b>3</b>. It is also worth pointing out that good cellular JAK1 selectivity was more difficult to achieve than cellular JAK2 selectivity. We suggest this observation is a reflection of the weaker ATP <i>K</i><sub>m</sub> for JAK1 compared to JAK2 (55 vs 15 μM).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Compound <b>19</b> was profiled against a broad panel of kinases at 180 nM (100-fold in excess of its TYK2 <i>K</i><sub>i</sub>) and was found to be reasonably selective. The Gini coefficient of its kinase selectivity was calculated to be 0.65.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Among the 187 kinases tested, compound <b>19</b> demonstrated >50% inhibition against only six kinases: 80% inhibition against RSK3 and RSK4, 73% against RSK2, 68% against LRRK, and 61% against CDK5 and LCK, respectively.</div><div class="NLM_p">After determining that a nitrile was the optimal substituent at the C4-position on the 2,6-dichlorophenyl fragment, we then turned our attention to optimization of the cyclopropylamide moiety. As highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, there is a residue difference between TYK2 (Arg901) and JAK2 (Gln853) that we hoped to probe through substitution at the C2-position on the cyclopropylamide group. For any given C2-substituent on the cyclopropylamide, <i>cis</i>- and <i>trans</i>-isomers are possible, with each mixture consisting of a pair of enantiomers. Since the preferred stereochemistry of this substituent could not be predicted with confidence from modeling, we proceeded by preparing and testing both the <i>cis</i>- and <i>trans</i>-isomers, each as a racemic mixture. If the initial enzyme inhibition data for the racemic mixture were promising, the <i>cis</i>- or <i>trans</i>-mixture was subject to further purification by chiral HPLC or SFC to give single enantiomers for testing. A general trend quickly emerged from our SAR exploration, where for every C2-substituent evaluated, the racemic <i>cis</i>-isomeric mixture was always more potent than the corresponding <i>trans</i>-isomeric mixture. Furthermore, when the racemic <i>cis</i>-isomers were separated, there was usually a significant difference in the TYK2 potency between the two enantiomers. To illustrate this point, data for four diastereomers of the <i>C</i>2-fluoro analogue (compound <b>23</b>–<b>26</b>) are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. For other C2<i>-</i>substituents, data for only the more active <i>cis</i>-enantiomer are included.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of C2-Substituted Cyclopropylamide</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Unless otherwise indicated, compounds are single enantiomers of unknown absolute configuration.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Biochemical assays. Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3). On average, the coefficients of variation were less than 0.3 times the mean for biochemical assays.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">(JAK1 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">(JAK2 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div></div><div></div></div><div class="NLM_p">When compared to the unsubstituted cyclopropylamide <b>3</b>, <i>cis</i>-<i>C</i>2-fluoro analogue <b>23</b> showed a small but statistically significant improvement in TYK2 enzyme potency (2.5 vs 4.8 nM) and slightly better biochemical JAK1 and JAK2 indexes. The TYK2 enzyme pocket where the cyclopropylamide was bound seemed sensitive to steric bulk. As the size of the C2-substituent increased from F to Cl to CH<sub>3</sub> (compounds <b>23</b>, <b>27</b>, and <b>28</b>), the TYK2 potency gradually decreased. Polar substituents at the C2-position were also examined in hopes of achieving favorable interactions with the polar side chain of Arg901 in the TYK2 enzyme. We expected that polar substituents would also offer an opportunity to reduce the lipophilicity of compound <b>3</b>. Contrary to expectations, most of the polar C2-substituents (<b>29</b>–<b>31</b>) resulted in reduced TYK2 potency when compared to compound <b>3</b>. An exception to this trend was one of the <i>cis</i>-enantiomers of carboxylic acid (analogue <b>32</b>). It was especially interesting to note that compound <b>32</b> showed remarkably high biochemical JAK1 and JAK2 indexes. A single crystal structure of compound <b>32</b> was obtained, and its absolute stereochemistry was determined to be 1<i>R</i>,2<i>S</i> (see <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>). On the basis of the residue difference between the TYK2 and JAK2 enzyme in this area of the binding pocket (Arg901 vs Gln853), we propose that the electrostatic interaction between the positively charged arginine (Arg901) in the TYK2 enzyme and the negatively charged carboxylate in analogue <b>32</b> might partially explain the excellent JAK2 selectivity observed (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). This hypothesis, however, does not explain the high degree of JAK1 selectivity for compound <b>32</b>. JAK1 and TYK2 share the same residue (arginine) at this position, implying that there might be other significant differences in structure or dynamics between the two enzymes in this area.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Modeling of acid <b>32</b> binding with TYK2 enzyme. The <i>C</i>2-carboxylic acid is proposed to have favorable electrostatic interaction with the positively charged arginine (Arg901) in the TYK2 enzyme. (b) X-ray crystal structure of compound <b>23</b> in complex with the TYK2 enzyme. The resolution of the X-ray structure is 2.4 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a follow-up to this interesting discovery, we prepared the <i>cis</i> enantiomers of the corresponding <i>C</i>2-tetrazole and triazole. The tetrazole <b>33</b> was much less selective, although slightly more potent, than the carboxylic acid analogue <b>32</b>. Replacement of the acid with triazole (<b>34</b>), however, resulted in a 5-fold drop in potency against the TYK2 enzyme. This result is consistent with our hypothesis that the good TYK2 potency observed for acid <b>32</b> and tetrazole <b>33</b> is partially derived from favorable electrostatic interactions with Arg901. Despite their excellent TYK2 enzyme potencies, acid <b>32</b> and tetrazole <b>33</b> were both inactive in the TYK2 cell assay (IL-12 pSTAT4 EC<sub>50</sub> > 5.0 μM). Both the acid and tetrazole, with calculated p<i>K</i><sub>a</sub> of 3.7 and 4.6, respectively, should be ionized at physiological pH and likely have poor passive cell permeability.</div><div class="NLM_p">The lack of cell potency for acid <b>32</b> and tetrazole <b>33</b> underscored the importance of identifying a C2-substituent that was not only potent in biochemical assays but was also cellularly permeable. Fortunately, the <i>C</i>2-fluoro analogue <b>23</b> showed excellent cell potency (IL-12 pSTAT4 EC<sub>50</sub> = 193 nM). Compound <b>23</b> displayed cell JAK1 and JAK2 indexes of 17× and 18×, respectively, meeting our criteria for cellular JAK1 and JAK2 selectivity. Excited by its cell potency and selectivity, we decided to use this particular <i>cis</i>-2-fluorocyclopropylamide for future SAR investigation. To define its stereochemistry, we obtained a single crystal X-ray structure of the compound <b>23</b> (see <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>) and found that this molecule possessed (1<i>R</i>,2<i>R</i>) stereochemistry. We also solved the crystal structure of compound <b>23</b> in complex with the TYK2 enzyme at 2.4 Å resolution (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b). In this cocrystal structure, the fluorine atom is 3.1 Å away from the terminal amino of Arg901. The electronegative fluorine might be slightly favored at the C2-position because of proximity to the positively charged arginine. Since fluorine atoms usually do not act as H-bond acceptors within protein–ligand complexes,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> we propose that the favorable dipolar interaction between the <i>C</i>2-fluorine and Arg901 is responsible for the small TYK2 potency improvement of analogue <b>23</b>. It was also noteworthy that the distance between the fluorine atom and the methyl carbon of Leu903 is 3.2 Å, which is approximately the sum of van der Waals radii of both atoms. This compact packing between the <i>C</i>2-fluorine and the methyl group of Leu903 might explain why other groups with larger van der Waals radii, such as chloride or methyl, are not as well-tolerated at this position.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Combining (1<i>R</i>,2<i>R</i>)-2-<i>F</i>-Cyclopropylamide with Various Benzamides, in Comparison to Ruxolitinib (<b>2</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0013.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">TYK2 <i>K</i><sub>i</sub> <a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">JAK1 index<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (biochemical)</th><th class="colsep0 rowsep0" align="center">JAK2 index<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (biochemical)</th><th class="colsep0 rowsep0" align="center">JAK3 index<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> (biochemical)</th><th class="colsep0 rowsep0" align="center">IL-12 pSTAT4 EC<sub>50</sub> <a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> (nM)</th><th class="colsep0 rowsep0" align="center">JAK1 index<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a> (cell)</th><th class="colsep0 rowsep0" align="center">JAK2 index<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a> (cell)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left">69×</td><td class="colsep0 rowsep0" align="left">33×</td><td class="colsep0 rowsep0" align="left">178×</td><td class="colsep0 rowsep0" align="left">145</td><td class="colsep0 rowsep0" align="left">16×</td><td class="colsep0 rowsep0" align="left">20×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">76×</td><td class="colsep0 rowsep0" align="left">43×</td><td class="colsep0 rowsep0" align="left">194×</td><td class="colsep0 rowsep0" align="left">211</td><td class="colsep0 rowsep0" align="left">24×</td><td class="colsep0 rowsep0" align="left">22×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="left">60×</td><td class="colsep0 rowsep0" align="left">39×</td><td class="colsep0 rowsep0" align="left">239×</td><td class="colsep0 rowsep0" align="left">224</td><td class="colsep0 rowsep0" align="left">10×</td><td class="colsep0 rowsep0" align="left">21×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">0.4×</td><td class="colsep0 rowsep0" align="left">0.2×</td><td class="colsep0 rowsep0" align="left">6×</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2×</td><td class="colsep0 rowsep0" align="left">1×</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Biochemical assays. Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3). On average, the coefficients of variation were less than 0.3 times the mean for biochemical assays.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">(JAK1 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">(JAK2 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">(JAK3 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Cell-based assay of TYK2 inhibition. Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3). On average, the coefficients of variation were less than 0.5 times the mean for cell-based assays.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">(IL-6 pSTAT3 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>).</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">(EPO pSTAT5 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>).</p></div></div></div><div class="NLM_p">The next logical step in the SAR progression was to combine the (1<i>R</i>,2<i>R</i>)-2-<i>F</i>-cyclopropylamide moiety with our preferred 2,6-dichloro-4-cyanophenyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We were pleased to find that the potency and selectivity improvement attributed to these two substitutions seemed to be “additive”: analogue <b>35</b> was more potent and more selective than either of the predecessor molecules (<b>19</b> or <b>23</b>). To better understand the origins of the improved potency and selectivity of analogue <b>35</b>, we obtained a crystal structure of the inhibitor in complex with the TYK2 enzyme at 2.5 Å resolution (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). In this crystal structure, the fluorine atom is located 2.8 Å away from Arg901, possibly engaged in the same favorable dipolar interaction as observed in the previously described crystal structure of <b>23</b> with the TYK2 enzyme. In addition, the carbon atom of the <i>C</i>4-nitrile and the carbonyl oxygen of Glu905 are almost orthogonal to each other with a measured distance of 3.2 Å. This positioning is well within the favorable angle and distance range of an orthogonal multipolar interaction.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> We believe that the SAR observed for compound <b>35</b> could be attributed to the presence of both favorable interactions from the fluorine atom as well as the nitrile group with the TYK2 enzyme.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of compound <b>35</b> in complex with the TYK2 enzyme. The resolution of the X-ray structure is 2.5 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In cell assays, compound <b>35</b> was found to be a potent inhibitor of the IL-12 pathway (pSTAT4 EC<sub>50</sub> = 145 nM) and displayed excellent cell JAK1 and JAK2 indexes of 16× and 20×, respectively. In order to capitalize on this exciting discovery, we expanded the SAR by preparing analogues with 2-chloro-6-fluorophenyl substitution. In our previous publication,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> comparable TYK2 potency was observed for 2-chloro-6-fluorophenyl analogue and the corresponding 2,6-dichlorophenyl analogue. We reasoned that replacement of chlorine with fluorine could lower the lipophilicity of our molecules. When the 2-chloro-6-fluorophenyl analogue <b>36</b> was prepared and tested in biochemical assays, we were encouraged that it was slightly more active and more selective than analogue <b>23</b>. Therefore, compound <b>37</b>, with a <i>C</i>4-nitrile on the phenyl ring, was synthesized. Compound <b>37</b> was equipotent to <b>36</b>, with comparable JAK1 and JAK2 indexes. In cell-based assays, compound <b>37</b> showed IL-12 pSTAT4 EC<sub>50</sub> of 224 nM, with its cell JAK1 and JAK2 indexes meeting our selectivity criteria. Furthermore, we tested compound <b>37</b> in both human peripheral blood mononuclear cells (PBMC) and human whole blood, stimulated with IL-12 in combination with IL-18 and using downstream IFNγ production as a readout.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In the PBMC assay, compound <b>37</b> showed an EC<sub>50</sub> of 168 nM, comparable to its IL-12 pSTAT4 EC<sub>50</sub> of 224 nM. In human whole blood, an EC<sub>50</sub> of 737 nM was obtained for compound <b>37</b>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Compounds <b>35</b>, <b>36</b>, and <b>37</b> were also profiled against a broad panel of kinases at concentrations 100 times their corresponding TYK2 <i>K</i><sub>i</sub> values, resulting in Gini coefficients of 0.68, 0.59, and 0.61, respectively. The kinases against which the three analogues showed >50% inhibition were identical to those identified for compound <b>19</b>.</div><div class="NLM_p">The physiochemical and in vitro ADME properties of key analogues described in this work are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, along with data of the initial lead <b>3</b> for comparison. Compound <b>19</b>, which incorporated the 4-nitrile on 2,6-dichlorophenyl ring, was slightly less ligand efficient than <b>3</b> (LE of 0.49 vs 0.51), but it was also slightly less lipophilic (LogD of 3.2 vs 3.4). As a result, the calculated lipophilic ligand efficiency (LLE) was higher for <b>19</b> than for <b>3</b> (5.5 vs 4.9). It was interesting that analogue <b>23</b>, with the (1<i>R</i>,2<i>R</i>)-2-<i>F</i>-cyclopropylamide, had an experimental LogD that was 0.5 units lower than that of <b>3</b> (2.9 vs 3.4). It has been reported that fluorine substitutions on alkanes, especially in the presence of adjacent oxygen atom, usually result in lowered lipophilicity.<a onclick="showRef(event, 'cit52a'); return false;" href="javascript:void(0);" class="ref cit52a">(52a)</a> Through the combination of improved potency and lower LogD, compound <b>23</b> has higher LLE than <b>3</b> (5.7 vs 4.9). The same trends were observed when the (1<i>R</i>,2<i>R</i>)-2-<i>F</i>-cyclopropylamide and 4-nitrile phenyl group were combined to give compound <b>35</b> (LLE = 6.0). Replacement of one of the chlorines on the phenyl ring present in <b>35</b> with fluorine yielded compound <b>37</b>, which showed an experimental LogD of 2.5, a drop of 0.3 units. Consequently, compound <b>37</b> had the highest LLE (6.3) of all analogues in this scaffold. Aqueous solubility of these analogues at pH 7.4 was decent. The cell permeability, as measured in MDCK cells, was high. The plasma protein binding (PPB) of these compounds was examined in human, rat, and mouse. Most of them are highly plasma protein bound. Consistent with its lower lipophilicity, compound <b>37</b> showed the lowest plasma protein binding in all three species. It is also interesting to note that for <b>37</b>, its plasma protein binding in mouse is considerably higher than in human.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Physiochemical and in Vitro DMPK Properties of Key Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">physiochemical properties</th><th class="rowsep1 colsep0" colspan="2" align="center">in vitro DMPK properties</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">LE<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LLE<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">log <i>D</i> <a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">tPSA</th><th class="colsep0 rowsep0" align="center">aqueous solubility (μg/mL)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">MDCK A–B<i>P</i><sub>app</sub> <a class="ref internalNav" href="#t4fn5" aria-label="e">e</a> (×10<sup>–6</sup> cm/s)(ratio (B–A)/(A–B))</th><th class="colsep0 rowsep0" align="center">plasma protein binding in human, rat, mouse (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">0.51</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">30 (0.4)</td><td class="colsep0 rowsep0" align="left">95.1, 95.9, 95.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">15 (1.0)</td><td class="colsep0 rowsep0" align="left">97.8, 94.1, 96.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">126</td><td class="colsep0 rowsep0" align="left">20 (0.8)</td><td class="colsep0 rowsep0" align="left">97.5, 95.2, 98.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">6.0</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">12 (1.5)</td><td class="colsep0 rowsep0" align="left">93.2, 91.8, 98.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">0.51</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">30 (0.4)</td><td class="colsep0 rowsep0" align="left">93.4, 87.8, 96.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">11 (1.5)</td><td class="colsep0 rowsep0" align="left">86.6, 91.0, 95.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Ligand efficiency = (−1.4 log <i>K</i><sub>i</sub>)/(<i>n</i> heavy atoms).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Ligand–lipophilicity efficiency = (−log <i>K</i><sub>i</sub>) – cLogP.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Measured log of distribution coefficient between octanol and aqueous pH 7.4 buffer.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Aqueous solubility was determined in pH 7.4 PBS buffer.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Apparent permeability in MDCK Transwell culture. A–B: apical-to-basolateral. Ratio is determined by the apparent permeability of B–A basolateral-to-apical divided by A–B apical-to-basolateral.</p></div></div></div><div class="NLM_p">The in vitro metabolic stability and in vivo pharmacokinetic (PK) data of the key inhibitors are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Analogue <b>19</b> contained the 4-nitrile functionality on the phenyl group, and this substitution was designed to block oxidative metabolism that was observed for compound <b>3</b>. No significant difference in human liver microsomal stability, however, was observed between analogues <b>19</b> and <b>3</b>. Incubation of compound <b>19</b> with human liver microsomes showed only a small amount (<2%) of the corresponding cyclopropylamide hydrolysis product, and no metabolites related to oxidation on the phenyl ring were detected. Comparison of in vivo metabolic stability in mouse and rat between compounds <b>3</b> and <b>19</b> reveals that addition of <i>C</i>4-nitrile on the phenyl ring clearly had significant impact, as clearance was reduced from 21 to 3.1 mL/min/kg in rat and from 65 to 13 mL/min/kg in mouse, respectively. When compound <b>19</b> was dosed orally in mouse at 100 mg/kg, excellent oral exposure (AUC = 818 μM·h) was observed.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Metabolic Stability and in Vivo PK Parameters of Key Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="10" align="center">in vivo PK</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">in vitro metabolic stability, LM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>(mL/min/kg)</th><th class="rowsep1 colsep0" colspan="4" align="center">rat<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">mouse<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">high dose mouse<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center">Cl<sub>p</sub>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (μM·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">818</td><td class="colsep0 rowsep0" align="char" char=".">119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1090</td><td class="colsep0 rowsep0" align="char" char=".">143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">917</td><td class="colsep0 rowsep0" align="char" char=".">108</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Hepatic clearance predicted from liver microsome stability.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Male Sprague rats or CD-1 mice were dosed with each compound iv 1 mg/kg and po 5 mg/kg as a solution in 60% PEG.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">CD-1 mice were dosed po 100 mg/kg as a MCT suspension.</p></div></div></div><div class="NLM_p">For analogue <b>23</b>, we were initially concerned that fluorine substitution on the cyclopropylamide would reduce metabolic stability. Cyclopropylamide hydrolysis was one of the major metabolic pathways observed for compound <b>3</b>, and the strongly electron-withdrawing fluorine in compound <b>23</b> could conceivably, through its inductive effect, render the cyclopropylamide carbonyl even more susceptible to nucleophilic attack. The liver microsomes stability of compound <b>23</b> was comparable to <b>3</b> in all three species. To confirm these stability trends, we evaluated the clearance of analogue <b>23</b> in vivo and obtained a clearance value of 15 mL/min/kg in rat, similar to that of <b>3</b> (21 mL/min/kg). When compound <b>23</b> was dosed orally at 100 mg/kg in mouse, however, modest exposure (AUC = 50 μM·h) was observed.</div><div class="NLM_p">When the <i>(</i>1<i>R</i>,2<i>R</i>)-2-<i>F</i>-cyclopropylamide fragment was combined with the 4-cyano-substituted phenyl groups (compound <b>35</b> and <b>37</b>), attractive PK profiles were obtained. For compound <b>35</b> with the 2,6-dichloro-4-cyanophenyl group, the in vitro metabolic stability in rat and mouse was comparable to that of <b>19</b>. In vivo, a clearance value of 4.6 mL/min/kg was observed in rat. In a high dose mouse PK experiment with compound <b>35</b>, excellent oral exposure (AUC = 1090 μM·h) was observed, with maximal total concentration (<i>C</i><sub>max</sub>) reaching 149 μM. However, 2-chloro-6-fluoro analogue <b>36</b>, lacking a 4-nitrile on its phenyl group, showed a relatively high clearance (39 mL/min/kg) in rat. When nitrile was introduced at the C4-position of the phenyl group, resulting in analogue <b>37</b>, in vitro metabolic stability was comparable to that of compounds <b>19</b> and <b>35</b>. Once again, low clearance (1.0 mL/min/kg) was observed in rat for compound <b>37</b>, with excellent oral exposure achieved in mouse.</div><div class="NLM_p">It was gratifying to see that the changes introduced into the lead molecule <b>3</b>, leading to optimized compounds <b>35</b> and <b>37</b>, improve not only potency and selectivity but also clearance in rat and oral exposure in mouse. With these compounds in hand, we proceeded to in vivo PK/PD studies. While compound <b>35</b> was more potent in the IL-12 pSTAT4 assay than <b>37</b>, it also had higher plasma protein binding in mouse (98.3% vs 95.0%). As a result, unbound drug level relative to its cell EC<sub>50</sub> for analogue <b>37</b> was slightly higher than that for <b>35</b> (24× vs 17×) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). On the basis of these calculations, compound <b>37</b> was selected for in vivo PK/PD study.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. High dose (po 100 mg/kg) mouse PK of compound <b>35</b> and <b>37</b>. Three CD-1 mice were dosed orally with <b>35</b> or <b>37</b> at 100 mg/kg as a MCT suspension. At different time intervals, a blood sample was taken from each animal and plasma concentration was determined. Reported values were the average of three animals. The unbound concentration was calculated by multiplying the plasma concentration with the corresponding unbound fraction in mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine if a TYK2-selective inhibitor could inhibit the IL-12 pathway in vivo, a mouse PK/PD model was developed. Administration of recombinant mouse IL-12 in combination with mouse IL-18 resulted in a time- and dose-dependent increase in systemic IFNγ production (data not shown). After optimization of the time and dose required for induction, compound <b>37</b> was tested for its ability to inhibit IFNγ production in this model. Anti-p40 antibody, which neutralizes the IL-12 cytokine, was used as a positive control and resulted in near complete (94%) inhibition of IFNγ production (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a). Thirty minutes prior to cytokine stimulation, ascending doses of <b>37</b> were administered orally via gavage (see <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a> for the time course of mouse IL-12 PK/PD experiment). Three hours after cytokine stimulation, systemic levels of IFNγ were measured by cytokine ELISA, and total plasma concentration of compound <b>37</b> was also determined for this time point. Statistically significant inhibition of the IL-12 pathway was observed for doses of ≥10 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a), with maximal PD response at the 70 mg/kg dose. The lowest dose of 3 mg/kg, however, failed to produce a meaningful pharmacological effect. The 100 mg/kg dose did not give significantly higher unbound drug levels than the 70 mg/kg dose (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b), and thus, the PD response was comparable. Overall, the PK/PD relationship suggested that a significant attenuation of cytokine IFNγ production could be achieved at doses of 100, 70, 30, and 10 mg/kg when unbound drug concentration is ≥2-fold of the corresponding IL-12 pSTAT4 EC<sub>50</sub> value.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0007.jpeg" id="GRAPHIC-d7e2600-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Mouse IL-12 PD response with different doses of compound <b>37</b>, showing inhibition of IFNγ production by compound <b>37</b>. Values shown are the average of eight animals at each dose (<i>n</i> = 8). Anti-p40 antibody (aP40), which neutralizes IL-12, was used as a positive control. Anti-ragweed antibody (aRW) was used as a negative control. An asterisk denotes <i>p</i> < 0.05 compared to control. MCT was used as the vehicle for oral dosing of compound <b>37</b>. (b) Measured unbound concentration of compound <b>37</b> at 3.5 h after oral dosing: plot of the unbound concentration of compound <b>37</b> at the 3.5 h time point for different doses. Values shown are the average of eight animals at each dose (<i>n</i> = 8). The ratio of unbound concentration of <b>37</b> over its IL-12 pSTAT4 EC<sub>50</sub> was also calculated for all doses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Preparation of compounds reported in this work is summarized in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, utilizing chemistry similar to what was reported in our previous publication.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The syntheses of various benzoic acids are described in the <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>. Briefly, a 2,6-dichlorobenzoic acid <b>38</b> was converted to its corresponding acid chloride, which was coupled with 2-bromo 4-aminopyridine <b>39</b> to give amide <b>40</b>. With 2-bromopyridine <b>40</b> in hand, we developed two methods to prepare cyclopropylamide <b>42</b> (methods A and B in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). A palladium-catalyzed Buchwald coupling reaction of bromide <b>40</b> with primary amide <b>41</b> (method A) could be carried out smoothly to give cyclopropylamide <b>42</b>. Alternatively, the 2-bromopyridine <b>40</b> could be first transformed to 2-aminopyridine <b>43</b>. Standard amide coupling reactions of 2-aminopyridine <b>43</b> with a cyclopropylcarboxylic acid <b>44</b>, or an acid chloride <b>45</b>, also led to cyclopropylamide <b>42</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of 2-Cyclopropylamides–Pyridyl-4-benzamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thionyl chloride, toluene, 100 °C; then NaH, DMF, 0 °C; (b) Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, DavePhos, LHMDS, 1,4-dioxane, 100 °C; then 1 N HCl; (d) HATU, DIPEA, DMF, 70 °C; (e) NEt<sub>3</sub>, dichloromethane, 0 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting with lead molecule <b>3</b>, we carried out comprehensive and systematic SAR investigation of the 2,6-dichlorophenyl and cyclopropylamide moieties, aided by structure-based design. Optimization of the benzamide portion of <b>3</b> led to identification of the 2,6-dichloro-4-cyanophenyl group, which showed improved TYK2 potency as well as JAK1 and JAK2 selectivity. This illustrates that selectivity can be obtained not only by directly targeting residue differences but also by utilizing the overall difference in P-loop conformation or flexibility. Furthermore, incorporation of the <i>C</i>4-nitrile substituent reduced clearance in vivo, likely as a result of blocking oxidative metabolism on the phenyl group. Subsequent exploration of various C2-substituent on the cyclopropylamide present in <b>3</b> led to identification of the (1<i>R</i>,2<i>R</i>)-2-fluorocyclopropylamide moiety that further improved TYK2 potency and JAK1 and JAK2 indexes, without compromising metabolic stability. When the two separately optimized moieties were combined, the resulting compound <b>35</b> and the closely related analogue <b>37</b> displayed excellent cell potency and selectivity profiles. Both analogues also exhibited good oral exposures when dosed in mouse. Accordingly, compound <b>37</b> was selected for a mouse PK/PD experiment because of it having the best ratio of unbound drug level in mouse over its cell IL-12 pSTAT4 EC<sub>50</sub>. Significant suppression of IFNγ production was achieved when compound <b>37</b> was dosed at greater than 3 mg/kg in a mouse IL-12 PK/PD model. This result supports our hypothesis that inhibition of the TYK2 kinase alone could lead to blocking of the IL-12 signaling pathway in vivo.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p last">Unless otherwise indicated, all reagents and solvents were purchased from commercial sources and used without further purification. Moisture or oxygen sensitive reactions were conducted under an atmosphere nitrogen gas. Unless otherwise stated, <sup>1</sup>H spectra were recorded at room temperature using Varian Unity Inova Bruker AVANCE III UltraShield-Plus Digital NMR spectrometer at indicated frequencies. Chemical shifts are expressed in ppm relative to an internal standard: tetramethylsilane (=0.00 ppm). The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet. Purification by silica gel chromatography was carried out using a CombiFlash by Teledyne ISCO system with prepacked cartridges. Purification by reverse phase high performance liquid chromatography (HPLC) was also used, and the conditions were described as indicated. Racemic mixtures of final compounds were separated into individual enantiomers by chiral supercritical fluid chromatography (SFC) under the indicated conditions. All final compounds were purified to >95% chemical purity, as assessed by HPLC (column, Agilent SD-C18, 2.1 mm × 30 mm, 1.8 μm; mobile phases, water with 0.5% TFA, CH<sub>3</sub>CN with 0.5% TFA; flow rate of 0.4 mL/min; run time of 8.5 min; oven temperature of 40 °C; UV detection at 254 and 210 nm. In cases where enantiomers or diastereomers were separated by chiral stationary phase HPLC or chiral SFC, the final products were >98% ee or de.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2,6-Dichloro-4-cyano-<i>N</i>-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (<b>19</b>)</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Step 1</h4><div class="NLM_p">A solution of 2,6-dichloro-4-cyanobenzoic acid (1.15 g, 5.32 mmol) in thionyl chloride (5.0 mL) was heated to reflux under nitrogen overnight. The next day, the mixture was concentrated via rotavap to give the desired acid chloride as a white solid, which was used in the next step without further purification.</div><div class="NLM_p last">To a solution of 2-bromo-4-aminopyridine (0.912 g, 5.32 mmol) in anhydrous DMF (5.0 mL) at 0 °C was carefully added NaH (0.424 g, 10.6 mmol, 60% dispersion in mineral oil). Ice bath was removed, and the suspension was warmed to room temperature and stirred for 30 min before being cooled to 0 °C again. To this reaction mixture was slowly added a solution of the above acid chloride dissolved in anhydrous DMF (4.0 mL). Ice bath was removed, and the mixture was warmed to room temperature and stirred for 1 h under nitrogen. Ice–water (20 mL) was added, and the reaction mixture was extracted with ethyl acetate (3 × 50 mL). Combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated via rotavap, and purified by flash column chromatography on silica gel (EtOAc/petroleum ether = 1:10) to afford <i>N</i>-(2-bromopyridin-4-yl)-2,6-dichloro-4-cyanobenzamide as a white solid (1.18 g, 59% yield). LCMS (ESI) <i>m</i>/<i>z</i>: 369.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Step 2</h4><div class="NLM_p last">A 10 mL microwave tube equipped with a magnetic stirring bar was charged with <i>N</i>-(2-bromopyridin-4-yl)-2,6-dichloro-4-cyanobenzamide (74 mg, 0.20 mmol), followed by cyclopropanecarboxamide (34 mg, 0.40 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (18 mg, 0.020 mmol), XantPhos (23 mg, 0.040 mmol), Cs<sub>2</sub>CO<sub>3</sub> (131 mg, 0.40 mmol), and 1,4-dioxane (1.2 mL). The tube was flushed with nitrogen for 5 min before being sealed and heated at 140 °C for 1 h in a microwave reactor. The tube was cooled to room temperature, and the reaction mixture was filtered through Celite. The filter cake was washed with additional EtOAc (2 × 5 mL). Combined filtrate was evaporated to dryness and purified by preparative HPLC (Gilson GX 281; column, Shim-pack PRC-ODS 250 mm × 20 mm 15 μm; mobile phase CH<sub>3</sub>CN/10 mM NH<sub>4</sub>HCO<sub>3</sub>; flow rate of 30 mL/min; run time of 17 min) to afford the desired product (30 mg, 40% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.28 (s, 1H), 10.79 (s, 1H), 8.36–8.24 (m, 4H), 7.47 (m, 1H), 2.00 (m, 1H), 0.81–0.79 (m, 4H). LCMS (ESI) <i>m</i>/<i>z</i>: 375.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,6-Dichloro-<i>N</i>-(2-((1<i>R</i>,2<i>R</i>)<i>-</i>2-fluorocyclopropanecarboxamido)pyridin-4-yl)benzamide (<b>23</b>) and 2,6-Dichloro-<i>N</i>-(2-((1<i>S</i>,2<i>S</i>)-2-fluorocyclopropanecarboxamido)pyridin-4-yl)benzamide (<b>24</b>)</h3><div class="NLM_p">To a 25 mL round-bottom flask was added <i>N</i>-(2-aminopyridin-4-yl)-2,6-dichlorobenzamide (60 mg, 0.213 mmol), followed by anhydrous DMF (2.0 mL), <i>cis</i>-2-fluorocyclopropanecarboxylic acid<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (111 mg, 1.06 mmol), DIPEA (137 mg, 1.06 mmol), and HATU (404 mg, 1.06 mmol). The reaction mixture was heated at 60 °C under nitrogen for 12 h when monitoring the reaction by LCMS showed complete conversion. The reaction mixture was cooled to room temperature, diluted with saturated NH<sub>4</sub>Cl solution (20 mL), and then extracted with EtOAc (3 × 20 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated via rotavap. The crude product was purified by chiral SFC (Chiralpak IC, 35% IPA + 0.1% NEt<sub>3</sub>, 5 min) to give two desired products as the following:</div><div class="NLM_p"><b>23</b>: second eluting peak, 21 mg (27% yield), >99% ee (retention time 0.87 min, Chiralpak IC, 35% IPA + 0.1% NEt<sub>3</sub>, 5 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.15 (s, 1H), 10.77 (s, 1H), 8.39 (s, 1H), 8.24 (d, <i>J</i> = 5.6 Hz, 1H), 7.62–7.55 (m, 2H), 7.55–7.43 (m, 2H), 4.91 (dddd, <i>J</i> = 66.3, 6.3, 6.2, 3.6 Hz, 1H), 2.21 (dddd, <i>J</i> = 9.0, 6.8, 6.3, 5.9 Hz, 1H), 1.65 (dddd, <i>J</i> = 23.4, 6.8, 6.7, 3.6 Hz, 1H), 1.16 (dddd, <i>J</i> = 12.4, 9.0, 6.8, 6.3 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i>: 368.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><b>24</b>: first eluting peak, 22 mg (28% yield), >99% ee (retention time 0.61 min, Chiralpak IC, 35% IPA + 0.1% NEt<sub>3</sub>, 5 min). <sup>1</sup>H NMR and LCMS match <b>23</b>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2,6-Dichloro-<i>N</i>-(2-(<i>trans</i>-2-fluorocyclopropanecarboxamido)pyridin-4-yl)benzamide Enantiomer 1 (<b>25</b>) and Enantiomer 2 (<b>26</b>)</h3><div class="NLM_p">A 10 mL round-bottom flask was charged with <i>N</i>-(2-aminopyridin-4-yl)-2,6-dichlorobenzamide (28 mg, 0.10 mmol), followed by anhydrous DMF (1 mL), <i>trans</i>-2-fluorocyclopropanecarboxylic acid<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> (31 mg, 0.30 mmol), DIPEA (52 mg, 0.40 mmol), and HATU (114 mg, 0.30 mmol). The reaction mixture was stirred at room temperature under nitrogen for 18 h. The reaction mixture was diluted with a saturated NH<sub>4</sub>Cl solution (20 mL) and extracted with EtOAc (2 × 20 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated via rotavap. The crude product was purified by chiral SFC (Chiralpak IC, 20% MeOH + 0.1% NEt<sub>3</sub>, 5 min) to give two desired products as the following:</div><div class="NLM_p"><b>25</b>: first eluting peak, 3.4 mg (9.2% yield), >99% ee (retention time 0.65 min, Chiralpak IC, 20% MeOH + 0.1% NEt<sub>3</sub>, 5 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.14 (s, 1H), 10.88 (s, 1H), 8.38 (d, <i>J</i> = 1.6 Hz, 1H), 8.24 (d, <i>J</i> = 5.6 Hz, 1H), 7.62–7.55 (m, 2H), 7.51 (dd, <i>J</i> = 9.2, 6.8 Hz, 1H), 7.46 (dd, <i>J</i> = 5.6, 1.9 Hz, 1H), 4.86 (dddd, <i>J</i> = 64.7, 5.8, 3.2, 1.4 Hz, 1H), 2.56 (dddd, <i>J</i> = 22.3, 10.1, 6.4, 1.4 Hz, 1H), 1.51 (dddd, <i>J</i> = 22.3, 10.1, 6.4, 3.2 Hz, 1H), 1.23 (dddd, <i>J</i> = 12.9, 6.5, 6.4, 6.3 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i>: 368.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><b>26</b>: second eluting peak, 3.3 mg (9.0% yield), >99% ee (retention time 0.74 min, Chiralpak IC, 20% MeOH + 0.1% NEt<sub>3</sub>, 5 min). <sup>1</sup>H NMR and LCMS match <b>25</b>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (1<i>R</i>,2<i>S</i>)-2-(4-(2,6-Dichlorobenzamido)pyridin-2-ylcarbamoyl)cyclopropanecarboxylic Acid (<b>32</b>)</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Step 1</h4><div class="NLM_p last">A solution of <i>N</i>-(2-aminopyridin-4-yl)-2,6-dichlorobenzamide (1.41 g, 5 mmol) and 3-oxabicyclo[3.1.0]hexane-2,4-dione (2.24 g, 20 mmol) in 1,4-dioxane (25 mL) was heated at 90 °C under nitrogen for 4 h. The reaction mixture was cooled to room temperature and the precipitated white solid was collected by filtration to give 2,6-dichloro-<i>N</i>-(2-(-2,4-dioxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-4-yl)benzamide (1.28 g, 68% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.42 (s, 1H), 8.47 (d, <i>J</i> = 5.6 Hz, 1H), 7.69 (d, <i>J</i> = 1.8 Hz, 1H), 7.67–7.59 (m, 3H), 7.55 (dd, <i>J</i> = 9.2, 6.8 Hz, 1H), 2.74 (dd, <i>J</i> = 8.0, 3.6 Hz, 2H), 1.69 (ddt, <i>J</i> = 20.6, 8.1, 4.2 Hz, 2H). LCMS (ESI) <i>m</i>/<i>z</i>: 376.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Step 2</h4><div class="NLM_p">To a suspension of 2,6-dichloro-<i>N</i>-(2-(-2,4-dioxo-3-azabicyclo[3.1.0]hexan-3-yl)pyridin-4-yl)benzamide (136 mg, 0.36 mmol) in THF (4.0 mL) was added a solution of LiOH (1 N, 2 mL, 2 mmol). The reaction mixture was stirred at room temperature for 2 h. The mixture was then extracted with EtOAc (10 mL). The aqueous layer was acidified with 1 N HCl to pH 2.0. The precipitated white solid was collected by filtration. The crude product was subsequently purified by chiral SFC (Chiralpak AD-H, 35% EtOH + 0.1% NEt<sub>3</sub>, 6 min) to give two pure enantiomers as the following:</div><div class="NLM_p"><b>32</b>: second eluting peak, 41 mg (29% yield), >99% ee (retention time 0.66 min, Chiralpak AD-H, 35% EtOH + 0.1% NEt<sub>3</sub>, 3 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.10 (s, 1H), 11.13 (s, 1H), 10.85 (s, 1H), 8.36 (d, <i>J</i> = 1.5 Hz, 1H), 8.22 (d, <i>J</i> = 5.6 Hz, 1H), 7.61–7.55 (m, 2H), 7.54–7.50 (m, 1H), 7.48 (dd, <i>J</i> = 5.5, 1.8 Hz, 1H), 2.27 (dd, <i>J</i> = 14.6, 7.5 Hz, 1H), 2.01 (dd, <i>J</i> = 15.9, 8.5 Hz, 1H), 1.39 (td, <i>J</i> = 6.6, 4.2 Hz, 1H), 1.16 (td, <i>J</i> = 8.3, 4.1 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i>: 394.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><b>Enantiomer of 32</b>: first eluting peak, 43 mg (30% yield), >99% ee (retention time 0.56 min, Chiralpak AD-H, 35% EtOH + 0.1% NEt<sub>3</sub>, 3 min). <sup>1</sup>H NMR and LCMS match <b>32</b>.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2,6-Dichloro-4-cyano-<i>N</i>-(2-((1<i>R</i>,2<i>R</i>)-(2-fluorocyclopropanecarboxamido)pyridin-4-yl)benzamide (<b>35</b>)</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Step 1</h4><div class="NLM_p last">A solution of 2,6-dichloro-4-cyanobenzoic acid (324 mg, 1.5 mmol) in thionyl chloride (10 mL) was heated to reflux under nitrogen overnight. The next day, the reaction mixture was cooled to room temperature and volatiles were removed via rotavap. The corresponding acid chloride was obtained in quantitative yield as a yellow solid, which was used in the next step without purification.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Step 2</h4><div class="NLM_p last">A 50 mL round-bottom flask was charged with 2-bromo-4-aminopyridine (295 mg, 1.5 mmol), followed by anhydrous DMF (5.0 mL). The resulting solution was cooled to 0 °C, and NaH (120 mg, 3.0 mmol, 60% dispersion in mineral oil) was added carefully under nitrogen. Ice bath was removed, and the mixture was warmed to room temperature and stirred for 30 min before being cooled to 0 °C again. To this reaction mixture was slowly added a solution of the above acid chloride dissolved in anhydrous DMF (5.0 mL). The resulting mixture was stirred for another 1 h at room temperature. Then ice–water (20 mL) was added and the resulting mixture was extracted with ethyl acetate (3 × 50 mL). The combined organic layers were washed with brine (20 mL), dried over MgSO<sub>4</sub>, and filtered. After removal of solvent under vacuum, the residue was purified by flash chromatography (ethyl acetate/petroleum ether = 1:10) to give <i>N</i>-(2-bromopyridin-4-yl)-2,6-dichloro-4-cyanobenzamide (389 mg, 70% yield). LCMS (ESI) <i>m</i>/<i>z</i>: 369.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step 3</h4><div class="NLM_p">To a 25 mL microwave tube was added <i>cis</i>-2-fluorocyclopropanecarboxamide (0.045 g, 0.44 mmol), followed by <i>N</i>-(2-bromopyridin-4-yl)-2,6-dichloro-4-cyanobenzamide (0.16 g, 0.40 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (0.045 g, 0.049 mmol), XantPhos (0.035 g, 0.061 mmol), Cs<sub>2</sub>CO<sub>3</sub> (0.51 g, 1.6 mmol), and 1,4-dioxane (6.0 mL). The mixture was degassed with nitrogen for 10 min. The tube was sealed and irradiated in a microwave reactor at 140 °C for 1 h before being cooled to room temperature. The mixture was filtered with Celite, and the filter cake was washed with additional EtOAc (2 × 10 mL). Combined filtrate was concentrated via rotavap, and the crude mixture was purified by preparative HPLC (Gilson GX 281; column, Shim-pack PRC-ODS 250 mm × 20 mm 15 μm; mobile phase CH<sub>3</sub>CN/10 mM NH<sub>4</sub>HCO<sub>3</sub>; flow rate of 30 mL/min; run time of 17 min) to give the racemic mixture as a white solid (40 mg). This racemic mixture was then purified by chiral SFC (Chiralpak IC, 15% MeOH, 5 min) to give two pure enantiomers as following:</div><div class="NLM_p"><b>35</b>: second eluting peak, 10 mg (6.4% yield), >99% ee (retention time 1.31 min, Chiralpak IC, 15% MeOH, 5 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.32 (s, 1H), 10.86 (s, 1H), 8.37 (d, <i>J</i> = 1.7 Hz, 1H), 8.32–8.24 (m, 3H), 7.49 (dd, <i>J</i> = 5.6, 1.9, 25 Hz, 1H), 4.95 (dddd, <i>J</i> = 66.2, 6.2, 6.2, 3.7 Hz, 1H), 2.21 (dddd, <i>J</i> = 9.1, 6.7, 6.2, 3.7 Hz, 1H), 1.63 (dddd, <i>J</i> = 23.2, 6.7, 6.2, 3.7 Hz, 1H), 1.16 (dddd, <i>J</i> = 12.4, 9.1, 6.2, 6.2 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i>: 393.0 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The other enantiomer was also obtained (12.5 mg, 8.0% yield), >99% ee (retention time 1.12 min, Chiralpak IC, 15% MeOH, 5 min). <sup>1</sup>H NMR and LCMS match <b>35</b>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Chloro-4-cyano-6-fluoro-<i>N</i>-(2-((1<i>R</i>,2<i>R</i>)-2-fluorocyclopropanecarboxamido)pyridin-4-yl)benzamide (<b>37</b>)</h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step 1</h4><div class="NLM_p last">A 10 mL round-bottom flask containing a suspension of 2-chloro-4-cyano-6-fluorobenzoic acid (443 mg, 2.22 mmol) in thionyl chloride (2.0 mL) was heated to reflux for 3 h under nitrogen. The mixture was cooled to room temperature, concentrated to dryness, and azeotroped with anhydrous toluene (2 × 5 mL) to give crude 2-chloro-4-cyano-6-fluorobenzoyl chloride as a white solid which was used in the next step without purification.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step 2</h4><div class="NLM_p last">A 25 mL round-bottom flask was charged with 4-amino-2-bromopyridine (346 mg, 2.0 mmol) and DIPEA (461 mg, 4.0 mmol), followed by anhydrous DCM (5.0 mL) and CH<sub>3</sub>CN (0.5 mL). The resulting clear solution was cooled to 0 °C under nitrogen, and a solution of 2-chloro-4-cyano-6-fluorobenzoyl chloride (484 mg, 2.2 mmol) in DCM (2.0 mL) was added dropwise. Ice bath was removed, and the reaction mixture was warmed to room temperature and stirred for 16 h. The reaction mixture was diluted with a saturated NH<sub>4</sub>Cl solution (40 mL) and extracted with EtOAc (3 × 50 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness. The crude product was purified by flash column chromatography on silica gel (0–50% EtOAc/hexane) to give <i>N</i>-(2-bromopyridin-4-yl)-2-chloro-4-cyano-6-fluorobenzamide as an off-white solid (379 mg, 53% yield).</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Step 3</h4><div class="NLM_p">To a 25 mL microwave tube was added <i>N</i>-(2-bromopyridin-4-yl)-2-chloro-4-cyano-6-fluorobenzamide (681 mg, 1.92 mmol), followed by <i>cis</i>-2-fluorocyclopropanecarboxamide (218 mg, 2.11 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (88 mg, 0.096 mmol), XantPhos (0.111 g, 192 mmol), Cs<sub>2</sub>CO<sub>3</sub> (1.25 g, 3.84 mmol), 1,4-dioxane (10.0 mL), and 1,2-dimethoxyethane (3.0 mL). The mixture was degassed with nitrogen for 10 min. The tube was sealed and irradiated in a microwave reactor at 130 °C for 0.5 h. After being cooled to room temperature, the mixture was filtered with Celite and the filtrate was concentrated under vacuum. The resulting residue was purified by chiral SFC (Chiralpak AS-H, 15% MeOH, 12 min) to give two pure enantiomers as the following:</div><div class="NLM_p"><b>37</b>: second eluting peak, 288 mg (40% yield), >99% ee (retention time 1.23 min, Chiralpak AS-H, 15% MeOH, 2.5 min). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.33 (s, 1H), 10.82 (s, 1H), 8.35 (d, <i>J</i> = 1.6 Hz, 1H), 8.26 (d, <i>J</i> = 5.6 Hz, 1H), 8.17–8.08 (m, 2H), 7.49 (dd, <i>J</i> = 5.6, 1.9 Hz, 1H), 4.94 (dddd, <i>J</i> = 66.2, 6.3, 6.2, 3.7 Hz, 1H), 2.21 (dddd, <i>J</i> = 12.4, 9.2, 6.9, 6.3 Hz, 1H), 1.64 (dddd, <i>J</i> = 23.2, 6.9, 6.8, 3.7 Hz, 1H), 1.16 (dddd, <i>J</i> = 12.4, 9.2, 6.3, 6.3 Hz, 1H). LCMS (ESI) <i>m</i>/<i>z</i>: 377.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The other enantiomer was also obtained (290 mg, 40% yield), >99% ee (retention time 1.03 min, Chiralpak AS-H, 15% MeOH, 2.5 min). <sup>1</sup>H NMR and LCMS data match <b>37</b>.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Computational Chemistry</h3><div class="NLM_p last">To orthogonally validate the multipolar interaction described in ref <a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a> and depicted by Proasis for the TYK2 X-ray structures with <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) and <b>35</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), quantum calculations were carried out on model systems. The carbonyl was represented by a propan-2-one molecule, and the nitrile was represented by an acetonitile molecule, both starting in the same coordinates as in the crystal structure of <b>19</b>. The program Jaguar (Schrodinger, Inc.) was used to carry out geometry optimization runs at the B3LYP/6-31G** level with PBF aqueous solvation for the propan-2-one alone, the acetonitrile alone, and the propan-2-one/acetonitrile complex with distance and angle constraints between the carbonyl and the nitrile to maintain the starting geometry of the complex. At the end of the geometry optimization runs, the interaction energy was calculated via subtraction of the sum of the solution phase energies for each separate molecule from the solution phase energy of the complex system. A similar method was used by Pierce and co-workers<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> to predict CH···O hydrogen bond strengths. Our calculation yielded an interaction energy of −0.9 kcal/mol, indicating a favorable interaction. To further verify the method and compare results with SAR, we used the same method on a system in which the acetylnitrile was switched to a prop-1-yne. This system mimics compound <b>20</b>, and the resulting interaction energy was −0.1 kcal/mol, too small to conclude whether the interaction is favorable. This set of results is consistent with compound <b>19</b> having TYK2 <i>K</i><sub>i</sub> of 1.8 nM and compound <b>20</b> having TYK2 <i>K</i><sub>i</sub> of 9.5 nM.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm400266t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental procedures for different benzoic acids and the rest of compounds shown in this work; single X-ray crystal structures of compounds <b>23</b> and <b>32</b>; crystallographic methods and procedures for <b>19</b> in complex with TYK2, <b>23</b> in complex with TYK2, and <b>35</b> in complex with TYK2; time course of mouse IL-12 PK/PD experiment. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400266t/suppl_file/jm400266t_si_001.pdf">jm400266t_si_001.pdf (723.53 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400266t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Liang</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#69050008070e47031c07290e0c070c470a0604"><span class="__cf_email__" data-cfemail="365a5f575851185c435876515358531855595b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne van Abbema</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercedesz Balazs</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Barrett</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leo Berezhkovsky</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wade Blair</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Chang</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donnie Delarosa</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason DeVoss</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Driscoll</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Eigenbrot</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nico Ghilardi</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gibbons</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Halladay</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Johnson</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawan Bir Kohli</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingjie Lai</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanzhou Liu</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Lyssikatos</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Priscilla Mantik</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kapil Menghrajani</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Murray</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivan Peng</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy Sambrone</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Shia</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Young Shin</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Smith</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sue Sohn</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vickie Tsui</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Ultsch</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawren C. Wu</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yisong Xiao</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenqian Yang</span> - <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judy Young</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Birong Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing-yan Zhu</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Magnuson</span> - <span class="hlFld-Affiliation affiliation">Departments of †Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Formulation, #Structural Biology, and ∞Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California
94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">ChemPartner Co. Ltd., 998 Halei Road, Zhangjiang Hi-Tech
Park, Shanghai, 201203, P. R.
China</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi
AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free
Trade Zone, Shanghai,
200131, P. R. China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d7e3473-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34043" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34043" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank, Mengling Wong, Chris Hamman, Michael Hayes, Baiwei Lin, Deven Wang, Yutao Jiang for purification and analytical support; Daniel Hascall, Grady Howes, Gigi Yuen, and Garima Porwal for compound management support; Hoa Le and Qin Yue for ADME support; Emile Plise and Jonathan Cheng for MDCK data; Ning Liu for microsomal stability; Jasleen Sodhi for reversible CYP inhibition measurement; Quynh Ho for plasma protein binding measurement; Pete Dragovich, Steve Staben, and Kirk Robarge for many helpful comments and suggestions. Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource, operated for the U.S. Department of Energy Office of Science by Stanford University, CA. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, National Institute of General Medical Sciences (NIH) (including Grant P41GM103393), and the National Center for Research Resources (Grant P41RR001209).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> Abbreviations Used</h2><tr><td class="NLM_term">AIBN</td><td class="NLM_def"><p class="first last">2,2′-azobis(2-methylpropionitrile)</p></td></tr><tr><td class="NLM_term">Arg</td><td class="NLM_def"><p class="first last">arginine</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">Boc<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl dicarbonate</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl carbamate</p></td></tr><tr><td class="NLM_term">brine</td><td class="NLM_def"><p class="first last">a saturated aqueous solution of sodium chloride</p></td></tr><tr><td class="NLM_term">CHCl<sub>3</sub></td><td class="NLM_def"><p class="first last">chloroform</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">CCl<sub>4</sub></td><td class="NLM_def"><p class="first last">carbon tetrachloride</p></td></tr><tr><td class="NLM_term">Cl<sub>p</sub></td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Cs<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">cesium carbonate</p></td></tr><tr><td class="NLM_term">CO</td><td class="NLM_def"><p class="first last">carbon monoxide</p></td></tr><tr><td class="NLM_term">DavePhos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)biphenyl</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">dppp</td><td class="NLM_def"><p class="first last">1,3-bis(diphenylphosphino)propane</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal effective concentration</p></td></tr><tr><td class="NLM_term">EPO</td><td class="NLM_def"><p class="first last">erythropoietin</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">Ex</td><td class="NLM_def"><p class="first last">example</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">Gln</td><td class="NLM_def"><p class="first last">glutamine</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">glutamic acid</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">H</td><td class="NLM_def"><p class="first last">hydrogen</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O</td><td class="NLM_def"><p class="first last">water</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>SO<sub>4</sub></td><td class="NLM_def"><p class="first last">sulfuric acid</p></td></tr><tr><td class="NLM_term"><i>i</i>-BuNO<sub>2</sub></td><td class="NLM_def"><p class="first last">isobutyl nitrite</p></td></tr><tr><td class="NLM_term">IBX</td><td class="NLM_def"><p class="first last">2-iodoxybenzoic acid</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">IL-12</td><td class="NLM_def"><p class="first last">interleukin-12</p></td></tr><tr><td class="NLM_term">IL-23</td><td class="NLM_def"><p class="first last">interleukin-23</p></td></tr><tr><td class="NLM_term">IFNγ</td><td class="NLM_def"><p class="first last">interferon-γ</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropyl alcohol</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">biochemcal JAK1 index</td><td class="NLM_def"><p class="first last">(JAK1 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>)</p></td></tr><tr><td class="NLM_term">cellular JAK1 index</td><td class="NLM_def"><p class="first last">(IL-6 pSTAT3 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>)</p></td></tr><tr><td class="NLM_term">biochemcal JAK2 index</td><td class="NLM_def"><p class="first last">(JAK2 <i>K</i><sub>i</sub>)/(TYK2 <i>K</i><sub>i</sub>)</p></td></tr><tr><td class="NLM_term">cellular JAK2 index</td><td class="NLM_def"><p class="first last">(EPO pSTAT5 EC<sub>50</sub>)/(IL-12 pSTAT4 EC<sub>50</sub>)</p></td></tr><tr><td class="NLM_term">K<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">potassium carbonate</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">LHDMS</td><td class="NLM_def"><p class="first last">lithium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">LiI</td><td class="NLM_def"><p class="first last">lithium iodide</p></td></tr><tr><td class="NLM_term">log <i>D</i></td><td class="NLM_def"><p class="first last">log of partition coefficient between octanol and aqueous buffer</p></td></tr><tr><td class="NLM_term">Leu</td><td class="NLM_def"><p class="first last">leucine</p></td></tr><tr><td class="NLM_term">LM</td><td class="NLM_def"><p class="first last">liver microsome</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">methylcellulose/Tween</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">NaHCO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium bicarbonate</p></td></tr><tr><td class="NLM_term">NaNO<sub>2</sub></td><td class="NLM_def"><p class="first last">sodium nitrite</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">NEt<sub>3</sub></td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium</p></td></tr><tr><td class="NLM_term">Pd(dppf)Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocenepalladium(II) dichloride</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetics/pharmakodynamics</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">by mouth</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">Tf<sub>2</sub>O</td><td class="NLM_def"><p class="first last">trifluoromethanesulfonic anhydride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">XantPhos</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimthylxanthene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christophers, E.</span><span> </span><span class="NLM_article-title">Psoriasis-epidemiology and clinical spectrum</span> <span class="citation_source-journal">Clin. Exp. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1046%2Fj.1365-2230.2001.00832.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=11422182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD3MzmtFymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2001&pages=314-320&author=E.+Christophers&title=Psoriasis-epidemiology+and+clinical+spectrum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Psoriasis--epidemiology and clinical spectrum</span></div><div class="casAuthors">Christophers E</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental dermatology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-20</span>
        ISSN:<span class="NLM_cas:issn">0307-6938</span>.
    </div><div class="casAbstract">Despite psoriasis being a common skin disease, there are still a number of unanswered questions.  One of these is the prevalence of the disease, as there is a lack of specific data, with the majority of studies reporting estimates only.  Population based studies are rare and longitudinal observations on changing prevalence rates are lacking.  This contrasts with other T-cell mediated autoimmune diseases where the number of those affected is rising.  Epidemiological studies revealed that a distinct group of diseases is quite frequently associated with psoriasis, e.g. arthritis, colitis, diabetes and hypertension.  In contrast, atopic dermatitis and allergies are less frequently seen compared to normal rates of occurrence.  As the psoriatic immune response pattern relates to activated Th-1 cells, psoriasis and atopic dermatitis appear to be mutually exclusive due to the Th-1/Th-2 dichotomy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJw2OQYtZeopdYoSR9eyvsfW6udTcc2ebw_JFhV_PDbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzmtFymtQ%253D%253D&md5=2b65ecb7487d9d5733d8437e5f227b42</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2230.2001.00832.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2230.2001.00832.x%26sid%3Dliteratum%253Aachs%26aulast%3DChristophers%26aufirst%3DE.%26atitle%3DPsoriasis-epidemiology%2520and%2520clinical%2520spectrum%26jtitle%3DClin.%2520Exp.%2520Dermatol.%26date%3D2001%26volume%3D26%26spage%3D314%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lowes, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowcock, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Pathogenesis and therapy of psoriasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">445</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2007&pages=866-873&author=M.+A.+Lowesauthor=A.+M.+Bowcockauthor=J.+G.+Krueger&title=Pathogenesis+and+therapy+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowes%26aufirst%3DM.%2BA.%26aulast%3DBowcock%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DPathogenesis%2520and%2520therapy%2520of%2520psoriasis%26jtitle%3DNature%26date%3D2007%26volume%3D445%26spage%3D866%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abraham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">2066</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMra0804647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19923578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVequ7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Abraham%2C+C.%3B+Cho%2C+J.+H.N.+Engl.+J.+Med.+2009%2C+361%2C+2066%E2%80%932078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory bowel disease</span></div><div class="casAuthors">Abraham, Clara; Cho, Judy H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2066-2078</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review of the intestinal immune system; innate immune response genes and Crohn's disease; and comparative gene assocn. studies in Crohn's disease and ulcerative colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6uGqNG14dZLVg90H21EOLACvtfcHk0lgzNH8v9DsCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVequ7bE&md5=e285d4acbe17c564d3ff92be5333fd90</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0804647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0804647%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DC.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D2066%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garrette, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, L. H.</span><span> </span><span class="NLM_article-title">Homeostasis and inflammation in the intestine</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=859-870&author=W.+S.+Garretteauthor=J.+I.+Gordonauthor=L.+H.+Glimcher&title=Homeostasis+and+inflammation+in+the+intestine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarrette%26aufirst%3DW.%2BS.%26aulast%3DGordon%26aufirst%3DJ.%2BI.%26aulast%3DGlimcher%26aufirst%3DL.%2BH.%26atitle%3DHomeostasis%2520and%2520inflammation%2520in%2520the%2520intestine%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D859%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeissig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumberg, R. S.</span><span> </span><span class="NLM_article-title">Inflammatory bowel disease</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1146%2Fannurev-immunol-030409-101225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20192811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=573-621&author=A.+Kaserauthor=S.+Zeissigauthor=R.+S.+Blumberg&title=Inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory bowel disease</span></div><div class="casAuthors">Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">573-621</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Insights into inflammatory bowel disease (IBD) are advancing rapidly owing to immunol. investigations of a plethora of animal models of intestinal inflammation, ground-breaking advances in the interrogation of diseases that are inherited as complex genetic traits, and the development of culture-independent methods to define the compn. of the intestinal microbiota.  These advances are bringing a deeper understanding to the genetically detd. interplay between the commensal microbiota, intestinal epithelial cells, and the immune system and the manner in which this interplay might be modified by relevant environmental factors in the pathogenesis of IBD.  This review examines these interactions and, where possible, potential lessons from IBD-directed, biol. therapies that may allow for elucidation of pathways that are central to disease pathogenesis in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraDPk992Ncv7Vg90H21EOLACvtfcHk0lgzNH8v9DsCUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSmsL0%253D&md5=549596996e9557e713a68d3a345e60c0</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-030409-101225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-030409-101225%26sid%3Dliteratum%253Aachs%26aulast%3DKaser%26aufirst%3DA.%26aulast%3DZeissig%26aufirst%3DS.%26aulast%3DBlumberg%26aufirst%3DR.%2BS.%26atitle%3DInflammatory%2520bowel%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D28%26spage%3D573%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gelfand, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neimann, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. J.</span><span> </span><span class="NLM_article-title">Prevalence and treatment of psoriasis in the United Kingdom—a population study</span> <span class="citation_source-journal">Arch. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">1537</span><span class="NLM_x">–</span> <span class="NLM_lpage">1541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1001%2Farchderm.141.12.1537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16365254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnns1Gnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2005&pages=1537-1541&author=J.+M.+Gelfandauthor=R.+Weinsteinauthor=S.+B.+Porterauthor=A.+L.+Neimannauthor=J.+A.+Berlinauthor=D.+J.+Margolis&title=Prevalence+and+treatment+of+psoriasis+in+the+United+Kingdom%E2%80%94a+population+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence and treatment of psoriasis in the United Kingdom: a population-based study</span></div><div class="casAuthors">Gelfand Joel M; Weinstein Rachel; Porter Steven B; Neimann Andrea L; Berlin Jesse A; Margolis David J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of dermatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1537-41</span>
        ISSN:<span class="NLM_cas:issn">0003-987X</span>.
    </div><div class="casAbstract">OBJECTIVE:  To measure the prevalence and treatment of psoriasis in the United Kingdom.  DESIGN:  Cross-sectional study to determine prevalence and cohort study to determine treatment patterns.  SETTING:  Outpatient practices of general practitioners.  PATIENTS:  We included in the analysis all patients who were registered with a general practitioner in the General Practice Research Database from 1987 to 2002.  MAIN OUTCOME MEASURES:  The prevalence and treatment of psoriasis.  RESULTS:  We identified 114 521 patients with psoriasis of a total population of 7 533 475 patients, yielding a prevalence of 1.5%.  The prevalence of psoriasis increases more rapidly in young female patients compared with young male patients and declines significantly in patients 70 years and older, regardless of sex.  Overall, 91.8% of patients with a diagnosis of psoriasis received a prescription for psoriasis treatment on or after the date of their first diagnostic code of psoriasis in the General Practice Research Database.  Most of the patients (55.2%) received only 1 or 2 prescriptions for psoriasis in the first year after psoriasis was documented in the General Practice Research Database.  CONCLUSIONS:  The epidemiology of psoriasis in the General Practice Research Database population is similar to that of other epidemiologic studies of psoriasis performed in the United Kingdom, the United States, and other Western countries.  Psoriasis carries a substantial burden given its high prevalence and its associated need for prescription therapy.  Additional studies are necessary to determine why the prevalence of psoriasis increases more rapidly in female patients and to determine why the prevalence decreases in patients 70 years and older.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSArR_-beAVIz0SWnHPWbmmfW6udTcc2eby908dcltseLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnns1Gnsw%253D%253D&md5=42a9de77318149028a49429c0c8aba6c</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1001%2Farchderm.141.12.1537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchderm.141.12.1537%26sid%3Dliteratum%253Aachs%26aulast%3DGelfand%26aufirst%3DJ.%2BM.%26aulast%3DWeinstein%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DS.%2BB.%26aulast%3DNeimann%26aufirst%3DA.%2BL.%26aulast%3DBerlin%26aufirst%3DJ.%2BA.%26aulast%3DMargolis%26aufirst%3DD.%2BJ.%26atitle%3DPrevalence%2520and%2520treatment%2520of%2520psoriasis%2520in%2520the%2520United%2520Kingdom%25E2%2580%2594a%2520population%2520study%26jtitle%3DArch.%2520Dermatol.%26date%3D2005%26volume%3D141%26spage%3D1537%26epage%3D1541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kurd, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, J. M.</span><span> </span><span class="NLM_article-title">The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004</span> <span class="citation_source-journal">J. Am Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.jaad.2008.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19022533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FnvVeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=218-224&author=S.+K.+Kurdauthor=J.+M.+Gelfand&title=The+prevalence+of+previously+diagnosed+and+undiagnosed+psoriasis+in+US+adults%3A+results+from+NHANES+2003%E2%80%932004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004</span></div><div class="casAuthors">Kurd Shanu Kohli; Gelfand Joel M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Psoriasis is a predictor of morbidity.  It is important to determine the extent to which psoriasis remains undiagnosed.  OBJECTIVE:  To determine the prevalence of psoriasis.  METHODS:  We conducted a cross-sectional study using the National Health and Nutrition Examination Survey 2003-2004.  RESULTS:  The prevalence of diagnosed psoriasis was 3.15% (95% confidence interval [CI], 2.18-4.53), corresponding to 5 million adults.  Approximately 17% of these patients have moderate to severe psoriasis based on body surface area report and 25% rate psoriasis a large problem in everyday life.  The prevalence of undiagnosed active psoriasis by conservative estimate was 0.4% (95% CI, 0.19-0.82), corresponding to approximately 600,000 US adults, and 2.28% (95% CI, 1.47-3.50) by a broader definition, corresponding to 3.6 million US adults.  Undiagnosed patients had a trend toward being more likely to be male, nonwhite, less educated, and unmarried compared with patients who had received a diagnosis.  LIMITATIONS:  The method for determining the presence of psoriasis had limited ability to detect mild disease and only fair interrater agreement.  CONCLUSION:  More than 5 million adults have been diagnosed with psoriasis.  A large number have undiagnosed psoriasis and there are important disparities which may be associated with not receiving medical attention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStWyJe6nlp5suCWE5mhx1RfW6udTcc2eby908dcltseLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FnvVeiuw%253D%253D&md5=555d19571f64507068e9b3ea99daa7e7</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2008.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2008.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DKurd%26aufirst%3DS.%2BK.%26aulast%3DGelfand%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520prevalence%2520of%2520previously%2520diagnosed%2520and%2520undiagnosed%2520psoriasis%2520in%2520US%2520adults%253A%2520results%2520from%2520NHANES%25202003%25E2%2580%25932004%26jtitle%3DJ.%2520Am%2520Acad.%2520Dermatol.%26date%3D2009%26volume%3D60%26spage%3D218%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mikhail, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinfeld, N. S.</span><span> </span><span class="NLM_article-title">Therapy treatment options for psoriasis: topical and systemic</span> <span class="citation_source-journal">Therapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.2217%2F14750708.1.2.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGqu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=319-330&author=M.+Mikhailauthor=N.+S.+Scheinfeld&title=Therapy+treatment+options+for+psoriasis%3A+topical+and+systemic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy treatment options for psoriasis: Topical and systemic</span></div><div class="casAuthors">Mikhail, Maryann; Scheinfeld, Noah S.</div><div class="citationInfo"><span class="NLM_cas:title">Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">THERCR</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Psoriasis is a common disease in the western world, with a prevalence of between 1 and 3%.  It has a variety of manifestions the most common of which being erythematous, scaly, well-demarcated plaques.  Limited disease can be treated with topical therapies.  The mainstay of topical treatment is topical corticosteroids.  Topical tar prepns. are effective but messy.  Calcipotriol and tazarotene are also useful topical therapies and can be combined with topical corticosteroids.  Moderate disease is treated effectively with oral methotrexate and phototherapy with UV B, narrow band UV B (311 nm) or psoralen (oral, topical or bath) and UV A.  Other std. oral therapies include acitretin and cyclosporin.  Acetretin can be combined with UV therapy.  There are new monoclonal antibody therapies termed biol. therapies that include alefacept, etanercept and efalizumab.  Other biol. therapies exist but have yet to be approved.  Psoriasis is a treatable but not curable skin disease with a variety of treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9t1w8G3-cS7Vg90H21EOLACvtfcHk0lhEDdrZIc6gKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGqu7vM&md5=aae7366bf2761eb474b892cf3b70aaad</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.2217%2F14750708.1.2.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14750708.1.2.319%26sid%3Dliteratum%253Aachs%26aulast%3DMikhail%26aufirst%3DM.%26aulast%3DScheinfeld%26aufirst%3DN.%2BS.%26atitle%3DTherapy%2520treatment%2520options%2520for%2520psoriasis%253A%2520topical%2520and%2520systemic%26jtitle%3DTherapy%26date%3D2004%26volume%3D1%26spage%3D319%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nograles, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Anti-cytokine therapies for psoriasis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.yexcr.2011.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21300061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVyjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=1293-1300&author=K.+E.+Nogralesauthor=J.+G.+Krueger&title=Anti-cytokine+therapies+for+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cytokine therapies for psoriasis</span></div><div class="casAuthors">Nograles, Kristine E.; Krueger, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1293-1300</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Current approaches for the treatment of psoriasis with anti-cytokine therapies involve the blockade of TNF-α, or the p40 sub-unit of IL-12 and IL-23.  However, the field is currently evolving to test more selective antagonists, such as anti-IL-23p19, IL-17 and other inflammatory cytokines.  Here we discuss our current understanding of dendritic cell and T cell subsets that are relevant in psoriasis, and the pharmacol. strategies that temper their activity in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw1M4ultrUuLVg90H21EOLACvtfcHk0lhEDdrZIc6gKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVyjt7Y%253D&md5=e72195064c385a77dd6b834fe8a2e739</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2011.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2011.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DNograles%26aufirst%3DK.%2BE.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DAnti-cytokine%2520therapies%2520for%2520psoriasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2011%26volume%3D317%26spage%3D1293%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Loftus, E. V.</span><span> </span><span class="NLM_article-title">Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1053%2Fj.gastro.2004.01.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15168363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD2c3msl2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=1504-1517&author=E.+V.+Loftus&title=Clinical+epidemiology+of+inflammatory+bowel+disease%3A+incidence%2C+prevalence%2C+and+environmental+influences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences</span></div><div class="casAuthors">Loftus Edward V Jr</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1504-17</span>
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    </div><div class="casAbstract">Although the incidence and prevalence of ulcerative colitis and Crohn's disease are beginning to stabilize in high-incidence areas such as northern Europe and North America, they continue to rise in low-incidence areas such as southern Europe, Asia, and much of the developing world.  As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases.  Previously noted racial and ethnic differences seem to be narrowing.  Differences in incidence across age, time, and geographic region suggest that environmental factors significantly modify the expression of Crohn's disease and ulcerative colitis.  The strongest environmental factors identified are cigarette smoking and appendectomy.  Whether other factors such as diet, oral contraceptives, perinatal/childhood infections, or atypical mycobacterial infections play a role in expression of inflammatory bowel disease remains unclear.  Additional epidemiologic studies to define better the burden of illness, explore the mechanism of association with environmental factors, and identify new risk factors are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0IkZFtv66G0PI-fCgwosgfW6udTcc2ebjUwFQ1SiWP7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3msl2msw%253D%253D&md5=dbc8688086e2c2148de85024f5615ba1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2004.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2004.01.063%26sid%3Dliteratum%253Aachs%26aulast%3DLoftus%26aufirst%3DE.%2BV.%26atitle%3DClinical%2520epidemiology%2520of%2520inflammatory%2520bowel%2520disease%253A%2520incidence%252C%2520prevalence%252C%2520and%2520environmental%2520influences%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D126%26spage%3D1504%26epage%3D1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanauer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachmilewitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span> </span><span class="NLM_article-title">Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1541</span><span class="NLM_x">–</span> <span class="NLM_lpage">1549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2002&pages=1541-1549&author=S.+B.+Hanauerauthor=B.+G.+Feaganauthor=G.+R.+Lichtensteinauthor=L.+F.+Mayerauthor=S.+Schreiberauthor=J.+F.+Colombelauthor=D.+Rachmilewitzauthor=D.+C.+Wolfauthor=A.+Olsonauthor=W.+Baoauthor=P.+Rutgeerts&title=Maintenance+infliximab+for+Crohn%E2%80%99s+disease%3A+the+ACCENT+I+randomized+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DLichtenstein%26aufirst%3DG.%2BR.%26aulast%3DMayer%26aufirst%3DL.%2BF.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26aulast%3DRachmilewitz%26aufirst%3DD.%26aulast%3DWolf%26aufirst%3DD.%2BC.%26aulast%3DOlson%26aufirst%3DA.%26aulast%3DBao%26aufirst%3DW.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DMaintenance%2520infliximab%2520for%2520Crohn%25E2%2580%2599s%2520disease%253A%2520the%2520ACCENT%2520I%2520randomized%2520trial%26jtitle%3DLancet%26date%3D2002%26volume%3D359%26spage%3D1541%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandborn, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachmilewitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Villiers, W. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Present, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span> </span><span class="NLM_article-title">Infliximab for induction and maintenance therapy for ulcerative colitis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2462</span><span class="NLM_x">–</span> <span class="NLM_lpage">2476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa050516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16339095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2462-2476&author=P.+Rutgeertsauthor=W.+J.+Sandbornauthor=B.+G.+Feaganauthor=W.+Reinischauthor=A.+Olsonauthor=J.+Johannsauthor=S.+Traversauthor=D.+Rachmilewitzauthor=S.+B.+Hanauerauthor=G.+Lichtensteinauthor=W.+J.+S.+de+Villiersauthor=D.+Presentauthor=B.+E.+Sandsauthor=J.+F.+Colombel&title=Infliximab+for+induction+and+maintenance+therapy+for+ulcerative+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Infliximab for induction and maintenance therapy for ulcerative colitis</span></div><div class="casAuthors">Rutgeerts, Paul; Sandborn, William J.; Feagan, Brian G.; Reinisch, Walter; Olson, Allan; Johanns, Jewel; Travers, Suzanne; Rachmilewitz, Daniel; Hanauer, Stephen B.; Lichtenstein, Gary R.; de Villiers, Willem J. S.; Present, Daniel; Sands, Bruce E.; Colombel, Jean Frederic</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2462-2476</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor α, is an established treatment for Crohn's disease but not ulcerative colitis.  METHODS: Two randomized, double-blind, placebo-controlled studies - the Active Ulcerative Colitis Trials 1 and 2 (ACT 1 and ACT 2, resp.) - evaluated the efficacy of infliximab for induction and maintenance therapy in adults with ulcerative colitis.  In each study, 364 patients with moderate-to-severe active ulcerative colitis despite treatment with concurrent medications received placebo or infliximab (5 mg or 10 mg per kilo- gram of body wt.) i.v. at weeks 0, 2, and 6 and then every eight weeks through week 46 (in ACT 1) or week 22 (in ACT 2).  Patients were followed for 54 wk in ACT 1 and 30 wk in ACT 2.  RESULTS: In ACT 1, 69 % of patients who received 5 mg of infliximab and 61 % of those who received 10 mg had a clin. response at week 8, as compared with 37 % of those who received placebo (P < 0.001 for both comparisons with placebo).  A response was defined as a decrease in the Mayo score of at least 3 points and at least 30 %, with an accompanying decrease in the subscore for rectal bleeding of at least 1 point or an abs. rectal-bleeding subscore of 0 or 1.  In ACT 2, 64 % of patients who received 5 mg of infliximab and 69 % of those who received 10 mg had a clin. response at week 8, as compared with 29 % of those who received placebo (P < 0.001 for both comparisons with placebo).  In both studies, patients who received infliximab were more likely to have a clin. response at week 30 (P ≤ 0.002 for all comparisons).  In ACT 1, more patients who received 5 mg or 10 mg of infliximab had a clin. response at week 54 (45 % and 44 %, resp.) than did those who received placebo (20 %, P < 0.001 for both comparisons).  CONCLUSIONS: Patients with moderate-to-severe active ulcerative colitis treated with infliximab at weeks 0, 2, and 6 and every eight weeks thereafter were more likely to have a clin. response at weeks 8, 30, and 54 than were those receiving placebo. (Clin. Trials.gov nos., NCT00036439 and NCT00096655.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7HpWjy_Czh7Vg90H21EOLACvtfcHk0lgz7VJzYkAc4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShurjE&md5=1611e3bf4856e8f1c57fe783ef75e92c</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050516%26sid%3Dliteratum%253Aachs%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DSandborn%26aufirst%3DW.%2BJ.%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DOlson%26aufirst%3DA.%26aulast%3DJohanns%26aufirst%3DJ.%26aulast%3DTravers%26aufirst%3DS.%26aulast%3DRachmilewitz%26aufirst%3DD.%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26aulast%3DLichtenstein%26aufirst%3DG.%26aulast%3Dde%2BVilliers%26aufirst%3DW.%2BJ.%2BS.%26aulast%3DPresent%26aufirst%3DD.%26aulast%3DSands%26aufirst%3DB.%2BE.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26atitle%3DInfliximab%2520for%2520induction%2520and%2520maintenance%2520therapy%2520for%2520ulcerative%2520colitis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2462%26epage%3D2476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ngo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolvo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. J.</span><span> </span><span class="NLM_article-title">Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety</span> <span class="citation_source-journal">Curr. Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFarurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=145-152&author=B.+Ngoauthor=C.+P.+Farrellauthor=M.+Barrauthor=K.+Wolvoauthor=R.+Baileyauthor=J.+M.+Mullinauthor=J.+J.+Thornton&title=Tumor+necrosis+factor+blockade+for+treatment+of+inflammatory+bowel+disease%3A+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Necrosis Factor blockade for treatment of inflammatory bowel disease: efficacy and safety</span></div><div class="casAuthors">Ngo, Benjamin; Farrell, Christopher P.; Barr, Maura; Wolov, Kevin; Bailey, Robert; Mullin, James M.; Thornton, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">CMPUB6</span>;
        ISSN:<span class="NLM_cas:issn">1874-4672</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammatory bowel disease (IBD), including Crohn's Disease (CD) and Ulcerative Colitis (UC), is characterized by inflammation of the gastrointestinal tract.  In UC, inflammation is confirmed to the mucosa, initially involving the rectum, and may extend proximally to involve the entire colon.  In CD, transmural inflammation may affect any portion of the G1 tract.  The etiol. of these disease processes has remained unclear.  Therapies are aimed at reduing inflammation and thereby improving symptomatol. and morbidity.  Traditional medical therapies have included corticosteroids, aminosalicylates, and immunomodulators.  Within the past decade, another class of medications has been utilized targeting Tumor Necrosis Factor (TNF), a key, early signaling mol. in the inflammatory cascade.  Increased levels of TNF have been found in the blood, epithelial tissue, and stool of patients with active IBD.  Anti-TNF medications can not only have direct effects on immune system components, but they also can ameliorate apoptotic cell death and tight junction compromise in the gastrointestinal epithelium.  Several randomized, placebo controlled studies have demonstrated the efficacy of these medications in achieving induction and maintaining remission of disease.  Their safety profile, however, remains a concern.  There has been a reported assocn. of biol. therapy and increased opportunistic infections.  A link between biol. therapy and the development of certain malignancies has also been described.  Despite these assocns., TNF blockade remains an important therapeutic development in the modern therapy of IBD.  The role of barrier breakdown at the tight junction level in IBD, and of TNF induction of barrier disruptio, is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri51WyVgFbSbVg90H21EOLACvtfcHk0lgz7VJzYkAc4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFarurbI&md5=caf6a5b5fd0ec7de27f54e048caeda27</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DB.%26aulast%3DFarrell%26aufirst%3DC.%2BP.%26aulast%3DBarr%26aufirst%3DM.%26aulast%3DWolvo%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DR.%26aulast%3DMullin%26aufirst%3DJ.%2BM.%26aulast%3DThornton%26aufirst%3DJ.%2BJ.%26atitle%3DTumor%2520necrosis%2520factor%2520blockade%2520for%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%253A%2520efficacy%2520and%2520safety%26jtitle%3DCurr.%2520Mol.%2520Pharmacol.%26date%3D2010%26volume%3D3%26spage%3D145%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Caprioli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteleone, G.</span><span> </span><span class="NLM_article-title">Cytokine therapies in Crohn’s disease: Where are we now and where should we go?</span> <span class="citation_source-journal">Inflammation Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.2174%2F187152811794352051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1antLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=47-53&author=F.+Caprioliauthor=F.+Palloneauthor=G.+Monteleone&title=Cytokine+therapies+in+Crohn%E2%80%99s+disease%3A+Where+are+we+now+and+where+should+we+go%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine therapies in crohn's disease: where are we now and where should we go?</span></div><div class="casAuthors">Caprioli, Flavio; Pallone, Francesco; Monteleone, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation & Allergy: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">IADTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1871-5281</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the gut of patients with Crohn's disease (CD), one of the major forms of inflammatory bowel disease in humans, distinct subsets of T helper (Th) cells produce large amts. of cytokines, which are supposed to orchestrate the immuno-inflammatory process leading to the tissue damage.  Indeed, cytokine blockers, including the three licensed anti-TNF-α and the neutralizing IL-12/p40 antibodies, have already been tested with success in CD.  More than one third of patients do not respond to these treatments and response can wane with time.  Moreover, blockade of such cytokines has been reported to assoc. with development of severe side effects and/or new immune-mediated pathologies.  These findings and our better understanding of cytokine-assocd. effector pathways of tissue destruction suggest that necessity of novel cytokine-based therapies in CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxoRtYpBkNYrVg90H21EOLACvtfcHk0li4yZZldmnugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1antLc%253D&md5=b359914a7359377f205cc48a7b4ed204</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.2174%2F187152811794352051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152811794352051%26sid%3Dliteratum%253Aachs%26aulast%3DCaprioli%26aufirst%3DF.%26aulast%3DPallone%26aufirst%3DF.%26aulast%3DMonteleone%26aufirst%3DG.%26atitle%3DCytokine%2520therapies%2520in%2520Crohn%25E2%2580%2599s%2520disease%253A%2520Where%2520are%2520we%2520now%2520and%2520where%2520should%2520we%2520go%253F%26jtitle%3DInflammation%2520Allergy%26date%3D2011%26volume%3D10%26spage%3D47%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assche, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haens, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabonez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span> </span><span class="NLM_article-title">Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa020888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=12584368" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=601-608&author=F.+Baerauthor=M.+Nomanauthor=S.+Vermeireauthor=G.+V.+Asscheauthor=G.+D.+Haensauthor=A.+Cabonezauthor=P.+Rutgeerts&title=Influence+of+immunogenicity+on+the+long-term+efficacy+of+infliximab+in+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020888%26sid%3Dliteratum%253Aachs%26aulast%3DBaer%26aufirst%3DF.%26aulast%3DNoman%26aufirst%3DM.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DAssche%26aufirst%3DG.%2BV.%26aulast%3DHaens%26aufirst%3DG.%2BD.%26aulast%3DCabonez%26aufirst%3DA.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DInfluence%2520of%2520immunogenicity%2520on%2520the%2520long-term%2520efficacy%2520of%2520infliximab%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D601%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ben-Horin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowers, Y.</span><span> </span><span class="NLM_article-title">Loss of response to anti-TNF treatments in Crohn’s disease</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1365-2036.2011.04612.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21366636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtF2gurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=987-995&author=S.+Ben-Horinauthor=Y.+Chowers&title=Loss+of+response+to+anti-TNF+treatments+in+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: loss of response to anti-TNF treatments in Crohn's disease</span></div><div class="casAuthors">Ben-Horin, S.; Chowers, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">987-995</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Background Loss of response to anti-TNF agents in Crohn's disease is an emerging clin. problem.  Aim To review the causes, incidence and management approach of loss of response.  Methods A search of medical database (PubMed) and of meetings' proceedings for definitions, causes and incidence of loss of response was carried out.  Personal correspondence with principal investigators was conducted to retrieve missing data.  Results Various definitions of loss of response abound, hampering the ability to assess accurately the magnitude and management of this clin. problem.  We propose to distinguish between a clin. worsening on anti-TNF treatment and a true loss of response to anti-TNFs.  Accordingly, loss of response to anti-TNFs at 12 mo of therapy occurs in 23-46% of patients when judged by dose intensification, or 5-13% when gauged by drug discontinuation rates.  The management of loss of response should allow for a period of watchful waiting as quite often the patients' symptoms may resolve without alteration of therapy.  If they do not, then identifying the correct mechanism responsible for clin. deterioration is prudent.  Once symptoms are ascertained to arise from inflammatory IBD activity, drug level and antidrug antibody measurement can then help distinguish between non-adherence to therapy, immunogenicity and non-immune clearance of anti-TNF, or an un-chequered inflammation despite adequate anti-TNF levels.  The latter finding may be best addressed by a switch to another class of immunomodulators, whereas a low drug level should probably be managed by dose intensification or a switch to another anti-TNF.  Conclusion Studies defining how best to translate drug-level monitoring and other mechanistic considerations into clin. decisions are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhW9G6jVZHHLVg90H21EOLACvtfcHk0li4yZZldmnugw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtF2gurc%253D&md5=35841a6f9be42de4905bbe9db9e140cb</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2011.04612.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2011.04612.x%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Horin%26aufirst%3DS.%26aulast%3DChowers%26aufirst%3DY.%26atitle%3DLoss%2520of%2520response%2520to%2520anti-TNF%2520treatments%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D33%26spage%3D987%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bernstein, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wajda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. F.</span><span> </span><span class="NLM_article-title">The clustering of other chronic inflammatory disease in inflammatory bowel disease: a population-based study</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2005&pages=827-836&author=C.+N.+Bernsteinauthor=A.+Wajdaauthor=J.+F.+Blanchard&title=The+clustering+of+other+chronic+inflammatory+disease+in+inflammatory+bowel+disease%3A+a+population-based+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DC.%2BN.%26aulast%3DWajda%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520clustering%2520of%2520other%2520chronic%2520inflammatory%2520disease%2520in%2520inflammatory%2520bowel%2520disease%253A%2520a%2520population-based%2520study%26jtitle%3DGastroenterology%26date%3D2005%26volume%3D129%26spage%3D827%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">de Mesquita, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henckaerts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaessens, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hlavaty, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuerbeek, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assche, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, I.</span><span> </span><span class="NLM_article-title">Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease</span> <span class="citation_source-journal">Eur. J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1007%2Fs00431-008-0798-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18670786" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2009&pages=575-583&author=M.+B.+de+Mesquitaauthor=M.+Ferranteauthor=L.+Henckaertsauthor=M.+Joossensauthor=V.+Jaessensauthor=T.+Hlavatyauthor=M.+Pierikauthor=S.+Joossensauthor=M.+V.+Schuerbeekauthor=G.+V.+Asscheauthor=P.+Rutgeertsauthor=S.+Vermeireauthor=I.+Hoffman&title=Clustering+of+%28auto%29immune+diseases+with+early-onset+and+complicated+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1007%2Fs00431-008-0798-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00431-008-0798-7%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMesquita%26aufirst%3DM.%2BB.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DHenckaerts%26aufirst%3DL.%26aulast%3DJoossens%26aufirst%3DM.%26aulast%3DJaessens%26aufirst%3DV.%26aulast%3DHlavaty%26aufirst%3DT.%26aulast%3DPierik%26aufirst%3DM.%26aulast%3DJoossens%26aufirst%3DS.%26aulast%3DSchuerbeek%26aufirst%3DM.%2BV.%26aulast%3DAssche%26aufirst%3DG.%2BV.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DI.%26atitle%3DClustering%2520of%2520%2528auto%2529immune%2520diseases%2520with%2520early-onset%2520and%2520complicated%2520inflammatory%2520bowel%2520disease%26jtitle%3DEur.%2520J.%2520Pediatr.%26date%3D2009%26volume%3D168%26spage%3D575%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ellinghaus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellinghaus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metspalu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debrus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raelson, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejasvi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balschun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabesch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembath, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecasis, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichenthal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nothnagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, A.</span><span> </span><span class="NLM_article-title">Combined analysis of genome-wide association studies for Crohn’s disease and psoriasis identifies seven shared susceptibility loci</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.ajhg.2012.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=22482804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFCrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=636-645&author=D.+Ellinghausauthor=E.+Ellinghausauthor=R.+P.+Nairauthor=P.+E.+Stuartauthor=T.+Eskoauthor=A.+Metspaluauthor=S.+Debrusauthor=J.+V.+Raelsonauthor=T.+Tejasviauthor=M.+Belouchiauthor=S.+L.+Westauthor=J.+N.+Barkerauthor=S.+Koksauthor=K.+Kingoauthor=T.+Balschunauthor=O.+Palmieriauthor=V.+Anneseauthor=C.+Giegerauthor=H.+E.+Wichmannauthor=M.+Kabeschauthor=R.+C.+Trembathauthor=C.+G.+Mathewauthor=G.+R.+Abecasisauthor=S.+Weidingerauthor=S.+Nikolausauthor=S.+Schreiberauthor=J.+T.+Elderauthor=M.+Weichenthalauthor=M.+Nothnagelauthor=A.+Franke&title=Combined+analysis+of+genome-wide+association+studies+for+Crohn%E2%80%99s+disease+and+psoriasis+identifies+seven+shared+susceptibility+loci"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci</span></div><div class="casAuthors">Ellinghaus, David; Ellinghaus, Eva; Nair, Rajan P.; Stuart, Philip E.; Esko, Tonu; Metspalu, Andres; Debrus, Sophie; Raelson, John V.; Tejasvi, Trilokraj; Belouchi, Majid; West, Sarah L.; Barker, Jonathan N.; Koks, Sulev; Kingo, Kuelli; Balschun, Tobias; Palmieri, Orazio; Annese, Vito; Gieger, Christian; Wichmann, H. Erich; Kabesch, Michael; Trembath, Richard C.; Mathew, Christopher G.; Abecasis, Goncalo R.; Weidinger, Stephan; Nikolaus, Susanna; Schreiber, Stefan; Elder, James T.; Weichenthal, Michael; Nothnagel, Michael; Franke, Andre</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-647</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Psoriasis (PS) and Crohn disease (CD) have been shown to be epidemiol., pathol., and therapeutically connected, but little is known about their shared genetic causes.  We performed meta-analyses of five published genome-wide assocn. studies on PS (2,529 cases and 4,955 controls) and CD (2,142 cases and 5,505 controls), followed up 20 loci that showed strongest evidence for shared disease assocn. and, furthermore, tested cross-disease assocns. for previously reported PS and CD risk alleles in addnl. 6,115 PS cases, 4,073 CD cases, and 10,100 controls.  We identified seven susceptibility loci outside the human leukocyte antigen region (9p24 near JAK2, 10q22 at ZMIZ1, 11q13 near PRDX5, 16p13 near SOCS1, 17q21 at STAT3, 19p13 near FUT2, and 22q11 at YDJC) shared between PS and CD with genome-wide significance (p < 5 × 10-8) and confirmed four already established PS and CD risk loci (IL23R, IL12B, REL, and TYK2).  Three of the shared loci are also genome-wide significantly assocd. with PS alone (10q22 at ZMIZ1, prs1250544 = 3.53 × 10-8, 11q13 near PRDX5, prs694739 = 3.71 × 10-09, 22q11 at YDJC, prs181359 = 8.02 × 10-10).  In addn., we identified one susceptibility locus for CD (16p13 near SOCS1, prs4780355 = 4.99 × 10-8).  Refinement of assocn. signals identified shared genome-wide significant assocns. for exonic SNPs at 10q22 (ZMIZ1) and in silico expression quant. trait locus analyses revealed that the assocns. at ZMIZ1 and near SOCS1 have a potential functional effect on gene expression.  Our results show the usefulness of joint analyses of clin. distinct immune-mediated diseases and enlarge the map of shared genetic risk loci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-JSPvqV1dZLVg90H21EOLACvtfcHk0ljKTGu_y3iyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFCrsr4%253D&md5=0169f350017714242399f503a1791640</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2012.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2012.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DEllinghaus%26aufirst%3DD.%26aulast%3DEllinghaus%26aufirst%3DE.%26aulast%3DNair%26aufirst%3DR.%2BP.%26aulast%3DStuart%26aufirst%3DP.%2BE.%26aulast%3DEsko%26aufirst%3DT.%26aulast%3DMetspalu%26aufirst%3DA.%26aulast%3DDebrus%26aufirst%3DS.%26aulast%3DRaelson%26aufirst%3DJ.%2BV.%26aulast%3DTejasvi%26aufirst%3DT.%26aulast%3DBelouchi%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%2BL.%26aulast%3DBarker%26aufirst%3DJ.%2BN.%26aulast%3DKoks%26aufirst%3DS.%26aulast%3DKingo%26aufirst%3DK.%26aulast%3DBalschun%26aufirst%3DT.%26aulast%3DPalmieri%26aufirst%3DO.%26aulast%3DAnnese%26aufirst%3DV.%26aulast%3DGieger%26aufirst%3DC.%26aulast%3DWichmann%26aufirst%3DH.%2BE.%26aulast%3DKabesch%26aufirst%3DM.%26aulast%3DTrembath%26aufirst%3DR.%2BC.%26aulast%3DMathew%26aufirst%3DC.%2BG.%26aulast%3DAbecasis%26aufirst%3DG.%2BR.%26aulast%3DWeidinger%26aufirst%3DS.%26aulast%3DNikolaus%26aufirst%3DS.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DElder%26aufirst%3DJ.%2BT.%26aulast%3DWeichenthal%26aufirst%3DM.%26aulast%3DNothnagel%26aufirst%3DM.%26aulast%3DFranke%26aufirst%3DA.%26atitle%3DCombined%2520analysis%2520of%2520genome-wide%2520association%2520studies%2520for%2520Crohn%25E2%2580%2599s%2520disease%2520and%2520psoriasis%2520identifies%2520seven%2520shared%2520susceptibility%2520loci%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2012%26volume%3D90%26spage%3D636%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lees, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satsangi, J.</span><span> </span><span class="NLM_article-title">New IBD genetics: common pathways with other diseases</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1739-1753&author=C.+W.+Leesauthor=J.+C.+Barrettauthor=M.+Parkesauthor=J.+Satsangi&title=New+IBD+genetics%3A+common+pathways+with+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DC.%2BW.%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DParkes%26aufirst%3DM.%26aulast%3DSatsangi%26aufirst%3DJ.%26atitle%3DNew%2520IBD%2520genetics%253A%2520common%2520pathways%2520with%2520other%2520diseases%26jtitle%3DGut%26date%3D2011%26volume%3D60%26spage%3D1739%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, B.</span><span> </span><span class="NLM_article-title">Innate immunity in the pathogenesis of psoriasis</span> <span class="citation_source-journal">Arch. Dermatol. Res</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1007%2Fs00403-011-1169-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21863252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFantbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2011&pages=691-705&author=C.+Sweeneyauthor=A.-M.+Tobinauthor=B.+Kirby&title=Innate+immunity+in+the+pathogenesis+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immunity in the pathogenesis of psoriasis</span></div><div class="casAuthors">Sweeney, Cheryl M.; Tobin, Ann-Marie; Kirby, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">691-705</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Psoriasis is a common, immune-mediated inflammatory skin disorder.  T helper(h)1 and Th17 lymphocytes contribute to the pathogenesis of psoriasis through the release of inflammatory cytokines that promote further recruitment of immune cells, keratinocyte proliferation and sustained inflammation.  The innate immune system is the first line of defense against infection and plays a crucial role in the initiation of the adaptive immune response.  The presence of innate immune cells and their products in psoriatic skin plaques suggests a role for innate immunity in this disease.  In addn., the innate immune system can direct the development of pathogenic Th cells in psoriasis.  In this article, we will summarize the role of the innate immune system in psoriasis with particular emphasis on the role of cytokines, signaling pathways and cells of the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSeJoKa9Zfw7Vg90H21EOLACvtfcHk0ljKTGu_y3iyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFantbvN&md5=1d9a37fa3d9027569f420f7370889dcf</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1007%2Fs00403-011-1169-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00403-011-1169-1%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DTobin%26aufirst%3DA.-M.%26aulast%3DKirby%26aufirst%3DB.%26atitle%3DInnate%2520immunity%2520in%2520the%2520pathogenesis%2520of%2520psoriasis%26jtitle%3DArch.%2520Dermatol.%2520Res%26date%3D2011%26volume%3D303%26spage%3D691%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monteleone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, T.</span><span> </span><span class="NLM_article-title">Emerging immunological targets in inflammatory bowel disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.coph.2011.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=22000933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=640-645&author=G.+Monteleoneauthor=F.+Palloneauthor=T.+MacDonald&title=Emerging+immunological+targets+in+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging immunological targets in inflammatory bowel disease</span></div><div class="casAuthors">Monteleone, Giovanni; Pallone, Francesco; MacDonald, Thomas T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">640-645</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Crohn's disease (CD) and ulcerative colitis (UC) are the major forms of inflammatory bowel diseases (IBD) in man.  They are caused by damage to the lining of the intestine and deeper layers, due to an excessive immune response directed against components of the gut microflora and poorly controlled by counter-regulatory mechanisms.  CD and UC are however immunol. distinct.  CD-related inflammation is characterized by a marked mucosal infiltration of T lymphocytes secreting T helper type (Th) 1 and Th17 cytokines.  In UC, the local immune response is less polarized but may show enhanced prodn. of IL-5, IL-13 and Th17 cytokines.  Downstream however CD and UC share important end-stage effector pathways of intestinal injury, mediated by an active cross-talk between immune and non-immune cells.  The clarification of the complex networks of immune-inflammatory mediators operating in the gut of IBD patients has led to the identification of new targets that should facilitate the development of novel biol. therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0xg_FG-l1wrVg90H21EOLACvtfcHk0lgLmD2v49Tx4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbfN&md5=13fb9f263a05d63c52308943417ed3cb</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DMonteleone%26aufirst%3DG.%26aulast%3DPallone%26aufirst%3DF.%26aulast%3DMacDonald%26aufirst%3DT.%26atitle%3DEmerging%2520immunological%2520targets%2520in%2520inflammatory%2520bowel%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D640%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mucida, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheroutre, H.</span><span> </span><span class="NLM_article-title">The many face-lifts of CD4 T helper cells</span> <span class="citation_source-journal">Adv. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=139-152&author=D.+Mucidaauthor=H.+Cheroutre&title=The+many+face-lifts+of+CD4+T+helper+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMucida%26aufirst%3DD.%26aulast%3DCheroutre%26aufirst%3DH.%26atitle%3DThe%2520many%2520face-lifts%2520of%2520CD4%2520T%2520helper%2520cells%26jtitle%3DAdv.%2520Immunol.%26date%3D2010%26volume%3D107%26spage%3D139%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Garra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D.</span><span> </span><span class="NLM_article-title">Development and function of T-helper 1 cells</span> <span class="citation_source-journal">Adv. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2004&pages=133-162&author=A.+O%E2%80%99Garraauthor=D.+Robinson&title=Development+and+function+of+T-helper+1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Garra%26aufirst%3DA.%26aulast%3DRobinson%26aufirst%3DD.%26atitle%3DDevelopment%2520and%2520function%2520of%2520T-helper%25201%2520cells%26jtitle%3DAdv.%2520Immunol.%26date%3D2004%26volume%3D83%26spage%3D133%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Murphy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiner, S.</span><span> </span><span class="NLM_article-title">The lineage decisions of helper T cells</span> <span class="citation_source-journal">Nat. Rev. Immunol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fnri954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=12461566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFKnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=933-944&author=K.+M.+Murphyauthor=S.+Reiner&title=The+lineage+decisions+of+helper+T+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The lineage decisions of helper T cells</span></div><div class="casAuthors">Murphy, Kenneth M.; Reiner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">933-944</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  After encountering antigen, helper T (TH) cells undergo differentiation to effector cells, which can secrete high levels of interferon-γ, interleukin-4 (IL-4), IL-10 and other immunomodulators.  How TH cells acquire, and remember, new patterns of gene expression is an area of intensive investigation.  The process is remarkably plastic, with cytokines being key regulators.  Extrinsic signals seem to be integrated into cell-intrinsic programming, in what is becoming an intriguing story of regulated development.  The authors summarize the latest insights into mechanisms that govern the lineage choices that are made during TH-cell responses to foreign pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGW2uqaEevbVg90H21EOLACvtfcHk0lgLmD2v49Tx4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFKnu7g%253D&md5=877fad48cff0be1506229d7934c12955</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fnri954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri954%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DK.%2BM.%26aulast%3DReiner%26aufirst%3DS.%26atitle%3DThe%2520lineage%2520decisions%2520of%2520helper%2520T%2520cells%26jtitle%3DNat.%2520Rev.%2520Immunol%26date%3D2002%26volume%3D2%26spage%3D933%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Skokos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waite, J. C.</span><span> </span><span class="NLM_article-title">Th17 response and inflammatory autoimmune diseases</span> <span class="citation_source-journal">Int. J. Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">819467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=819467&author=D.+Skokosauthor=J.+C.+Waite&title=Th17+response+and+inflammatory+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 response and inflammatory autoimmune diseases</span></div><div class="casAuthors">Waite, Janelle C.; Skokos, Dimitris</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Inflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">819467, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJINDV</span>;
        ISSN:<span class="NLM_cas:issn">2042-0099</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  The proinflammatory activity of T helper 17 (Th17) cells can be beneficial to the host during infection.  However, uncontrolled or inappropriate Th17 activation has been linked to several autoimmune and autoinflammatory pathologies.  Indeed, preclin. and clin. data show that Th17 cells are assocd. with several autoimmune diseases such as arthritis, multiple sclerosis, psoriasis, and lupus.  Furthermore, targeting the interleukin-17 (IL-17) pathway has attenuated disease severity in preclin. models of autoimmune diseases.  Interestingly, a recent report brings to light a potential role for Th17 cells in the autoinflammatory disorder adult-onset Still's disease (AOSD).  Whether Th17 cells are the cause or are directly involved in AOSD remains to be shown.  In this paper, we discuss the biol. of Th17 cells, their role in autoimmune disease development, and in AOSD in particular, as well as the growing interest of the pharmaceutical industry in their use as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonoZYU0uSmLrVg90H21EOLACvtfcHk0lgLmD2v49Tx4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaksbs%253D&md5=1c697669aafb3d8f90b35e8cd0a31993</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkokos%26aufirst%3DD.%26aulast%3DWaite%26aufirst%3DJ.%2BC.%26atitle%3DTh17%2520response%2520and%2520inflammatory%2520autoimmune%2520diseases%26jtitle%3DInt.%2520J.%2520Inflammation%26date%3D2012%26spage%3D819467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Miossec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuchroo, V. K.</span><span> </span><span class="NLM_article-title">Interleukin-17 and type 17 helper cells</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMra0707449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19710487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=888-898&author=P.+Miossecauthor=T.+Kornauthor=V.+K.+Kuchroo&title=Interleukin-17+and+type+17+helper+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: interleukin-17 and type 17 helper T cells</span></div><div class="casAuthors">Miossec, Pierre; Korn, Thomas; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">888-898</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses interleukin-17, Th17 type cell differentiation, and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-E1d7Mv0fFLVg90H21EOLACvtfcHk0lh_sR6mlM0lXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhtLrP&md5=aeab15ba0bfd6ad228782a8aa51fe2d8</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0707449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0707449%26sid%3Dliteratum%253Aachs%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DInterleukin-17%2520and%2520type%252017%2520helper%2520cells%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D888%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Louten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malefyt, R. d. W.</span><span> </span><span class="NLM_article-title">Development and function of Th17 cells in health and disease</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.jaci.2009.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19410689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlyitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=1004-1011&author=J.+Loutenauthor=K.+Bonifaceauthor=R.+d.+W.+Malefyt&title=Development+and+function+of+Th17+cells+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Development and function of TH17 cells in health and disease</span></div><div class="casAuthors">Louten, Jennifer; Boniface, Katia; de Waal Malefyt, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1004-1011</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  TH17 cells are the newest member of the TH cell family and are characterized by their ability to produce specific cytokines such as IL-17, IL-22, IL-17F, and CCL20.  In this review, conditions for the differentiation of TH17 cells are defined in both murine and human systems, with discussion of TH17-specific cytokines and transcription factors.  Functionally, TH17 cells contribute to host defense as a new effector TH cell subset with a role in protection against extracellular bacteria through activities on immune and nonimmune cells.  Their activities, however, are also pivotal in the development of autoimmune diseases under pathol. conditions.  TH17 cells are also beginning to be assocd. with the development and pathophysiol. of allergic diseases, such as allergic contact dermatitis, atopic dermatitis, and asthma.  Lymphoid tissue inducer-like cells and natural killer-like cells, termed RORγt+NKp46+ or NK-22 cells, might also play a role in allergic diseases because of their propensity to produce IL-17 and IL-22.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy2s99FUQKLbVg90H21EOLACvtfcHk0lh_sR6mlM0lXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlyitLw%253D&md5=5160c6ebef97b46a7e6d21bf95344968</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2009.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2009.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DLouten%26aufirst%3DJ.%26aulast%3DBoniface%26aufirst%3DK.%26aulast%3DMalefyt%26aufirst%3DR.%2Bd.%2BW.%26atitle%3DDevelopment%2520and%2520function%2520of%2520Th17%2520cells%2520in%2520health%2520and%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2009%26volume%3D123%26spage%3D1004%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boniface, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleft, R. d. W.</span><span> </span><span class="NLM_article-title">From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1600-065X.2008.00714.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19161421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2008&pages=132-146&author=K.+Bonifaceauthor=B.+Blomauthor=Y.-J.+Liuauthor=R.+d.+W.+Maleft&title=From+interleukin-23+to+T-helper+17+cells%3A+human+T-helper+cell+differentiation+revisited"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited</span></div><div class="casAuthors">Boniface, Katia; Blom, Bianca; Liu, Yong-Jun; de Waal Malefyt, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-146</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protracted inflammation leading to dysregulation of effector T-cell responses represents a common feature of a wide range of autoimmune diseases.  The interleukin-12 (IL-12)/T-helper 1 (Th1) pathway was thought to be responsible for the pathogenesis of multiple chronic inflammatory diseases, including psoriasis, inflammatory bowel disease, arthritis, or multiple sclerosis, mainly through their prodn. of interferon-γ and its effects on macrophage activation and chemokine prodn.  However, this initial concept of T-cell-mediated chronic inflammation required an adjustment with the discovery of an IL-12-related cytokine, designated IL-23.  IL-23 was rapidly recognized for its involvement in the establishment of chronic inflammation and in the development of a Th cell subset producing IL-17, designated Th17, which is distinct from the previously reported Th1 and Th2 populations.  This review aims to describe the characterization of IL-23 and its receptor, its biol. activities, as well as its involvement in the development of human Th17 cells and autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGxsSHrkO_CbVg90H21EOLACvtfcHk0lh_sR6mlM0lXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls77E&md5=1c74afb324f0d76b1f8c314616971e32</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00714.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00714.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoniface%26aufirst%3DK.%26aulast%3DBlom%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DMaleft%26aufirst%3DR.%2Bd.%2BW.%26atitle%3DFrom%2520interleukin-23%2520to%2520T-helper%252017%2520cells%253A%2520human%2520T-helper%2520cell%2520differentiation%2520revisited%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D226%26spage%3D132%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Trinchieri, G.</span><span> </span><span class="NLM_article-title">Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1146%2Fannurev.iy.13.040195.001343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=7612223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK2MXltFamtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1995&pages=251-276&author=G.+Trinchieri&title=Interleukin-12%3A+a+proinflammatory+cytokine+with+immunoregulatory+functions+that+bridge+innate+resistance+and+antigen-specific+adaptive+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity</span></div><div class="casAuthors">Trinchieri, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">251-76</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 97 refs.  Interleukin-12 (IL-12) is a heterodimeric cytokine produced mostly by phagocytic cells and to some degree by B lymphocytes.  IL-12 induces cytokine prodn., acts as a growth factor for activated NK and T cells, enhances the cytotoxic activity of NK cells, and favors cytotoxic T lymphocyte generation.  In vivo IL-12 acts primarily at 3 stages during the innate resistance/adaptive immune response to infection:.  1. Early in the infection, IL-12 is produced and induces prodn. from NK and T cells of IFN-γ, which contributes to phagocytic cell activation and inflammation; 2. IL-12 and IL-12-induced IFN-γ favor Th1 cell differentiation by priming CD4+ T cells for high IFN-γ prodn.; and 3. IL-12 contributes to optimal IFN-γ prodn. and to proliferation of differentiated Th1 cells in response to antigen.  The early preference expressed in the immune response depends on the balance between IL-12, which favors Th1 responses, and IL-4, which favors Th2 responses.  Thus, IL-12 represents a functional bridge between the early nonspecific innate resistance and the subsequent antigen-specific adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo96uU3A_QjDbVg90H21EOLACvtfcHk0lh_sR6mlM0lXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltFamtbg%253D&md5=0d1cc60a810592ecb7efce6ea9f98092</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.iy.13.040195.001343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.iy.13.040195.001343%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchieri%26aufirst%3DG.%26atitle%3DInterleukin-12%253A%2520a%2520proinflammatory%2520cytokine%2520with%2520immunoregulatory%2520functions%2520that%2520bridge%2520innate%2520resistance%2520and%2520antigen-specific%2520adaptive%2520immunity%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1995%26volume%3D13%26spage%3D251%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C.</span><span> </span><span class="NLM_article-title">Don’t leave home without it: the IL-23 visa to Th17 cells</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fni0309-236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19221553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFKjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=236-238&author=Y.+Chungauthor=C.+Dong&title=Don%E2%80%99t+leave+home+without+it%3A+the+IL-23+visa+to+Th17+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Don't leave home without it: the IL-23 visa to TH-17 cells</span></div><div class="casAuthors">Chung, Yeonseok; Dong, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">236-238</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interleukin 23 is tightly assocd. with TH-17 cell-mediated inflammation and autoimmunity.  A new study of mice deficient in its receptor shows that interleukin 23 is required for the terminal differentiation of TH-17 cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNeQ--WiJrULVg90H21EOLACvtfcHk0lgbg6lhfErXDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFKjsbo%253D&md5=b1aad75f9637c462409b91f7bd967f57</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fni0309-236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni0309-236%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DDon%25E2%2580%2599t%2520leave%2520home%2520without%2520it%253A%2520the%2520IL-23%2520visa%2520to%2520Th17%2520cells%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26spage%3D236%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chua, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chizzonite, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrier, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, U.</span><span> </span><span class="NLM_article-title">Expression cloning of a human IL-12 receptor component</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=128-136&author=A.+O.+Chuaauthor=R.+Chizzoniteauthor=B.+B.+Desaiauthor=T.+P.+Truittauthor=P.+Nunesauthor=L.+J.+Minettiauthor=R.+R.+Warrierauthor=D.+H.+Preskyauthor=J.+F.+Levineauthor=M.+K.+Gatelyauthor=U.+Gubler&title=Expression+cloning+of+a+human+IL-12+receptor+component"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DA.%2BO.%26aulast%3DChizzonite%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DB.%2BB.%26aulast%3DTruitt%26aufirst%3DT.%2BP.%26aulast%3DNunes%26aufirst%3DP.%26aulast%3DMinetti%26aufirst%3DL.%2BJ.%26aulast%3DWarrier%26aufirst%3DR.%2BR.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DLevine%26aufirst%3DJ.%2BF.%26aulast%3DGately%26aufirst%3DM.%2BK.%26aulast%3DGubler%26aufirst%3DU.%26atitle%3DExpression%2520cloning%2520of%2520a%2520human%2520IL-12%2520receptor%2520component%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabavi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, U.</span><span> </span><span class="NLM_article-title">A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">14002</span><span class="NLM_x">–</span> <span class="NLM_lpage">14007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=14002-14007&author=D.+H.+Preskyauthor=H.+Yangauthor=L.+J.+Minettiauthor=A.+O.+Chuaauthor=N.+Nabaviauthor=C.-Y.+Wuauthor=M.+K.+Gatelyauthor=U.+Gubler&title=A+functional+interleukin+12+receptor+complex+is+composed+of+two+%CE%B2-type+cytokine+receptor+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DMinetti%26aufirst%3DL.%2BJ.%26aulast%3DChua%26aufirst%3DA.%2BO.%26aulast%3DNabavi%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DC.-Y.%26aulast%3DGately%26aufirst%3DM.%2BK.%26aulast%3DGubler%26aufirst%3DU.%26atitle%3DA%2520functional%2520interleukin%252012%2520receptor%2520complex%2520is%2520composed%2520of%2520two%2520%25CE%25B2-type%2520cytokine%2520receptor%2520subunits%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D14002%26epage%3D14007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Parham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirica, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflanz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Farrell, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClanahan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurawski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastlein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleft, R. d. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. W.</span><span> </span><span class="NLM_article-title">A receptor for the heterodimeric cytokine IL-23 is composed of IL-12β1 and a novel cytokine receptor subunit, IL-23R</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">5699</span><span class="NLM_x">–</span> <span class="NLM_lpage">5708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=5699-5708&author=C.+Parhamauthor=M.+Chiricaauthor=J.+Timansauthor=E.+Vaisbergauthor=M.+Travisauthor=J.+Cheungauthor=S.+Pflanzauthor=R.+Zhangauthor=K.+Singhauthor=F.+Vegaauthor=W.+Toauthor=J.+Wagnerauthor=A.-M.+O%E2%80%99Farrellauthor=T.+McClanahanauthor=S.+Zurawskiauthor=C.+Hannumauthor=D.+Gormanauthor=D.+Rennickauthor=R.+A.+Kastleinauthor=R.+d.+W.+Maleftauthor=K.+W.+Moore&title=A+receptor+for+the+heterodimeric+cytokine+IL-23+is+composed+of+IL-12%CE%B21+and+a+novel+cytokine+receptor+subunit%2C+IL-23R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParham%26aufirst%3DC.%26aulast%3DChirica%26aufirst%3DM.%26aulast%3DTimans%26aufirst%3DJ.%26aulast%3DVaisberg%26aufirst%3DE.%26aulast%3DTravis%26aufirst%3DM.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DPflanz%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DVega%26aufirst%3DF.%26aulast%3DTo%26aufirst%3DW.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DA.-M.%26aulast%3DMcClanahan%26aufirst%3DT.%26aulast%3DZurawski%26aufirst%3DS.%26aulast%3DHannum%26aufirst%3DC.%26aulast%3DGorman%26aufirst%3DD.%26aulast%3DRennick%26aufirst%3DD.%26aulast%3DKastlein%26aufirst%3DR.%2BA.%26aulast%3DMaleft%26aufirst%3DR.%2Bd.%2BW.%26aulast%3DMoore%26aufirst%3DK.%2BW.%26atitle%3DA%2520receptor%2520for%2520the%2520heterodimeric%2520cytokine%2520IL-23%2520is%2520composed%2520of%2520IL-12%25CE%25B21%2520and%2520a%2520novel%2520cytokine%2520receptor%2520subunit%252C%2520IL-23R%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D5699%26epage%3D5708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Firmbach-Kraft, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shows, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalla-Favera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolewski, J. J.</span><span> </span><span class="NLM_article-title">TYK2, prototype of a novel class of non-receptor tyrosine kinase genes</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=2216457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1990&pages=1329-1336&author=I.+Firmbach-Kraftauthor=M.+Byersauthor=T.+Showsauthor=R.+Dalla-Faveraauthor=J.+J.+Krolewski&title=TYK2%2C+prototype+of+a+novel+class+of+non-receptor+tyrosine+kinase+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">tyk2, Prototype of a novel class of non-receptor tyrosine kinase genes</span></div><div class="casAuthors">Firmbach-Kraft, Iris; Byers, Mary; Shows, Thomas; Dalla-Favera, Riccardo; Krolewski, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1329-36</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">The authors previously identified a novel protein tyrosine kinase gene, tyk2, by screening a human lymphoid cDNA library with a tyrosine kinase domain specific c-fms restriction fragment under low stringency hybridization conditions.  They now isolated and sequenced a full length tyk2 cDNA clone; demonstrated that this gene is widely expressed in hematopoietic and non-hematopoietic cell lines; and mapped it to chromosome 19p13.2.  The cDNA clone is 4176 nucleotides long and codes for a putative protein with a mol. wt. of 134 kilodaltons.  Hydrophobicity anal. of the sequence does not identify a transmembrane domain, which is found in all members of the receptor class of protein tyrosine kinases; nor can the authors detect an SH2 domain, found in all previously identified non-receptor protein kinases.  They propose that tyk2 is the prototype of a new class of non-receptor protein tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhLoFCW2FDWrVg90H21EOLACvtfcHk0lgbg6lhfErXDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyjuro%253D&md5=c7a4180a140f0bcdc98140a265fb4cb4</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFirmbach-Kraft%26aufirst%3DI.%26aulast%3DByers%26aufirst%3DM.%26aulast%3DShows%26aufirst%3DT.%26aulast%3DDalla-Favera%26aufirst%3DR.%26aulast%3DKrolewski%26aufirst%3DJ.%2BJ.%26atitle%3DTYK2%252C%2520prototype%2520of%2520a%2520novel%2520class%2520of%2520non-receptor%2520tyrosine%2520kinase%2520genes%26jtitle%3DOncogene%26date%3D1990%26volume%3D5%26spage%3D1329%26epage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, U.</span><span> </span><span class="NLM_article-title">Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and β2 and JAK kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">6073</span><span class="NLM_x">–</span> <span class="NLM_lpage">6077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=6073-6077&author=J.+Zouauthor=D.+H.+Preskyauthor=C.-Y.+Wuauthor=U.+Gubler&title=Differential+associations+between+the+cytoplasmic+regions+of+the+interleukin-12+receptor+subunits+%CE%B21+and+%CE%B22+and+JAK+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DWu%26aufirst%3DC.-Y.%26aulast%3DGubler%26aufirst%3DU.%26atitle%3DDifferential%2520associations%2520between%2520the%2520cytoplasmic%2520regions%2520of%2520the%2520interleukin-12%2520receptor%2520subunits%2520%25CE%25B21%2520and%2520%25CE%25B22%2520and%2520JAK%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D6073%26epage%3D6077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Harpur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemiecki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">JAK2, a third member of the JAK family of protein tyrosine kinases</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=1620548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK38XmtVOrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1992&pages=1347-1353&author=A.+G.+Harpurauthor=A.+C.+Andresauthor=A.+Ziemieckiauthor=R.+R.+Astonauthor=A.+F.+Wilks&title=JAK2%2C+a+third+member+of+the+JAK+family+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">JAK2, a third member of the JAK family of protein tyrosine kinases</span></div><div class="casAuthors">Harpur, Ailsa G.; Andres, Anne Catherine; Ziemiecki, Andrew; Aston, Raja R.; Wilks, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1347-53</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">CDNA clones encoding a third, widely expressed, member of the JAK family of protein tyrosine kinases (PTKs) were isolated.  The anticipated amino acid sequence of JAK2 predicts the presence of two kinase-related domains, a feature characteristic of this family of PTKs.  The structural similarity of JAK2 to the other members of this family extends towards their N-termini, beyond the two kinase-related domains, and reveals five further domains of substantial amino acid similarity.  The C-terminal portion of one of these domains, the JH4 domain, bears an intriguing, albeit tenuous, similarity to the core element of the SH2 domain, whereas the remaining JAK homol. domains do not appear to be a feature of other known proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquGgx2uwGEN7Vg90H21EOLACvtfcHk0lhNb3-sf1b7jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmtVOrtLc%253D&md5=db385133406115942157615e9c56b47f</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarpur%26aufirst%3DA.%2BG.%26aulast%3DAndres%26aufirst%3DA.%2BC.%26aulast%3DZiemiecki%26aufirst%3DA.%26aulast%3DAston%26aufirst%3DR.%2BR.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DJAK2%252C%2520a%2520third%2520member%2520of%2520the%2520JAK%2520family%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DOncogene%26date%3D1992%26volume%3D7%26spage%3D1347%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyasaka, N.</span><span> </span><span class="NLM_article-title">Physical interaction between interleukin-12 receptor β2 subunit and JAK2 tyrosine kinase: JAK2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor β2 via amino terminus</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1999&pages=400-404&author=K.+Yamamotoauthor=F.+Shibataauthor=O.+Miuraauthor=R.+Kamiyamaauthor=S.+Hirosawaauthor=N.+Miyasaka&title=Physical+interaction+between+interleukin-12+receptor+%CE%B22+subunit+and+JAK2+tyrosine+kinase%3A+JAK2+associates+with+cytoplasmic+membrane-proximal+region+of+interleukin-12+receptor+%CE%B22+via+amino+terminus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DF.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DKamiyama%26aufirst%3DR.%26aulast%3DHirosawa%26aufirst%3DS.%26aulast%3DMiyasaka%26aufirst%3DN.%26atitle%3DPhysical%2520interaction%2520between%2520interleukin-12%2520receptor%2520%25CE%25B22%2520subunit%2520and%2520JAK2%2520tyrosine%2520kinase%253A%2520JAK2%2520associates%2520with%2520cytoplasmic%2520membrane-proximal%2520region%2520of%2520interleukin-12%2520receptor%2520%25CE%25B22%2520via%2520amino%2520terminus%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D257%26spage%3D400%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurban, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemiecki, A.</span><span> </span><span class="NLM_article-title">Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2057</span><span class="NLM_x">–</span> <span class="NLM_lpage">2065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1128%2FMCB.11.4.2057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=1848670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK3MXlslyju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=2057-2065&author=A.+F.+Wilksauthor=A.+G.+Harpurauthor=R.+R.+Kurbanauthor=S.+J.+Ralphauthor=G.+Zurcherauthor=A.+Ziemiecki&title=Two+novel+protein-tyrosine+kinases%2C+each+with+a+second+phosphotransferase-related+catalytic+domain%2C+define+a+new+class+of+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase</span></div><div class="casAuthors">Wilks, Andrew F.; Harpur, Ailsa G.; Kurban, R. R.; Ralph, Stephen J.; Zuercher, Gisela; Ziemiecki, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2057-65</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The protein tyrosine kinases (PTKs) are a burgeoning family of proteins, each of which bears a conserved domain of 250-300 amino acids capable of phosphorylating substrate proteins on tyrosine residues.  Recently, the existence of 2 highly conserved sequence elements within the catalytic domain was exploited to generate PTK-specific degenerate oligonucleotide primers.  By application of the polymerase chain reaction, portions of the catalytic domains of several novel PTKs were amplified.  Here, the primary sequence is reported of one of these new PTKs, JAK1 (from Janus kinase), a member of a new class of PTK characterized by the presence of a 2nd phosphotransferase-related domain immediately N-terminal to the PTK domain.  The sequence was derived from the cDNA sequence of a human fibroblast clone.  The 2nd phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differed significantly from that of the PTK and threonine/serine kinase family members.  A 2nd member of this family (JAK2) was partially characterized and exhibited a similar array of kinase-related domains.  JAK1 is a large, widely expressed membrane-assocd. phosphoprotein of ∼130 kDa.  The PTK activity of JAK1 was located in the C-terminal PTK-like domain.  The role of the 2nd kinase-like domain is unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8XPv7ZSQ7kbVg90H21EOLACvtfcHk0lhNb3-sf1b7jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlslyju7s%253D&md5=7094cf98426dbe3ed5470ced76dc839b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FMCB.11.4.2057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.11.4.2057%26sid%3Dliteratum%253Aachs%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DHarpur%26aufirst%3DA.%2BG.%26aulast%3DKurban%26aufirst%3DR.%2BR.%26aulast%3DRalph%26aufirst%3DS.%2BJ.%26aulast%3DZurcher%26aufirst%3DG.%26aulast%3DZiemiecki%26aufirst%3DA.%26atitle%3DTwo%2520novel%2520protein-tyrosine%2520kinases%252C%2520each%2520with%2520a%2520second%2520phosphotransferase-related%2520catalytic%2520domain%252C%2520define%2520a%2520new%2520class%2520of%2520protein%2520kinase%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1991%26volume%3D11%26spage%3D2057%26epage%3D2065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. E.</span><span> </span><span class="NLM_article-title">JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2045</span><span class="NLM_x">–</span> <span class="NLM_lpage">2052</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=2045-2052&author=S.+G.+Raneauthor=P.+E.+Reddy&title=JAK3%3A+a+novel+JAK+kinase+associated+with+terminal+differentiation+of+hematopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DReddy%26aufirst%3DP.%2BE.%26atitle%3DJAK3%253A%2520a%2520novel%2520JAK%2520kinase%2520associated%2520with%2520terminal%2520differentiation%2520of%2520hematopoietic%2520cells%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D2045%26epage%3D2052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirasaw, T.</span><span> </span><span class="NLM_article-title">Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=1994&pages=124-128&author=T.+Takahashiauthor=T.+Shirasaw&title=Molecular+cloning+of+rat+JAK3%2C+a+novel+member+of+the+JAK+family+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DShirasaw%26aufirst%3DT.%26atitle%3DMolecular%2520cloning%2520of%2520rat%2520JAK3%252C%2520a%2520novel%2520member%2520of%2520the%2520JAK%2520family%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D342%26spage%3D124%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shaker, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moustafa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essmat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Halim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Komy, M.</span><span> </span><span class="NLM_article-title">The role of interleukin-12 in the pathogenesis of psoriasis</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.clinbiochem.2005.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16386240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsF2hs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=119-125&author=O.+G.+Shakerauthor=W.+Moustafaauthor=S.+Essmatauthor=M.+Abdel-Halimauthor=M.+El-Komy&title=The+role+of+interleukin-12+in+the+pathogenesis+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of interleukin-12 in the pathogenesis of psoriasis</span></div><div class="casAuthors">Shaker, Olfat G.; Moustafa, Wedad; Essmat, Samia; Abdel-Halim, Mona; El-Komy, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-125</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Objective was to verify the role of IL-12 in the pathogenesis of psoriasis and det. its relation to IFNγ.  Skin biopsies from lesional and non-lesional skin of 30 patients and 10 healthy controls were obtained for quant. PCR examn. of IL-12 (p40) and IFNγ mRNA as well as in situ PCR of IL-12 (p40) and IFNγ mRNA.  IL-12 and IFNγ levels were higher in lesional skin than in non-lesional and control skin.  A significant correlation between IL-12 and IFNγ was found.  By in situ PCR hybridization, IL-12 expression was only found in the dermis, while IFNγ was invariably expressed in the dermis and/or epidermis.  Apparently, IL-12 independently and through IFNγ induction may have a crucial role in the development of the active psoriatic lesion itself, where it is probably produced locally in the dermis as a step in the evolution of the psoriatic lesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquyM3Tk2T7aLVg90H21EOLACvtfcHk0lgSzk_yS1hwnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsF2hs7Y%253D&md5=21ea41d270ee47a8725b57a729953e18</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.clinbiochem.2005.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinbiochem.2005.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DO.%2BG.%26aulast%3DMoustafa%26aufirst%3DW.%26aulast%3DEssmat%26aufirst%3DS.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26aulast%3DEl-Komy%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520interleukin-12%2520in%2520the%2520pathogenesis%2520of%2520psoriasis%26jtitle%3DClin.%2520Biochem.%26date%3D2006%26volume%3D39%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Piskin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylva-Steenland, R. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teunissen, M. B. M.</span><span> </span><span class="NLM_article-title">In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="NLM_x">–</span> <span class="NLM_lpage">1915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1908-1915&author=G.+Piskinauthor=R.+M.+R.+Sylva-Steenlandauthor=J.+D.+Bosauthor=M.+B.+M.+Teunissen&title=In+vitro+and+in+situ+expression+of+IL-23+by+keratinocytes+in+healthy+skin+and+psoriasis+lesions%3A+enhanced+expression+in+psoriatic+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiskin%26aufirst%3DG.%26aulast%3DSylva-Steenland%26aufirst%3DR.%2BM.%2BR.%26aulast%3DBos%26aufirst%3DJ.%2BD.%26aulast%3DTeunissen%26aufirst%3DM.%2BB.%2BM.%26atitle%3DIn%2520vitro%2520and%2520in%2520situ%2520expression%2520of%2520IL-23%2520by%2520keratinocytes%2520in%2520healthy%2520skin%2520and%2520psoriasis%2520lesions%253A%2520enhanced%2520expression%2520in%2520psoriatic%2520skin%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D1908%26epage%3D1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepicchio, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oestreicher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhodapkar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Increased expression of interleukin 23p19 and p40 in lesional skin of patients with psoriasis vulgris</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2004&pages=125-130&author=E.+Leeauthor=W.+L.+Trepicchioauthor=J.+Oestreicherauthor=D.+Pittmanauthor=F.+Wangauthor=F.+Chamianauthor=M.+Dhodapkarauthor=J.+G.+Krueger&title=Increased+expression+of+interleukin+23p19+and+p40+in+lesional+skin+of+patients+with+psoriasis+vulgris"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DTrepicchio%26aufirst%3DW.%2BL.%26aulast%3DOestreicher%26aufirst%3DJ.%26aulast%3DPittman%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChamian%26aufirst%3DF.%26aulast%3DDhodapkar%26aufirst%3DM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DIncreased%2520expression%2520of%2520interleukin%252023p19%2520and%2520p40%2520in%2520lesional%2520skin%2520of%2520patients%2520with%2520psoriasis%2520vulgris%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2004%26volume%3D199%26spage%3D125%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yawalkar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braathen, L. R.</span><span> </span><span class="NLM_article-title">Expression of interleukin-12 is increased in psoriatic skin</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1998&pages=1053-1057&author=N.+Yawalkarauthor=S.+Karlenauthor=R.+Hungerauthor=C.+U.+Brandauthor=L.+R.+Braathen&title=Expression+of+interleukin-12+is+increased+in+psoriatic+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYawalkar%26aufirst%3DN.%26aulast%3DKarlen%26aufirst%3DS.%26aulast%3DHunger%26aufirst%3DR.%26aulast%3DBrand%26aufirst%3DC.%2BU.%26aulast%3DBraathen%26aufirst%3DL.%2BR.%26atitle%3DExpression%2520of%2520interleukin-12%2520is%2520increased%2520in%2520psoriatic%2520skin%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D1998%26volume%3D111%26spage%3D1053%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, K.</span><span> </span><span class="NLM_article-title">Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by cyclosprin A</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1365-2133.2006.07180.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16704652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVKkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2006&pages=1180-1183&author=Y.+Tadaauthor=A.+Asahinaauthor=T.+Takekoshiauthor=E.+Kishimotoauthor=H.+Mitsuiauthor=H.+Saekiauthor=M.+Komineauthor=K.+Tamaki&title=Interleukin+12+production+by+monocytes+from+patients+with+psoriasis+and+its+inhibition+by+cyclosprin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by ciclosporin A</span></div><div class="casAuthors">Tada, Y.; Asahina, A.; Takekoshi, T.; Kishimoto, E.; Mitsui, H.; Saeki, H.; Komine, M.; Tamaki, K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1180-1183</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: Psoriasis is a T-helper (Th)1 cytokine-mediated chronic skin disease and interleukin (IL)-12 has been shown to play a major role in the development of Th1 responses.  Objectives: To elucidate the role of IL-12 in the pathogenesis of psoriasis and to study the effect of ciclosporin A (CsA) on Th1 deviation of this disease.  Patients/Methods: We investigated IL-12 prodn. by stimulated monocytes from patients with psoriasis who were treated with or without CsA.  Monocytes were stimulated with interferon-γ plus lipopolysaccharide (LPS) or Staphylococcus aureus Cowan strain I (SAC).  The amt. of IL-12 p70 produced by stimulated monocytes was evaluated by ELISA.  Results: Compared with those from normal controls, LPS- but not SAC-stimulated monocytes from patients with psoriasis produced significantly higher amts. of IL-12.  Interestingly, LPS-stimulated monocytes from patients with psoriasis treated with CsA produced significantly decreased amts. of IL-12 compared with those patients not treated with CsA.  Conclusions: Our results suggest that IL-12 prodn. by monocytes may have a crit. role in the pathogenesis of psoriasis, and that the therapeutic effect of CsA on psoriasis may be achieved by correcting the deviation of the Th1/Th2 balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo83AaDnVThWrVg90H21EOLACvtfcHk0lgSzk_yS1hwnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVKkur8%253D&md5=9438f6f5abd41f6047f936a1f19c25f6</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2006.07180.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2006.07180.x%26sid%3Dliteratum%253Aachs%26aulast%3DTada%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DA.%26aulast%3DTakekoshi%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DE.%26aulast%3DMitsui%26aufirst%3DH.%26aulast%3DSaeki%26aufirst%3DH.%26aulast%3DKomine%26aufirst%3DM.%26aulast%3DTamaki%26aufirst%3DK.%26atitle%3DInterleukin%252012%2520production%2520by%2520monocytes%2520from%2520patients%2520with%2520psoriasis%2520and%2520its%2520inhibition%2520by%2520cyclosprin%2520A%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2006%26volume%3D154%26spage%3D1180%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chamian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowes, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilleaudeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan-Whalen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardinale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatcherian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novitskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittkowski, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris</span> <span class="citation_source-journal">Proc. Natl. Acad Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2080</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=2075-2080&author=F.+Chamianauthor=M.+A.+Lowesauthor=S.-L.+Linauthor=E.+Leeauthor=T.+Kikuchiauthor=P.+Gilleaudeauauthor=M.+Sullivan-Whalenauthor=I.+Cardinaleauthor=A.+Khatcherianauthor=I.+Novitskayaauthor=K.+M.+Wittkowskiauthor=J.+G.+Krueger&title=Alefacept+reduces+infiltrating+T+cells%2C+activated+dendritic+cells%2C+and+inflammatory+genes+in+psoriasis+vulgaris"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChamian%26aufirst%3DF.%26aulast%3DLowes%26aufirst%3DM.%2BA.%26aulast%3DLin%26aufirst%3DS.-L.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DGilleaudeau%26aufirst%3DP.%26aulast%3DSullivan-Whalen%26aufirst%3DM.%26aulast%3DCardinale%26aufirst%3DI.%26aulast%3DKhatcherian%26aufirst%3DA.%26aulast%3DNovitskaya%26aufirst%3DI.%26aulast%3DWittkowski%26aufirst%3DK.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DAlefacept%2520reduces%2520infiltrating%2520T%2520cells%252C%2520activated%2520dendritic%2520cells%252C%2520and%2520inflammatory%2520genes%2520in%2520psoriasis%2520vulgaris%26jtitle%3DProc.%2520Natl.%2520Acad%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D2075%26epage%3D2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gottlieb, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardinale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abello, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowes, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=2721-2729&author=A.+B.+Gottliebauthor=F.+Chamianauthor=S.+Masudauthor=I.+Cardinaleauthor=M.+V.+Abelloauthor=M.+A.+Lowesauthor=F.+Chenauthor=M.+Maglioccoauthor=J.+G.+Krueger&title=TNF+inhibition+rapidly+down-regulates+multiple+proinflammatory+pathways+in+psoriasis+plaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DA.%2BB.%26aulast%3DChamian%26aufirst%3DF.%26aulast%3DMasud%26aufirst%3DS.%26aulast%3DCardinale%26aufirst%3DI.%26aulast%3DAbello%26aufirst%3DM.%2BV.%26aulast%3DLowes%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DMagliocco%26aufirst%3DM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DTNF%2520inhibition%2520rapidly%2520down-regulates%2520multiple%2520proinflammatory%2520pathways%2520in%2520psoriasis%2520plaques%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D2721%26epage%3D2729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Piskin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tursen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylva-Steenland, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teunissen, M. B. M.</span><span> </span><span class="NLM_article-title">Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFNg inducers—IL-12, IL-18 and IL-23</span> <span class="citation_source-journal">Exp. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.0906-6705.2004.00246.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15560760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1yqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=764-772&author=G.+Piskinauthor=U.+Tursenauthor=R.+M.+Sylva-Steenlandauthor=J.+D.+Bosauthor=M.+B.+M.+Teunissen&title=Clinical+improvement+in+chronic+plaque-type+psoriasis+lesions+after+narrow-band+UVB+therapy+is+accompanied+by+a+decrease+in+the+expression+of+IFNg+inducers%E2%80%94IL-12%2C+IL-18+and+IL-23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20dR"><div class="casContent"><span class="casTitleNuber">20d</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers - IL-12, IL-18 and IL-23</span></div><div class="casAuthors">Piskin, G.; Tursen, U.; Sylva-Steenland, R. M. R.; Bos, J. D.; Tennissen, M. B. M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Dermatology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">764-772</span>CODEN:
                <span class="NLM_cas:coden">EXDEEY</span>;
        ISSN:<span class="NLM_cas:issn">0906-6705</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Type-1 cytokine-producing T cells are important in the pathogenesis of psoriasis vulgaris, for which efficient therapy is provided by means of narrow-band UV-B (NB-UVB).  The expression of the type-1 cytokine interferon-γ (IFN-γ) is regulated by interleukin-12 (IL-12), IL-15, IL-18 and IL-23; however, not much is known about the effect of this therapy on the levels of these cytokines in lesional psoriatic skin in situ.  In this study, we investigated the effects of NB-UVB therapy on the expression of IFN-γ-inducing cytokines.  Ten patients with chronic plaque-type psoriasis selected to be treated with NB-UVB therapy were recruited for these expts. and the expression of cytokines IL-12, IL-15, IL-18, IL-23 and IFN-γ in lesional psoriatic skin before, during and after therapy was detd. with the help of immunohistochem.  Double staining was performed in order to det. the cell types expressing these cytokines.  The decrease in the psoriasis area and severity index was accompanied by a significant decrease in the expression of IFN-γ, and concomitantly, significant redn. of IFN-γ-inducers IL-12, IL-18 and IL-23.  Thus, we concluded that the decrease of IFN-γ expression in psoriasis lesions after NB-UVB therapy could be a result of diminished expression of IL-12, IL-18 and IL-23 in lesional skin.  Therapies targeting these three cytokines should, therefore, be considered in the treatment of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaPDkoT64eYLVg90H21EOLACvtfcHk0ljXIyp3x7Hr1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1yqug%253D%253D&md5=4986e2e8d38599e548dde1732564ac09</span></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1111%2Fj.0906-6705.2004.00246.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0906-6705.2004.00246.x%26sid%3Dliteratum%253Aachs%26aulast%3DPiskin%26aufirst%3DG.%26aulast%3DTursen%26aufirst%3DU.%26aulast%3DSylva-Steenland%26aufirst%3DR.%2BM.%26aulast%3DBos%26aufirst%3DJ.%2BD.%26aulast%3DTeunissen%26aufirst%3DM.%2BB.%2BM.%26atitle%3DClinical%2520improvement%2520in%2520chronic%2520plaque-type%2520psoriasis%2520lesions%2520after%2520narrow-band%2520UVB%2520therapy%2520is%2520accompanied%2520by%2520a%2520decrease%2520in%2520the%2520expression%2520of%2520IFNg%2520inducers%25E2%2580%2594IL-12%252C%2520IL-18%2520and%2520IL-23%26jtitle%3DExp.%2520Dermatol.%26date%3D2004%26volume%3D13%26spage%3D764%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kopp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bello-Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastelein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupper, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span> </span><span class="NLM_article-title">IL-23 production by co-secretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">5438</span><span class="NLM_x">–</span> <span class="NLM_lpage">5444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=5438-5444&author=T.+Koppauthor=P.+Lenzauthor=C.+Bello-Fernandezauthor=R.+Kasteleinauthor=T.+S.+Kupperauthor=G.+Stingl&title=IL-23+production+by+co-secretion+of+endogenous+p19+and+transgenic+p40+in+keratin+14%2Fp40+transgenic+mice%3A+evidence+for+enhanced+cutaneous+immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DLenz%26aufirst%3DP.%26aulast%3DBello-Fernandez%26aufirst%3DC.%26aulast%3DKastelein%26aufirst%3DR.%26aulast%3DKupper%26aufirst%3DT.%2BS.%26aulast%3DStingl%26aufirst%3DG.%26atitle%3DIL-23%2520production%2520by%2520co-secretion%2520of%2520endogenous%2520p19%2520and%2520transgenic%2520p40%2520in%2520keratin%252014%252Fp40%2520transgenic%2520mice%253A%2520evidence%2520for%2520enhanced%2520cutaneous%2520immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D5438%26epage%3D5444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kopp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strommer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupper, T. S.</span><span> </span><span class="NLM_article-title">Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2001&pages=618-626&author=T.+Koppauthor=J.+D.+Kiefferauthor=A.+Rotauthor=S.+Strommerauthor=G.+Stinglauthor=T.+S.+Kupper&title=Inflammatory+skin+disease+in+K14%2Fp40+transgenic+mice%3A+evidence+for+interleukin-12-like+activities+of+p40"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DKieffer%26aufirst%3DJ.%2BD.%26aulast%3DRot%26aufirst%3DA.%26aulast%3DStrommer%26aufirst%3DS.%26aulast%3DStingl%26aufirst%3DG.%26aulast%3DKupper%26aufirst%3DT.%2BS.%26atitle%3DInflammatory%2520skin%2520disease%2520in%2520K14%252Fp40%2520transgenic%2520mice%253A%2520evidence%2520for%2520interleukin-12-like%2520activities%2520of%2520p40%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2001%26volume%3D117%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Clarke, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domagala, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mraovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewmaker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennings, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doylce, A. G.</span><span> </span><span class="NLM_article-title">A novel class of anti-IL-12p40 antibodies</span> <span class="citation_source-journal">mAbs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=539-549&author=A.+W.+Clarkeauthor=L.+Poultonauthor=H.+Y.+Waiauthor=S.+A.+Walkerauthor=S.+D.+Victorauthor=T.+Domagalaauthor=D.+Mraovicauthor=D.+Buttauthor=N.+Shewmakerauthor=P.+Henningsauthor=A.+G.+Doylce&title=A+novel+class+of+anti-IL-12p40+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DA.%2BW.%26aulast%3DPoulton%26aufirst%3DL.%26aulast%3DWai%26aufirst%3DH.%2BY.%26aulast%3DWalker%26aufirst%3DS.%2BA.%26aulast%3DVictor%26aufirst%3DS.%2BD.%26aulast%3DDomagala%26aufirst%3DT.%26aulast%3DMraovic%26aufirst%3DD.%26aulast%3DButt%26aufirst%3DD.%26aulast%3DShewmaker%26aufirst%3DN.%26aulast%3DHennings%26aufirst%3DP.%26aulast%3DDoylce%26aufirst%3DA.%2BG.%26atitle%3DA%2520novel%2520class%2520of%2520anti-IL-12p40%2520antibodies%26jtitle%3DmAbs%26date%3D2010%26volume%3D2%26spage%3D539%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kimball, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakharzadeh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeilding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szapary, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, K. A.</span><span> </span><span class="NLM_article-title">Long-term efficacy of ustekinumab in moderate-to-severe psoriasis: results from the PHOENIX 1 trials through up to 3 years</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1365-2133.2012.10901.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=22356258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVyntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=861-872&author=A.+B.+Kimballauthor=K.+B.+Gordonauthor=S.+Fakharzadehauthor=N.+Yeildingauthor=P.+O.+Szaparyauthor=B.+Schenkelauthor=C.+Guzzoauthor=S.+Liauthor=K.+A.+Papp&title=Long-term+efficacy+of+ustekinumab+in+moderate-to-severe+psoriasis%3A+results+from+the+PHOENIX+1+trials+through+up+to+3+years"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years</span></div><div class="casAuthors">Kimball, A. B.; Gordon, K. B.; Fakharzadeh, S.; Yeilding, N.; Szapary, P. O.; Schenkel, B.; Guzzo, C.; Li, S.; Papp, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: An unmet need remains for safe and effective long-term treatments of psoriasis.  Objectives: To evaluate ustekinumab efficacy and safety for up to 3 years in the PHOENIX 1 trial.  Methods: Patients (n = 766) with moderate-to-severe psoriasis were randomized to ustekinumab 45 mg or 90 mg at weeks 0 and 4, and then every 12 wk, or placebo at weeks 0 and 4, with crossover to ustekinumab at week 12.  Ustekinumab responders [≥ 75% improvement from baseline in the Psoriasis Area and Severity Index (PASI 75) at weeks 28 and 40] were re-randomized at week 40 to continue or withdraw from treatment until psoriasis recurrence.  Partial responders (week 28: PASI 50-74; week 40: < PASI 75) switched to dosing every 8 wk.  Clin. efficacy was assessed by PASI, the Physician's Global Assessment (PGA), and the Dermatol. Life Quality Index (DLQI) measures.  Results: Overall, 79.8% of the ustekinumab-treated patients remained in the study for 3 years.  PASI 75 response rates (45 mg: 61.2%; 90 mg: 72.4%) at week 76 were maintained through year 3 (45 mg: 62.7%; 90 mg: 72.2%); PGA response was similarly durable.  At year 3, 80.9% (45 mg) and 82.7% (90 mg) of week 40 responders continuing treatment every 12 wk achieved a PASI 75 response, while 42.6% (45 mg) and 58.0% (90 mg) achieved a PASI 90 response.  Among partial responders adjusted to dosing every 8 wk, 50.9% (45 mg) and 52.0% (90 mg) had a PASI 75 response at year 3.  DLQI responses paralleled the PASI responses.  Through year 3, no dose response was obsd. in rates of adverse events (AEs), overall infections, serious AEs, or AEs leading to discontinuation; nor was there evidence of cumulative organ toxicity.  Conclusions: Continuous, stable, maintenance dosing with ustekinumab was generally well tolerated and sustained durable efficacy for up to 3 years of treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnKvRavgx127Vg90H21EOLACvtfcHk0lgDv3_RIRx7-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVyntbo%253D&md5=21ebebcae4c961ad61a790e5bd1957e1</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2012.10901.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2012.10901.x%26sid%3Dliteratum%253Aachs%26aulast%3DKimball%26aufirst%3DA.%2BB.%26aulast%3DGordon%26aufirst%3DK.%2BB.%26aulast%3DFakharzadeh%26aufirst%3DS.%26aulast%3DYeilding%26aufirst%3DN.%26aulast%3DSzapary%26aufirst%3DP.%2BO.%26aulast%3DSchenkel%26aufirst%3DB.%26aulast%3DGuzzo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DK.%2BA.%26atitle%3DLong-term%2520efficacy%2520of%2520ustekinumab%2520in%2520moderate-to-severe%2520psoriasis%253A%2520results%2520from%2520the%2520PHOENIX%25201%2520trials%2520through%2520up%2520to%25203%2520years%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2012%26volume%3D166%26spage%3D861%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Papp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szapary, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeilding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, K.</span><span> </span><span class="NLM_article-title">Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1675-1684&author=K.+A.+Pappauthor=R.+G.+Langleyauthor=M.+Lebwohlauthor=G.+G.+Kruegerauthor=P.+Szaparyauthor=N.+Yeildingauthor=C.+Guzzoauthor=M.-C.+Hsuauthor=Y.+Wangauthor=S.+Liauthor=L.+T.+Dooleyauthor=K.+Reich&title=Efficacy+and+safety+of+ustekinumab%2C+a+human+interleukin-12%2F23+monoclonal+antibody%2C+in+patients+with+psoriasis%3A+52-week+results+from+a+randomized%2C+double-blind%2C+placebo-controlled+trial+%28PHOENIX+2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapp%26aufirst%3DK.%2BA.%26aulast%3DLangley%26aufirst%3DR.%2BG.%26aulast%3DLebwohl%26aufirst%3DM.%26aulast%3DKrueger%26aufirst%3DG.%2BG.%26aulast%3DSzapary%26aufirst%3DP.%26aulast%3DYeilding%26aufirst%3DN.%26aulast%3DGuzzo%26aufirst%3DC.%26aulast%3DHsu%26aufirst%3DM.-C.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDooley%26aufirst%3DL.%2BT.%26aulast%3DReich%26aufirst%3DK.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520ustekinumab%252C%2520a%2520human%2520interleukin-12%252F23%2520monoclonal%2520antibody%252C%2520in%2520patients%2520with%2520psoriasis%253A%252052-week%2520results%2520from%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520%2528PHOENIX%25202%2529%26jtitle%3DLancet%26date%3D2008%26volume%3D371%26spage%3D1675%26epage%3D1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Leonardi, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeilding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, K. B.</span><span> </span><span class="NLM_article-title">Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1665</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1665-1674&author=G.+L.+Leonardiauthor=A.+B.+Kimballauthor=K.+A.+Pappauthor=N.+Yeildingauthor=C.+Guzzoauthor=Y.+Wangauthor=S.+Liauthor=L.+T.+Dooleyauthor=K.+B.+Gordon&title=Efficacy+and+safety+of+ustekinumab%2C+a+human+interleukin-12%2F23+monoclonal+antibody%2C+in+patients+with+psoriasis%3A+76-week+results+from+a+randomized%2C+double-blind%2C+placebo-controlled+trial+%28PHOENIX+1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeonardi%26aufirst%3DG.%2BL.%26aulast%3DKimball%26aufirst%3DA.%2BB.%26aulast%3DPapp%26aufirst%3DK.%2BA.%26aulast%3DYeilding%26aufirst%3DN.%26aulast%3DGuzzo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDooley%26aufirst%3DL.%2BT.%26aulast%3DGordon%26aufirst%3DK.%2BB.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520ustekinumab%252C%2520a%2520human%2520interleukin-12%252F23%2520monoclonal%2520antibody%252C%2520in%2520patients%2520with%2520psoriasis%253A%252076-week%2520results%2520from%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520%2528PHOENIX%25201%2529%26jtitle%3DLancet%26date%3D2008%26volume%3D371%26spage%3D1665%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Benson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treacy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodmerkel, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascelli, M. A.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=615-624&author=J.+M.+Bensonauthor=C.+W.+Sachsauthor=G.+Treacyauthor=H.+Zhouauthor=C.+Pendleyauthor=C.+M.+Brodmerkelauthor=G.+Shankarauthor=M.+A.+Mascelli&title=Therapeutic+targeting+of+the+IL-12%2F23+pathways%3A+generation+and+characterization+of+ustekinumab"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DJ.%2BM.%26aulast%3DSachs%26aufirst%3DC.%2BW.%26aulast%3DTreacy%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DPendley%26aufirst%3DC.%26aulast%3DBrodmerkel%26aufirst%3DC.%2BM.%26aulast%3DShankar%26aufirst%3DG.%26aulast%3DMascelli%26aufirst%3DM.%2BA.%26atitle%3DTherapeutic%2520targeting%2520of%2520the%2520IL-12%252F23%2520pathways%253A%2520generation%2520and%2520characterization%2520of%2520ustekinumab%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D615%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barrett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansoul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolae, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duerr, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brant, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverberg, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassopoulos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kistner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtha, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regueiro, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumm, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhart, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libioulle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lathrop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belaiche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laukens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossum, A. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenika, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchimont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugot, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onnie, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumpstead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwilliam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremelling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deloukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satsangi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span> </span><span class="NLM_article-title">Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fng.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18587394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFSqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=955-962&author=J.+C.+Barrettauthor=S.+Hansoulauthor=D.+L.+Nicolaeauthor=J.+H.+Choauthor=R.+H.+Duerrauthor=J.+D.+Riouxauthor=S.+R.+Brantauthor=M.+K.+Silverbergauthor=K.+D.+Taylorauthor=M.+M.+Barmadaauthor=A.+Bittonauthor=T.+Dassopoulosauthor=L.+W.+Dattaauthor=T.+Greenauthor=A.+M.+Griffithsauthor=E.+O.+Kistnerauthor=M.+T.+Murthaauthor=M.+D.+Regueiroauthor=J.+T.+Rotterauthor=L.+P.+Schummauthor=A.+H.+Steinhartauthor=S.+T.+Targanauthor=R.+J.+Xavierauthor=C.+Libioulleauthor=C.+Sandorauthor=M.+Lathropauthor=J.+Belaicheauthor=O.+Dewitauthor=I.+Gutauthor=S.+Heathauthor=D.+Laukensauthor=M.+Mniauthor=P.+Rutgeertsauthor=A.+v.+Gossumauthor=D.+Zelenikaauthor=D.+Franchimontauthor=J.-P.+Hugotauthor=M.+de+Vosauthor=S.+Vermeireauthor=E.+Louisauthor=L.+R.+Cardonauthor=C.+A.+Andersonauthor=H.+Drummondauthor=E.+Nimmoauthor=T.+Ahmadauthor=N.+J.+Prescottauthor=C.+M.+Onnieauthor=S.+A.+Fisherauthor=J.+Marchiniauthor=J.+Ghoriauthor=S.+Bumpsteadauthor=R.+Gwilliamauthor=M.+Tremellingauthor=P.+Deloukasauthor=J.+Mansfieldauthor=D.+Jewelauthor=J.+Satsangiauthor=C.+G.+Mathewauthor=M.+Parkesauthor=M.+Georgesauthor=M.+J.+Daly&title=Genome-wide+association+defines+more+than+30+distinct+susceptibility+loci+for+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease</span></div><div class="casAuthors">Barrett, Jeffrey C.; Hansoul, Sarah; Nicolae, Dan L.; Cho, Judy H.; Duerr, Richard H.; Rioux, John D.; Brant, Steven R.; Silverberg, Mark S.; Taylor, Kent D.; Barmada, M. Michael; Bitton, Alain; Dassopoulos, Themistocles; Datta, Lisa Wu; Green, Todd; Griffiths, Anne M.; Kistner, Emily O.; Murtha, Michael T.; Regueiro, Miguel D.; Rotter, Jerome I.; Schumm, L. Philip; Steinhart, A. Hillary; Targan, Stephan R.; Xavier, Ramnik J.; Libioulle, Cecile; Sandor, Cynthia; Lathrop, Mark; Belaiche, Jacques; Dewit, Olivier; Gut, Ivo; Heath, Simon; Laukens, Debby; Mni, Myriam; Rutgeerts, Paul; Van Gossum, Andre; Zelenika, Diana; Franchimont, Denis; Hugot, Jean-Pierre; de Vos, Martine; Vermeire, Severine; Louis, Edouard; Cardon, Lon R.; Anderson, Carl A.; Drummond, Hazel; Nimmo, Elaine; Ahmad, Tariq; Prescott, Natalie J.; Onnie, Clive M.; Fisher, Sheila A.; Marchini, Jonathan; Ghori, Jilur; Bumpstead, Suzannah; Gwilliam, Rhian; Tremelling, Mark; Deloukas, Panos; Mansfield, John; Jewell, Derek; Satsangi, Jack; Mathew, Christopher G.; Parkes, Miles; Georges, Michel; Daly, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">955-962</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mark Daly and colleagues present results of a combined anal. of data from three recent genome-wide assocn. studies for Crohn's disease, followed by replication in a large independent sample collection.  Their results confirm 11 previously reported risk loci and provide genome-wide significant evidence for 21 new loci assocd. with the disease.  Mark Daly and colleagues present results of a combined anal. of data from three recent genome-wide assocn. studies for Crohn's disease, followed by replication in a large independent sample collection.  Their results confirm 11 previously reported risk loci and provide genome-wide significant evidence for 21 new loci assocd. with the disease.  Several risk factors for Crohn's disease have been identified in recent genome-wide assocn. studies.  To advance gene discovery further, we combined data from three studies on Crohn's disease (a total of 3,230 cases and 4,829 controls) and carried out replication in 3,664 independent cases with a mixt. of population-based and family-based controls.  The results strongly confirm 11 previously reported loci and provide genome-wide significant evidence for 21 addnl. loci, including the regions contg. STAT3, JAK2, ICOSLG, CDKAL1 and ITLN1.  The expanded mol. understanding of the basis of this disease offers promise for informed therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXvOZmM6KfrLVg90H21EOLACvtfcHk0liUtnt0U-6XZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFSqs7k%253D&md5=c2f2805316b115765c02aa1dc503626b</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1038%2Fng.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.175%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DHansoul%26aufirst%3DS.%26aulast%3DNicolae%26aufirst%3DD.%2BL.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DDuerr%26aufirst%3DR.%2BH.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DBrant%26aufirst%3DS.%2BR.%26aulast%3DSilverberg%26aufirst%3DM.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%2BD.%26aulast%3DBarmada%26aufirst%3DM.%2BM.%26aulast%3DBitton%26aufirst%3DA.%26aulast%3DDassopoulos%26aufirst%3DT.%26aulast%3DDatta%26aufirst%3DL.%2BW.%26aulast%3DGreen%26aufirst%3DT.%26aulast%3DGriffiths%26aufirst%3DA.%2BM.%26aulast%3DKistner%26aufirst%3DE.%2BO.%26aulast%3DMurtha%26aufirst%3DM.%2BT.%26aulast%3DRegueiro%26aufirst%3DM.%2BD.%26aulast%3DRotter%26aufirst%3DJ.%2BT.%26aulast%3DSchumm%26aufirst%3DL.%2BP.%26aulast%3DSteinhart%26aufirst%3DA.%2BH.%26aulast%3DTargan%26aufirst%3DS.%2BT.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DLibioulle%26aufirst%3DC.%26aulast%3DSandor%26aufirst%3DC.%26aulast%3DLathrop%26aufirst%3DM.%26aulast%3DBelaiche%26aufirst%3DJ.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DGut%26aufirst%3DI.%26aulast%3DHeath%26aufirst%3DS.%26aulast%3DLaukens%26aufirst%3DD.%26aulast%3DMni%26aufirst%3DM.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DGossum%26aufirst%3DA.%2Bv.%26aulast%3DZelenika%26aufirst%3DD.%26aulast%3DFranchimont%26aufirst%3DD.%26aulast%3DHugot%26aufirst%3DJ.-P.%26aulast%3Dde%2BVos%26aufirst%3DM.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DLouis%26aufirst%3DE.%26aulast%3DCardon%26aufirst%3DL.%2BR.%26aulast%3DAnderson%26aufirst%3DC.%2BA.%26aulast%3DDrummond%26aufirst%3DH.%26aulast%3DNimmo%26aufirst%3DE.%26aulast%3DAhmad%26aufirst%3DT.%26aulast%3DPrescott%26aufirst%3DN.%2BJ.%26aulast%3DOnnie%26aufirst%3DC.%2BM.%26aulast%3DFisher%26aufirst%3DS.%2BA.%26aulast%3DMarchini%26aufirst%3DJ.%26aulast%3DGhori%26aufirst%3DJ.%26aulast%3DBumpstead%26aufirst%3DS.%26aulast%3DGwilliam%26aufirst%3DR.%26aulast%3DTremelling%26aufirst%3DM.%26aulast%3DDeloukas%26aufirst%3DP.%26aulast%3DMansfield%26aufirst%3DJ.%26aulast%3DJewel%26aufirst%3DD.%26aulast%3DSatsangi%26aufirst%3DJ.%26aulast%3DMathew%26aufirst%3DC.%2BG.%26aulast%3DParkes%26aufirst%3DM.%26aulast%3DGeorges%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26atitle%3DGenome-wide%2520association%2520defines%2520more%2520than%252030%2520distinct%2520susceptibility%2520loci%2520for%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2008%26volume%3D40%26spage%3D955%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Duerr, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brant, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverberg, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhart, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regueiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassopoulos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kistner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumm, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregersen, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolae, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span><span> </span><span class="NLM_article-title">A genome-wide association study identifies IL23R as an inflammatory bowel disease gene</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=1461-1463&author=R.+H.+Duerrauthor=K.+D.+Taylorauthor=S.+R.+Brantauthor=J.+D.+Riouxauthor=M.+S.+Silverbergauthor=M.+J.+Dalyauthor=A.+H.+Steinhartauthor=C.+Abrahamauthor=M.+Regueiroauthor=A.+Griffithsauthor=T.+Dassopoulosauthor=A.+Bittonauthor=H.+Yangauthor=S.+Targanauthor=L.+W.+Dattaauthor=E.+O.+Kistnerauthor=L.+P.+Schummauthor=A.+T.+Leeauthor=P.+K.+Gregersenauthor=M.+M.+Barmadaauthor=J.+I.+Rotterauthor=D.+L.+Nicolaeauthor=J.+H.+Cho&title=A+genome-wide+association+study+identifies+IL23R+as+an+inflammatory+bowel+disease+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuerr%26aufirst%3DR.%2BH.%26aulast%3DTaylor%26aufirst%3DK.%2BD.%26aulast%3DBrant%26aufirst%3DS.%2BR.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DSilverberg%26aufirst%3DM.%2BS.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DSteinhart%26aufirst%3DA.%2BH.%26aulast%3DAbraham%26aufirst%3DC.%26aulast%3DRegueiro%26aufirst%3DM.%26aulast%3DGriffiths%26aufirst%3DA.%26aulast%3DDassopoulos%26aufirst%3DT.%26aulast%3DBitton%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTargan%26aufirst%3DS.%26aulast%3DDatta%26aufirst%3DL.%2BW.%26aulast%3DKistner%26aufirst%3DE.%2BO.%26aulast%3DSchumm%26aufirst%3DL.%2BP.%26aulast%3DLee%26aufirst%3DA.%2BT.%26aulast%3DGregersen%26aufirst%3DP.%2BK.%26aulast%3DBarmada%26aufirst%3DM.%2BM.%26aulast%3DRotter%26aufirst%3DJ.%2BI.%26aulast%3DNicolae%26aufirst%3DD.%2BL.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26atitle%3DA%2520genome-wide%2520association%2520study%2520identifies%2520IL23R%2520as%2520an%2520inflammatory%2520bowel%2520disease%2520gene%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D1461%26epage%3D1463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahern, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounocore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullberg, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cua, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pwrie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloy, K. J.</span><span> </span><span class="NLM_article-title">Interleukin-23 drives innate and T cell-mediated intestinal inflammation</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">2473</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2473-2483&author=S.+Hueauthor=P.+Ahernauthor=S.+Bounocoreauthor=M.+C.+Kullbergauthor=D.+J.+Cuaauthor=B.+S.+McKenzieauthor=F.+Pwrieauthor=K.+J.+Maloy&title=Interleukin-23+drives+innate+and+T+cell-mediated+intestinal+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHue%26aufirst%3DS.%26aulast%3DAhern%26aufirst%3DP.%26aulast%3DBounocore%26aufirst%3DS.%26aulast%3DKullberg%26aufirst%3DM.%2BC.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DPwrie%26aufirst%3DF.%26aulast%3DMaloy%26aufirst%3DK.%2BJ.%26atitle%3DInterleukin-23%2520drives%2520innate%2520and%2520T%2520cell-mediated%2520intestinal%2520inflammation%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2473%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kullberg, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorelick, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cua, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powrie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheever, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloy, K, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, A.</span><span> </span><span class="NLM_article-title">IL-23 plays a key role in <i>Helicobacter hepaticus</i>-induced T cell-dependent colitis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2485-2494&author=M.+C.+Kullbergauthor=D.+Jankovicauthor=C.+G.+Fengauthor=S.+Hueauthor=P.+L.+Gorelickauthor=B.+S.+McKenzieauthor=D.+J.+Cuaauthor=F.+Powrieauthor=A.+W.+Cheeverauthor=K%2C+J.+Maloyauthor=A.+Sher&title=IL-23+plays+a+key+role+in+Helicobacter+hepaticus-induced+T+cell-dependent+colitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKullberg%26aufirst%3DM.%2BC.%26aulast%3DJankovic%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DC.%2BG.%26aulast%3DHue%26aufirst%3DS.%26aulast%3DGorelick%26aufirst%3DP.%2BL.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DPowrie%26aufirst%3DF.%26aulast%3DCheever%26aufirst%3DA.%2BW.%26aulast%3DMaloy%26aufirst%3DK%252C%2BJ.%26aulast%3DSher%26aufirst%3DA.%26atitle%3DIL-23%2520plays%2520a%2520key%2520role%2520in%2520Helicobacter%2520hepaticus-induced%2520T%2520cell-dependent%2520colitis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2485%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sandborn, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorak, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisher, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span> </span><span class="NLM_article-title">A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=1130-1141&author=W.+J.+Sandbornauthor=B.+Feaganauthor=R.+N.+Fedorakauthor=E.+Scherlauthor=M.+R.+Fleisherauthor=S.+Katzauthor=J.+Johannsauthor=M.+Blankauthor=P.+Rutgeerts&title=A+randomized+trial+of+ustekinumab%2C+a+human+interleukin-12%2F23+monoclonal+antibody%2C+in+patients+with+moderate-to-severe+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandborn%26aufirst%3DW.%2BJ.%26aulast%3DFeagan%26aufirst%3DB.%26aulast%3DFedorak%26aufirst%3DR.%2BN.%26aulast%3DScherl%26aufirst%3DE.%26aulast%3DFleisher%26aufirst%3DM.%2BR.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DJohanns%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DM.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DA%2520randomized%2520trial%2520of%2520ustekinumab%252C%2520a%2520human%2520interleukin-12%252F23%2520monoclonal%2520antibody%252C%2520in%2520patients%2520with%2520moderate-to-severe%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DGastroenterology%26date%3D2008%26volume%3D135%26spage%3D1130%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kralovics, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passamonti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passweg, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoda, R.</span><span> </span><span class="NLM_article-title">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa051113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15858187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1779-1790&author=R.+Kralovicsauthor=F.+Passamontiauthor=A.+S.+Buserauthor=S.-S.+Teoauthor=R.+Tiedtauthor=J.+R.+Passwegauthor=A.+Tichelliauthor=M.+Cazzolaauthor=R.+Skoda&title=A+gain-of-function+mutation+of+JAK2+in+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span></div><div class="casAuthors">Kralovics, Robert; Passamonti, Francesco; Buser, Andreas S.; Teo, Soon-Siong; Tiedt, Ralph; Passweg, Jakob R.; Tichelli, Andre; Cazzola, Mario; Skoda, Radek C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1779-1790</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multi-potent progenitor.  The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases.  METHODS We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis).  RESULTS Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene.  In patients with 9pLOH, JAK2 had a homozygous G→T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F).  All 51 patients with 9pLOH had the V617F mutation.  Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation.  The frequency of V617F was 65 % among patients with polycythemia vera (83 of 128), 57 % among patients with idiopathic myelofibrosis (13 of 23), and 23 % among patients with essential thrombocythemia (21 of 93).  V617F is a somatic mutation present in hematopoietic cells.  Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F.  Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages.  Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2.  CONCLUSIONS A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTe7EsB_527Vg90H21EOLACvtfcHk0ljFuxMjUNAl_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D&md5=5dd4bc090ded1c812b61923cad36e77e</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051113%26sid%3Dliteratum%253Aachs%26aulast%3DKralovics%26aufirst%3DR.%26aulast%3DPassamonti%26aufirst%3DF.%26aulast%3DBuser%26aufirst%3DA.%2BS.%26aulast%3DTeo%26aufirst%3DS.-S.%26aulast%3DTiedt%26aufirst%3DR.%26aulast%3DPassweg%26aufirst%3DJ.%2BR.%26aulast%3DTichelli%26aufirst%3DA.%26aulast%3DCazzola%26aufirst%3DM.%26aulast%3DSkoda%26aufirst%3DR.%26atitle%3DA%2520gain-of-function%2520mutation%2520of%2520JAK2%2520in%2520myeloproliferative%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1779%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couedic, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A unique clonal JAK2 mutation leading to constitutive signaling causes polytheamia vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.-P.+Couedicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Garconauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennaceur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signaling+causes+polytheamia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DCouedic%26aufirst%3DJ.-P.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGarcon%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennaceur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520unique%2520clonal%2520JAK2%2520mutation%2520leading%2520to%2520constitutive%2520signaling%2520causes%2520polytheamia%2520vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Parganas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stravopodis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanin, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colamonici, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deursen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosveld, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 is essential for signaling through a variety of cytokine receptors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=385-395&author=E.+Parganasauthor=D.+Wangauthor=D.+Stravopodisauthor=D.+J.+Tophamauthor=J.+C.+Marineauthor=S.+Teglundauthor=E.+F.+Vaninauthor=S.+Bodnerauthor=O.+R.+Colamoniciauthor=J.+M.+van+Deursenauthor=G.+Grosveldauthor=J.+N.+Ihle&title=JAK2+is+essential+for+signaling+through+a+variety+of+cytokine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParganas%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DStravopodis%26aufirst%3DD.%26aulast%3DTopham%26aufirst%3DD.%2BJ.%26aulast%3DMarine%26aufirst%3DJ.%2BC.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DVanin%26aufirst%3DE.%2BF.%26aulast%3DBodner%26aufirst%3DS.%26aulast%3DColamonici%26aufirst%3DO.%2BR.%26aulast%3Dvan%2BDeursen%26aufirst%3DJ.%2BM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520is%2520essential%2520for%2520signaling%2520through%2520a%2520variety%2520of%2520cytokine%2520receptors%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Neubauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffstadt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeffer, K.</span><span> </span><span class="NLM_article-title">JAK2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=397-409&author=H.+Neubauerauthor=A.+Cumanoauthor=M.+Mullerauthor=H.+Wuauthor=U.+Huffstadtauthor=K.+Pfeffer&title=JAK2+deficiency+defines+an+essential+developmental+checkpoint+in+definitive+hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%26aulast%3DCumano%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHuffstadt%26aufirst%3DU.%26aulast%3DPfeffer%26aufirst%3DK.%26atitle%3DJAK2%2520deficiency%2520defines%2520an%2520essential%2520developmental%2520checkpoint%2520in%2520definitive%2520hematopoiesis%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2721-2730&author=A.+Tefferi&title=JAK+inhibitors+for+myeloproliferative+neoplasms%3A+clarifying+facts+from+myths"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DJAK%2520inhibitors%2520for%2520myeloproliferative%2520neoplasms%253A%2520clarifying%2520facts%2520from%2520myths%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2721%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1200%2FJCO.2010.32.8021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21220608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=789-796&author=A.+Pardananiauthor=J.+Gotlibauthor=C.+Jamiesonauthor=J.+E.+Cortesauthor=M.+Talpazauthor=R.+M.+Stoneauthor=M.+H.+Silvermanauthor=D.+G.+Gillilandauthor=J.+Shorrauthor=A.+Tefferi&title=Safety+and+efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Pardanani, Animesh; Gotlib, Jason R.; Jamieson, Catriona; Cortes, Jorge E.; Talpaz, Moshe; Stone, Richard M.; Silverman, Michael H.; Gilliland, D. Gary; Shorr, Jolene; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">789-796</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Myelofibrosis is a myeloid malignancy assocd. with anemia, splenomegaly, and constitutional symptoms.  Patients frequently harbor JAK-STAT activating mutations that are sensitive to TG101348, a selective small-mol. Janus kinase 2 (JAK2) inhibitor.  Patients and Methods In a multicenter phase I trial, oral TG101348 was administered once a day to patients with high- or intermediate-risk primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.  Results Fifty-nine patients were treated, including 28 in the dose-escalation phase.  The max.-tolerated dose was 680 mg/d, and dose-limiting toxicity was a reversible and asymptomatic increase in the serum amylase level.  Forty-three patients (73%) continued treatment beyond six cycles; the median cumulative exposure to TG101348 was 380 days.  Adverse events included nausea, vomiting, diarrhea, anemia, and thrombocytopenia; corresponding grades 3 to 4 incidence rates were 3%, 3%, 10%, 35%, and 24%.  TG101348 treatment had modest effect on serum cytokine levels, but greater than half of the patients with early satiety, night sweats, fatigue, pruritus, and cough achieved rapid and durable improvement in these symptoms.  By six and 12 cycles of treatment, 39% and 47% of patients, resp., had achieved a spleen response per International Working Group criteria.  The majority of patients with leukocytosis or thrombocytosis at baseline (n = 28 and n = 10, resp.) achieved normalization of blood counts after six (57% and 90%, resp.) and 12 (56% and 88%, resp.) cycles.  A significant decrease in JAK2 V617F allele burden was obsd. at 6 mo in mutation-pos. patients (n = 51; P = .04), particularly in the subgroup with allele burden greater than 20% (n = 23; P < .01); the decrease was durable at 12 mo.  Conclusion TG101348 is well tolerated and produces significant redn. in disease burden and durable clin. benefit in patients with myelofibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4BD7RVGmfLVg90H21EOLACvtfcHk0lhz28NqGDkjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D&md5=8b69a31d9dcf09b3b121e477f98d103b</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.32.8021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.32.8021%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DShorr%26aufirst%3DJ.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520myelofibrosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D789%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Verstovsek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa1002028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20843246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1117-1127&author=S.+Verstovsekauthor=H.+Kantarjianauthor=R.+A.+Mesaauthor=A.+Pardananiauthor=J.+Cortes-Francoauthor=D.+A.+Thomasauthor=Z.+Estrovauthor=J.+S.+Fridmanauthor=E.+C.+Bradleyauthor=S.+Erickson-Viitanenauthor=K.+Vaddiauthor=R.+Levyauthor=A.+Tefferi&title=Safety+and+efficacy+of+INCB018424%2C+a+JAK1+and+JAK2+inhibitor%2C+in+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Verstovsek, Srdan; Kantarjian, Hagop; Mesa, Ruben A.; Pardanani, Animesh D.; Cortes-Franco, Jorge; Thomas, Deborah A.; Estrov, Zeev; Fridman, Jordan S.; Bradley, Edward C.; Erickson-Viitanen, Susan; Vaddi, Kris; Levy, Richard; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1117-1127</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Myelofibrosis is a Philadelphia chromosome-neg. myeloproliferative neoplasm assocd. with cytopenias, splenomegaly, poor quality of life, and shortened survival.  About half of patients with myelofibrosis carry a gain-of-function mutation in the Janus kinase 2 gene (JAK2 V617F) that contributes to the pathophysiol. of the disease.  INCB018424 is a potent and selective Janus kinase 1 (JAK1) and JAK2 inhibitor.  Methods: We conducted a phase 1-2 trial of INCB018424 in patients with JAK2 V617F-pos. or JAK2 V617F-neg. primary myelofibrosis, post-essential thrombocythemia myelofibrosis, or post-polycythemia vera myelofibrosis.  Results: A total of 153 patients received INCB018424 for a median duration of more than 14.7 mo.  The initial dose-escalation phase established 25 mg twice daily or 100 mg once daily as max. tolerated doses, on the basis of reversible thrombocytopenia.  A dose-dependent suppression of phosphorylated signal transducer and activator of transcription 3 (STAT3), a marker of JAK signaling, was demonstrated in patients with wild-type JAK2 and in patients with the JAK2 V617F mutation.  We studied addnl. doses and established that a 15-mg twice-daily starting dose, followed by individualized dose titrn., was the most effective and safest dosing regimen.  At this dose, 17 of 33 patients (52%) had a rapid objective response (>50% redn. of splenomegaly) lasting for 12 mo or more, and this therapy was assocd. with grade 3 or grade 4 adverse events (mainly myelosuppression) in less than 10% of patients.  Patients with debilitating symptoms, including wt. loss, fatigue, night sweats, and pruritus, had rapid improvement.  Clin. benefits were assocd. with a marked diminution of levels of circulating inflammatory cytokines that are commonly elevated in myelofibrosis.  Conclusions: INCB018424 was assocd. with marked and durable clin. benefits in patients with myelofibrosis for whom no approved therapies existed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUi05ApP1FLrVg90H21EOLACvtfcHk0lhz28NqGDkjWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ&md5=ba6fe766323a10a1508c686fdb3720b1</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002028%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DCortes-Franco%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBradley%26aufirst%3DE.%2BC.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520INCB018424%252C%2520a%2520JAK1%2520and%2520JAK2%2520inhibitor%252C%2520in%2520myelofibrosis%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1117%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Ishizaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muromoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshira, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekine, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oritani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span> </span><span class="NLM_article-title">Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2011&pages=181-89&author=M.+Ishizakiauthor=T.+Akimotoauthor=R.+Muromotoauthor=M.+Yokoyamaauthor=Y.+Ohshiraauthor=Y.+Sekineauthor=H.+Maedaauthor=K.+Shimodaauthor=K.+Oritaniauthor=T.+Matsuda&title=Involvement+of+tyrosine+kinase-2+in+both+the+IL-12%2FTh1+and+IL-23%2FTh17+axes+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizaki%26aufirst%3DM.%26aulast%3DAkimoto%26aufirst%3DT.%26aulast%3DMuromoto%26aufirst%3DR.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DOhshira%26aufirst%3DY.%26aulast%3DSekine%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DShimoda%26aufirst%3DK.%26aulast%3DOritani%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26atitle%3DInvolvement%2520of%2520tyrosine%2520kinase-2%2520in%2520both%2520the%2520IL-12%252FTh1%2520and%2520IL-23%252FTh17%2520axes%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D187%26spage%3D181%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Minegishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agematsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yachie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujieda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abinun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochs, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belohradsky, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasuyama, H.</span><span> </span><span class="NLM_article-title">Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.immuni.2006.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=17088085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=745-755&author=Y.+Minegishiauthor=M.+Saitoauthor=T.+Morioauthor=K.+Watanabeauthor=K.+Agematsuauthor=S.+Tsuchiyaauthor=H.+Takadaauthor=T.+Haraauthor=N.+Kawamuraauthor=T.+Arigaauthor=H.+Kanekoauthor=N.+Kondoauthor=I.+Tsugeauthor=A.+Yachieauthor=Y.+Sakiyamaauthor=T.+Iwataauthor=F.+Besshoauthor=T.+Ohishiauthor=K.+Johauthor=K.+Imaiauthor=K.+Kogawaauthor=M.+Shinoharaauthor=M.+Fujiedaauthor=H.+Wakiguchiauthor=S.+Pasicauthor=M.+Abinunauthor=H.+D.+Ochsauthor=E.+D.+Rennerauthor=A.+Janssonauthor=B.+H.+Belohradskyauthor=A.+Melinauthor=N.+Shimizuauthor=S.+Mizutaniauthor=T.+Miyawakiauthor=S.+Nonoyamaauthor=H.+Karasuyama&title=Human+tyrosine+kinase+2+deficiency+reveals+its+requisite+roles+in+multiple+cytokine+signals+involved+in+innate+and+acquired+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</span></div><div class="casAuthors">Minegishi, Yoshiyuki; Saito, Masako; Morio, Tomohiro; Watanabe, Ken; Agematsu, Kazunaga; Tsuchiya, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Kaneko, Hideo; Kondo, Naomi; Tsuge, Ikuya; Yachie, Akihiro; Sakiyama, Yukio; Iwata, Tsutomu; Bessho, Fumio; Ohishi, Tsutomu; Joh, Kosuke; Imai, Kohsuke; Kogawa, Kazuhiro; Shinohara, Miwa; Fujieda, Mikiya; Wakiguchi, Hiroshi; Pasic, Srdjan; Abinun, Mario; Ochs, Hans D.; Renner, Eleonore D.; Jansson, Annette; Belohradsky, Bernd H.; Metin, Ayse; Shimizu, Norio; Mizutani, Shuki; Miyawaki, Toshio; Nonoyama, Shigeaki; Karasuyama, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family.  Here we identified a homozygous Tyk2 mutation in a patient who had been clin. diagnosed with hyper-IgE syndrome.  This patient showed unusual susceptibility to various microorganisms including virus, fungi, and mycobacteria and suffered from atopic dermatitis with elevated serum IgE.  The patient's cells displayed defects in multiple cytokine signaling pathways including those for type I interferon (IFN), interleukin (IL)-6, IL-10, IL-12, and IL-23.  The cytokine signals were successfully restored by transducing the intact Tyk2 gene.  Thus, the Tyk2 deficiency is likely to account for the patient's complex clin. manifestations, including the phenotype of impaired T helper 1 (Th1) differentiation and accelerated Th2 differentiation.  This study identifies human Tyk2 deficiency and demonstrates that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially from Tyk2 function in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TTbAIzXM-bVg90H21EOLACvtfcHk0lh_ZU0W40-IpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI&md5=debec30b44a7e1dc111d7cfb1c92f7dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DMorio%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DAgematsu%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DN.%26aulast%3DAriga%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DN.%26aulast%3DTsuge%26aufirst%3DI.%26aulast%3DYachie%26aufirst%3DA.%26aulast%3DSakiyama%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DBessho%26aufirst%3DF.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DJoh%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DKogawa%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DM.%26aulast%3DFujieda%26aufirst%3DM.%26aulast%3DWakiguchi%26aufirst%3DH.%26aulast%3DPasic%26aufirst%3DS.%26aulast%3DAbinun%26aufirst%3DM.%26aulast%3DOchs%26aufirst%3DH.%2BD.%26aulast%3DRenner%26aufirst%3DE.%2BD.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DBelohradsky%26aufirst%3DB.%2BH.%26aulast%3DMelin%26aufirst%3DA.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DMiyawaki%26aufirst%3DT.%26aulast%3DNonoyama%26aufirst%3DS.%26aulast%3DKarasuyama%26aufirst%3DH.%26atitle%3DHuman%2520tyrosine%2520kinase%25202%2520deficiency%2520reveals%2520its%2520requisite%2520roles%2520in%2520multiple%2520cytokine%2520signals%2520involved%2520in%2520innate%2520and%2520acquired%2520immunity%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D745%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sohn, S. J.; Barrett, K.; van Abbema, A.; Chang, C.; Kohli, P. B.; Kanda, H.; Smith, J.; Lai, Y.; Zhou, A.; Williams, K.; Macleod, C.; Hurley, C. A.; Kulagowski, J. K.; Lewis-Koh, N.; Johnson, A. R.; Ghilardi, N.; Zak, M.; Liang, J.; Blair, W. S.; Magnuson, S.; Wu, L. C.</span><span> </span><span class="NLM_article-title">A restricted role for TYK2 catalytic activity in human cytokine response</span>. J. Immunol., submitted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sohn%2C+S.+J.%3B+Barrett%2C+K.%3B+van+Abbema%2C+A.%3B+Chang%2C+C.%3B+Kohli%2C+P.+B.%3B+Kanda%2C+H.%3B+Smith%2C+J.%3B+Lai%2C+Y.%3B+Zhou%2C+A.%3B+Williams%2C+K.%3B+Macleod%2C+C.%3B+Hurley%2C+C.+A.%3B+Kulagowski%2C+J.+K.%3B+Lewis-Koh%2C+N.%3B+Johnson%2C+A.+R.%3B+Ghilardi%2C+N.%3B+Zak%2C+M.%3B+Liang%2C+J.%3B+Blair%2C+W.+S.%3B+Magnuson%2C+S.%3B+Wu%2C+L.+C.+A+restricted+role+for+TYK2+catalytic+activity+in+human+cytokine+response.+J.+Immunol.%2C+submitted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSohn%26aufirst%3DS.%2BJ.%26atitle%3DA%2520restricted%2520role%2520for%2520TYK2%2520catalytic%2520activity%2520in%2520human%2520cytokine%2520response%26jtitle%3DJ.%2520Immunol." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span> </span><span class="NLM_article-title">Immunotherapeutic implication of IL-6 blockade</span> <span class="citation_source-journal">Immunotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=87-105&author=T.+Tanakaauthor=T.+Kishimoto&title=Immunotherapeutic+implication+of+IL-6+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DImmunotherapeutic%2520implication%2520of%2520IL-6%2520blockade%26jtitle%3DImmunotherapy%26date%3D2012%26volume%3D4%26spage%3D87%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the JAK1 gene demonstrates obligatory and nonredundant roles of the JAKs in cytokine-induced biologic response</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+A.+Arthurauthor=K.+L.+Kingauthor=K.+C.+F.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+JAK1+gene+demonstrates+obligatory+and+nonredundant+roles+of+the+JAKs+in+cytokine-induced+biologic+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BA.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%2BF.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520JAK1%2520gene%2520demonstrates%2520obligatory%2520and%2520nonredundant%2520roles%2520of%2520the%2520JAKs%2520in%2520cytokine-induced%2520biologic%2520response%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Comejo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span> </span><span class="NLM_article-title">JAK3: a two-faced player in hematological disorders</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2376</span><span class="NLM_x">–</span> <span class="NLM_lpage">2379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.biocel.2009.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19747563" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=2376-2379&author=M.+G.+Comejoauthor=T.+J.+Boggonauthor=T.+Mercher&title=JAK3%3A+a+two-faced+player+in+hematological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2009.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2009.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DComejo%26aufirst%3DM.%2BG.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DMercher%26aufirst%3DT.%26atitle%3DJAK3%253A%2520a%2520two-faced%2520player%2520in%2520hematological%2520disorders%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D2376%26epage%3D2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">JAK3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.0105-2896.2005.00220.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15661026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2005&pages=127-142&author=M.+Pesuauthor=F.+Candottiauthor=M.+Husaauthor=S.+R.+Hofmannauthor=L.+D.+Notarangeloauthor=J.+J.+O%E2%80%99Shea&title=JAK3%2C+severe+combined+immunodeficiency%2C+and+a+new+class+of+immunosuppressive+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span></div><div class="casAuthors">Pesu, Marko; Candotti, Fabio; Husa, Matthew; Hofmann, Sigrun R.; Notarangelo, Luigi D.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent elucidation of the multiple mol. mechanisms underlying severe combined immunodeficiency (SCID) is an impressive example of the power of mol. medicine.  Anal. of patients and the concomitant generation of animal models mimicking these disorders have quickly provided great insights into the pathophysiol. of these potentially devastating illnesses.  Here, the authors summarize the discoveries that led to the understanding of the role of cytokine receptors and a specific tyrosine kinase, Janus kinase 3 (Jak3), in the pathogenesis of SCID.  The authors discuss how the identification of mutations of Jak3 in autosomal recessive SCID has facilitated the diagnosis of these disorders, offered new insights into the biol. of this kinase, permitted new avenues for therapy, and provided the rationale for a generation of a new class of immunosuppressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYir7OTbMwFbVg90H21EOLACvtfcHk0lh_ZU0W40-IpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D&md5=038b25b97798eda4b6aa1818238e45ba</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1111%2Fj.0105-2896.2005.00220.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0105-2896.2005.00220.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DHusa%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DS.%2BR.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK3%252C%2520severe%2520combined%2520immunodeficiency%252C%2520and%2520a%2520new%2520class%2520of%2520immunosuppressive%2520drugs%26jtitle%3DImmunol.%2520Rev.%26date%3D2005%26volume%3D203%26spage%3D127%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugazio, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badolato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaese, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span> </span><span class="NLM_article-title">Structural and functional basis for JAK3-deficient severe combined immunodeficiency</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">3996</span><span class="NLM_x">–</span> <span class="NLM_lpage">4003</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=3996-4003&author=F.+Candottiauthor=S.+A.+Oakesauthor=J.+A.+Johnsonauthor=S.+Gilianiauthor=R.+F.+Schumacherauthor=P.+Mellaauthor=M.+Fioiniauthor=A.+G.+Ugazioauthor=R.+Badolatoauthor=L.+D.+Notarangeloauthor=F.+Bozziauthor=P.+Macchiauthor=D.+Strinaauthor=P.+Vezzoniauthor=R.+M.+Blaeseauthor=J.+J.+O%E2%80%99Sheaauthor=A.+Villa&title=Structural+and+functional+basis+for+JAK3-deficient+severe+combined+immunodeficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DOakes%26aufirst%3DS.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DGiliani%26aufirst%3DS.%26aulast%3DSchumacher%26aufirst%3DR.%2BF.%26aulast%3DMella%26aufirst%3DP.%26aulast%3DFioini%26aufirst%3DM.%26aulast%3DUgazio%26aufirst%3DA.%2BG.%26aulast%3DBadolato%26aufirst%3DR.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DBozzi%26aufirst%3DF.%26aulast%3DMacchi%26aufirst%3DP.%26aulast%3DStrina%26aufirst%3DD.%26aulast%3DVezzoni%26aufirst%3DP.%26aulast%3DBlaese%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DVilla%26aufirst%3DA.%26atitle%3DStructural%2520and%2520functional%2520basis%2520for%2520JAK3-deficient%2520severe%2520combined%2520immunodeficiency%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D3996%26epage%3D4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Russell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedy, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migone, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Mutation of JAK3 in a patient with SCID: essential role of JAK3 in lymphoid development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=797-800&author=S.+M.+Russellauthor=N.+Tayebiauthor=H.+Nakajimaauthor=M.+C.+Riedyauthor=J.+Robertsauthor=M.+J.+Amanauthor=T.-S.+Migoneauthor=M.+Noguchiauthor=M.+L.+Markertauthor=R.+H.+Buckleyauthor=J.+J.+O%E2%80%99Sheaauthor=W.+J.+Leonard&title=Mutation+of+JAK3+in+a+patient+with+SCID%3A+essential+role+of+JAK3+in+lymphoid+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%2BM.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DAman%26aufirst%3DM.%2BJ.%26aulast%3DMigone%26aufirst%3DT.-S.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DMarkert%26aufirst%3DM.%2BL.%26aulast%3DBuckley%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DMutation%2520of%2520JAK3%2520in%2520a%2520patient%2520with%2520SCID%253A%2520essential%2520role%2520of%2520JAK3%2520in%2520lymphoid%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D797%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8468</span><span class="NLM_x">–</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Littieauthor=K.+S.+Magnussonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+a+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lgUOgSpKVP_PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLittie%26aufirst%3DB.%2BM.%26aulast%3DMagnusson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520a%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarijian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1182%2Fblood-2009-04-214957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20130243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quintas-Cardamaauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarijianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span></div><div class="casAuthors">Quintas-Cardama, Alfonso; Vaddi, Kris; Liu, Phillip; Manshouri, Taghi; Li, Jun; Scherle, Peggy A.; Caulder, Eian; Wen, Xiaoming; Li, Yanlong; Waeltz, Paul; Rupar, Mark; Burn, Timothy; Lo, Yvonne; Kelley, Jennifer; Covington, Maryanne; Shepard, Stacey; Rodgers, James D.; Haley, Patrick; Kantarjian, Hagop; Fridman, Jordan S.; Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3109-3117</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Constitutive JAK2 activation in hematopoietic cells by the JAK2V617F mutation recapitulates myeloproliferative neoplasm (MPN) phenotypes in mice, establishing JAK2 inhibition as a potential therapeutic strategy.  Although most polycythemia vera patients carry the JAK2V617F mutation, half of those with essential thrombocythemia or primary myelofibrosis do not, suggesting alternative mechanisms for constitutive JAK-STAT signaling in MPNs.  Most patients with primary myelofibrosis have elevated levels of JAK-dependent proinflammatory cytokines (eg, interleukin-6) consistent with our observation of JAK1 hyperactivation.  Accordingly, we evaluated the effectiveness of selective JAK1/2 inhibition in exptl. models relevant to MPNs and report on the effects of INCB018424, the first potent, selective, oral JAK1/JAK2 inhibitor to enter the clinic.  INCB018424 inhibited interleukin-6 signaling (50% inhibitory concn. [IC50] = 281nM), and proliferation of JAK2V617F+ Ba/F3 cells (IC50 = 127nM).  In primary cultures, INCB018424 preferentially suppressed erythroid progenitor colony formation from JAK2V617F+ polycythemia vera patients (IC50 = 67nM) vs. healthy donors (IC50 > 400nM).  In a mouse model of JAK2V617F+ MPN, oral INCB018424 markedly reduced splenomegaly and circulating levels of inflammatory cytokines, and preferentially eliminated neoplastic cells, resulting in significantly prolonged survival without myelosuppressive or immunosuppressive effects.  Preliminary clin. results support these preclin. data and establish INCB018424 as a promising oral agent for the treatment of MPNs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKGz1l6Y-CbVg90H21EOLACvtfcHk0liaanQlnCc03g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D&md5=cd52b7013d76ed00ca2df22444c45160</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-04-214957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-04-214957%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarijian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Alicea-Velazquez, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span> </span><span class="NLM_article-title">The use of structural biology in Janus kinase targeted drug discovery</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.2174%2F138945011794751528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21126226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=546-555&author=N.+L.+Alicea-Velazquezauthor=T.+J.+Boggon&title=The+use+of+structural+biology+in+Janus+kinase+targeted+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The use of structural biology in Janus kinase targeted drug discovery</span></div><div class="casAuthors">Alicea-Velazquez, Nilda L.; Boggon, Titus J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">546-555</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (or Jak kinases) mediate cytokine and growth factor signal transduction.  Acquired or inherited Jak mutations can result in dysregulation of Jak-mediated signal transduction and can be crit. to disease acquisition in neoplasias including acute myeloid, acute lymphoblastic and acute megakaryoblastic leukemias, and in rare X-linked severe combined immunodeficiency.  The discovery of an acquired Jak2 point mutation, V617F, in significant nos. of patients with classical myeloproliferative disorders has increased the interest in development of Jak2-specific tyrosine kinase inhibitors and consequently there are now over 20 publically available structures of Jak kinase domains that describe all four family members, Jak1, Jak2, Jak3, and Tyk2.  Here we review the recent advances in understanding the druggable structure and function of the Jak family, with a focus on the structural biol. of the Jak kinase domain.  We will discuss how these advances impact the development of Jak-targeted therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJwEtMK-lOu7Vg90H21EOLACvtfcHk0liaanQlnCc03g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOkurg%253D&md5=5e76fc7eda3ffe580dc4e28044a88c2c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F138945011794751528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945011794751528%26sid%3Dliteratum%253Aachs%26aulast%3DAlicea-Velazquez%26aufirst%3DN.%2BL.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520use%2520of%2520structural%2520biology%2520in%2520Janus%2520kinase%2520targeted%2520drug%2520discovery%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2011%26volume%3D12%26spage%3D546%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40d"><span><span class="NLM_contrib-group">Goodacre, S. C.; Lai, Y.; Liang, J.; Magnuson, S. R.; Robarge, K. D.; Stanley, M. S.; Tsui, V.; Williams, K.; Zhang, B.; Zhou, A.</span><span> </span><span class="NLM_article-title">Janus Kinase Inhibitor Compounds and Methods</span>. WO2010142752,<span class="NLM_x"> </span><span class="NLM_year">2010</span>. The following patent applications describing TYK2 inhibitors were also published:</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+C.+Goodacre&author=Y.+Lai&author=J.+Liang&author=S.+R.+Magnuson&author=K.+D.+Robarge&author=M.+S.+Stanley&author=V.+Tsui&author=K.+Williams&author=B.+Zhang&author=A.+Zhou&title=Janus+Kinase+Inhibitor+Compounds+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26atitle%3DJanus%2520Kinase%2520Inhibitor%2520Compounds%2520and%2520Methods%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Buchmann, B.; Eis, K.; Bothe, U.; Bonin, A.; Bomer, U.</span>; <span> </span><span class="NLM_article-title">Carbonylamino-Substituierte Aniline-Pyromidinderivative als TYK-Inhibitoren, deren Herstellung und Verwendug als Arzneimittel</span>. DE2009001438,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Buchmann&author=K.+Eis&author=U.+Bothe&author=A.+Bonin&author=U.+Bomer&title=Carbonylamino-Substituierte+Aniline-Pyromidinderivative+als+TYK-Inhibitoren%2C+deren+Herstellung+und+Verwendug+als+Arzneimittel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DCarbonylamino-Substituierte%2520Aniline-Pyromidinderivative%2520als%2520TYK-Inhibitoren%252C%2520deren%2520Herstellung%2520und%2520Verwendug%2520als%2520Arzneimittel%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Boys, M, L.; Burgess, L. E.; Groneberg, R. D.; Harvey, D. M.; Huang, L.; Kercher, T.; Kraser, C. F.; Laird, E.; Tarlton, E.; Zhao, Q.</span><span> </span><span class="NLM_article-title">5,7-Substituted-imidazo[1,2-<i>c</i>]pyrimidines as Inhibitors of JAK Kinases</span>. WO2011130146,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M%2C+L.+Boys&author=L.+E.+Burgess&author=R.+D.+Groneberg&author=D.+M.+Harvey&author=L.+Huang&author=T.+Kercher&author=C.+F.+Kraser&author=E.+Laird&author=E.+Tarlton&author=Q.+Zhao&title=5%2C7-Substituted-imidazo%5B1%2C2-c%5Dpyrimidines+as+Inhibitors+of+JAK+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoys%26aufirst%3DM%252C%2BL.%26atitle%3D5%252C7-Substituted-imidazo%255B1%252C2-c%255Dpyrimidines%2520as%2520Inhibitors%2520of%2520JAK%2520Kinases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ellard, K.; Major, J.; Jones, A.; Lynch, R.; Ramsden, N.</span><span> </span><span class="NLM_article-title">Pyridine Compounds and Aza Analogs Thereof as TYK2 Inhibitors</span>. WO2012062704,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+Ellard&author=J.+Major&author=A.+Jones&author=R.+Lynch&author=N.+Ramsden&title=Pyridine+Compounds+and+Aza+Analogs+Thereof+as+TYK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEllard%26aufirst%3DK.%26atitle%3DPyridine%2520Compounds%2520and%2520Aza%2520Analogs%2520Thereof%2520as%2520TYK2%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Liang, J.; Tsui, V.; van Abbema, A.; Bao, L.; Barrett, K.; Beresini, M.; Berezhkovsky, B.; Blair, W.; Chang, C.; Driscoll, J.; Eigenbrot, C.; Ghilardi, N.; Gibbons, P.; Halladay, J.; Johnson, A.; Kohli, P. B.; Lai, Y.; Liimatta, M.; Mantik, P.; Menghrajani, K.; Murray, J.; Sambrone, A.; Shao, Y.; Shia, S.; Shin, Y.; Smith, J.; Sohn, S.; Stanley, M.; Ultsch, M.; Zhang, B.; Magnuson, S.</span><span> </span><span class="NLM_article-title">Lead identification of novel and selective TYK2 inhibitors</span>.  <span class="citation_source-journal">Eur. J. Med. Chem.</span>, accepted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liang%2C+J.%3B+Tsui%2C+V.%3B+van+Abbema%2C+A.%3B+Bao%2C+L.%3B+Barrett%2C+K.%3B+Beresini%2C+M.%3B+Berezhkovsky%2C+B.%3B+Blair%2C+W.%3B+Chang%2C+C.%3B+Driscoll%2C+J.%3B+Eigenbrot%2C+C.%3B+Ghilardi%2C+N.%3B+Gibbons%2C+P.%3B+Halladay%2C+J.%3B+Johnson%2C+A.%3B+Kohli%2C+P.+B.%3B+Lai%2C+Y.%3B+Liimatta%2C+M.%3B+Mantik%2C+P.%3B+Menghrajani%2C+K.%3B+Murray%2C+J.%3B+Sambrone%2C+A.%3B+Shao%2C+Y.%3B+Shia%2C+S.%3B+Shin%2C+Y.%3B+Smith%2C+J.%3B+Sohn%2C+S.%3B+Stanley%2C+M.%3B+Ultsch%2C+M.%3B+Zhang%2C+B.%3B+Magnuson%2C+S.+Lead+identification+of+novel+and+selective+TYK2+inhibitors.+Eur.+J.+Med.+Chem.%2C+accepted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26atitle%3DLead%2520identification%2520of%2520novel%2520and%2520selective%2520TYK2%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">Our compounds were found to be consistently much less active against the JAK3 enzyme than TYK2 (>50-fold difference between the JAK3 <i>K</i><sub>i</sub> and TYK2 <i>K</i><sub>i</sub>). JAK3 inhibitory activities were not reported for the majority of compounds described in this work except for compound <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and compounds <b>35</b>–<b>37</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Recent reports also suggested that JAK3 inhibition is not sufficient in blocking effects of type I cytokines and that JAK1 is the dominant kinase: </p></div><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovlering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">JAK1 has a dominant role over JAK3 in signal transduction through γc-containing cytokine receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rovleringauthor=F.+Raultauthor=M.+Kappauthor=P.+Druckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=JAK1+has+a+dominant+role+over+JAK3+in+signal+transduction+through+%CE%B3c-containing+cytokine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0lhKKprsGx5PTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRovlering%26aufirst%3DC.%26aulast%3DRault%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJAK1%2520has%2520a%2520dominant%2520role%2520over%2520JAK3%2520in%2520signal%2520transduction%2520through%2520%25CE%25B3c-containing%2520cytokine%2520receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchetto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangrevelinghe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+Janus+kinase+3+inhibitor+with+high+selectivity+within+the+Janus+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520Janus%2520kinase%25203%2520inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520Janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D284%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhKKprsGx5PTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spingthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Spingthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liEne5a--PUAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpingthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="note"><p class="first last">Kinase P-loop is known to be flexible: </p></div><div class="NLM_citation" id="cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornev, A. P.</span><span> </span><span class="NLM_article-title">Protein kinases: evolution of dynamic regulatory protein</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=65-77&author=S.+S.+Taylorauthor=A.+P.+Kornev&title=Protein+kinases%3A+evolution+of+dynamic+regulatory+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DKornev%26aufirst%3DA.%2BP.%26atitle%3DProtein%2520kinases%253A%2520evolution%2520of%2520dynamic%2520regulatory%2520protein%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2011%26volume%3D36%26spage%3D65%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Defining the conserved internal architecture of a protein kinase</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=440-444&author=A.+P.+Kornevauthor=S.+S.+Taylor&title=Defining+the+conserved+internal+architecture+of+a+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DDefining%2520the%2520conserved%2520internal%2520architecture%2520of%2520a%2520protein%2520kinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D440%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosati, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Boeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, R.</span><span> </span><span class="NLM_article-title">Metasite: understanding metabolism in human cytochromes from the perspective of the chemist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6970</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050529c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6970-6979&author=G.+Crucianiauthor=E.+Carosatiauthor=B.+De+Boeckauthor=K.+Ethirajuluauthor=C.+Mackieauthor=T.+Howeauthor=R.+Vianello&title=Metasite%3A+understanding+metabolism+in+human+cytochromes+from+the+perspective+of+the+chemist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050529c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050529c%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarosati%26aufirst%3DE.%26aulast%3DDe%2BBoeck%26aufirst%3DB.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DVianello%26aufirst%3DR.%26atitle%3DMetasite%253A%2520understanding%2520metabolism%2520in%2520human%2520cytochromes%2520from%2520the%2520perspective%2520of%2520the%2520chemist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6970%26epage%3D6979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hill, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46a</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0lg8skgFsM5ADw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D648%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Richie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability—Are too many aromatic rings a liability in drug design?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&author=T.+J.+Richieauthor=S.+J.+F.+MacDonald&title=The+impact+of+aromatic+ring+count+on+compound+developability%E2%80%94Are+too+many+aromatic+rings+a+liability+in+drug+design%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%25E2%2580%2594Are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Orthogonal multipolar interactions in structural chemistry and biology</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1002%2Fanie.200462213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1788-1805&author=R.+Pauliniauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=Orthogonal+multipolar+interactions+in+structural+chemistry+and+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Orthogonal multipolar interactions in structural chemistry and biology</span></div><div class="casAuthors">Paulini, Ralph; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1788-1805</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The past few decades of mol. recognition studies have greatly enhanced our knowledge on apolar, ion-dipole, and hydrogen-bonding interactions.  However, much less attention has been given to the role that multipolar interactions, in particular those with orthogonal dipolar alignment, play in organizing a crystal lattice or stabilizing complexes involving biol. receptors.  By using results from database mining, this review attempts to give an overview of types and structural features of these previously rather overlooked interactions.  A no. of illustrative examples of these interactions found in X-ray crystal structures of small mols. and protein-ligand complexes demonstrate their propensity and thus potential importance for both, chem. and biol. mol. recognition processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGHoutIq12LVg90H21EOLACvtfcHk0lhjavvSwy3W4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D&md5=6ad842547313b27fc1676e9c3a001909</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462213%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOrthogonal%2520multipolar%2520interactions%2520in%2520structural%2520chemistry%2520and%2520biology%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D1788%26epage%3D1805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reutlinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N. R.</span><span> </span><span class="NLM_article-title">Rationalizing tight ligand binding through cooperative interaction networks</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3180</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200319e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=3180-3198&author=B.+Kuhnauthor=J.+E.+Fuchsauthor=M.+Reutlingerauthor=M.+Stahlauthor=N.+R.+Taylor&title=Rationalizing+tight+ligand+binding+through+cooperative+interaction+networks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rationalizing Tight Ligand Binding through Cooperative Interaction Networks</span></div><div class="casAuthors">Kuhn, Bernd; Fuchs, Julian E.; Reutlinger, Michael; Stahl, Martin; Taylor, Neil R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3180-3198</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small modifications of the mol. structure of a ligand sometimes cause strong gains in binding affinity to a protein target, rendering a weakly active chem. series suddenly attractive for further optimization.  Our goal in this study is to better rationalize and predict the occurrence of such interaction hot-spots in receptor binding sites.  To this end, we introduce two new concepts into the computational description of mol. recognition.  First, we take a broader view of noncovalent interactions and describe protein-ligand binding with a comprehensive set of favorable and unfavorable contact types, including for example halogen bonding and orthogonal multipolar interactions.  Second, we go beyond the commonly used pairwise additive treatment of at. interactions and use a small world network approach to describe how interactions are modulated by their environment.  This approach allows us to capture local cooperativity effects and considerably improves the performance of a newly derived empirical scoring function, Scorpions-core.  More importantly, however, we demonstrate how an intuitive visualization of key intermol. interactions, interaction networks, and binding hot-spots supports the identification and rationalization of tight ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCzUUIjVW8P7Vg90H21EOLACvtfcHk0lhjavvSwy3W4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7rI&md5=e8e1bdc3bad1cfdfc11253de5837e4c6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fci200319e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200319e%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DFuchs%26aufirst%3DJ.%2BE.%26aulast%3DReutlinger%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DN.%2BR.%26atitle%3DRationalizing%2520tight%2520ligand%2520binding%2520through%2520cooperative%2520interaction%2520networks%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D3180%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starovasnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span> </span><span class="NLM_article-title">A new regulatory switch in a JAK protein kinase</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=393-401&author=V.+Tsuiauthor=P.+Gibbonsauthor=M.+Ultschauthor=K.+Mortaraauthor=C.+Changauthor=W.+Blairauthor=R.+Pulkauthor=M.+Stanleyauthor=M.+Starovasnikauthor=D.+Williamsauthor=M.+Lamersauthor=P.+Leonardauthor=S.+Magnusonauthor=J.+Liangauthor=C.+Eigenbrot&title=A+new+regulatory+switch+in+a+JAK+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DStarovasnik%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26atitle%3DA%2520new%2520regulatory%2520switch%2520in%2520a%2520JAK%2520protein%2520kinase%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2011%26volume%3D79%26spage%3D393%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49bR"><div class="casContent"><span class="casTitleNuber">49b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lh0d1kh-_6kig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lh0d1kh-_6kig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Graczyk, P. P.</span><span> </span><span class="NLM_article-title">Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5773</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070562u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5773-5779&author=P.+P.+Graczyk&title=Gini+coefficient%3A+a+new+way+to+express+selectivity+of+kinase+inhibitors+against+a+family+of+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases</span></div><div class="casAuthors">Graczyk, Piotr P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5773-5779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel application of the Gini coeff. for expressing selectivity of kinase inhibitors against a panel of kinases is proposed.  This has been illustrated using single-point inhibition data for 40 com. available kinase inhibitors screened against 85 kinases.  Nonselective inhibitors are characterized by Gini values close to zero (Staurosporine, Gini 0.150).  Highly selective compds. exhibit Gini values close to 1 (PD184352 Gini 0.905).  The relative selectivity of inhibitors does not depend on the ATP concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUHpmF-C9u7Vg90H21EOLACvtfcHk0lh0d1kh-_6kig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL&md5=51f4902e49196dfef8e135c4a09182d7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm070562u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070562u%26sid%3Dliteratum%253Aachs%26aulast%3DGraczyk%26aufirst%3DP.%2BP.%26atitle%3DGini%2520coefficient%253A%2520a%2520new%2520way%2520to%2520express%2520selectivity%2520of%2520kinase%2520inhibitors%2520against%2520a%2520family%2520of%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5773%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Böhm, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.-J.+B%C3%B6hmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+M%C3%BCllerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52aR"><div class="casContent"><span class="casTitleNuber">52a</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2ebUu1QlTQymALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit52a&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6hm%26aufirst%3DH.-J.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit52b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Purser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouverneur, V.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1039%2FB610213C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18197348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=320-330&author=S.+Purserauthor=P.+R.+Mooreauthor=S.+Swallowauthor=V.+Gouverneur&title=Fluorine+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52bR"><div class="casContent"><span class="casTitleNuber">52b</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Purser, Sophie; Moore, Peter R.; Swallow, Steve; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-330</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  It has become evident that fluorinated compds. have a remarkable record in medicinal chem. and will play a continuing role in providing lead compds. for therapeutic applications.  This tutorial review provides a sampling of renowned fluorinated drugs and their mode of action with a discussion clarifying the role and impact of fluorine substitution on drug potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKAqJ3UbgGbVg90H21EOLACvtfcHk0lgxfh0sEevOhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D&md5=e6c9e3084e454c44a4ba245b98f7f1d7</span></div><a href="/servlet/linkout?suffix=cit52b&amp;dbid=16384&amp;doi=10.1039%2FB610213C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB610213C%26sid%3Dliteratum%253Aachs%26aulast%3DPurser%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DP.%2BR.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26spage%3D320%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit52c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hagmann, W. K.</span><span> </span><span class="NLM_article-title">The many roles for fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4359</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800219f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4359-4369&author=W.+K.+Hagmann&title=The+many+roles+for+fluorine+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52cR"><div class="casContent"><span class="casTitleNuber">52c</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles for Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Hagmann, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4359-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZV7sio8RhbVg90H21EOLACvtfcHk0lgxfh0sEevOhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D&md5=821f8076bb0f632f687b1c90b05dd382</span></div><a href="/servlet/linkout?suffix=cit52c&amp;dbid=16384&amp;doi=10.1021%2Fjm800219f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800219f%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DThe%2520many%2520roles%2520for%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4359%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><div class="note"><p class="first last">The relatively small shift (4.4-fold) of potency between PBMC and human whole blood for compound <b>37</b> is likely due to its modest (86.6%) human plasma protein binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A nice review of “free drug principle” with many recent examples could be found:</p></div><span class="NLM_contrib-group">Trainor, G. L.</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1517%2F17460441.2.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=23496037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+relatively+small+shift+%284.4-fold%29+of+potency+between+PBMC+and+human+whole+blood+for+compound+37+is+likely+due+to+its+modest+%2886.6%25%29+human+plasma+protein+binding+%28Table+4%29.+A+nice+review+of+%E2%80%9Cfree+drug+principle%E2%80%9D+with+many+recent+examples+could+be+found%3ATrainor%2C+G.+L.Expert+Opin.+Drug+Discovery+2007%2C+2%2C+51%E2%80%9364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of plasma protein binding in drug discovery</span></div><div class="casAuthors">Trainor, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Plasma protein binding of drugs is a well-recognized phenomena, but it is only recently that the implications for drug action in vivo have been fully appreciated.  Plasma proteins, by virtue of their high concn., control the free drug concn. in plasma and in compartments in equil. with plasma, thereby, effectively attenuating drug potency in vivo.  The historical background and thermodn. basis for the 'Free Drug Principle' is presented, along with special considerations for intracellular targets, deep compartments and α1-acid glycoprotein binding.  Real and apparent exceptions to the principle are discussed along with a survey of citations from the recent medicinal chem. literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyoyVEZ33iUbVg90H21EOLACvtfcHk0lgxfh0sEevOhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D&md5=06ed3a7f31e02588cf98e790abdc622f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D51%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="note"><p class="first last">Synthesis and chiral resolution of 2-fluorocyclopropanecarboxylic acid have been reported: </p></div><div class="NLM_citation" id="cit54a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Akiba, T.; Ikeya, T.; Kawanishi, H.; Yukimoto, Y.; Kamihara, S.; Ebata, T.</span><span> </span><span class="NLM_article-title">Selective Dehalogenation Process</span>. U.S. Patent 5,780,669,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=T.+Akiba&author=T.+Ikeya&author=H.+Kawanishi&author=Y.+Yukimoto&author=S.+Kamihara&author=T.+Ebata&title=Selective+Dehalogenation+Process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAkiba%26aufirst%3DT.%26atitle%3DSelective%2520Dehalogenation%2520Process%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit54b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atarashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, I.</span><span> </span><span class="NLM_article-title">(Fluorocyclopropyl)quinolones. 2. Synthesis and stereochemical structure–activity relationship of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3344</span><span class="NLM_x">–</span> <span class="NLM_lpage">3352</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00046a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3344-3352&author=Y.+Kimuraauthor=S.+Atarashiauthor=K.+Kawakamiauthor=K.+Satoauthor=I.+Hayakawa&title=%28Fluorocyclopropyl%29quinolones.+2.+Synthesis+and+stereochemical+structure%E2%80%93activity+relationship+of+chiral+7-%287-amino-5-azaspiro%5B2.4%5Dheptan-5-yl%29-1-%282-fluorocyclopropyl%29quinolone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54b&amp;dbid=16384&amp;doi=10.1021%2Fjm00046a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00046a019%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DAtarashi%26aufirst%3DS.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DHayakawa%26aufirst%3DI.%26atitle%3D%2528Fluorocyclopropyl%2529quinolones.%25202.%2520Synthesis%2520and%2520stereochemical%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520chiral%25207-%25287-amino-5-azaspiro%255B2.4%255Dheptan-5-yl%2529-1-%25282-fluorocyclopropyl%2529quinolone%2520antibacterial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3344%26epage%3D3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandretto, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span> </span><span class="NLM_article-title">Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=567-576&author=A.+C.+Pierceauthor=K.+L.+Sandrettoauthor=G.+W.+Bemis&title=Kinase+inhibitors+and+the+case+for+CH...O+hydrogen+bonds+in+protein-ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DSandretto%26aufirst%3DK.%2BL.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26atitle%3DKinase%2520inhibitors%2520and%2520the%2520case%2520for%2520CH...O%2520hydrogen%2520bonds%2520in%2520protein-ligand%2520binding%26jtitle%3DProteins%26date%3D2002%26volume%3D49%26spage%3D567%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b','cit11c','cit11d'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19a','cit19b','cit19c','cit19d'],'ref20':['cit20a','cit20b','cit20c','cit20d'],'ref21':['cit21a','cit21b'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29a','cit29b'],'ref30':['cit30a','cit30b','cit30c'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35a','cit35b'],'ref36':['cit36a','cit36b'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40d','cit40a','cit40b','cit40c'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43a','cit43b'],'ref44':['cit44a','cit44b'],'ref45':['cit45'],'ref46':['cit46a','cit46b'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49a','cit49b'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52a','cit52b','cit52c'],'ref53':['cit53'],'ref54':['cit54a','cit54b'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Timothy J. Giese, <span class="NLM_string-name hlFld-ContribAuthor">Darrin M. York</span>. </span><span class="cited-content_cbyCitation_article-title">Variational Method for Networkwide Analysis of Relative Ligand Binding Free Energies with Loop Closure and Experimental Constraints. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2021,</strong> <em>17 </em>
                                    (3)
                                     , 1326-1336. <a href="https://doi.org/10.1021/acs.jctc.0c01219" title="DOI URL">https://doi.org/10.1021/acs.jctc.0c01219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.0c01219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.0c01219%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DVariational%252BMethod%252Bfor%252BNetworkwide%252BAnalysis%252Bof%252BRelative%252BLigand%252BBinding%252BFree%252BEnergies%252Bwith%252BLoop%252BClosure%252Band%252BExperimental%252BConstraints%26aulast%3DGiese%26aufirst%3DTimothy%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23112020%26date%3D02022021%26volume%3D17%26issue%3D3%26spage%3D1326%26epage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mateusz K. Bieniek, Agastya P. Bhati, Shunzhou Wan, <span class="NLM_string-name hlFld-ContribAuthor">Peter V. Coveney</span>. </span><span class="cited-content_cbyCitation_article-title">TIES 20: Relative Binding Free Energy with a Flexible Superimposition Algorithm and Partial Ring Morphing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2021,</strong> <em>17 </em>
                                    (2)
                                     , 1250-1265. <a href="https://doi.org/10.1021/acs.jctc.0c01179" title="DOI URL">https://doi.org/10.1021/acs.jctc.0c01179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.0c01179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.0c01179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DTIES%252B20%25253A%252BRelative%252BBinding%252BFree%252BEnergy%252Bwith%252Ba%252BFlexible%252BSuperimposition%252BAlgorithm%252Band%252BPartial%252BRing%252BMorphing%26aulast%3DBieniek%26aufirst%3DMateusz%2BK.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D10112020%26date%3D25012021%26volume%3D17%26issue%3D2%26spage%3D1250%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chunjian Liu, James Lin, Charles Langevine, Daniel Smith, Jianqing Li, John S. Tokarski, Javed Khan, Max Ruzanov, Joann Strnad, Adriana Zupa-Fernandez, Lihong Cheng, Kathleen M. Gillooly, David Shuster, Yifan Zhang, Anil Thankappan, Kim W. McIntyre, Charu Chaudhry, Paul A. Elzinga, Manoj Chiney, Anjaneya Chimalakonda, Louis J. Lombardo, John E. Macor, Percy H. Carter, James R. Burke, <span class="NLM_string-name hlFld-ContribAuthor">David S. Weinstein</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 677-694. <a href="https://doi.org/10.1021/acs.jmedchem.0c01698" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01698</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01698%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBMS-986202%25253A%252BA%252BClinical%252BTyk2%252BInhibitor%252Bthat%252BBinds%252Bto%252BTyk2%252BJH2%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D28092020%26date%3D28122020%26volume%3D64%26issue%3D1%26spage%3D677%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maximilian Kuhn, Stuart Firth-Clark, Paolo Tosco, Antonia S. J. S. Mey, Mark Mackey, <span class="NLM_string-name hlFld-ContribAuthor">Julien Michel</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Binding Affinity via Alchemical Free-Energy Calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (6)
                                     , 3120-3130. <a href="https://doi.org/10.1021/acs.jcim.0c00165" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00165%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAssessment%252Bof%252BBinding%252BAffinity%252Bvia%252BAlchemical%252BFree-Energy%252BCalculations%26aulast%3DKuhn%26aufirst%3DMaximilian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14022020%26date%3D03062020%26date%3D21052020%26volume%3D60%26issue%3D6%26spage%3D3120%26epage%3D3130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ryan Moslin, Yanlei Zhang, Stephen T. Wrobleski, Shuqun Lin, Michael Mertzman, Steven Spergel, John S. Tokarski, Joann Strnad, Kathleen Gillooly, Kim W. McIntyre, Adriana Zupa-Fernandez, Lihong Cheng, Huadong Sun, Charu Chaudhry, Christine Huang, Celia D’Arienzo, Elizabeth Heimrich, Xiaoxia Yang, Jodi K. Muckelbauer, ChiehYing Chang, Jeffrey Tredup, Dawn Mulligan, Dianlin Xie, Nelly Aranibar, Manoj Chiney, James R. Burke, Louis Lombardo, Percy H. Carter, <span class="NLM_string-name hlFld-ContribAuthor">David S. Weinstein</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8953-8972. <a href="https://doi.org/10.1021/acs.jmedchem.9b00443" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00443%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BN-Methyl%252BNicotinamide%252Band%252BN-Methyl%252BPyridazine-3-Carboxamide%252BPseudokinase%252BDomain%252BLigands%252Bas%252BHighly%252BSelective%252BAllosteric%252BInhibitors%252Bof%252BTyrosine%252BKinase%252B2%252B%252528TYK2%252529%26aulast%3DMoslin%26aufirst%3DRyan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D17072019%26volume%3D62%26issue%3D20%26spage%3D8953%26epage%3D8972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chunjian Liu, James Lin, Ryan Moslin, John S. Tokarski, Jodi Muckelbauer, ChiehYing Chang, Jeffrey Tredup, Dianlin Xie, Hyunsoo Park, Peng Li, Dauh-Rurng Wu, Joann Strnad, Adriana Zupa-Fernandez, Lihong Cheng, Charu Chaudhry, Jing Chen, Cliff Chen, Huadong Sun, Paul Elzinga, Celia D’arienzo, Kathleen Gillooly, Tracy L. Taylor, Kim W. McIntyre, Luisa Salter-Cid, Louis J. Lombardo, Percy H. Carter, Nelly Aranibar, James R. Burke, <span class="NLM_string-name hlFld-ContribAuthor">David S. Weinstein</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 383-388. <a href="https://doi.org/10.1021/acsmedchemlett.9b00035" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00035%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BImidazo%25255B1%25252C2-b%25255Dpyridazine%252BDerivatives%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BActive%252BTyk2%252BJH2%252BInhibitors%26aulast%3DLiu%26aufirst%3DChunjian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28012019%26date%3D21022019%26date%3D25022019%26date%3D21022019%26volume%3D10%26issue%3D3%26spage%3D383%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Katarina Roos, Chuanjie Wu, Wolfgang Damm, Mark Reboul, James M. Stevenson, Chao Lu, Markus K. Dahlgren, Sayan Mondal, Wei Chen, Lingle Wang, Robert Abel, Richard A. Friesner, <span class="NLM_string-name hlFld-ContribAuthor">Edward D. Harder</span>. </span><span class="cited-content_cbyCitation_article-title">OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2019,</strong> <em>15 </em>
                                    (3)
                                     , 1863-1874. <a href="https://doi.org/10.1021/acs.jctc.8b01026" title="DOI URL">https://doi.org/10.1021/acs.jctc.8b01026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.8b01026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.8b01026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DOPLS3e%25253A%252BExtending%252BForce%252BField%252BCoverage%252Bfor%252BDrug-Like%252BSmall%252BMolecules%26aulast%3DRoos%26aufirst%3DKatarina%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D11102018%26date%3D04032019%26date%3D15022019%26volume%3D15%26issue%3D3%26spage%3D1863%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Chen, Yuqing Deng, Ellery Russell, Yujie Wu, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Lingle Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Accurate Calculation of Relative Binding Free Energies between Ligands with Different Net Charges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2018,</strong> <em>14 </em>
                                    (12)
                                     , 6346-6358. <a href="https://doi.org/10.1021/acs.jctc.8b00825" title="DOI URL">https://doi.org/10.1021/acs.jctc.8b00825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.8b00825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.8b00825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DAccurate%252BCalculation%252Bof%252BRelative%252BBinding%252BFree%252BEnergies%252Bbetween%252BLigands%252Bwith%252BDifferent%252BNet%252BCharges%26aulast%3DChen%26aufirst%3DWei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07082018%26date%3D12112018%26date%3D30102018%26volume%3D14%26issue%3D12%26spage%3D6346%26epage%3D6358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth Hatcher  Frush</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Sekharan</span>, and <span class="hlFld-ContribAuthor ">Shahar  Keinan</span>  . </span><span class="cited-content_cbyCitation_article-title">In Silico Prediction of Ligand Binding Energies in Multiple Therapeutic Targets and Diverse Ligand Sets—A Case Study on BACE1, TYK2, HSP90, and PERK Proteins. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2017,</strong> <em>121 </em>
                                    (34)
                                     , 8142-8148. <a href="https://doi.org/10.1021/acs.jpcb.7b07224" title="DOI URL">https://doi.org/10.1021/acs.jpcb.7b07224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.7b07224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.7b07224%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DIn%252BSilico%252BPrediction%252Bof%252BLigand%252BBinding%252BEnergies%252Bin%252BMultiple%252BTherapeutic%252BTargets%252Band%252BDiverse%252BLigand%252BSets%2525E2%252580%252594A%252BCase%252BStudy%252Bon%252BBACE1%25252C%252BTYK2%25252C%252BHSP90%25252C%252Band%252BPERK%252BProteins%26aulast%3DFrush%26aufirst%3DElizabeth%2BHatcher%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21072017%26date%3D28072017%26date%3D17082017%26date%3D31082017%26date%3D31072017%26volume%3D121%26issue%3D34%26spage%3D8142%26epage%3D8148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agastya P.  Bhati</span>, <span class="hlFld-ContribAuthor ">Shunzhou  Wan</span>, <span class="hlFld-ContribAuthor ">David W.  Wright</span>, and <span class="hlFld-ContribAuthor ">Peter V.  Coveney</span>  . </span><span class="cited-content_cbyCitation_article-title">Rapid, Accurate, Precise, and Reliable Relative Free Energy Prediction Using Ensemble Based Thermodynamic Integration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2017,</strong> <em>13 </em>
                                    (1)
                                     , 210-222. <a href="https://doi.org/10.1021/acs.jctc.6b00979" title="DOI URL">https://doi.org/10.1021/acs.jctc.6b00979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.6b00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.6b00979%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DRapid%25252C%252BAccurate%25252C%252BPrecise%25252C%252Band%252BReliable%252BRelative%252BFree%252BEnergy%252BPrediction%252BUsing%252BEnsemble%252BBased%252BThermodynamic%252BIntegration%26aulast%3DBhati%26aufirst%3DAgastya%2BP.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D05102016%26date%3D20122016%26date%3D10012017%26date%3D08122016%26volume%3D13%26issue%3D1%26spage%3D210%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Cappel</span>, <span class="hlFld-ContribAuthor ">Michelle Lynn  Hall</span>, <span class="hlFld-ContribAuthor ">Eelke B.  Lenselink</span>, <span class="hlFld-ContribAuthor ">Thijs  Beuming</span>, <span class="hlFld-ContribAuthor ">Jun  Qi</span>, <span class="hlFld-ContribAuthor ">James  Bradner</span>, and <span class="hlFld-ContribAuthor ">Woody  Sherman</span>  . </span><span class="cited-content_cbyCitation_article-title">Relative Binding Free Energy Calculations Applied to Protein Homology Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (12)
                                     , 2388-2400. <a href="https://doi.org/10.1021/acs.jcim.6b00362" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00362%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DRelative%252BBinding%252BFree%252BEnergy%252BCalculations%252BApplied%252Bto%252BProtein%252BHomology%252BModels%26aulast%3DCappel%26aufirst%3DDaniel%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D18112016%26date%3D27122016%26date%3D08112016%26volume%3D56%26issue%3D12%26spage%3D2388%26epage%3D2400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-You  Huang</span>, <span class="hlFld-ContribAuthor ">Jing-Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Ke  Song</span>, <span class="hlFld-ContribAuthor ">Qian  Chen</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhou</span>, <span class="hlFld-ContribAuthor ">Ge-Fei  Hao</span>, and <span class="hlFld-ContribAuthor ">Guang-Fu  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">One-Pot Approach to N-Quinolyl 3′/4′-Biaryl Carboxamides by Microwave-Assisted Suzuki–Miyaura Coupling and N-Boc Deprotection. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (20)
                                     , 9647-9657. <a href="https://doi.org/10.1021/acs.joc.6b01725" title="DOI URL">https://doi.org/10.1021/acs.joc.6b01725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b01725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b01725%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%252BApproach%252Bto%252BN-Quinolyl%252B3%2525E2%252580%2525B2%25252F4%2525E2%252580%2525B2-Biaryl%252BCarboxamides%252Bby%252BMicrowave-Assisted%252BSuzuki%2525E2%252580%252593Miyaura%252BCoupling%252Band%252BN-Boc%252BDeprotection%26aulast%3DHuang%26aufirst%3DZhi-You%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19072016%26date%3D03102016%26date%3D21102016%26date%3D20092016%26volume%3D81%26issue%3D20%26spage%3D9647%26epage%3D9657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Ruiz-Castillo</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12564-12649. <a href="https://doi.org/10.1021/acs.chemrev.6b00512" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DApplications%252Bof%252BPalladium-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252BReactions%26aulast%3DRuiz-Castillo%26aufirst%3DPaula%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03082016%26date%3D30092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12564%26epage%3D12649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takatoshi  Yogo</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nagamiya</span>, <span class="hlFld-ContribAuthor ">Masaki  Seto</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sasaki</span>, <span class="hlFld-ContribAuthor ">Huang  Shih-Chung</span>, <span class="hlFld-ContribAuthor ">Yusuke  Ohba</span>, <span class="hlFld-ContribAuthor ">Norihito  Tokunaga</span>, <span class="hlFld-ContribAuthor ">Gil Nam  Lee</span>, <span class="hlFld-ContribAuthor ">Chul Yun  Rhim</span>, <span class="hlFld-ContribAuthor ">Cheol Hwan  Yoon</span>, <span class="hlFld-ContribAuthor ">Suk Young  Cho</span>, <span class="hlFld-ContribAuthor ">Robert  Skene</span>, <span class="hlFld-ContribAuthor ">Syunsuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Yousuke  Satou</span>, <span class="hlFld-ContribAuthor ">Masako  Kuno</span>, <span class="hlFld-ContribAuthor ">Takahiro  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Atsutoshi  Okabe</span>, <span class="hlFld-ContribAuthor ">Shogo  Marui</span>, <span class="hlFld-ContribAuthor ">Kazuyoshi  Aso</span>, and <span class="hlFld-ContribAuthor ">Masato  Yoshida</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 733-749. <a href="https://doi.org/10.1021/acs.jmedchem.5b01857" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BSynthesis%252Bof%252B3-Amino-1%25252C5-dihydro-4H-pyrazolopyridin-4-one%252BDerivatives%252Bas%252BTyrosine%252BKinase%252B2%252BInhibitors%26aulast%3DYogo%26aufirst%3DTakatoshi%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D01122015%26date%3D08012016%26date%3D28012016%26date%3D24122015%26volume%3D59%26issue%3D2%26spage%3D733%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward  Harder</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Damm</span>, <span class="hlFld-ContribAuthor ">Jon  Maple</span>, <span class="hlFld-ContribAuthor ">Chuanjie  Wu</span>, <span class="hlFld-ContribAuthor ">Mark  Reboul</span>, <span class="hlFld-ContribAuthor ">Jin Yu  Xiang</span>, <span class="hlFld-ContribAuthor ">Lingle  Wang</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lupyan</span>, <span class="hlFld-ContribAuthor ">Markus K.  Dahlgren</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Knight</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Kaus</span>, <span class="hlFld-ContribAuthor ">David S.  Cerutti</span>, <span class="hlFld-ContribAuthor ">Goran  Krilov</span>, <span class="hlFld-ContribAuthor ">William L.  Jorgensen</span>, <span class="hlFld-ContribAuthor ">Robert  Abel</span>, and <span class="hlFld-ContribAuthor ">Richard A.  Friesner</span>  . </span><span class="cited-content_cbyCitation_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2016,</strong> <em>12 </em>
                                    (1)
                                     , 281-296. <a href="https://doi.org/10.1021/acs.jctc.5b00864" title="DOI URL">https://doi.org/10.1021/acs.jctc.5b00864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DOPLS3%25253A%252BA%252BForce%252BField%252BProviding%252BBroad%252BCoverage%252Bof%252BDrug-like%252BSmall%252BMolecules%252Band%252BProteins%26aulast%3DHarder%26aufirst%3DEdward%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D07092015%26date%3D01122015%26date%3D12012016%26date%3D17112015%26volume%3D12%26issue%3D1%26spage%3D281%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7611-7633. <a href="https://doi.org/10.1021/acs.jmedchem.5b00229" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStrategies%252Bfor%252Bthe%252BDiscovery%252Bof%252BTarget-Specific%252Bor%252BIsoform-Selective%252BModulators%26aulast%3DZhan%26aufirst%3DPeng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09022015%26date%3D01072015%26date%3D08102015%26date%3D18062015%26volume%3D58%26issue%3D19%26spage%3D7611%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingle  Wang</span>, <span class="hlFld-ContribAuthor ">Yujie  Wu</span>, <span class="hlFld-ContribAuthor ">Yuqing  Deng</span>, <span class="hlFld-ContribAuthor ">Byungchan  Kim</span>, <span class="hlFld-ContribAuthor ">Levi  Pierce</span>, <span class="hlFld-ContribAuthor ">Goran  Krilov</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lupyan</span>, <span class="hlFld-ContribAuthor ">Shaughnessy  Robinson</span>, <span class="hlFld-ContribAuthor ">Markus K.  Dahlgren</span>, <span class="hlFld-ContribAuthor ">Jeremy  Greenwood</span>, <span class="hlFld-ContribAuthor ">Donna L.  Romero</span>, <span class="hlFld-ContribAuthor ">Craig  Masse</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Knight</span>, <span class="hlFld-ContribAuthor ">Thomas  Steinbrecher</span>, <span class="hlFld-ContribAuthor ">Thijs  Beuming</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Damm</span>, <span class="hlFld-ContribAuthor ">Ed  Harder</span>, <span class="hlFld-ContribAuthor ">Woody  Sherman</span>, <span class="hlFld-ContribAuthor ">Mark  Brewer</span>, <span class="hlFld-ContribAuthor ">Ron  Wester</span>, <span class="hlFld-ContribAuthor ">Mark  Murcko</span>, <span class="hlFld-ContribAuthor ">Leah  Frye</span>, <span class="hlFld-ContribAuthor ">Ramy  Farid</span>, <span class="hlFld-ContribAuthor ">Teng  Lin</span>, <span class="hlFld-ContribAuthor ">David L.  Mobley</span>, <span class="hlFld-ContribAuthor ">William L.  Jorgensen</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Berne</span>, <span class="hlFld-ContribAuthor ">Richard A.  Friesner</span>, and <span class="hlFld-ContribAuthor ">Robert  Abel</span>  . </span><span class="cited-content_cbyCitation_article-title">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (7)
                                     , 2695-2703. <a href="https://doi.org/10.1021/ja512751q" title="DOI URL">https://doi.org/10.1021/ja512751q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja512751q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja512751q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAccurate%252Band%252BReliable%252BPrediction%252Bof%252BRelative%252BLigand%252BBinding%252BPotency%252Bin%252BProspective%252BDrug%252BDiscovery%252Bby%252BWay%252Bof%252Ba%252BModern%252BFree-Energy%252BCalculation%252BProtocol%252Band%252BForce%252BField%26aulast%3DWang%26aufirst%3DLingle%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D15122014%26date%3D12022015%26date%3D25022015%26date%3D27012015%26volume%3D137%26issue%3D7%26spage%3D2695%26epage%3D2703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonie C S  De Vries</span>, <span class="hlFld-ContribAuthor ">Mohammed  Ghiboub</span>, <span class="hlFld-ContribAuthor ">Patricia H P  van Hamersveld</span>, <span class="hlFld-ContribAuthor ">Olaf  Welting</span>, <span class="hlFld-ContribAuthor ">Caroline  Verseijden</span>, <span class="hlFld-ContribAuthor ">Matthew J  Bell</span>, <span class="hlFld-ContribAuthor ">Inmaculada  Rioja</span>, <span class="hlFld-ContribAuthor ">Rabinder K  Prinjha</span>, <span class="hlFld-ContribAuthor ">Pim J  Koelink</span>, <span class="hlFld-ContribAuthor ">Birgit  Strobl</span>, <span class="hlFld-ContribAuthor ">Mathias  Müller</span>, <span class="hlFld-ContribAuthor ">Geert R  D’Haens</span>, <span class="hlFld-ContribAuthor ">Manon E  Wildenberg</span>, <span class="hlFld-ContribAuthor ">Wouter J  De Jonge</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Crohn's and Colitis</span><span> <strong>2021,</strong> <em>15 </em>
                                    (4)
                                     , 617-630. <a href="https://doi.org/10.1093/ecco-jcc/jjaa199" title="DOI URL">https://doi.org/10.1093/ecco-jcc/jjaa199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ecco-jcc/jjaa199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fecco-jcc%2Fjjaa199%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Crohn%2527s%2520and%2520Colitis%26atitle%3DTyrosine%252BKinase%252B2%252BSignalling%252BDrives%252BPathogenic%252BT%252Bcells%252Bin%252BColitis%26aulast%3DDe%2BVries%26aufirst%3DLeonie%2BC%2BS%26date%3D2021%26date%3D2020%26volume%3D15%26issue%3D4%26spage%3D617%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Himanshu  Goel</span>, <span class="hlFld-ContribAuthor ">Anthony  Hazel</span>, <span class="hlFld-ContribAuthor ">Vincent D.  Ustach</span>, <span class="hlFld-ContribAuthor ">Sunhwan  Jo</span>, <span class="hlFld-ContribAuthor ">Wenbo  Yu</span>, <span class="hlFld-ContribAuthor ">Alexander D.  MacKerell</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid and accurate estimation of protein–ligand relative binding affinities using site-identification by ligand competitive saturation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>38 </em><a href="https://doi.org/10.1039/D1SC01781K" title="DOI URL">https://doi.org/10.1039/D1SC01781K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC01781K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC01781K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DRapid%252Band%252Baccurate%252Bestimation%252Bof%252Bprotein%2525E2%252580%252593ligand%252Brelative%252Bbinding%252Baffinities%252Busing%252Bsite-identification%252Bby%252Bligand%252Bcompetitive%252Bsaturation%26aulast%3DGoel%26aufirst%3DHimanshu%26date%3D2021%26date%3D2021%26volume%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Holderbach</span>, <span class="hlFld-ContribAuthor ">Lukas  Adam</span>, <span class="hlFld-ContribAuthor ">B.  Jayaram</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Wade</span>, <span class="hlFld-ContribAuthor ">Goutam  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">RASPD+: Fast Protein-Ligand Binding Free Energy Prediction Using Simplified Physicochemical Features. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fmolb.2020.601065" title="DOI URL">https://doi.org/10.3389/fmolb.2020.601065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2020.601065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2020.601065%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DRASPD%25252B%25253A%252BFast%252BProtein-Ligand%252BBinding%252BFree%252BEnergy%252BPrediction%252BUsing%252BSimplified%252BPhysicochemical%252BFeatures%26aulast%3DHolderbach%26aufirst%3DStefan%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian S.  Gerstenberger</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">James D.  Clark</span>, <span class="hlFld-ContribAuthor ">Martin E.  Dowty</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Roger  Gifford</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Griffor</span>, <span class="hlFld-ContribAuthor ">Martin  Hegen</span>, <span class="hlFld-ContribAuthor ">Brett D.  Hollingshead</span>, <span class="hlFld-ContribAuthor ">John D.  Knafels</span>, <span class="hlFld-ContribAuthor ">Tsung H.  Lin</span>, <span class="hlFld-ContribAuthor ">James F.  Smith</span>, <span class="hlFld-ContribAuthor ">Felix F.  Vajdos</span>. </span><span class="cited-content_cbyCitation_article-title">Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-65762-y" title="DOI URL">https://doi.org/10.1038/s41598-020-65762-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-65762-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-65762-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDemonstration%252Bof%252BIn%252BVitro%252Bto%252BIn%252BVivo%252BTranslation%252Bof%252Ba%252BTYK2%252BInhibitor%252BThat%252BShows%252BCross%252BSpecies%252BPotency%252BDifferences%26aulast%3DGerstenberger%26aufirst%3DBrian%2BS.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Safa  Daoud</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling of JAK1: A target infested with activity-cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>99 </em>, 107615. <a href="https://doi.org/10.1016/j.jmgm.2020.107615" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107615%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bmodeling%252Bof%252BJAK1%25253A%252BA%252Btarget%252Binfested%252Bwith%252Bactivity-cliffs%26aulast%3DDaoud%26aufirst%3DSafa%26date%3D2020%26volume%3D99%26spage%3D107615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elham Y.  Al-Barghouthy</span>, <span class="hlFld-ContribAuthor ">Areej  Abuhammad</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR-guided pharmacophore modeling and subsequent virtual screening identify novel TYK2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (9)
                                     , 1368-1387. <a href="https://doi.org/10.1007/s00044-019-02377-7" title="DOI URL">https://doi.org/10.1007/s00044-019-02377-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02377-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02377-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DQSAR-guided%252Bpharmacophore%252Bmodeling%252Band%252Bsubsequent%252Bvirtual%252Bscreening%252Bidentify%252Bnovel%252BTYK2%252Binhibitor%26aulast%3DAl-Barghouthy%26aufirst%3DElham%2BY.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D9%26spage%3D1368%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Itteboina</span>, <span class="hlFld-ContribAuthor ">Srilata  Ballu</span>, <span class="hlFld-ContribAuthor ">Sree Kanth  Sivan</span>, <span class="hlFld-ContribAuthor ">Vijjulatha  Manga</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking, 3D-QSAR, molecular dynamics, synthesis and anticancer activity of tyrosine kinase 2 (TYK 2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2018,</strong> <em>38 </em>
                                    (5-6)
                                     , 462-474. <a href="https://doi.org/10.1080/10799893.2019.1585453" title="DOI URL">https://doi.org/10.1080/10799893.2019.1585453</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2019.1585453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2019.1585453%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DMolecular%252Bdocking%25252C%252B3D-QSAR%25252C%252Bmolecular%252Bdynamics%25252C%252Bsynthesis%252Band%252Banticancer%252Bactivity%252Bof%252Btyrosine%252Bkinase%252B2%252B%252528TYK%252B2%252529%252Binhibitors%26aulast%3DItteboina%26aufirst%3DRamesh%26date%3D2018%26date%3D2019%26volume%3D38%26issue%3D5-6%26spage%3D462%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas  Hagberg</span>, <span class="hlFld-ContribAuthor ">Martin  Joelsson</span>, <span class="hlFld-ContribAuthor ">Dag  Leonard</span>, <span class="hlFld-ContribAuthor ">Sarah  Reid</span>, <span class="hlFld-ContribAuthor ">Maija-Leena  Eloranta</span>, <span class="hlFld-ContribAuthor ">John  Mo</span>, <span class="hlFld-ContribAuthor ">Magnus K  Nilsson</span>, <span class="hlFld-ContribAuthor ">Ann-Christine  Syvänen</span>, <span class="hlFld-ContribAuthor ">Yenan T  Bryceson</span>, <span class="hlFld-ContribAuthor ">Lars  Rönnblom</span>. </span><span class="cited-content_cbyCitation_article-title">The
              STAT4
              SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE. </span><span class="cited-content_cbyCitation_journal-name">Annals of the Rheumatic Diseases</span><span> <strong>2018,</strong> <em>77 </em>
                                    (7)
                                     , 1070-1077. <a href="https://doi.org/10.1136/annrheumdis-2017-212794" title="DOI URL">https://doi.org/10.1136/annrheumdis-2017-212794</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1136/annrheumdis-2017-212794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1136%2Fannrheumdis-2017-212794%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520Rheumatic%2520Diseases%26atitle%3DThe%252BSTAT4%252BSLE%252Brisk%252Ballele%252Brs7574865%25255BT%25255D%252Bis%252Bassociated%252Bwith%252Bincreased%252BIL-12-induced%252BIFN-%2525CE%2525B3%252Bproduction%252Bin%252BT%252Bcells%252Bfrom%252Bpatients%252Bwith%252BSLE%26aulast%3DHagberg%26aufirst%3DNiklas%26date%3D2018%26date%3D2018%26volume%3D77%26issue%3D7%26spage%3D1070%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxu  Qi</span>, <span class="hlFld-ContribAuthor ">Feng  Yu</span>, <span class="hlFld-ContribAuthor ">Pinhong  Chen</span>, <span class="hlFld-ContribAuthor ">Guosheng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Intermolecular Palladium‐Catalyzed Oxidative Fluorocarbonylation of Unactivated Alkenes: Efficient Access to β‐Fluorocarboxylic Esters. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (41)
                                     , 12866-12870. <a href="https://doi.org/10.1002/ange.201706401" title="DOI URL">https://doi.org/10.1002/ange.201706401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201706401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201706401%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DIntermolecular%252BPalladium%2525E2%252580%252590Catalyzed%252BOxidative%252BFluorocarbonylation%252Bof%252BUnactivated%252BAlkenes%25253A%252BEfficient%252BAccess%252Bto%252B%2525CE%2525B2%2525E2%252580%252590Fluorocarboxylic%252BEsters%26aulast%3DQi%26aufirst%3DXiaoxu%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D41%26spage%3D12866%26epage%3D12870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxu  Qi</span>, <span class="hlFld-ContribAuthor ">Feng  Yu</span>, <span class="hlFld-ContribAuthor ">Pinhong  Chen</span>, <span class="hlFld-ContribAuthor ">Guosheng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Intermolecular Palladium‐Catalyzed Oxidative Fluorocarbonylation of Unactivated Alkenes: Efficient Access to β‐Fluorocarboxylic Esters. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (41)
                                     , 12692-12696. <a href="https://doi.org/10.1002/anie.201706401" title="DOI URL">https://doi.org/10.1002/anie.201706401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201706401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201706401%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DIntermolecular%252BPalladium%2525E2%252580%252590Catalyzed%252BOxidative%252BFluorocarbonylation%252Bof%252BUnactivated%252BAlkenes%25253A%252BEfficient%252BAccess%252Bto%252B%2525CE%2525B2%2525E2%252580%252590Fluorocarboxylic%252BEsters%26aulast%3DQi%26aufirst%3DXiaoxu%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D41%26spage%3D12692%26epage%3D12696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Liang</span>, <span class="hlFld-ContribAuthor ">Anne  Van Abbema</span>, <span class="hlFld-ContribAuthor ">Mercedesz  Balazs</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Leo  Berezhkovsky</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Donnie  Delarosa</span>, <span class="hlFld-ContribAuthor ">Jason  DeVoss</span>, <span class="hlFld-ContribAuthor ">Jim  Driscoll</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Simon  Goodacre</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Calum  MacLeod</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Pawan  Bir Kohli</span>, <span class="hlFld-ContribAuthor ">Yingjie  Lai</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Lin</span>, <span class="hlFld-ContribAuthor ">Priscilla  Mantik</span>, <span class="hlFld-ContribAuthor ">Kapil  Menghrajani</span>, <span class="hlFld-ContribAuthor ">Hieu  Nguyen</span>, <span class="hlFld-ContribAuthor ">Ivan  Peng</span>, <span class="hlFld-ContribAuthor ">Amy  Sambrone</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Jan  Smith</span>, <span class="hlFld-ContribAuthor ">Sue  Sohn</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Karen  Williams</span>, <span class="hlFld-ContribAuthor ">Lawren C.  Wu</span>, <span class="hlFld-ContribAuthor ">Wenqian  Yang</span>, <span class="hlFld-ContribAuthor ">Birong  Zhang</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4370-4376. <a href="https://doi.org/10.1016/j.bmcl.2017.08.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Ban%252Bimidazopyridine%252Bscaffold%252Bto%252Bgenerate%252Bpotent%252Band%252Bselective%252BTYK2%252Binhibitors%252Bthat%252Bdemonstrate%252Bactivity%252Bin%252Ban%252Bin%252Bvivo%252Bpsoriasis%252Bmodel%26aulast%3DLiang%26aufirst%3DJun%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4370%26epage%3D4376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Moslin</span>, <span class="hlFld-ContribAuthor ">D.  Gardner</span>, <span class="hlFld-ContribAuthor ">J.  Santella</span>, <span class="hlFld-ContribAuthor ">Y.  Zhang</span>, <span class="hlFld-ContribAuthor ">J. V.  Duncia</span>, <span class="hlFld-ContribAuthor ">C.  Liu</span>, <span class="hlFld-ContribAuthor ">J.  Lin</span>, <span class="hlFld-ContribAuthor ">J. S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">J.  Strnad</span>, <span class="hlFld-ContribAuthor ">D.  Pedicord</span>, <span class="hlFld-ContribAuthor ">J.  Chen</span>, <span class="hlFld-ContribAuthor ">Y.  Blat</span>, <span class="hlFld-ContribAuthor ">A.  Zupa-Fernandez</span>, <span class="hlFld-ContribAuthor ">L.  Cheng</span>, <span class="hlFld-ContribAuthor ">H.  Sun</span>, <span class="hlFld-ContribAuthor ">C.  Chaudhry</span>, <span class="hlFld-ContribAuthor ">C.  Huang</span>, <span class="hlFld-ContribAuthor ">C.  D'Arienzo</span>, <span class="hlFld-ContribAuthor ">J. S.  Sack</span>, <span class="hlFld-ContribAuthor ">J. K.  Muckelbauer</span>, <span class="hlFld-ContribAuthor ">C.  Chang</span>, <span class="hlFld-ContribAuthor ">J.  Tredup</span>, <span class="hlFld-ContribAuthor ">D.  Xie</span>, <span class="hlFld-ContribAuthor ">N.  Aranibar</span>, <span class="hlFld-ContribAuthor ">J. R.  Burke</span>, <span class="hlFld-ContribAuthor ">P. H.  Carter</span>, <span class="hlFld-ContribAuthor ">D. S.  Weinstein</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of imidazo[1,2-
              b
              ]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 700-712. <a href="https://doi.org/10.1039/C6MD00560H" title="DOI URL">https://doi.org/10.1039/C6MD00560H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00560H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00560H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Bimidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazine%252BTYK2%252Bpseudokinase%252Bligands%252Bas%252Bpotent%252Band%252Bselective%252Ballosteric%252Binhibitors%252Bof%252BTYK2%252Bsignalling%26aulast%3DMoslin%26aufirst%3DR.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D4%26spage%3D700%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Ehrlich</span>, <span class="hlFld-ContribAuthor ">Andreas H.  Göller</span>, <span class="hlFld-ContribAuthor ">Stefan  Grimme</span>. </span><span class="cited-content_cbyCitation_article-title">Towards full Quantum-Mechanics-based Protein-Ligand Binding Affinities. </span><span class="cited-content_cbyCitation_journal-name">ChemPhysChem</span><span> <strong>2017,</strong> <em>18 </em>
                                    (8)
                                     , 898-905. <a href="https://doi.org/10.1002/cphc.201700082" title="DOI URL">https://doi.org/10.1002/cphc.201700082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cphc.201700082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcphc.201700082%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhysChem%26atitle%3DTowards%252Bfull%252BQuantum-Mechanics-based%252BProtein-Ligand%252BBinding%252BAffinities%26aulast%3DEhrlich%26aufirst%3DStephan%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D8%26spage%3D898%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koshi  Akahane</span>, <span class="hlFld-ContribAuthor ">Zhaodong  Li</span>, <span class="hlFld-ContribAuthor ">Julia  Etchin</span>, <span class="hlFld-ContribAuthor ">Alla  Berezovskaya</span>, <span class="hlFld-ContribAuthor ">Evisa  Gjini</span>, <span class="hlFld-ContribAuthor ">Craig E.  Masse</span>, <span class="hlFld-ContribAuthor ">Wenyan  Miao</span>, <span class="hlFld-ContribAuthor ">Jennifer  Rocnik</span>, <span class="hlFld-ContribAuthor ">Rosana  Kapeller</span>, <span class="hlFld-ContribAuthor ">Jeremy R.  Greenwood</span>, <span class="hlFld-ContribAuthor ">Hong  Tiv</span>, <span class="hlFld-ContribAuthor ">Takaomi  Sanda</span>, <span class="hlFld-ContribAuthor ">David M.  Weinstock</span>, <span class="hlFld-ContribAuthor ">A. Thomas  Look</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Haematology</span><span> <strong>2017,</strong> <em>177 </em>
                                    (2)
                                     , 271-282. <a href="https://doi.org/10.1111/bjh.14563" title="DOI URL">https://doi.org/10.1111/bjh.14563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bjh.14563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbjh.14563%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Haematology%26atitle%3DAnti-leukaemic%252Bactivity%252Bof%252Bthe%252BTYK2%252Bselective%252Binhibitor%252BNDI-031301%252Bin%252BT-cell%252Bacute%252Blymphoblastic%252Bleukaemia%26aulast%3DAkahane%26aufirst%3DKoshi%26date%3D2017%26date%3D2017%26volume%3D177%26issue%3D2%26spage%3D271%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn G.  Roberts</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Gu</span>, <span class="hlFld-ContribAuthor ">Debbie  Payne-Turner</span>, <span class="hlFld-ContribAuthor ">Kelly  McCastlain</span>, <span class="hlFld-ContribAuthor ">Richard C.  Harvey</span>, <span class="hlFld-ContribAuthor ">I-Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Deqing  Pei</span>, <span class="hlFld-ContribAuthor ">Ilaria  Iacobucci</span>, <span class="hlFld-ContribAuthor ">Marcus  Valentine</span>, <span class="hlFld-ContribAuthor ">Stanley B.  Pounds</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Yongjin  Li</span>, <span class="hlFld-ContribAuthor ">Jinghui  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Cheng</span>, <span class="hlFld-ContribAuthor ">Alessandro  Rambaldi</span>, <span class="hlFld-ContribAuthor ">Manuela  Tosi</span>, <span class="hlFld-ContribAuthor ">Orietta  Spinelli</span>, <span class="hlFld-ContribAuthor ">Jerald P.  Radich</span>, <span class="hlFld-ContribAuthor ">Mark D.  Minden</span>, <span class="hlFld-ContribAuthor ">Jacob M.  Rowe</span>, <span class="hlFld-ContribAuthor ">Selina  Luger</span>, <span class="hlFld-ContribAuthor ">Mark R.  Litzow</span>, <span class="hlFld-ContribAuthor ">Martin S.  Tallman</span>, <span class="hlFld-ContribAuthor ">Peter H.  Wiernik</span>, <span class="hlFld-ContribAuthor ">Ravi  Bhatia</span>, <span class="hlFld-ContribAuthor ">Ibrahim  Aldoss</span>, <span class="hlFld-ContribAuthor ">Jessica  Kohlschmidt</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Mrózek</span>, <span class="hlFld-ContribAuthor ">Guido  Marcucci</span>, <span class="hlFld-ContribAuthor ">Clara D.  Bloomfield</span>, <span class="hlFld-ContribAuthor ">Wendy  Stock</span>, <span class="hlFld-ContribAuthor ">Stephen  Kornblau</span>, <span class="hlFld-ContribAuthor ">Hagop M.  Kantarjian</span>, <span class="hlFld-ContribAuthor ">Marina  Konopleva</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Paietta</span>, <span class="hlFld-ContribAuthor ">Cheryl L.  Willman</span>, <span class="hlFld-ContribAuthor ">Charles G.  Mullighan</span>. </span><span class="cited-content_cbyCitation_article-title">High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2017,</strong> <em>35 </em>
                                    (4)
                                     , 394-401. <a href="https://doi.org/10.1200/JCO.2016.69.0073" title="DOI URL">https://doi.org/10.1200/JCO.2016.69.0073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.2016.69.0073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.2016.69.0073%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DHigh%252BFrequency%252Band%252BPoor%252BOutcome%252Bof%252BPhiladelphia%252BChromosome%2525E2%252580%252593Like%252BAcute%252BLymphoblastic%252BLeukemia%252Bin%252BAdults%26aulast%3DRoberts%26aufirst%3DKathryn%2BG.%26date%3D2017%26volume%3D35%26issue%3D4%26spage%3D394%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Song</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianwei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free [2+2+2] Cycloaddition of Ynamides and Nitriles: Mild and Regioselective Synthesis of Fully Substituted Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2016,</strong> <em>128 </em>
                                    (33)
                                     , 9856-9860. <a href="https://doi.org/10.1002/ange.201603889" title="DOI URL">https://doi.org/10.1002/ange.201603889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201603889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201603889%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DMetal-Free%252B%25255B2%25252B2%25252B2%25255D%252BCycloaddition%252Bof%252BYnamides%252Band%252BNitriles%25253A%252BMild%252Band%252BRegioselective%252BSynthesis%252Bof%252BFully%252BSubstituted%252BPyridines%26aulast%3DWang%26aufirst%3DYong%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D33%26spage%3D9856%26epage%3D9860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Juan  Song</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianwei  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free [2+2+2] Cycloaddition of Ynamides and Nitriles: Mild and Regioselective Synthesis of Fully Substituted Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2016,</strong> <em>55 </em>
                                    (33)
                                     , 9704-9708. <a href="https://doi.org/10.1002/anie.201603889" title="DOI URL">https://doi.org/10.1002/anie.201603889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201603889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201603889%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DMetal-Free%252B%25255B2%25252B2%25252B2%25255D%252BCycloaddition%252Bof%252BYnamides%252Band%252BNitriles%25253A%252BMild%252Band%252BRegioselective%252BSynthesis%252Bof%252BFully%252BSubstituted%252BPyridines%26aulast%3DWang%26aufirst%3DYong%26date%3D2016%26date%3D2016%26volume%3D55%26issue%3D33%26spage%3D9704%26epage%3D9708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guangni  Ding</span>, <span class="hlFld-ContribAuthor ">Chengjun  Li</span>, <span class="hlFld-ContribAuthor ">Yifan  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Lu</span>, <span class="hlFld-ContribAuthor ">Zhaoguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Potassium Hydroxide-Catalyzed Chemoselective Reduction of Cyclic Imides with Hydrosilanes: Synthesis of ω-Hydroxylactams and Lactams. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2016,</strong> <em>358 </em>
                                    (8)
                                     , 1241-1250. <a href="https://doi.org/10.1002/adsc.201501093" title="DOI URL">https://doi.org/10.1002/adsc.201501093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201501093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201501093%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DPotassium%252BHydroxide-Catalyzed%252BChemoselective%252BReduction%252Bof%252BCyclic%252BImides%252Bwith%252BHydrosilanes%25253A%252BSynthesis%252Bof%252B%2525CF%252589-Hydroxylactams%252Band%252BLactams%26aulast%3DDing%26aufirst%3DGuangni%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D8%26spage%3D1241%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Pankaj  Sharma</span>, <span class="hlFld-ContribAuthor ">Rai-Shung  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamide-directed gold-catalyzed [2+2+2]-cycloadditions of nitriles with two discrete ynamides to construct 2,4-diaminopyridine cores. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (15)
                                     , 3187-3190. <a href="https://doi.org/10.1039/C5CC09688J" title="DOI URL">https://doi.org/10.1039/C5CC09688J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC09688J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC09688J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSulfonamide-directed%252Bgold-catalyzed%252B%25255B2%25252B2%25252B2%25255D-cycloadditions%252Bof%252Bnitriles%252Bwith%252Btwo%252Bdiscrete%252Bynamides%252Bto%252Bconstruct%252B2%25252C4-diaminopyridine%252Bcores%26aulast%3DChen%26aufirst%3DYu-Ling%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D15%26spage%3D3187%26epage%3D3190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Woo Dae  Jang</span>, <span class="hlFld-ContribAuthor ">Jun-Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Hoon Young  Son</span>, <span class="hlFld-ContribAuthor ">Seung Yeon  Park</span>, <span class="hlFld-ContribAuthor ">Young Sik  Cho</span>, <span class="hlFld-ContribAuthor ">Tae-sung  Koo</span>, <span class="hlFld-ContribAuthor ">Hyuk  Lee</span>, <span class="hlFld-ContribAuthor ">Nam Sook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Tyk2 inhibitors via the virtual site-directed fragment-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (18)
                                     , 3947-3952. <a href="https://doi.org/10.1016/j.bmcl.2015.07.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BTyk2%252Binhibitors%252Bvia%252Bthe%252Bvirtual%252Bsite-directed%252Bfragment-based%252Bdrug%252Bdesign%26aulast%3DJang%26aufirst%3DWoo%2BDae%26date%3D2015%26volume%3D25%26issue%3D18%26spage%3D3947%26epage%3D3952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwen A.  Feng</span>, <span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Jeff M.  Blaney</span>, <span class="hlFld-ContribAuthor ">Erin K.  Bradley</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Man-Ling  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Johnny  Wu</span>, <span class="hlFld-ContribAuthor ">Alberto  Gobbi</span>. </span><span class="cited-content_cbyCitation_article-title">An integrated suite of modeling tools that empower scientists in structure- and property-based drug design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (6)
                                     , 511-523. <a href="https://doi.org/10.1007/s10822-015-9845-4" title="DOI URL">https://doi.org/10.1007/s10822-015-9845-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9845-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9845-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DAn%252Bintegrated%252Bsuite%252Bof%252Bmodeling%252Btools%252Bthat%252Bempower%252Bscientists%252Bin%252Bstructure-%252Band%252Bproperty-based%252Bdrug%252Bdesign%26aulast%3DFeng%26aufirst%3DJianwen%2BA.%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D6%26spage%3D511%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Adriana  Zupa-Fernandez</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Tredup</span>, <span class="hlFld-ContribAuthor ">Kristen  Pike</span>, <span class="hlFld-ContribAuthor ">ChiehYing  Chang</span>, <span class="hlFld-ContribAuthor ">Dianlin  Xie</span>, <span class="hlFld-ContribAuthor ">Lihong  Cheng</span>, <span class="hlFld-ContribAuthor ">Donna  Pedicord</span>, <span class="hlFld-ContribAuthor ">Jodi  Muckelbauer</span>, <span class="hlFld-ContribAuthor ">Stephen R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Sophie  Wu</span>, <span class="hlFld-ContribAuthor ">Suzanne C.  Edavettal</span>, <span class="hlFld-ContribAuthor ">Yang  Hong</span>, <span class="hlFld-ContribAuthor ">Mark R.  Witmer</span>, <span class="hlFld-ContribAuthor ">Lisa L.  Elkin</span>, <span class="hlFld-ContribAuthor ">Yuval  Blat</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">David S.  Weinstein</span>, <span class="hlFld-ContribAuthor ">James R.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2015,</strong> <em>290 </em>
                                    (17)
                                     , 11061-11074. <a href="https://doi.org/10.1074/jbc.M114.619502" title="DOI URL">https://doi.org/10.1074/jbc.M114.619502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.619502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.619502%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DTyrosine%252BKinase%252B2-mediated%252BSignal%252BTransduction%252Bin%252BT%252BLymphocytes%252BIs%252BBlocked%252Bby%252BPharmacological%252BStabilization%252Bof%252BIts%252BPseudokinase%252BDomain%26aulast%3DTokarski%26aufirst%3DJohn%2BS.%26date%3D2015%26volume%3D290%26issue%3D17%26spage%3D11061%26epage%3D11074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerhard  Gross</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for Enhancing Oral Bioavailability and Brain Penetration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 631-655. <a href="https://doi.org/10.1016/B978-0-12-417205-0.00027-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-417205-0.00027-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417205-0.00027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417205-0.00027-4%26sid%3Dliteratum%253Aachs%26atitle%3DStrategies%252Bfor%252BEnhancing%252BOral%252BBioavailability%252Band%252BBrain%252BPenetration%26aulast%3DGross%26aufirst%3DGerhard%26date%3D2015%26spage%3D631%26epage%3D655%26pub%3DElsevier%26atitle%3DThe%252BPractice%252Bof%252BMedicinal%252BChemistry%26date%3D2015%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa G.  Works</span>, <span class="hlFld-ContribAuthor ">Fangfang  Yin</span>, <span class="hlFld-ContribAuthor ">Catherine C.  Yin</span>, <span class="hlFld-ContribAuthor ">Ying  Yiu</span>, <span class="hlFld-ContribAuthor ">Kenneth  Shew</span>, <span class="hlFld-ContribAuthor ">Thanh-Thuy  Tran</span>, <span class="hlFld-ContribAuthor ">Nahoko  Dunlap</span>, <span class="hlFld-ContribAuthor ">Jennifer  Lam</span>, <span class="hlFld-ContribAuthor ">Tim  Mitchell</span>, <span class="hlFld-ContribAuthor ">John  Reader</span>, <span class="hlFld-ContribAuthor ">Paul L.  Stein</span>, <span class="hlFld-ContribAuthor ">Annalisa  D’Andrea</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Immunology</span><span> <strong>2014,</strong> <em>193 </em>
                                    (7)
                                     , 3278-3287. <a href="https://doi.org/10.4049/jimmunol.1400205" title="DOI URL">https://doi.org/10.4049/jimmunol.1400205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4049/jimmunol.1400205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4049%2Fjimmunol.1400205%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Immunology%26atitle%3DInhibition%252Bof%252BTYK2%252Band%252BJAK1%252BAmeliorates%252BImiquimod-Induced%252BPsoriasis-like%252BDermatitis%252Bby%252BInhibiting%252BIL-22%252Band%252Bthe%252BIL-23%25252FIL-17%252BAxis%26aulast%3DWorks%26aufirst%3DMelissa%2BG.%26date%3D2014%26date%3D2014%26volume%3D193%26issue%3D7%26spage%3D3278%26epage%3D3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J  Menet</span>. </span><span class="cited-content_cbyCitation_article-title">Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (4)
                                     , 449-466. <a href="https://doi.org/10.4155/ppa.14.23" title="DOI URL">https://doi.org/10.4155/ppa.14.23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.23%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DToward%252Bselective%252BTYK2%252Binhibitors%252Bas%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DMenet%26aufirst%3DChristel%2BJ%26date%3D2014%26volume%3D3%26issue%3D4%26spage%3D449%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">M.  Ultsch</span>, <span class="hlFld-ContribAuthor ">H.  Wallweber</span>, <span class="hlFld-ContribAuthor ">P.  Bir Kohli</span>, <span class="hlFld-ContribAuthor ">A. R.  Johnson</span>, <span class="hlFld-ContribAuthor ">C.  Eigenbrot</span>. </span><span class="cited-content_cbyCitation_article-title">Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2014,</strong> <em>111 </em>
                                    (22)
                                     , 8025-8030. <a href="https://doi.org/10.1073/pnas.1401180111" title="DOI URL">https://doi.org/10.1073/pnas.1401180111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1401180111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1401180111%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DStructure%252Bof%252Bthe%252Bpseudokinase-kinase%252Bdomains%252Bfrom%252Bprotein%252Bkinase%252BTYK2%252Breveals%252Ba%252Bmechanism%252Bfor%252BJanus%252Bkinase%252B%252528JAK%252529%252Bautoinhibition%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26date%3D2014%26date%3D2014%26volume%3D111%26issue%3D22%26spage%3D8025%26epage%3D8030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haoyue  Xiang</span>, <span class="hlFld-ContribAuthor ">Jianyang  Chen</span>, <span class="hlFld-ContribAuthor ">Zehong  Miao</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade synthesis of novel functionalized pyridine-fused coumarins in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (31)
                                     , 16132. <a href="https://doi.org/10.1039/C4RA01848F" title="DOI URL">https://doi.org/10.1039/C4RA01848F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA01848F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA01848F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCascade%252Bsynthesis%252Bof%252Bnovel%252Bfunctionalized%252Bpyridine-fused%252Bcoumarins%252Bin%252Baqueous%252Bmedium%26aulast%3DXiang%26aufirst%3DHaoyue%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D31%26spage%3D16132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of WO2013125543, WO2013146963 and EP2634185: the first Tyk2 inhibitors from Takeda and Sareum. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 361-368. <a href="https://doi.org/10.1517/13543776.2014.864637" title="DOI URL">https://doi.org/10.1517/13543776.2014.864637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.864637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.864637%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEvaluation%252Bof%252BWO2013125543%25252C%252BWO2013146963%252Band%252BEP2634185%25253A%252Bthe%252Bfirst%252BTyk2%252Binhibitors%252Bfrom%252BTakeda%252Band%252BSareum%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D361%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biochemical and cell-based assay data of <b>1</b>, <b>2</b>, and <b>3</b>. <sup><i>a</i></sup>Biochemical assays. <sup><i>b</i></sup>Arithmetic mean of at least four separate runs (<i>n</i> ≥ 4). On average, the coefficients of variation were less than 0.3 times the mean for biochemical assays. <sup><i>c</i></sup>Cell-based assays. Arithmetic mean of at least four separate runs (<i>n</i> ≥ 4). On average, the coefficients of variation were less than 0.5 times the mean for cell-based assays. <sup><i>d</i></sup>Cell-based assay of TYK2 inhibition. <sup><i>e</i></sup>Cell-based assay of JAK1 inhibition. <sup><i>f</i></sup>Cell-based assay of JAK2 inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of the TYK2 and JAK2 crystal structures with compound <b>3</b> (TYK2 sandy brown, JAK2 blue), highlighting the different P-loop conformations between the TYK2 and JAK2 enzymes and the residue difference (Arg901 vs Gln853) in the area where cyclopropylamide group was bound. The resolutions of the X-ray structures are 2.0 Å (TYK2) and 2.4 Å (JAK2), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of compound <b>19</b> in complex with the TYK2 enzyme. The resolution of the X-ray structure is 2.3 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Modeling of acid <b>32</b> binding with TYK2 enzyme. The <i>C</i>2-carboxylic acid is proposed to have favorable electrostatic interaction with the positively charged arginine (Arg901) in the TYK2 enzyme. (b) X-ray crystal structure of compound <b>23</b> in complex with the TYK2 enzyme. The resolution of the X-ray structure is 2.4 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of compound <b>35</b> in complex with the TYK2 enzyme. The resolution of the X-ray structure is 2.5 Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. High dose (po 100 mg/kg) mouse PK of compound <b>35</b> and <b>37</b>. Three CD-1 mice were dosed orally with <b>35</b> or <b>37</b> at 100 mg/kg as a MCT suspension. At different time intervals, a blood sample was taken from each animal and plasma concentration was determined. Reported values were the average of three animals. The unbound concentration was calculated by multiplying the plasma concentration with the corresponding unbound fraction in mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0007.jpeg" id="rightTab-GRAPHIC-d7e2600-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Mouse IL-12 PD response with different doses of compound <b>37</b>, showing inhibition of IFNγ production by compound <b>37</b>. Values shown are the average of eight animals at each dose (<i>n</i> = 8). Anti-p40 antibody (aP40), which neutralizes IL-12, was used as a positive control. Anti-ragweed antibody (aRW) was used as a negative control. An asterisk denotes <i>p</i> < 0.05 compared to control. MCT was used as the vehicle for oral dosing of compound <b>37</b>. (b) Measured unbound concentration of compound <b>37</b> at 3.5 h after oral dosing: plot of the unbound concentration of compound <b>37</b> at the 3.5 h time point for different doses. Values shown are the average of eight animals at each dose (<i>n</i> = 8). The ratio of unbound concentration of <b>37</b> over its IL-12 pSTAT4 EC<sub>50</sub> was also calculated for all doses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/medium/jm-2013-00266t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of 2-Cyclopropylamides–Pyridyl-4-benzamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm400266t/production/images/large/jm-2013-00266t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400266t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) thionyl chloride, toluene, 100 °C; then NaH, DMF, 0 °C; (b) Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 130 °C, microwave; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, DavePhos, LHMDS, 1,4-dioxane, 100 °C; then 1 N HCl; (d) HATU, DIPEA, DMF, 70 °C; (e) NEt<sub>3</sub>, dichloromethane, 0 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christophers, E.</span><span> </span><span class="NLM_article-title">Psoriasis-epidemiology and clinical spectrum</span> <span class="citation_source-journal">Clin. Exp. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1046%2Fj.1365-2230.2001.00832.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=11422182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD3MzmtFymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2001&pages=314-320&author=E.+Christophers&title=Psoriasis-epidemiology+and+clinical+spectrum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Psoriasis--epidemiology and clinical spectrum</span></div><div class="casAuthors">Christophers E</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental dermatology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-20</span>
        ISSN:<span class="NLM_cas:issn">0307-6938</span>.
    </div><div class="casAbstract">Despite psoriasis being a common skin disease, there are still a number of unanswered questions.  One of these is the prevalence of the disease, as there is a lack of specific data, with the majority of studies reporting estimates only.  Population based studies are rare and longitudinal observations on changing prevalence rates are lacking.  This contrasts with other T-cell mediated autoimmune diseases where the number of those affected is rising.  Epidemiological studies revealed that a distinct group of diseases is quite frequently associated with psoriasis, e.g. arthritis, colitis, diabetes and hypertension.  In contrast, atopic dermatitis and allergies are less frequently seen compared to normal rates of occurrence.  As the psoriatic immune response pattern relates to activated Th-1 cells, psoriasis and atopic dermatitis appear to be mutually exclusive due to the Th-1/Th-2 dichotomy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJw2OQYtZeopdYoSR9eyvsfW6udTcc2eYReqOYbYL84rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzmtFymtQ%253D%253D&md5=2b65ecb7487d9d5733d8437e5f227b42</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2230.2001.00832.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2230.2001.00832.x%26sid%3Dliteratum%253Aachs%26aulast%3DChristophers%26aufirst%3DE.%26atitle%3DPsoriasis-epidemiology%2520and%2520clinical%2520spectrum%26jtitle%3DClin.%2520Exp.%2520Dermatol.%26date%3D2001%26volume%3D26%26spage%3D314%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lowes, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowcock, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Pathogenesis and therapy of psoriasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">445</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2007&pages=866-873&author=M.+A.+Lowesauthor=A.+M.+Bowcockauthor=J.+G.+Krueger&title=Pathogenesis+and+therapy+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowes%26aufirst%3DM.%2BA.%26aulast%3DBowcock%26aufirst%3DA.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DPathogenesis%2520and%2520therapy%2520of%2520psoriasis%26jtitle%3DNature%26date%3D2007%26volume%3D445%26spage%3D866%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Abraham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">2066</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMra0804647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19923578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVequ7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Abraham%2C+C.%3B+Cho%2C+J.+H.N.+Engl.+J.+Med.+2009%2C+361%2C+2066%E2%80%932078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory bowel disease</span></div><div class="casAuthors">Abraham, Clara; Cho, Judy H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2066-2078</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review of the intestinal immune system; innate immune response genes and Crohn's disease; and comparative gene assocn. studies in Crohn's disease and ulcerative colitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6uGqNG14dZLVg90H21EOLACvtfcHk0lhYA9Kfp-x1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVequ7bE&md5=e285d4acbe17c564d3ff92be5333fd90</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0804647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0804647%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DC.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D2066%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garrette, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, L. H.</span><span> </span><span class="NLM_article-title">Homeostasis and inflammation in the intestine</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=859-870&author=W.+S.+Garretteauthor=J.+I.+Gordonauthor=L.+H.+Glimcher&title=Homeostasis+and+inflammation+in+the+intestine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarrette%26aufirst%3DW.%2BS.%26aulast%3DGordon%26aufirst%3DJ.%2BI.%26aulast%3DGlimcher%26aufirst%3DL.%2BH.%26atitle%3DHomeostasis%2520and%2520inflammation%2520in%2520the%2520intestine%26jtitle%3DCell%26date%3D2010%26volume%3D140%26spage%3D859%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeissig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumberg, R. S.</span><span> </span><span class="NLM_article-title">Inflammatory bowel disease</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1146%2Fannurev-immunol-030409-101225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20192811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=573-621&author=A.+Kaserauthor=S.+Zeissigauthor=R.+S.+Blumberg&title=Inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory bowel disease</span></div><div class="casAuthors">Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">573-621</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Insights into inflammatory bowel disease (IBD) are advancing rapidly owing to immunol. investigations of a plethora of animal models of intestinal inflammation, ground-breaking advances in the interrogation of diseases that are inherited as complex genetic traits, and the development of culture-independent methods to define the compn. of the intestinal microbiota.  These advances are bringing a deeper understanding to the genetically detd. interplay between the commensal microbiota, intestinal epithelial cells, and the immune system and the manner in which this interplay might be modified by relevant environmental factors in the pathogenesis of IBD.  This review examines these interactions and, where possible, potential lessons from IBD-directed, biol. therapies that may allow for elucidation of pathways that are central to disease pathogenesis in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraDPk992Ncv7Vg90H21EOLACvtfcHk0lhYA9Kfp-x1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSmsL0%253D&md5=549596996e9557e713a68d3a345e60c0</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-030409-101225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-030409-101225%26sid%3Dliteratum%253Aachs%26aulast%3DKaser%26aufirst%3DA.%26aulast%3DZeissig%26aufirst%3DS.%26aulast%3DBlumberg%26aufirst%3DR.%2BS.%26atitle%3DInflammatory%2520bowel%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D28%26spage%3D573%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gelfand, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neimann, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D. J.</span><span> </span><span class="NLM_article-title">Prevalence and treatment of psoriasis in the United Kingdom—a population study</span> <span class="citation_source-journal">Arch. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">1537</span><span class="NLM_x">–</span> <span class="NLM_lpage">1541</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1001%2Farchderm.141.12.1537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16365254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnns1Gnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2005&pages=1537-1541&author=J.+M.+Gelfandauthor=R.+Weinsteinauthor=S.+B.+Porterauthor=A.+L.+Neimannauthor=J.+A.+Berlinauthor=D.+J.+Margolis&title=Prevalence+and+treatment+of+psoriasis+in+the+United+Kingdom%E2%80%94a+population+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence and treatment of psoriasis in the United Kingdom: a population-based study</span></div><div class="casAuthors">Gelfand Joel M; Weinstein Rachel; Porter Steven B; Neimann Andrea L; Berlin Jesse A; Margolis David J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of dermatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1537-41</span>
        ISSN:<span class="NLM_cas:issn">0003-987X</span>.
    </div><div class="casAbstract">OBJECTIVE:  To measure the prevalence and treatment of psoriasis in the United Kingdom.  DESIGN:  Cross-sectional study to determine prevalence and cohort study to determine treatment patterns.  SETTING:  Outpatient practices of general practitioners.  PATIENTS:  We included in the analysis all patients who were registered with a general practitioner in the General Practice Research Database from 1987 to 2002.  MAIN OUTCOME MEASURES:  The prevalence and treatment of psoriasis.  RESULTS:  We identified 114 521 patients with psoriasis of a total population of 7 533 475 patients, yielding a prevalence of 1.5%.  The prevalence of psoriasis increases more rapidly in young female patients compared with young male patients and declines significantly in patients 70 years and older, regardless of sex.  Overall, 91.8% of patients with a diagnosis of psoriasis received a prescription for psoriasis treatment on or after the date of their first diagnostic code of psoriasis in the General Practice Research Database.  Most of the patients (55.2%) received only 1 or 2 prescriptions for psoriasis in the first year after psoriasis was documented in the General Practice Research Database.  CONCLUSIONS:  The epidemiology of psoriasis in the General Practice Research Database population is similar to that of other epidemiologic studies of psoriasis performed in the United Kingdom, the United States, and other Western countries.  Psoriasis carries a substantial burden given its high prevalence and its associated need for prescription therapy.  Additional studies are necessary to determine why the prevalence of psoriasis increases more rapidly in female patients and to determine why the prevalence decreases in patients 70 years and older.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSArR_-beAVIz0SWnHPWbmmfW6udTcc2eYtFwoR27Ib8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnns1Gnsw%253D%253D&md5=42a9de77318149028a49429c0c8aba6c</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1001%2Farchderm.141.12.1537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchderm.141.12.1537%26sid%3Dliteratum%253Aachs%26aulast%3DGelfand%26aufirst%3DJ.%2BM.%26aulast%3DWeinstein%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DS.%2BB.%26aulast%3DNeimann%26aufirst%3DA.%2BL.%26aulast%3DBerlin%26aufirst%3DJ.%2BA.%26aulast%3DMargolis%26aufirst%3DD.%2BJ.%26atitle%3DPrevalence%2520and%2520treatment%2520of%2520psoriasis%2520in%2520the%2520United%2520Kingdom%25E2%2580%2594a%2520population%2520study%26jtitle%3DArch.%2520Dermatol.%26date%3D2005%26volume%3D141%26spage%3D1537%26epage%3D1541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kurd, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, J. M.</span><span> </span><span class="NLM_article-title">The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004</span> <span class="citation_source-journal">J. Am Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.jaad.2008.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19022533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FnvVeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=218-224&author=S.+K.+Kurdauthor=J.+M.+Gelfand&title=The+prevalence+of+previously+diagnosed+and+undiagnosed+psoriasis+in+US+adults%3A+results+from+NHANES+2003%E2%80%932004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004</span></div><div class="casAuthors">Kurd Shanu Kohli; Gelfand Joel M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">218-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Psoriasis is a predictor of morbidity.  It is important to determine the extent to which psoriasis remains undiagnosed.  OBJECTIVE:  To determine the prevalence of psoriasis.  METHODS:  We conducted a cross-sectional study using the National Health and Nutrition Examination Survey 2003-2004.  RESULTS:  The prevalence of diagnosed psoriasis was 3.15% (95% confidence interval [CI], 2.18-4.53), corresponding to 5 million adults.  Approximately 17% of these patients have moderate to severe psoriasis based on body surface area report and 25% rate psoriasis a large problem in everyday life.  The prevalence of undiagnosed active psoriasis by conservative estimate was 0.4% (95% CI, 0.19-0.82), corresponding to approximately 600,000 US adults, and 2.28% (95% CI, 1.47-3.50) by a broader definition, corresponding to 3.6 million US adults.  Undiagnosed patients had a trend toward being more likely to be male, nonwhite, less educated, and unmarried compared with patients who had received a diagnosis.  LIMITATIONS:  The method for determining the presence of psoriasis had limited ability to detect mild disease and only fair interrater agreement.  CONCLUSION:  More than 5 million adults have been diagnosed with psoriasis.  A large number have undiagnosed psoriasis and there are important disparities which may be associated with not receiving medical attention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStWyJe6nlp5suCWE5mhx1RfW6udTcc2eYtFwoR27Ib8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FnvVeiuw%253D%253D&md5=555d19571f64507068e9b3ea99daa7e7</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2008.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2008.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DKurd%26aufirst%3DS.%2BK.%26aulast%3DGelfand%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520prevalence%2520of%2520previously%2520diagnosed%2520and%2520undiagnosed%2520psoriasis%2520in%2520US%2520adults%253A%2520results%2520from%2520NHANES%25202003%25E2%2580%25932004%26jtitle%3DJ.%2520Am%2520Acad.%2520Dermatol.%26date%3D2009%26volume%3D60%26spage%3D218%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mikhail, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinfeld, N. S.</span><span> </span><span class="NLM_article-title">Therapy treatment options for psoriasis: topical and systemic</span> <span class="citation_source-journal">Therapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.2217%2F14750708.1.2.319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGqu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=319-330&author=M.+Mikhailauthor=N.+S.+Scheinfeld&title=Therapy+treatment+options+for+psoriasis%3A+topical+and+systemic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy treatment options for psoriasis: Topical and systemic</span></div><div class="casAuthors">Mikhail, Maryann; Scheinfeld, Noah S.</div><div class="citationInfo"><span class="NLM_cas:title">Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">THERCR</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Psoriasis is a common disease in the western world, with a prevalence of between 1 and 3%.  It has a variety of manifestions the most common of which being erythematous, scaly, well-demarcated plaques.  Limited disease can be treated with topical therapies.  The mainstay of topical treatment is topical corticosteroids.  Topical tar prepns. are effective but messy.  Calcipotriol and tazarotene are also useful topical therapies and can be combined with topical corticosteroids.  Moderate disease is treated effectively with oral methotrexate and phototherapy with UV B, narrow band UV B (311 nm) or psoralen (oral, topical or bath) and UV A.  Other std. oral therapies include acitretin and cyclosporin.  Acetretin can be combined with UV therapy.  There are new monoclonal antibody therapies termed biol. therapies that include alefacept, etanercept and efalizumab.  Other biol. therapies exist but have yet to be approved.  Psoriasis is a treatable but not curable skin disease with a variety of treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9t1w8G3-cS7Vg90H21EOLACvtfcHk0lgJ7IfgEtYOnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGqu7vM&md5=aae7366bf2761eb474b892cf3b70aaad</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.2217%2F14750708.1.2.319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14750708.1.2.319%26sid%3Dliteratum%253Aachs%26aulast%3DMikhail%26aufirst%3DM.%26aulast%3DScheinfeld%26aufirst%3DN.%2BS.%26atitle%3DTherapy%2520treatment%2520options%2520for%2520psoriasis%253A%2520topical%2520and%2520systemic%26jtitle%3DTherapy%26date%3D2004%26volume%3D1%26spage%3D319%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nograles, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Anti-cytokine therapies for psoriasis</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.yexcr.2011.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21300061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVyjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2011&pages=1293-1300&author=K.+E.+Nogralesauthor=J.+G.+Krueger&title=Anti-cytokine+therapies+for+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cytokine therapies for psoriasis</span></div><div class="casAuthors">Nograles, Kristine E.; Krueger, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1293-1300</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Current approaches for the treatment of psoriasis with anti-cytokine therapies involve the blockade of TNF-α, or the p40 sub-unit of IL-12 and IL-23.  However, the field is currently evolving to test more selective antagonists, such as anti-IL-23p19, IL-17 and other inflammatory cytokines.  Here we discuss our current understanding of dendritic cell and T cell subsets that are relevant in psoriasis, and the pharmacol. strategies that temper their activity in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw1M4ultrUuLVg90H21EOLACvtfcHk0lgJ7IfgEtYOnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVyjt7Y%253D&md5=e72195064c385a77dd6b834fe8a2e739</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2011.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2011.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DNograles%26aufirst%3DK.%2BE.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DAnti-cytokine%2520therapies%2520for%2520psoriasis%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2011%26volume%3D317%26spage%3D1293%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Loftus, E. V.</span><span> </span><span class="NLM_article-title">Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1504</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1053%2Fj.gastro.2004.01.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15168363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD2c3msl2msw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=1504-1517&author=E.+V.+Loftus&title=Clinical+epidemiology+of+inflammatory+bowel+disease%3A+incidence%2C+prevalence%2C+and+environmental+influences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences</span></div><div class="casAuthors">Loftus Edward V Jr</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1504-17</span>
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    </div><div class="casAbstract">Although the incidence and prevalence of ulcerative colitis and Crohn's disease are beginning to stabilize in high-incidence areas such as northern Europe and North America, they continue to rise in low-incidence areas such as southern Europe, Asia, and much of the developing world.  As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases.  Previously noted racial and ethnic differences seem to be narrowing.  Differences in incidence across age, time, and geographic region suggest that environmental factors significantly modify the expression of Crohn's disease and ulcerative colitis.  The strongest environmental factors identified are cigarette smoking and appendectomy.  Whether other factors such as diet, oral contraceptives, perinatal/childhood infections, or atypical mycobacterial infections play a role in expression of inflammatory bowel disease remains unclear.  Additional epidemiologic studies to define better the burden of illness, explore the mechanism of association with environmental factors, and identify new risk factors are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0IkZFtv66G0PI-fCgwosgfW6udTcc2eaNBsseDeXjbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3msl2msw%253D%253D&md5=dbc8688086e2c2148de85024f5615ba1</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2004.01.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2004.01.063%26sid%3Dliteratum%253Aachs%26aulast%3DLoftus%26aufirst%3DE.%2BV.%26atitle%3DClinical%2520epidemiology%2520of%2520inflammatory%2520bowel%2520disease%253A%2520incidence%252C%2520prevalence%252C%2520and%2520environmental%2520influences%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D126%26spage%3D1504%26epage%3D1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanauer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachmilewitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span> </span><span class="NLM_article-title">Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">359</span><span class="NLM_x">, </span> <span class="NLM_fpage">1541</span><span class="NLM_x">–</span> <span class="NLM_lpage">1549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2002&pages=1541-1549&author=S.+B.+Hanauerauthor=B.+G.+Feaganauthor=G.+R.+Lichtensteinauthor=L.+F.+Mayerauthor=S.+Schreiberauthor=J.+F.+Colombelauthor=D.+Rachmilewitzauthor=D.+C.+Wolfauthor=A.+Olsonauthor=W.+Baoauthor=P.+Rutgeerts&title=Maintenance+infliximab+for+Crohn%E2%80%99s+disease%3A+the+ACCENT+I+randomized+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DLichtenstein%26aufirst%3DG.%2BR.%26aulast%3DMayer%26aufirst%3DL.%2BF.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26aulast%3DRachmilewitz%26aufirst%3DD.%26aulast%3DWolf%26aufirst%3DD.%2BC.%26aulast%3DOlson%26aufirst%3DA.%26aulast%3DBao%26aufirst%3DW.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DMaintenance%2520infliximab%2520for%2520Crohn%25E2%2580%2599s%2520disease%253A%2520the%2520ACCENT%2520I%2520randomized%2520trial%26jtitle%3DLancet%26date%3D2002%26volume%3D359%26spage%3D1541%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandborn, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachmilewitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanauer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Villiers, W. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Present, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span> </span><span class="NLM_article-title">Infliximab for induction and maintenance therapy for ulcerative colitis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">2462</span><span class="NLM_x">–</span> <span class="NLM_lpage">2476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa050516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16339095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlShurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2005&pages=2462-2476&author=P.+Rutgeertsauthor=W.+J.+Sandbornauthor=B.+G.+Feaganauthor=W.+Reinischauthor=A.+Olsonauthor=J.+Johannsauthor=S.+Traversauthor=D.+Rachmilewitzauthor=S.+B.+Hanauerauthor=G.+Lichtensteinauthor=W.+J.+S.+de+Villiersauthor=D.+Presentauthor=B.+E.+Sandsauthor=J.+F.+Colombel&title=Infliximab+for+induction+and+maintenance+therapy+for+ulcerative+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Infliximab for induction and maintenance therapy for ulcerative colitis</span></div><div class="casAuthors">Rutgeerts, Paul; Sandborn, William J.; Feagan, Brian G.; Reinisch, Walter; Olson, Allan; Johanns, Jewel; Travers, Suzanne; Rachmilewitz, Daniel; Hanauer, Stephen B.; Lichtenstein, Gary R.; de Villiers, Willem J. S.; Present, Daniel; Sands, Bruce E.; Colombel, Jean Frederic</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2462-2476</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor α, is an established treatment for Crohn's disease but not ulcerative colitis.  METHODS: Two randomized, double-blind, placebo-controlled studies - the Active Ulcerative Colitis Trials 1 and 2 (ACT 1 and ACT 2, resp.) - evaluated the efficacy of infliximab for induction and maintenance therapy in adults with ulcerative colitis.  In each study, 364 patients with moderate-to-severe active ulcerative colitis despite treatment with concurrent medications received placebo or infliximab (5 mg or 10 mg per kilo- gram of body wt.) i.v. at weeks 0, 2, and 6 and then every eight weeks through week 46 (in ACT 1) or week 22 (in ACT 2).  Patients were followed for 54 wk in ACT 1 and 30 wk in ACT 2.  RESULTS: In ACT 1, 69 % of patients who received 5 mg of infliximab and 61 % of those who received 10 mg had a clin. response at week 8, as compared with 37 % of those who received placebo (P < 0.001 for both comparisons with placebo).  A response was defined as a decrease in the Mayo score of at least 3 points and at least 30 %, with an accompanying decrease in the subscore for rectal bleeding of at least 1 point or an abs. rectal-bleeding subscore of 0 or 1.  In ACT 2, 64 % of patients who received 5 mg of infliximab and 69 % of those who received 10 mg had a clin. response at week 8, as compared with 29 % of those who received placebo (P < 0.001 for both comparisons with placebo).  In both studies, patients who received infliximab were more likely to have a clin. response at week 30 (P ≤ 0.002 for all comparisons).  In ACT 1, more patients who received 5 mg or 10 mg of infliximab had a clin. response at week 54 (45 % and 44 %, resp.) than did those who received placebo (20 %, P < 0.001 for both comparisons).  CONCLUSIONS: Patients with moderate-to-severe active ulcerative colitis treated with infliximab at weeks 0, 2, and 6 and every eight weeks thereafter were more likely to have a clin. response at weeks 8, 30, and 54 than were those receiving placebo. (Clin. Trials.gov nos., NCT00036439 and NCT00096655.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7HpWjy_Czh7Vg90H21EOLACvtfcHk0lgalZz0MkY0qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlShurjE&md5=1611e3bf4856e8f1c57fe783ef75e92c</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050516%26sid%3Dliteratum%253Aachs%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DSandborn%26aufirst%3DW.%2BJ.%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DOlson%26aufirst%3DA.%26aulast%3DJohanns%26aufirst%3DJ.%26aulast%3DTravers%26aufirst%3DS.%26aulast%3DRachmilewitz%26aufirst%3DD.%26aulast%3DHanauer%26aufirst%3DS.%2BB.%26aulast%3DLichtenstein%26aufirst%3DG.%26aulast%3Dde%2BVilliers%26aufirst%3DW.%2BJ.%2BS.%26aulast%3DPresent%26aufirst%3DD.%26aulast%3DSands%26aufirst%3DB.%2BE.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26atitle%3DInfliximab%2520for%2520induction%2520and%2520maintenance%2520therapy%2520for%2520ulcerative%2520colitis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D353%26spage%3D2462%26epage%3D2476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ngo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolvo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. J.</span><span> </span><span class="NLM_article-title">Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety</span> <span class="citation_source-journal">Curr. Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFarurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=145-152&author=B.+Ngoauthor=C.+P.+Farrellauthor=M.+Barrauthor=K.+Wolvoauthor=R.+Baileyauthor=J.+M.+Mullinauthor=J.+J.+Thornton&title=Tumor+necrosis+factor+blockade+for+treatment+of+inflammatory+bowel+disease%3A+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Necrosis Factor blockade for treatment of inflammatory bowel disease: efficacy and safety</span></div><div class="casAuthors">Ngo, Benjamin; Farrell, Christopher P.; Barr, Maura; Wolov, Kevin; Bailey, Robert; Mullin, James M.; Thornton, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">CMPUB6</span>;
        ISSN:<span class="NLM_cas:issn">1874-4672</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inflammatory bowel disease (IBD), including Crohn's Disease (CD) and Ulcerative Colitis (UC), is characterized by inflammation of the gastrointestinal tract.  In UC, inflammation is confirmed to the mucosa, initially involving the rectum, and may extend proximally to involve the entire colon.  In CD, transmural inflammation may affect any portion of the G1 tract.  The etiol. of these disease processes has remained unclear.  Therapies are aimed at reduing inflammation and thereby improving symptomatol. and morbidity.  Traditional medical therapies have included corticosteroids, aminosalicylates, and immunomodulators.  Within the past decade, another class of medications has been utilized targeting Tumor Necrosis Factor (TNF), a key, early signaling mol. in the inflammatory cascade.  Increased levels of TNF have been found in the blood, epithelial tissue, and stool of patients with active IBD.  Anti-TNF medications can not only have direct effects on immune system components, but they also can ameliorate apoptotic cell death and tight junction compromise in the gastrointestinal epithelium.  Several randomized, placebo controlled studies have demonstrated the efficacy of these medications in achieving induction and maintaining remission of disease.  Their safety profile, however, remains a concern.  There has been a reported assocn. of biol. therapy and increased opportunistic infections.  A link between biol. therapy and the development of certain malignancies has also been described.  Despite these assocns., TNF blockade remains an important therapeutic development in the modern therapy of IBD.  The role of barrier breakdown at the tight junction level in IBD, and of TNF induction of barrier disruptio, is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri51WyVgFbSbVg90H21EOLACvtfcHk0lgalZz0MkY0qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFarurbI&md5=caf6a5b5fd0ec7de27f54e048caeda27</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DB.%26aulast%3DFarrell%26aufirst%3DC.%2BP.%26aulast%3DBarr%26aufirst%3DM.%26aulast%3DWolvo%26aufirst%3DK.%26aulast%3DBailey%26aufirst%3DR.%26aulast%3DMullin%26aufirst%3DJ.%2BM.%26aulast%3DThornton%26aufirst%3DJ.%2BJ.%26atitle%3DTumor%2520necrosis%2520factor%2520blockade%2520for%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%253A%2520efficacy%2520and%2520safety%26jtitle%3DCurr.%2520Mol.%2520Pharmacol.%26date%3D2010%26volume%3D3%26spage%3D145%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Caprioli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteleone, G.</span><span> </span><span class="NLM_article-title">Cytokine therapies in Crohn’s disease: Where are we now and where should we go?</span> <span class="citation_source-journal">Inflammation Allergy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.2174%2F187152811794352051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1antLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=47-53&author=F.+Caprioliauthor=F.+Palloneauthor=G.+Monteleone&title=Cytokine+therapies+in+Crohn%E2%80%99s+disease%3A+Where+are+we+now+and+where+should+we+go%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine therapies in crohn's disease: where are we now and where should we go?</span></div><div class="casAuthors">Caprioli, Flavio; Pallone, Francesco; Monteleone, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation & Allergy: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-53</span>CODEN:
                <span class="NLM_cas:coden">IADTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1871-5281</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In the gut of patients with Crohn's disease (CD), one of the major forms of inflammatory bowel disease in humans, distinct subsets of T helper (Th) cells produce large amts. of cytokines, which are supposed to orchestrate the immuno-inflammatory process leading to the tissue damage.  Indeed, cytokine blockers, including the three licensed anti-TNF-α and the neutralizing IL-12/p40 antibodies, have already been tested with success in CD.  More than one third of patients do not respond to these treatments and response can wane with time.  Moreover, blockade of such cytokines has been reported to assoc. with development of severe side effects and/or new immune-mediated pathologies.  These findings and our better understanding of cytokine-assocd. effector pathways of tissue destruction suggest that necessity of novel cytokine-based therapies in CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxoRtYpBkNYrVg90H21EOLACvtfcHk0lgalZz0MkY0qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1antLc%253D&md5=b359914a7359377f205cc48a7b4ed204</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.2174%2F187152811794352051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152811794352051%26sid%3Dliteratum%253Aachs%26aulast%3DCaprioli%26aufirst%3DF.%26aulast%3DPallone%26aufirst%3DF.%26aulast%3DMonteleone%26aufirst%3DG.%26atitle%3DCytokine%2520therapies%2520in%2520Crohn%25E2%2580%2599s%2520disease%253A%2520Where%2520are%2520we%2520now%2520and%2520where%2520should%2520we%2520go%253F%26jtitle%3DInflammation%2520Allergy%26date%3D2011%26volume%3D10%26spage%3D47%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Baer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assche, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haens, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabonez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span> </span><span class="NLM_article-title">Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa020888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=12584368" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2003&pages=601-608&author=F.+Baerauthor=M.+Nomanauthor=S.+Vermeireauthor=G.+V.+Asscheauthor=G.+D.+Haensauthor=A.+Cabonezauthor=P.+Rutgeerts&title=Influence+of+immunogenicity+on+the+long-term+efficacy+of+infliximab+in+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020888%26sid%3Dliteratum%253Aachs%26aulast%3DBaer%26aufirst%3DF.%26aulast%3DNoman%26aufirst%3DM.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DAssche%26aufirst%3DG.%2BV.%26aulast%3DHaens%26aufirst%3DG.%2BD.%26aulast%3DCabonez%26aufirst%3DA.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DInfluence%2520of%2520immunogenicity%2520on%2520the%2520long-term%2520efficacy%2520of%2520infliximab%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2003%26volume%3D348%26spage%3D601%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ben-Horin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowers, Y.</span><span> </span><span class="NLM_article-title">Loss of response to anti-TNF treatments in Crohn’s disease</span> <span class="citation_source-journal">Aliment. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1365-2036.2011.04612.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21366636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtF2gurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=987-995&author=S.+Ben-Horinauthor=Y.+Chowers&title=Loss+of+response+to+anti-TNF+treatments+in+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Review article: loss of response to anti-TNF treatments in Crohn's disease</span></div><div class="casAuthors">Ben-Horin, S.; Chowers, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Alimentary Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">987-995</span>CODEN:
                <span class="NLM_cas:coden">APTHEN</span>;
        ISSN:<span class="NLM_cas:issn">0269-2813</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Background Loss of response to anti-TNF agents in Crohn's disease is an emerging clin. problem.  Aim To review the causes, incidence and management approach of loss of response.  Methods A search of medical database (PubMed) and of meetings' proceedings for definitions, causes and incidence of loss of response was carried out.  Personal correspondence with principal investigators was conducted to retrieve missing data.  Results Various definitions of loss of response abound, hampering the ability to assess accurately the magnitude and management of this clin. problem.  We propose to distinguish between a clin. worsening on anti-TNF treatment and a true loss of response to anti-TNFs.  Accordingly, loss of response to anti-TNFs at 12 mo of therapy occurs in 23-46% of patients when judged by dose intensification, or 5-13% when gauged by drug discontinuation rates.  The management of loss of response should allow for a period of watchful waiting as quite often the patients' symptoms may resolve without alteration of therapy.  If they do not, then identifying the correct mechanism responsible for clin. deterioration is prudent.  Once symptoms are ascertained to arise from inflammatory IBD activity, drug level and antidrug antibody measurement can then help distinguish between non-adherence to therapy, immunogenicity and non-immune clearance of anti-TNF, or an un-chequered inflammation despite adequate anti-TNF levels.  The latter finding may be best addressed by a switch to another class of immunomodulators, whereas a low drug level should probably be managed by dose intensification or a switch to another anti-TNF.  Conclusion Studies defining how best to translate drug-level monitoring and other mechanistic considerations into clin. decisions are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhW9G6jVZHHLVg90H21EOLACvtfcHk0lgjeZMEAsqKcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtF2gurc%253D&md5=35841a6f9be42de4905bbe9db9e140cb</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2036.2011.04612.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2036.2011.04612.x%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Horin%26aufirst%3DS.%26aulast%3DChowers%26aufirst%3DY.%26atitle%3DLoss%2520of%2520response%2520to%2520anti-TNF%2520treatments%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DAliment.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D33%26spage%3D987%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bernstein, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wajda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. F.</span><span> </span><span class="NLM_article-title">The clustering of other chronic inflammatory disease in inflammatory bowel disease: a population-based study</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2005&pages=827-836&author=C.+N.+Bernsteinauthor=A.+Wajdaauthor=J.+F.+Blanchard&title=The+clustering+of+other+chronic+inflammatory+disease+in+inflammatory+bowel+disease%3A+a+population-based+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DC.%2BN.%26aulast%3DWajda%26aufirst%3DA.%26aulast%3DBlanchard%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520clustering%2520of%2520other%2520chronic%2520inflammatory%2520disease%2520in%2520inflammatory%2520bowel%2520disease%253A%2520a%2520population-based%2520study%26jtitle%3DGastroenterology%26date%3D2005%26volume%3D129%26spage%3D827%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">de Mesquita, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henckaerts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaessens, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hlavaty, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuerbeek, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assche, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, I.</span><span> </span><span class="NLM_article-title">Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease</span> <span class="citation_source-journal">Eur. J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1007%2Fs00431-008-0798-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18670786" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2009&pages=575-583&author=M.+B.+de+Mesquitaauthor=M.+Ferranteauthor=L.+Henckaertsauthor=M.+Joossensauthor=V.+Jaessensauthor=T.+Hlavatyauthor=M.+Pierikauthor=S.+Joossensauthor=M.+V.+Schuerbeekauthor=G.+V.+Asscheauthor=P.+Rutgeertsauthor=S.+Vermeireauthor=I.+Hoffman&title=Clustering+of+%28auto%29immune+diseases+with+early-onset+and+complicated+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1007%2Fs00431-008-0798-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00431-008-0798-7%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMesquita%26aufirst%3DM.%2BB.%26aulast%3DFerrante%26aufirst%3DM.%26aulast%3DHenckaerts%26aufirst%3DL.%26aulast%3DJoossens%26aufirst%3DM.%26aulast%3DJaessens%26aufirst%3DV.%26aulast%3DHlavaty%26aufirst%3DT.%26aulast%3DPierik%26aufirst%3DM.%26aulast%3DJoossens%26aufirst%3DS.%26aulast%3DSchuerbeek%26aufirst%3DM.%2BV.%26aulast%3DAssche%26aufirst%3DG.%2BV.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DHoffman%26aufirst%3DI.%26atitle%3DClustering%2520of%2520%2528auto%2529immune%2520diseases%2520with%2520early-onset%2520and%2520complicated%2520inflammatory%2520bowel%2520disease%26jtitle%3DEur.%2520J.%2520Pediatr.%26date%3D2009%26volume%3D168%26spage%3D575%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ellinghaus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellinghaus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metspalu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debrus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raelson, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejasvi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balschun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annese, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabesch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembath, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abecasis, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolaus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elder, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichenthal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nothnagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, A.</span><span> </span><span class="NLM_article-title">Combined analysis of genome-wide association studies for Crohn’s disease and psoriasis identifies seven shared susceptibility loci</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.ajhg.2012.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=22482804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFCrsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=636-645&author=D.+Ellinghausauthor=E.+Ellinghausauthor=R.+P.+Nairauthor=P.+E.+Stuartauthor=T.+Eskoauthor=A.+Metspaluauthor=S.+Debrusauthor=J.+V.+Raelsonauthor=T.+Tejasviauthor=M.+Belouchiauthor=S.+L.+Westauthor=J.+N.+Barkerauthor=S.+Koksauthor=K.+Kingoauthor=T.+Balschunauthor=O.+Palmieriauthor=V.+Anneseauthor=C.+Giegerauthor=H.+E.+Wichmannauthor=M.+Kabeschauthor=R.+C.+Trembathauthor=C.+G.+Mathewauthor=G.+R.+Abecasisauthor=S.+Weidingerauthor=S.+Nikolausauthor=S.+Schreiberauthor=J.+T.+Elderauthor=M.+Weichenthalauthor=M.+Nothnagelauthor=A.+Franke&title=Combined+analysis+of+genome-wide+association+studies+for+Crohn%E2%80%99s+disease+and+psoriasis+identifies+seven+shared+susceptibility+loci"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci</span></div><div class="casAuthors">Ellinghaus, David; Ellinghaus, Eva; Nair, Rajan P.; Stuart, Philip E.; Esko, Tonu; Metspalu, Andres; Debrus, Sophie; Raelson, John V.; Tejasvi, Trilokraj; Belouchi, Majid; West, Sarah L.; Barker, Jonathan N.; Koks, Sulev; Kingo, Kuelli; Balschun, Tobias; Palmieri, Orazio; Annese, Vito; Gieger, Christian; Wichmann, H. Erich; Kabesch, Michael; Trembath, Richard C.; Mathew, Christopher G.; Abecasis, Goncalo R.; Weidinger, Stephan; Nikolaus, Susanna; Schreiber, Stefan; Elder, James T.; Weichenthal, Michael; Nothnagel, Michael; Franke, Andre</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">636-647</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Psoriasis (PS) and Crohn disease (CD) have been shown to be epidemiol., pathol., and therapeutically connected, but little is known about their shared genetic causes.  We performed meta-analyses of five published genome-wide assocn. studies on PS (2,529 cases and 4,955 controls) and CD (2,142 cases and 5,505 controls), followed up 20 loci that showed strongest evidence for shared disease assocn. and, furthermore, tested cross-disease assocns. for previously reported PS and CD risk alleles in addnl. 6,115 PS cases, 4,073 CD cases, and 10,100 controls.  We identified seven susceptibility loci outside the human leukocyte antigen region (9p24 near JAK2, 10q22 at ZMIZ1, 11q13 near PRDX5, 16p13 near SOCS1, 17q21 at STAT3, 19p13 near FUT2, and 22q11 at YDJC) shared between PS and CD with genome-wide significance (p < 5 × 10-8) and confirmed four already established PS and CD risk loci (IL23R, IL12B, REL, and TYK2).  Three of the shared loci are also genome-wide significantly assocd. with PS alone (10q22 at ZMIZ1, prs1250544 = 3.53 × 10-8, 11q13 near PRDX5, prs694739 = 3.71 × 10-09, 22q11 at YDJC, prs181359 = 8.02 × 10-10).  In addn., we identified one susceptibility locus for CD (16p13 near SOCS1, prs4780355 = 4.99 × 10-8).  Refinement of assocn. signals identified shared genome-wide significant assocns. for exonic SNPs at 10q22 (ZMIZ1) and in silico expression quant. trait locus analyses revealed that the assocns. at ZMIZ1 and near SOCS1 have a potential functional effect on gene expression.  Our results show the usefulness of joint analyses of clin. distinct immune-mediated diseases and enlarge the map of shared genetic risk loci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-JSPvqV1dZLVg90H21EOLACvtfcHk0lgjeZMEAsqKcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFCrsr4%253D&md5=0169f350017714242399f503a1791640</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2012.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2012.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DEllinghaus%26aufirst%3DD.%26aulast%3DEllinghaus%26aufirst%3DE.%26aulast%3DNair%26aufirst%3DR.%2BP.%26aulast%3DStuart%26aufirst%3DP.%2BE.%26aulast%3DEsko%26aufirst%3DT.%26aulast%3DMetspalu%26aufirst%3DA.%26aulast%3DDebrus%26aufirst%3DS.%26aulast%3DRaelson%26aufirst%3DJ.%2BV.%26aulast%3DTejasvi%26aufirst%3DT.%26aulast%3DBelouchi%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%2BL.%26aulast%3DBarker%26aufirst%3DJ.%2BN.%26aulast%3DKoks%26aufirst%3DS.%26aulast%3DKingo%26aufirst%3DK.%26aulast%3DBalschun%26aufirst%3DT.%26aulast%3DPalmieri%26aufirst%3DO.%26aulast%3DAnnese%26aufirst%3DV.%26aulast%3DGieger%26aufirst%3DC.%26aulast%3DWichmann%26aufirst%3DH.%2BE.%26aulast%3DKabesch%26aufirst%3DM.%26aulast%3DTrembath%26aufirst%3DR.%2BC.%26aulast%3DMathew%26aufirst%3DC.%2BG.%26aulast%3DAbecasis%26aufirst%3DG.%2BR.%26aulast%3DWeidinger%26aufirst%3DS.%26aulast%3DNikolaus%26aufirst%3DS.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DElder%26aufirst%3DJ.%2BT.%26aulast%3DWeichenthal%26aufirst%3DM.%26aulast%3DNothnagel%26aufirst%3DM.%26aulast%3DFranke%26aufirst%3DA.%26atitle%3DCombined%2520analysis%2520of%2520genome-wide%2520association%2520studies%2520for%2520Crohn%25E2%2580%2599s%2520disease%2520and%2520psoriasis%2520identifies%2520seven%2520shared%2520susceptibility%2520loci%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2012%26volume%3D90%26spage%3D636%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lees, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satsangi, J.</span><span> </span><span class="NLM_article-title">New IBD genetics: common pathways with other diseases</span> <span class="citation_source-journal">Gut</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1739-1753&author=C.+W.+Leesauthor=J.+C.+Barrettauthor=M.+Parkesauthor=J.+Satsangi&title=New+IBD+genetics%3A+common+pathways+with+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DC.%2BW.%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DParkes%26aufirst%3DM.%26aulast%3DSatsangi%26aufirst%3DJ.%26atitle%3DNew%2520IBD%2520genetics%253A%2520common%2520pathways%2520with%2520other%2520diseases%26jtitle%3DGut%26date%3D2011%26volume%3D60%26spage%3D1739%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, B.</span><span> </span><span class="NLM_article-title">Innate immunity in the pathogenesis of psoriasis</span> <span class="citation_source-journal">Arch. Dermatol. Res</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">691</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1007%2Fs00403-011-1169-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21863252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFantbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2011&pages=691-705&author=C.+Sweeneyauthor=A.-M.+Tobinauthor=B.+Kirby&title=Innate+immunity+in+the+pathogenesis+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immunity in the pathogenesis of psoriasis</span></div><div class="casAuthors">Sweeney, Cheryl M.; Tobin, Ann-Marie; Kirby, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Dermatological Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">691-705</span>CODEN:
                <span class="NLM_cas:coden">ADREDL</span>;
        ISSN:<span class="NLM_cas:issn">0340-3696</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Psoriasis is a common, immune-mediated inflammatory skin disorder.  T helper(h)1 and Th17 lymphocytes contribute to the pathogenesis of psoriasis through the release of inflammatory cytokines that promote further recruitment of immune cells, keratinocyte proliferation and sustained inflammation.  The innate immune system is the first line of defense against infection and plays a crucial role in the initiation of the adaptive immune response.  The presence of innate immune cells and their products in psoriatic skin plaques suggests a role for innate immunity in this disease.  In addn., the innate immune system can direct the development of pathogenic Th cells in psoriasis.  In this article, we will summarize the role of the innate immune system in psoriasis with particular emphasis on the role of cytokines, signaling pathways and cells of the innate immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSeJoKa9Zfw7Vg90H21EOLACvtfcHk0lgHD2i1bxG8rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFantbvN&md5=1d9a37fa3d9027569f420f7370889dcf</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1007%2Fs00403-011-1169-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00403-011-1169-1%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DTobin%26aufirst%3DA.-M.%26aulast%3DKirby%26aufirst%3DB.%26atitle%3DInnate%2520immunity%2520in%2520the%2520pathogenesis%2520of%2520psoriasis%26jtitle%3DArch.%2520Dermatol.%2520Res%26date%3D2011%26volume%3D303%26spage%3D691%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monteleone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, T.</span><span> </span><span class="NLM_article-title">Emerging immunological targets in inflammatory bowel disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">645</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.coph.2011.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=22000933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=640-645&author=G.+Monteleoneauthor=F.+Palloneauthor=T.+MacDonald&title=Emerging+immunological+targets+in+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging immunological targets in inflammatory bowel disease</span></div><div class="casAuthors">Monteleone, Giovanni; Pallone, Francesco; MacDonald, Thomas T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">640-645</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Crohn's disease (CD) and ulcerative colitis (UC) are the major forms of inflammatory bowel diseases (IBD) in man.  They are caused by damage to the lining of the intestine and deeper layers, due to an excessive immune response directed against components of the gut microflora and poorly controlled by counter-regulatory mechanisms.  CD and UC are however immunol. distinct.  CD-related inflammation is characterized by a marked mucosal infiltration of T lymphocytes secreting T helper type (Th) 1 and Th17 cytokines.  In UC, the local immune response is less polarized but may show enhanced prodn. of IL-5, IL-13 and Th17 cytokines.  Downstream however CD and UC share important end-stage effector pathways of intestinal injury, mediated by an active cross-talk between immune and non-immune cells.  The clarification of the complex networks of immune-inflammatory mediators operating in the gut of IBD patients has led to the identification of new targets that should facilitate the development of novel biol. therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0xg_FG-l1wrVg90H21EOLACvtfcHk0lgHD2i1bxG8rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegsbfN&md5=13fb9f263a05d63c52308943417ed3cb</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DMonteleone%26aufirst%3DG.%26aulast%3DPallone%26aufirst%3DF.%26aulast%3DMacDonald%26aufirst%3DT.%26atitle%3DEmerging%2520immunological%2520targets%2520in%2520inflammatory%2520bowel%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2011%26volume%3D11%26spage%3D640%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mucida, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheroutre, H.</span><span> </span><span class="NLM_article-title">The many face-lifts of CD4 T helper cells</span> <span class="citation_source-journal">Adv. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=139-152&author=D.+Mucidaauthor=H.+Cheroutre&title=The+many+face-lifts+of+CD4+T+helper+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMucida%26aufirst%3DD.%26aulast%3DCheroutre%26aufirst%3DH.%26atitle%3DThe%2520many%2520face-lifts%2520of%2520CD4%2520T%2520helper%2520cells%26jtitle%3DAdv.%2520Immunol.%26date%3D2010%26volume%3D107%26spage%3D139%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Garra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D.</span><span> </span><span class="NLM_article-title">Development and function of T-helper 1 cells</span> <span class="citation_source-journal">Adv. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2004&pages=133-162&author=A.+O%E2%80%99Garraauthor=D.+Robinson&title=Development+and+function+of+T-helper+1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Garra%26aufirst%3DA.%26aulast%3DRobinson%26aufirst%3DD.%26atitle%3DDevelopment%2520and%2520function%2520of%2520T-helper%25201%2520cells%26jtitle%3DAdv.%2520Immunol.%26date%3D2004%26volume%3D83%26spage%3D133%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Murphy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiner, S.</span><span> </span><span class="NLM_article-title">The lineage decisions of helper T cells</span> <span class="citation_source-journal">Nat. Rev. Immunol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fnri954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=12461566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFKnu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=933-944&author=K.+M.+Murphyauthor=S.+Reiner&title=The+lineage+decisions+of+helper+T+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">The lineage decisions of helper T cells</span></div><div class="casAuthors">Murphy, Kenneth M.; Reiner, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">933-944</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  After encountering antigen, helper T (TH) cells undergo differentiation to effector cells, which can secrete high levels of interferon-γ, interleukin-4 (IL-4), IL-10 and other immunomodulators.  How TH cells acquire, and remember, new patterns of gene expression is an area of intensive investigation.  The process is remarkably plastic, with cytokines being key regulators.  Extrinsic signals seem to be integrated into cell-intrinsic programming, in what is becoming an intriguing story of regulated development.  The authors summarize the latest insights into mechanisms that govern the lineage choices that are made during TH-cell responses to foreign pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGW2uqaEevbVg90H21EOLACvtfcHk0lioaD4bXIguIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFKnu7g%253D&md5=877fad48cff0be1506229d7934c12955</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fnri954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri954%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DK.%2BM.%26aulast%3DReiner%26aufirst%3DS.%26atitle%3DThe%2520lineage%2520decisions%2520of%2520helper%2520T%2520cells%26jtitle%3DNat.%2520Rev.%2520Immunol%26date%3D2002%26volume%3D2%26spage%3D933%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Skokos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waite, J. C.</span><span> </span><span class="NLM_article-title">Th17 response and inflammatory autoimmune diseases</span> <span class="citation_source-journal">Int. J. Inflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">819467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=819467&author=D.+Skokosauthor=J.+C.+Waite&title=Th17+response+and+inflammatory+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 response and inflammatory autoimmune diseases</span></div><div class="casAuthors">Waite, Janelle C.; Skokos, Dimitris</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Inflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">819467, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJINDV</span>;
        ISSN:<span class="NLM_cas:issn">2042-0099</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  The proinflammatory activity of T helper 17 (Th17) cells can be beneficial to the host during infection.  However, uncontrolled or inappropriate Th17 activation has been linked to several autoimmune and autoinflammatory pathologies.  Indeed, preclin. and clin. data show that Th17 cells are assocd. with several autoimmune diseases such as arthritis, multiple sclerosis, psoriasis, and lupus.  Furthermore, targeting the interleukin-17 (IL-17) pathway has attenuated disease severity in preclin. models of autoimmune diseases.  Interestingly, a recent report brings to light a potential role for Th17 cells in the autoinflammatory disorder adult-onset Still's disease (AOSD).  Whether Th17 cells are the cause or are directly involved in AOSD remains to be shown.  In this paper, we discuss the biol. of Th17 cells, their role in autoimmune disease development, and in AOSD in particular, as well as the growing interest of the pharmaceutical industry in their use as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonoZYU0uSmLrVg90H21EOLACvtfcHk0lioaD4bXIguIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaksbs%253D&md5=1c697669aafb3d8f90b35e8cd0a31993</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkokos%26aufirst%3DD.%26aulast%3DWaite%26aufirst%3DJ.%2BC.%26atitle%3DTh17%2520response%2520and%2520inflammatory%2520autoimmune%2520diseases%26jtitle%3DInt.%2520J.%2520Inflammation%26date%3D2012%26spage%3D819467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Miossec, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuchroo, V. K.</span><span> </span><span class="NLM_article-title">Interleukin-17 and type 17 helper cells</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMra0707449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19710487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=888-898&author=P.+Miossecauthor=T.+Kornauthor=V.+K.+Kuchroo&title=Interleukin-17+and+type+17+helper+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: interleukin-17 and type 17 helper T cells</span></div><div class="casAuthors">Miossec, Pierre; Korn, Thomas; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">888-898</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses interleukin-17, Th17 type cell differentiation, and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-E1d7Mv0fFLVg90H21EOLACvtfcHk0lioaD4bXIguIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhtLrP&md5=aeab15ba0bfd6ad228782a8aa51fe2d8</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0707449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0707449%26sid%3Dliteratum%253Aachs%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DInterleukin-17%2520and%2520type%252017%2520helper%2520cells%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D888%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Louten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boniface, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malefyt, R. d. W.</span><span> </span><span class="NLM_article-title">Development and function of Th17 cells in health and disease</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.jaci.2009.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19410689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlyitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=1004-1011&author=J.+Loutenauthor=K.+Bonifaceauthor=R.+d.+W.+Malefyt&title=Development+and+function+of+Th17+cells+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Development and function of TH17 cells in health and disease</span></div><div class="casAuthors">Louten, Jennifer; Boniface, Katia; de Waal Malefyt, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1004-1011</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  TH17 cells are the newest member of the TH cell family and are characterized by their ability to produce specific cytokines such as IL-17, IL-22, IL-17F, and CCL20.  In this review, conditions for the differentiation of TH17 cells are defined in both murine and human systems, with discussion of TH17-specific cytokines and transcription factors.  Functionally, TH17 cells contribute to host defense as a new effector TH cell subset with a role in protection against extracellular bacteria through activities on immune and nonimmune cells.  Their activities, however, are also pivotal in the development of autoimmune diseases under pathol. conditions.  TH17 cells are also beginning to be assocd. with the development and pathophysiol. of allergic diseases, such as allergic contact dermatitis, atopic dermatitis, and asthma.  Lymphoid tissue inducer-like cells and natural killer-like cells, termed RORγt+NKp46+ or NK-22 cells, might also play a role in allergic diseases because of their propensity to produce IL-17 and IL-22.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy2s99FUQKLbVg90H21EOLACvtfcHk0lioaD4bXIguIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlyitLw%253D&md5=5160c6ebef97b46a7e6d21bf95344968</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2009.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2009.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DLouten%26aufirst%3DJ.%26aulast%3DBoniface%26aufirst%3DK.%26aulast%3DMalefyt%26aufirst%3DR.%2Bd.%2BW.%26atitle%3DDevelopment%2520and%2520function%2520of%2520Th17%2520cells%2520in%2520health%2520and%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2009%26volume%3D123%26spage%3D1004%26epage%3D1011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boniface, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blom, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleft, R. d. W.</span><span> </span><span class="NLM_article-title">From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1600-065X.2008.00714.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19161421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=2008&pages=132-146&author=K.+Bonifaceauthor=B.+Blomauthor=Y.-J.+Liuauthor=R.+d.+W.+Maleft&title=From+interleukin-23+to+T-helper+17+cells%3A+human+T-helper+cell+differentiation+revisited"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited</span></div><div class="casAuthors">Boniface, Katia; Blom, Bianca; Liu, Yong-Jun; de Waal Malefyt, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">132-146</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Protracted inflammation leading to dysregulation of effector T-cell responses represents a common feature of a wide range of autoimmune diseases.  The interleukin-12 (IL-12)/T-helper 1 (Th1) pathway was thought to be responsible for the pathogenesis of multiple chronic inflammatory diseases, including psoriasis, inflammatory bowel disease, arthritis, or multiple sclerosis, mainly through their prodn. of interferon-γ and its effects on macrophage activation and chemokine prodn.  However, this initial concept of T-cell-mediated chronic inflammation required an adjustment with the discovery of an IL-12-related cytokine, designated IL-23.  IL-23 was rapidly recognized for its involvement in the establishment of chronic inflammation and in the development of a Th cell subset producing IL-17, designated Th17, which is distinct from the previously reported Th1 and Th2 populations.  This review aims to describe the characterization of IL-23 and its receptor, its biol. activities, as well as its involvement in the development of human Th17 cells and autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGxsSHrkO_CbVg90H21EOLACvtfcHk0liZnhO-K5WyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls77E&md5=1c74afb324f0d76b1f8c314616971e32</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00714.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00714.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoniface%26aufirst%3DK.%26aulast%3DBlom%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DY.-J.%26aulast%3DMaleft%26aufirst%3DR.%2Bd.%2BW.%26atitle%3DFrom%2520interleukin-23%2520to%2520T-helper%252017%2520cells%253A%2520human%2520T-helper%2520cell%2520differentiation%2520revisited%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D226%26spage%3D132%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Trinchieri, G.</span><span> </span><span class="NLM_article-title">Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1146%2Fannurev.iy.13.040195.001343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=7612223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK2MXltFamtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1995&pages=251-276&author=G.+Trinchieri&title=Interleukin-12%3A+a+proinflammatory+cytokine+with+immunoregulatory+functions+that+bridge+innate+resistance+and+antigen-specific+adaptive+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity</span></div><div class="casAuthors">Trinchieri, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">251-76</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 97 refs.  Interleukin-12 (IL-12) is a heterodimeric cytokine produced mostly by phagocytic cells and to some degree by B lymphocytes.  IL-12 induces cytokine prodn., acts as a growth factor for activated NK and T cells, enhances the cytotoxic activity of NK cells, and favors cytotoxic T lymphocyte generation.  In vivo IL-12 acts primarily at 3 stages during the innate resistance/adaptive immune response to infection:.  1. Early in the infection, IL-12 is produced and induces prodn. from NK and T cells of IFN-γ, which contributes to phagocytic cell activation and inflammation; 2. IL-12 and IL-12-induced IFN-γ favor Th1 cell differentiation by priming CD4+ T cells for high IFN-γ prodn.; and 3. IL-12 contributes to optimal IFN-γ prodn. and to proliferation of differentiated Th1 cells in response to antigen.  The early preference expressed in the immune response depends on the balance between IL-12, which favors Th1 responses, and IL-4, which favors Th2 responses.  Thus, IL-12 represents a functional bridge between the early nonspecific innate resistance and the subsequent antigen-specific adaptive immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo96uU3A_QjDbVg90H21EOLACvtfcHk0liZnhO-K5WyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltFamtbg%253D&md5=0d1cc60a810592ecb7efce6ea9f98092</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.iy.13.040195.001343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.iy.13.040195.001343%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchieri%26aufirst%3DG.%26atitle%3DInterleukin-12%253A%2520a%2520proinflammatory%2520cytokine%2520with%2520immunoregulatory%2520functions%2520that%2520bridge%2520innate%2520resistance%2520and%2520antigen-specific%2520adaptive%2520immunity%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1995%26volume%3D13%26spage%3D251%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chung, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C.</span><span> </span><span class="NLM_article-title">Don’t leave home without it: the IL-23 visa to Th17 cells</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fni0309-236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19221553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFKjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=236-238&author=Y.+Chungauthor=C.+Dong&title=Don%E2%80%99t+leave+home+without+it%3A+the+IL-23+visa+to+Th17+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Don't leave home without it: the IL-23 visa to TH-17 cells</span></div><div class="casAuthors">Chung, Yeonseok; Dong, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">236-238</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Interleukin 23 is tightly assocd. with TH-17 cell-mediated inflammation and autoimmunity.  A new study of mice deficient in its receptor shows that interleukin 23 is required for the terminal differentiation of TH-17 cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNeQ--WiJrULVg90H21EOLACvtfcHk0liZnhO-K5WyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFKjsbo%253D&md5=b1aad75f9637c462409b91f7bd967f57</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2Fni0309-236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni0309-236%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DDon%25E2%2580%2599t%2520leave%2520home%2520without%2520it%253A%2520the%2520IL-23%2520visa%2520to%2520Th17%2520cells%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26spage%3D236%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chua, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chizzonite, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrier, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, U.</span><span> </span><span class="NLM_article-title">Expression cloning of a human IL-12 receptor component</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=128-136&author=A.+O.+Chuaauthor=R.+Chizzoniteauthor=B.+B.+Desaiauthor=T.+P.+Truittauthor=P.+Nunesauthor=L.+J.+Minettiauthor=R.+R.+Warrierauthor=D.+H.+Preskyauthor=J.+F.+Levineauthor=M.+K.+Gatelyauthor=U.+Gubler&title=Expression+cloning+of+a+human+IL-12+receptor+component"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChua%26aufirst%3DA.%2BO.%26aulast%3DChizzonite%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DB.%2BB.%26aulast%3DTruitt%26aufirst%3DT.%2BP.%26aulast%3DNunes%26aufirst%3DP.%26aulast%3DMinetti%26aufirst%3DL.%2BJ.%26aulast%3DWarrier%26aufirst%3DR.%2BR.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DLevine%26aufirst%3DJ.%2BF.%26aulast%3DGately%26aufirst%3DM.%2BK.%26aulast%3DGubler%26aufirst%3DU.%26atitle%3DExpression%2520cloning%2520of%2520a%2520human%2520IL-12%2520receptor%2520component%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabavi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, U.</span><span> </span><span class="NLM_article-title">A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">14002</span><span class="NLM_x">–</span> <span class="NLM_lpage">14007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=14002-14007&author=D.+H.+Preskyauthor=H.+Yangauthor=L.+J.+Minettiauthor=A.+O.+Chuaauthor=N.+Nabaviauthor=C.-Y.+Wuauthor=M.+K.+Gatelyauthor=U.+Gubler&title=A+functional+interleukin+12+receptor+complex+is+composed+of+two+%CE%B2-type+cytokine+receptor+subunits"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DMinetti%26aufirst%3DL.%2BJ.%26aulast%3DChua%26aufirst%3DA.%2BO.%26aulast%3DNabavi%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DC.-Y.%26aulast%3DGately%26aufirst%3DM.%2BK.%26aulast%3DGubler%26aufirst%3DU.%26atitle%3DA%2520functional%2520interleukin%252012%2520receptor%2520complex%2520is%2520composed%2520of%2520two%2520%25CE%25B2-type%2520cytokine%2520receptor%2520subunits%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D14002%26epage%3D14007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Parham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirica, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflanz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">To, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Farrell, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClanahan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurawski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastlein, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maleft, R. d. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, K. W.</span><span> </span><span class="NLM_article-title">A receptor for the heterodimeric cytokine IL-23 is composed of IL-12β1 and a novel cytokine receptor subunit, IL-23R</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">5699</span><span class="NLM_x">–</span> <span class="NLM_lpage">5708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2002&pages=5699-5708&author=C.+Parhamauthor=M.+Chiricaauthor=J.+Timansauthor=E.+Vaisbergauthor=M.+Travisauthor=J.+Cheungauthor=S.+Pflanzauthor=R.+Zhangauthor=K.+Singhauthor=F.+Vegaauthor=W.+Toauthor=J.+Wagnerauthor=A.-M.+O%E2%80%99Farrellauthor=T.+McClanahanauthor=S.+Zurawskiauthor=C.+Hannumauthor=D.+Gormanauthor=D.+Rennickauthor=R.+A.+Kastleinauthor=R.+d.+W.+Maleftauthor=K.+W.+Moore&title=A+receptor+for+the+heterodimeric+cytokine+IL-23+is+composed+of+IL-12%CE%B21+and+a+novel+cytokine+receptor+subunit%2C+IL-23R"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParham%26aufirst%3DC.%26aulast%3DChirica%26aufirst%3DM.%26aulast%3DTimans%26aufirst%3DJ.%26aulast%3DVaisberg%26aufirst%3DE.%26aulast%3DTravis%26aufirst%3DM.%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DPflanz%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DVega%26aufirst%3DF.%26aulast%3DTo%26aufirst%3DW.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Farrell%26aufirst%3DA.-M.%26aulast%3DMcClanahan%26aufirst%3DT.%26aulast%3DZurawski%26aufirst%3DS.%26aulast%3DHannum%26aufirst%3DC.%26aulast%3DGorman%26aufirst%3DD.%26aulast%3DRennick%26aufirst%3DD.%26aulast%3DKastlein%26aufirst%3DR.%2BA.%26aulast%3DMaleft%26aufirst%3DR.%2Bd.%2BW.%26aulast%3DMoore%26aufirst%3DK.%2BW.%26atitle%3DA%2520receptor%2520for%2520the%2520heterodimeric%2520cytokine%2520IL-23%2520is%2520composed%2520of%2520IL-12%25CE%25B21%2520and%2520a%2520novel%2520cytokine%2520receptor%2520subunit%252C%2520IL-23R%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D168%26spage%3D5699%26epage%3D5708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Firmbach-Kraft, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shows, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalla-Favera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolewski, J. J.</span><span> </span><span class="NLM_article-title">TYK2, prototype of a novel class of non-receptor tyrosine kinase genes</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=2216457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK3MXhsFyjuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1990&pages=1329-1336&author=I.+Firmbach-Kraftauthor=M.+Byersauthor=T.+Showsauthor=R.+Dalla-Faveraauthor=J.+J.+Krolewski&title=TYK2%2C+prototype+of+a+novel+class+of+non-receptor+tyrosine+kinase+genes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">tyk2, Prototype of a novel class of non-receptor tyrosine kinase genes</span></div><div class="casAuthors">Firmbach-Kraft, Iris; Byers, Mary; Shows, Thomas; Dalla-Favera, Riccardo; Krolewski, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1329-36</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">The authors previously identified a novel protein tyrosine kinase gene, tyk2, by screening a human lymphoid cDNA library with a tyrosine kinase domain specific c-fms restriction fragment under low stringency hybridization conditions.  They now isolated and sequenced a full length tyk2 cDNA clone; demonstrated that this gene is widely expressed in hematopoietic and non-hematopoietic cell lines; and mapped it to chromosome 19p13.2.  The cDNA clone is 4176 nucleotides long and codes for a putative protein with a mol. wt. of 134 kilodaltons.  Hydrophobicity anal. of the sequence does not identify a transmembrane domain, which is found in all members of the receptor class of protein tyrosine kinases; nor can the authors detect an SH2 domain, found in all previously identified non-receptor protein kinases.  They propose that tyk2 is the prototype of a new class of non-receptor protein tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhLoFCW2FDWrVg90H21EOLACvtfcHk0li7xQXL-ZnKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhsFyjuro%253D&md5=c7a4180a140f0bcdc98140a265fb4cb4</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFirmbach-Kraft%26aufirst%3DI.%26aulast%3DByers%26aufirst%3DM.%26aulast%3DShows%26aufirst%3DT.%26aulast%3DDalla-Favera%26aufirst%3DR.%26aulast%3DKrolewski%26aufirst%3DJ.%2BJ.%26atitle%3DTYK2%252C%2520prototype%2520of%2520a%2520novel%2520class%2520of%2520non-receptor%2520tyrosine%2520kinase%2520genes%26jtitle%3DOncogene%26date%3D1990%26volume%3D5%26spage%3D1329%26epage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, U.</span><span> </span><span class="NLM_article-title">Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and β2 and JAK kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">6073</span><span class="NLM_x">–</span> <span class="NLM_lpage">6077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=6073-6077&author=J.+Zouauthor=D.+H.+Preskyauthor=C.-Y.+Wuauthor=U.+Gubler&title=Differential+associations+between+the+cytoplasmic+regions+of+the+interleukin-12+receptor+subunits+%CE%B21+and+%CE%B22+and+JAK+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DWu%26aufirst%3DC.-Y.%26aulast%3DGubler%26aufirst%3DU.%26atitle%3DDifferential%2520associations%2520between%2520the%2520cytoplasmic%2520regions%2520of%2520the%2520interleukin-12%2520receptor%2520subunits%2520%25CE%25B21%2520and%2520%25CE%25B22%2520and%2520JAK%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D6073%26epage%3D6077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Harpur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemiecki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">JAK2, a third member of the JAK family of protein tyrosine kinases</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=1620548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK38XmtVOrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1992&pages=1347-1353&author=A.+G.+Harpurauthor=A.+C.+Andresauthor=A.+Ziemieckiauthor=R.+R.+Astonauthor=A.+F.+Wilks&title=JAK2%2C+a+third+member+of+the+JAK+family+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">JAK2, a third member of the JAK family of protein tyrosine kinases</span></div><div class="casAuthors">Harpur, Ailsa G.; Andres, Anne Catherine; Ziemiecki, Andrew; Aston, Raja R.; Wilks, Andrew F.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1347-53</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">CDNA clones encoding a third, widely expressed, member of the JAK family of protein tyrosine kinases (PTKs) were isolated.  The anticipated amino acid sequence of JAK2 predicts the presence of two kinase-related domains, a feature characteristic of this family of PTKs.  The structural similarity of JAK2 to the other members of this family extends towards their N-termini, beyond the two kinase-related domains, and reveals five further domains of substantial amino acid similarity.  The C-terminal portion of one of these domains, the JH4 domain, bears an intriguing, albeit tenuous, similarity to the core element of the SH2 domain, whereas the remaining JAK homol. domains do not appear to be a feature of other known proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquGgx2uwGEN7Vg90H21EOLACvtfcHk0li7xQXL-ZnKkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmtVOrtLc%253D&md5=db385133406115942157615e9c56b47f</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarpur%26aufirst%3DA.%2BG.%26aulast%3DAndres%26aufirst%3DA.%2BC.%26aulast%3DZiemiecki%26aufirst%3DA.%26aulast%3DAston%26aufirst%3DR.%2BR.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DJAK2%252C%2520a%2520third%2520member%2520of%2520the%2520JAK%2520family%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DOncogene%26date%3D1992%26volume%3D7%26spage%3D1347%26epage%3D1353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyasaka, N.</span><span> </span><span class="NLM_article-title">Physical interaction between interleukin-12 receptor β2 subunit and JAK2 tyrosine kinase: JAK2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor β2 via amino terminus</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1999&pages=400-404&author=K.+Yamamotoauthor=F.+Shibataauthor=O.+Miuraauthor=R.+Kamiyamaauthor=S.+Hirosawaauthor=N.+Miyasaka&title=Physical+interaction+between+interleukin-12+receptor+%CE%B22+subunit+and+JAK2+tyrosine+kinase%3A+JAK2+associates+with+cytoplasmic+membrane-proximal+region+of+interleukin-12+receptor+%CE%B22+via+amino+terminus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DF.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DKamiyama%26aufirst%3DR.%26aulast%3DHirosawa%26aufirst%3DS.%26aulast%3DMiyasaka%26aufirst%3DN.%26atitle%3DPhysical%2520interaction%2520between%2520interleukin-12%2520receptor%2520%25CE%25B22%2520subunit%2520and%2520JAK2%2520tyrosine%2520kinase%253A%2520JAK2%2520associates%2520with%2520cytoplasmic%2520membrane-proximal%2520region%2520of%2520interleukin-12%2520receptor%2520%25CE%25B22%2520via%2520amino%2520terminus%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D257%26spage%3D400%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurban, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurcher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemiecki, A.</span><span> </span><span class="NLM_article-title">Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2057</span><span class="NLM_x">–</span> <span class="NLM_lpage">2065</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1128%2FMCB.11.4.2057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=1848670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADyaK3MXlslyju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=2057-2065&author=A.+F.+Wilksauthor=A.+G.+Harpurauthor=R.+R.+Kurbanauthor=S.+J.+Ralphauthor=G.+Zurcherauthor=A.+Ziemiecki&title=Two+novel+protein-tyrosine+kinases%2C+each+with+a+second+phosphotransferase-related+catalytic+domain%2C+define+a+new+class+of+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase</span></div><div class="casAuthors">Wilks, Andrew F.; Harpur, Ailsa G.; Kurban, R. R.; Ralph, Stephen J.; Zuercher, Gisela; Ziemiecki, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2057-65</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The protein tyrosine kinases (PTKs) are a burgeoning family of proteins, each of which bears a conserved domain of 250-300 amino acids capable of phosphorylating substrate proteins on tyrosine residues.  Recently, the existence of 2 highly conserved sequence elements within the catalytic domain was exploited to generate PTK-specific degenerate oligonucleotide primers.  By application of the polymerase chain reaction, portions of the catalytic domains of several novel PTKs were amplified.  Here, the primary sequence is reported of one of these new PTKs, JAK1 (from Janus kinase), a member of a new class of PTK characterized by the presence of a 2nd phosphotransferase-related domain immediately N-terminal to the PTK domain.  The sequence was derived from the cDNA sequence of a human fibroblast clone.  The 2nd phosphotransferase domain bears all the hallmarks of a protein kinase, although its structure differed significantly from that of the PTK and threonine/serine kinase family members.  A 2nd member of this family (JAK2) was partially characterized and exhibited a similar array of kinase-related domains.  JAK1 is a large, widely expressed membrane-assocd. phosphoprotein of ∼130 kDa.  The PTK activity of JAK1 was located in the C-terminal PTK-like domain.  The role of the 2nd kinase-like domain is unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8XPv7ZSQ7kbVg90H21EOLACvtfcHk0lgm1HBWktdQ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlslyju7s%253D&md5=7094cf98426dbe3ed5470ced76dc839b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FMCB.11.4.2057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.11.4.2057%26sid%3Dliteratum%253Aachs%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DHarpur%26aufirst%3DA.%2BG.%26aulast%3DKurban%26aufirst%3DR.%2BR.%26aulast%3DRalph%26aufirst%3DS.%2BJ.%26aulast%3DZurcher%26aufirst%3DG.%26aulast%3DZiemiecki%26aufirst%3DA.%26atitle%3DTwo%2520novel%2520protein-tyrosine%2520kinases%252C%2520each%2520with%2520a%2520second%2520phosphotransferase-related%2520catalytic%2520domain%252C%2520define%2520a%2520new%2520class%2520of%2520protein%2520kinase%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1991%26volume%3D11%26spage%3D2057%26epage%3D2065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rane, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. E.</span><span> </span><span class="NLM_article-title">JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2045</span><span class="NLM_x">–</span> <span class="NLM_lpage">2052</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1994&pages=2045-2052&author=S.+G.+Raneauthor=P.+E.+Reddy&title=JAK3%3A+a+novel+JAK+kinase+associated+with+terminal+differentiation+of+hematopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRane%26aufirst%3DS.%2BG.%26aulast%3DReddy%26aufirst%3DP.%2BE.%26atitle%3DJAK3%253A%2520a%2520novel%2520JAK%2520kinase%2520associated%2520with%2520terminal%2520differentiation%2520of%2520hematopoietic%2520cells%26jtitle%3DOncogene%26date%3D1994%26volume%3D9%26spage%3D2045%26epage%3D2052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirasaw, T.</span><span> </span><span class="NLM_article-title">Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=1994&pages=124-128&author=T.+Takahashiauthor=T.+Shirasaw&title=Molecular+cloning+of+rat+JAK3%2C+a+novel+member+of+the+JAK+family+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DShirasaw%26aufirst%3DT.%26atitle%3DMolecular%2520cloning%2520of%2520rat%2520JAK3%252C%2520a%2520novel%2520member%2520of%2520the%2520JAK%2520family%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D342%26spage%3D124%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shaker, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moustafa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Essmat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Halim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Komy, M.</span><span> </span><span class="NLM_article-title">The role of interleukin-12 in the pathogenesis of psoriasis</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.clinbiochem.2005.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16386240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsF2hs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=119-125&author=O.+G.+Shakerauthor=W.+Moustafaauthor=S.+Essmatauthor=M.+Abdel-Halimauthor=M.+El-Komy&title=The+role+of+interleukin-12+in+the+pathogenesis+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of interleukin-12 in the pathogenesis of psoriasis</span></div><div class="casAuthors">Shaker, Olfat G.; Moustafa, Wedad; Essmat, Samia; Abdel-Halim, Mona; El-Komy, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-125</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Objective was to verify the role of IL-12 in the pathogenesis of psoriasis and det. its relation to IFNγ.  Skin biopsies from lesional and non-lesional skin of 30 patients and 10 healthy controls were obtained for quant. PCR examn. of IL-12 (p40) and IFNγ mRNA as well as in situ PCR of IL-12 (p40) and IFNγ mRNA.  IL-12 and IFNγ levels were higher in lesional skin than in non-lesional and control skin.  A significant correlation between IL-12 and IFNγ was found.  By in situ PCR hybridization, IL-12 expression was only found in the dermis, while IFNγ was invariably expressed in the dermis and/or epidermis.  Apparently, IL-12 independently and through IFNγ induction may have a crucial role in the development of the active psoriatic lesion itself, where it is probably produced locally in the dermis as a step in the evolution of the psoriatic lesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquyM3Tk2T7aLVg90H21EOLACvtfcHk0lgm1HBWktdQ4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsF2hs7Y%253D&md5=21ea41d270ee47a8725b57a729953e18</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.clinbiochem.2005.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinbiochem.2005.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DO.%2BG.%26aulast%3DMoustafa%26aufirst%3DW.%26aulast%3DEssmat%26aufirst%3DS.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26aulast%3DEl-Komy%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520interleukin-12%2520in%2520the%2520pathogenesis%2520of%2520psoriasis%26jtitle%3DClin.%2520Biochem.%26date%3D2006%26volume%3D39%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Piskin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylva-Steenland, R. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teunissen, M. B. M.</span><span> </span><span class="NLM_article-title">In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">1908</span><span class="NLM_x">–</span> <span class="NLM_lpage">1915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1908-1915&author=G.+Piskinauthor=R.+M.+R.+Sylva-Steenlandauthor=J.+D.+Bosauthor=M.+B.+M.+Teunissen&title=In+vitro+and+in+situ+expression+of+IL-23+by+keratinocytes+in+healthy+skin+and+psoriasis+lesions%3A+enhanced+expression+in+psoriatic+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiskin%26aufirst%3DG.%26aulast%3DSylva-Steenland%26aufirst%3DR.%2BM.%2BR.%26aulast%3DBos%26aufirst%3DJ.%2BD.%26aulast%3DTeunissen%26aufirst%3DM.%2BB.%2BM.%26atitle%3DIn%2520vitro%2520and%2520in%2520situ%2520expression%2520of%2520IL-23%2520by%2520keratinocytes%2520in%2520healthy%2520skin%2520and%2520psoriasis%2520lesions%253A%2520enhanced%2520expression%2520in%2520psoriatic%2520skin%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D1908%26epage%3D1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepicchio, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oestreicher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhodapkar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Increased expression of interleukin 23p19 and p40 in lesional skin of patients with psoriasis vulgris</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">199</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2004&pages=125-130&author=E.+Leeauthor=W.+L.+Trepicchioauthor=J.+Oestreicherauthor=D.+Pittmanauthor=F.+Wangauthor=F.+Chamianauthor=M.+Dhodapkarauthor=J.+G.+Krueger&title=Increased+expression+of+interleukin+23p19+and+p40+in+lesional+skin+of+patients+with+psoriasis+vulgris"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DTrepicchio%26aufirst%3DW.%2BL.%26aulast%3DOestreicher%26aufirst%3DJ.%26aulast%3DPittman%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DChamian%26aufirst%3DF.%26aulast%3DDhodapkar%26aufirst%3DM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DIncreased%2520expression%2520of%2520interleukin%252023p19%2520and%2520p40%2520in%2520lesional%2520skin%2520of%2520patients%2520with%2520psoriasis%2520vulgris%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2004%26volume%3D199%26spage%3D125%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Yawalkar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braathen, L. R.</span><span> </span><span class="NLM_article-title">Expression of interleukin-12 is increased in psoriatic skin</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1998&pages=1053-1057&author=N.+Yawalkarauthor=S.+Karlenauthor=R.+Hungerauthor=C.+U.+Brandauthor=L.+R.+Braathen&title=Expression+of+interleukin-12+is+increased+in+psoriatic+skin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYawalkar%26aufirst%3DN.%26aulast%3DKarlen%26aufirst%3DS.%26aulast%3DHunger%26aufirst%3DR.%26aulast%3DBrand%26aufirst%3DC.%2BU.%26aulast%3DBraathen%26aufirst%3DL.%2BR.%26atitle%3DExpression%2520of%2520interleukin-12%2520is%2520increased%2520in%2520psoriatic%2520skin%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D1998%26volume%3D111%26spage%3D1053%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takekoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamaki, K.</span><span> </span><span class="NLM_article-title">Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by cyclosprin A</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1365-2133.2006.07180.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=16704652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVKkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2006&pages=1180-1183&author=Y.+Tadaauthor=A.+Asahinaauthor=T.+Takekoshiauthor=E.+Kishimotoauthor=H.+Mitsuiauthor=H.+Saekiauthor=M.+Komineauthor=K.+Tamaki&title=Interleukin+12+production+by+monocytes+from+patients+with+psoriasis+and+its+inhibition+by+cyclosprin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by ciclosporin A</span></div><div class="casAuthors">Tada, Y.; Asahina, A.; Takekoshi, T.; Kishimoto, E.; Mitsui, H.; Saeki, H.; Komine, M.; Tamaki, K.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1180-1183</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: Psoriasis is a T-helper (Th)1 cytokine-mediated chronic skin disease and interleukin (IL)-12 has been shown to play a major role in the development of Th1 responses.  Objectives: To elucidate the role of IL-12 in the pathogenesis of psoriasis and to study the effect of ciclosporin A (CsA) on Th1 deviation of this disease.  Patients/Methods: We investigated IL-12 prodn. by stimulated monocytes from patients with psoriasis who were treated with or without CsA.  Monocytes were stimulated with interferon-γ plus lipopolysaccharide (LPS) or Staphylococcus aureus Cowan strain I (SAC).  The amt. of IL-12 p70 produced by stimulated monocytes was evaluated by ELISA.  Results: Compared with those from normal controls, LPS- but not SAC-stimulated monocytes from patients with psoriasis produced significantly higher amts. of IL-12.  Interestingly, LPS-stimulated monocytes from patients with psoriasis treated with CsA produced significantly decreased amts. of IL-12 compared with those patients not treated with CsA.  Conclusions: Our results suggest that IL-12 prodn. by monocytes may have a crit. role in the pathogenesis of psoriasis, and that the therapeutic effect of CsA on psoriasis may be achieved by correcting the deviation of the Th1/Th2 balance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo83AaDnVThWrVg90H21EOLACvtfcHk0lg30p-14aVpRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVKkur8%253D&md5=9438f6f5abd41f6047f936a1f19c25f6</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2006.07180.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2006.07180.x%26sid%3Dliteratum%253Aachs%26aulast%3DTada%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DA.%26aulast%3DTakekoshi%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DE.%26aulast%3DMitsui%26aufirst%3DH.%26aulast%3DSaeki%26aufirst%3DH.%26aulast%3DKomine%26aufirst%3DM.%26aulast%3DTamaki%26aufirst%3DK.%26atitle%3DInterleukin%252012%2520production%2520by%2520monocytes%2520from%2520patients%2520with%2520psoriasis%2520and%2520its%2520inhibition%2520by%2520cyclosprin%2520A%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2006%26volume%3D154%26spage%3D1180%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chamian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowes, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilleaudeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan-Whalen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardinale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatcherian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novitskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittkowski, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris</span> <span class="citation_source-journal">Proc. Natl. Acad Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2080</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=2075-2080&author=F.+Chamianauthor=M.+A.+Lowesauthor=S.-L.+Linauthor=E.+Leeauthor=T.+Kikuchiauthor=P.+Gilleaudeauauthor=M.+Sullivan-Whalenauthor=I.+Cardinaleauthor=A.+Khatcherianauthor=I.+Novitskayaauthor=K.+M.+Wittkowskiauthor=J.+G.+Krueger&title=Alefacept+reduces+infiltrating+T+cells%2C+activated+dendritic+cells%2C+and+inflammatory+genes+in+psoriasis+vulgaris"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChamian%26aufirst%3DF.%26aulast%3DLowes%26aufirst%3DM.%2BA.%26aulast%3DLin%26aufirst%3DS.-L.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DGilleaudeau%26aufirst%3DP.%26aulast%3DSullivan-Whalen%26aufirst%3DM.%26aulast%3DCardinale%26aufirst%3DI.%26aulast%3DKhatcherian%26aufirst%3DA.%26aulast%3DNovitskaya%26aufirst%3DI.%26aulast%3DWittkowski%26aufirst%3DK.%2BM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DAlefacept%2520reduces%2520infiltrating%2520T%2520cells%252C%2520activated%2520dendritic%2520cells%252C%2520and%2520inflammatory%2520genes%2520in%2520psoriasis%2520vulgaris%26jtitle%3DProc.%2520Natl.%2520Acad%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D2075%26epage%3D2080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Gottlieb, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardinale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abello, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowes, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliocco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, J. G.</span><span> </span><span class="NLM_article-title">TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2005&pages=2721-2729&author=A.+B.+Gottliebauthor=F.+Chamianauthor=S.+Masudauthor=I.+Cardinaleauthor=M.+V.+Abelloauthor=M.+A.+Lowesauthor=F.+Chenauthor=M.+Maglioccoauthor=J.+G.+Krueger&title=TNF+inhibition+rapidly+down-regulates+multiple+proinflammatory+pathways+in+psoriasis+plaques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DA.%2BB.%26aulast%3DChamian%26aufirst%3DF.%26aulast%3DMasud%26aufirst%3DS.%26aulast%3DCardinale%26aufirst%3DI.%26aulast%3DAbello%26aufirst%3DM.%2BV.%26aulast%3DLowes%26aufirst%3DM.%2BA.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DMagliocco%26aufirst%3DM.%26aulast%3DKrueger%26aufirst%3DJ.%2BG.%26atitle%3DTNF%2520inhibition%2520rapidly%2520down-regulates%2520multiple%2520proinflammatory%2520pathways%2520in%2520psoriasis%2520plaques%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D175%26spage%3D2721%26epage%3D2729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Piskin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tursen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylva-Steenland, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teunissen, M. B. M.</span><span> </span><span class="NLM_article-title">Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFNg inducers—IL-12, IL-18 and IL-23</span> <span class="citation_source-journal">Exp. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">772</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.0906-6705.2004.00246.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15560760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1yqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=764-772&author=G.+Piskinauthor=U.+Tursenauthor=R.+M.+Sylva-Steenlandauthor=J.+D.+Bosauthor=M.+B.+M.+Teunissen&title=Clinical+improvement+in+chronic+plaque-type+psoriasis+lesions+after+narrow-band+UVB+therapy+is+accompanied+by+a+decrease+in+the+expression+of+IFNg+inducers%E2%80%94IL-12%2C+IL-18+and+IL-23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20dR"><div class="casContent"><span class="casTitleNuber">20d</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers - IL-12, IL-18 and IL-23</span></div><div class="casAuthors">Piskin, G.; Tursen, U.; Sylva-Steenland, R. M. R.; Bos, J. D.; Tennissen, M. B. M.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Dermatology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">764-772</span>CODEN:
                <span class="NLM_cas:coden">EXDEEY</span>;
        ISSN:<span class="NLM_cas:issn">0906-6705</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Type-1 cytokine-producing T cells are important in the pathogenesis of psoriasis vulgaris, for which efficient therapy is provided by means of narrow-band UV-B (NB-UVB).  The expression of the type-1 cytokine interferon-γ (IFN-γ) is regulated by interleukin-12 (IL-12), IL-15, IL-18 and IL-23; however, not much is known about the effect of this therapy on the levels of these cytokines in lesional psoriatic skin in situ.  In this study, we investigated the effects of NB-UVB therapy on the expression of IFN-γ-inducing cytokines.  Ten patients with chronic plaque-type psoriasis selected to be treated with NB-UVB therapy were recruited for these expts. and the expression of cytokines IL-12, IL-15, IL-18, IL-23 and IFN-γ in lesional psoriatic skin before, during and after therapy was detd. with the help of immunohistochem.  Double staining was performed in order to det. the cell types expressing these cytokines.  The decrease in the psoriasis area and severity index was accompanied by a significant decrease in the expression of IFN-γ, and concomitantly, significant redn. of IFN-γ-inducers IL-12, IL-18 and IL-23.  Thus, we concluded that the decrease of IFN-γ expression in psoriasis lesions after NB-UVB therapy could be a result of diminished expression of IL-12, IL-18 and IL-23 in lesional skin.  Therapies targeting these three cytokines should, therefore, be considered in the treatment of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaPDkoT64eYLVg90H21EOLACvtfcHk0lg30p-14aVpRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1yqug%253D%253D&md5=4986e2e8d38599e548dde1732564ac09</span></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1111%2Fj.0906-6705.2004.00246.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0906-6705.2004.00246.x%26sid%3Dliteratum%253Aachs%26aulast%3DPiskin%26aufirst%3DG.%26aulast%3DTursen%26aufirst%3DU.%26aulast%3DSylva-Steenland%26aufirst%3DR.%2BM.%26aulast%3DBos%26aufirst%3DJ.%2BD.%26aulast%3DTeunissen%26aufirst%3DM.%2BB.%2BM.%26atitle%3DClinical%2520improvement%2520in%2520chronic%2520plaque-type%2520psoriasis%2520lesions%2520after%2520narrow-band%2520UVB%2520therapy%2520is%2520accompanied%2520by%2520a%2520decrease%2520in%2520the%2520expression%2520of%2520IFNg%2520inducers%25E2%2580%2594IL-12%252C%2520IL-18%2520and%2520IL-23%26jtitle%3DExp.%2520Dermatol.%26date%3D2004%26volume%3D13%26spage%3D764%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kopp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bello-Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kastelein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupper, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span> </span><span class="NLM_article-title">IL-23 production by co-secretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">5438</span><span class="NLM_x">–</span> <span class="NLM_lpage">5444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=5438-5444&author=T.+Koppauthor=P.+Lenzauthor=C.+Bello-Fernandezauthor=R.+Kasteleinauthor=T.+S.+Kupperauthor=G.+Stingl&title=IL-23+production+by+co-secretion+of+endogenous+p19+and+transgenic+p40+in+keratin+14%2Fp40+transgenic+mice%3A+evidence+for+enhanced+cutaneous+immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DLenz%26aufirst%3DP.%26aulast%3DBello-Fernandez%26aufirst%3DC.%26aulast%3DKastelein%26aufirst%3DR.%26aulast%3DKupper%26aufirst%3DT.%2BS.%26aulast%3DStingl%26aufirst%3DG.%26atitle%3DIL-23%2520production%2520by%2520co-secretion%2520of%2520endogenous%2520p19%2520and%2520transgenic%2520p40%2520in%2520keratin%252014%252Fp40%2520transgenic%2520mice%253A%2520evidence%2520for%2520enhanced%2520cutaneous%2520immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D5438%26epage%3D5444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kopp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieffer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strommer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupper, T. S.</span><span> </span><span class="NLM_article-title">Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2001&pages=618-626&author=T.+Koppauthor=J.+D.+Kiefferauthor=A.+Rotauthor=S.+Strommerauthor=G.+Stinglauthor=T.+S.+Kupper&title=Inflammatory+skin+disease+in+K14%2Fp40+transgenic+mice%3A+evidence+for+interleukin-12-like+activities+of+p40"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopp%26aufirst%3DT.%26aulast%3DKieffer%26aufirst%3DJ.%2BD.%26aulast%3DRot%26aufirst%3DA.%26aulast%3DStrommer%26aufirst%3DS.%26aulast%3DStingl%26aufirst%3DG.%26aulast%3DKupper%26aufirst%3DT.%2BS.%26atitle%3DInflammatory%2520skin%2520disease%2520in%2520K14%252Fp40%2520transgenic%2520mice%253A%2520evidence%2520for%2520interleukin-12-like%2520activities%2520of%2520p40%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2001%26volume%3D117%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Clarke, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domagala, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mraovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewmaker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennings, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doylce, A. G.</span><span> </span><span class="NLM_article-title">A novel class of anti-IL-12p40 antibodies</span> <span class="citation_source-journal">mAbs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">539</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=539-549&author=A.+W.+Clarkeauthor=L.+Poultonauthor=H.+Y.+Waiauthor=S.+A.+Walkerauthor=S.+D.+Victorauthor=T.+Domagalaauthor=D.+Mraovicauthor=D.+Buttauthor=N.+Shewmakerauthor=P.+Henningsauthor=A.+G.+Doylce&title=A+novel+class+of+anti-IL-12p40+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DA.%2BW.%26aulast%3DPoulton%26aufirst%3DL.%26aulast%3DWai%26aufirst%3DH.%2BY.%26aulast%3DWalker%26aufirst%3DS.%2BA.%26aulast%3DVictor%26aufirst%3DS.%2BD.%26aulast%3DDomagala%26aufirst%3DT.%26aulast%3DMraovic%26aufirst%3DD.%26aulast%3DButt%26aufirst%3DD.%26aulast%3DShewmaker%26aufirst%3DN.%26aulast%3DHennings%26aufirst%3DP.%26aulast%3DDoylce%26aufirst%3DA.%2BG.%26atitle%3DA%2520novel%2520class%2520of%2520anti-IL-12p40%2520antibodies%26jtitle%3DmAbs%26date%3D2010%26volume%3D2%26spage%3D539%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kimball, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fakharzadeh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeilding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szapary, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, K. A.</span><span> </span><span class="NLM_article-title">Long-term efficacy of ustekinumab in moderate-to-severe psoriasis: results from the PHOENIX 1 trials through up to 3 years</span> <span class="citation_source-journal">Br. J. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">861</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.1365-2133.2012.10901.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=22356258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVyntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=861-872&author=A.+B.+Kimballauthor=K.+B.+Gordonauthor=S.+Fakharzadehauthor=N.+Yeildingauthor=P.+O.+Szaparyauthor=B.+Schenkelauthor=C.+Guzzoauthor=S.+Liauthor=K.+A.+Papp&title=Long-term+efficacy+of+ustekinumab+in+moderate-to-severe+psoriasis%3A+results+from+the+PHOENIX+1+trials+through+up+to+3+years"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years</span></div><div class="casAuthors">Kimball, A. B.; Gordon, K. B.; Fakharzadeh, S.; Yeilding, N.; Szapary, P. O.; Schenkel, B.; Guzzo, C.; Li, S.; Papp, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">861-872</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: An unmet need remains for safe and effective long-term treatments of psoriasis.  Objectives: To evaluate ustekinumab efficacy and safety for up to 3 years in the PHOENIX 1 trial.  Methods: Patients (n = 766) with moderate-to-severe psoriasis were randomized to ustekinumab 45 mg or 90 mg at weeks 0 and 4, and then every 12 wk, or placebo at weeks 0 and 4, with crossover to ustekinumab at week 12.  Ustekinumab responders [≥ 75% improvement from baseline in the Psoriasis Area and Severity Index (PASI 75) at weeks 28 and 40] were re-randomized at week 40 to continue or withdraw from treatment until psoriasis recurrence.  Partial responders (week 28: PASI 50-74; week 40: < PASI 75) switched to dosing every 8 wk.  Clin. efficacy was assessed by PASI, the Physician's Global Assessment (PGA), and the Dermatol. Life Quality Index (DLQI) measures.  Results: Overall, 79.8% of the ustekinumab-treated patients remained in the study for 3 years.  PASI 75 response rates (45 mg: 61.2%; 90 mg: 72.4%) at week 76 were maintained through year 3 (45 mg: 62.7%; 90 mg: 72.2%); PGA response was similarly durable.  At year 3, 80.9% (45 mg) and 82.7% (90 mg) of week 40 responders continuing treatment every 12 wk achieved a PASI 75 response, while 42.6% (45 mg) and 58.0% (90 mg) achieved a PASI 90 response.  Among partial responders adjusted to dosing every 8 wk, 50.9% (45 mg) and 52.0% (90 mg) had a PASI 75 response at year 3.  DLQI responses paralleled the PASI responses.  Through year 3, no dose response was obsd. in rates of adverse events (AEs), overall infections, serious AEs, or AEs leading to discontinuation; nor was there evidence of cumulative organ toxicity.  Conclusions: Continuous, stable, maintenance dosing with ustekinumab was generally well tolerated and sustained durable efficacy for up to 3 years of treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnKvRavgx127Vg90H21EOLACvtfcHk0lijm46kRuvokw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVyntbo%253D&md5=21ebebcae4c961ad61a790e5bd1957e1</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2012.10901.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2012.10901.x%26sid%3Dliteratum%253Aachs%26aulast%3DKimball%26aufirst%3DA.%2BB.%26aulast%3DGordon%26aufirst%3DK.%2BB.%26aulast%3DFakharzadeh%26aufirst%3DS.%26aulast%3DYeilding%26aufirst%3DN.%26aulast%3DSzapary%26aufirst%3DP.%2BO.%26aulast%3DSchenkel%26aufirst%3DB.%26aulast%3DGuzzo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DK.%2BA.%26atitle%3DLong-term%2520efficacy%2520of%2520ustekinumab%2520in%2520moderate-to-severe%2520psoriasis%253A%2520results%2520from%2520the%2520PHOENIX%25201%2520trials%2520through%2520up%2520to%25203%2520years%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2012%26volume%3D166%26spage%3D861%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Papp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szapary, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeilding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, K.</span><span> </span><span class="NLM_article-title">Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1675</span><span class="NLM_x">–</span> <span class="NLM_lpage">1684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1675-1684&author=K.+A.+Pappauthor=R.+G.+Langleyauthor=M.+Lebwohlauthor=G.+G.+Kruegerauthor=P.+Szaparyauthor=N.+Yeildingauthor=C.+Guzzoauthor=M.-C.+Hsuauthor=Y.+Wangauthor=S.+Liauthor=L.+T.+Dooleyauthor=K.+Reich&title=Efficacy+and+safety+of+ustekinumab%2C+a+human+interleukin-12%2F23+monoclonal+antibody%2C+in+patients+with+psoriasis%3A+52-week+results+from+a+randomized%2C+double-blind%2C+placebo-controlled+trial+%28PHOENIX+2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapp%26aufirst%3DK.%2BA.%26aulast%3DLangley%26aufirst%3DR.%2BG.%26aulast%3DLebwohl%26aufirst%3DM.%26aulast%3DKrueger%26aufirst%3DG.%2BG.%26aulast%3DSzapary%26aufirst%3DP.%26aulast%3DYeilding%26aufirst%3DN.%26aulast%3DGuzzo%26aufirst%3DC.%26aulast%3DHsu%26aufirst%3DM.-C.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDooley%26aufirst%3DL.%2BT.%26aulast%3DReich%26aufirst%3DK.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520ustekinumab%252C%2520a%2520human%2520interleukin-12%252F23%2520monoclonal%2520antibody%252C%2520in%2520patients%2520with%2520psoriasis%253A%252052-week%2520results%2520from%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520%2528PHOENIX%25202%2529%26jtitle%3DLancet%26date%3D2008%26volume%3D371%26spage%3D1675%26epage%3D1684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Leonardi, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeilding, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dooley, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, K. B.</span><span> </span><span class="NLM_article-title">Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1665</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2008&pages=1665-1674&author=G.+L.+Leonardiauthor=A.+B.+Kimballauthor=K.+A.+Pappauthor=N.+Yeildingauthor=C.+Guzzoauthor=Y.+Wangauthor=S.+Liauthor=L.+T.+Dooleyauthor=K.+B.+Gordon&title=Efficacy+and+safety+of+ustekinumab%2C+a+human+interleukin-12%2F23+monoclonal+antibody%2C+in+patients+with+psoriasis%3A+76-week+results+from+a+randomized%2C+double-blind%2C+placebo-controlled+trial+%28PHOENIX+1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeonardi%26aufirst%3DG.%2BL.%26aulast%3DKimball%26aufirst%3DA.%2BB.%26aulast%3DPapp%26aufirst%3DK.%2BA.%26aulast%3DYeilding%26aufirst%3DN.%26aulast%3DGuzzo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DDooley%26aufirst%3DL.%2BT.%26aulast%3DGordon%26aufirst%3DK.%2BB.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520ustekinumab%252C%2520a%2520human%2520interleukin-12%252F23%2520monoclonal%2520antibody%252C%2520in%2520patients%2520with%2520psoriasis%253A%252076-week%2520results%2520from%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520%2528PHOENIX%25201%2529%26jtitle%3DLancet%26date%3D2008%26volume%3D371%26spage%3D1665%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Benson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treacy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pendley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodmerkel, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascelli, M. A.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=615-624&author=J.+M.+Bensonauthor=C.+W.+Sachsauthor=G.+Treacyauthor=H.+Zhouauthor=C.+Pendleyauthor=C.+M.+Brodmerkelauthor=G.+Shankarauthor=M.+A.+Mascelli&title=Therapeutic+targeting+of+the+IL-12%2F23+pathways%3A+generation+and+characterization+of+ustekinumab"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DJ.%2BM.%26aulast%3DSachs%26aufirst%3DC.%2BW.%26aulast%3DTreacy%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DPendley%26aufirst%3DC.%26aulast%3DBrodmerkel%26aufirst%3DC.%2BM.%26aulast%3DShankar%26aufirst%3DG.%26aulast%3DMascelli%26aufirst%3DM.%2BA.%26atitle%3DTherapeutic%2520targeting%2520of%2520the%2520IL-12%252F23%2520pathways%253A%2520generation%2520and%2520characterization%2520of%2520ustekinumab%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D615%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barrett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansoul, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolae, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duerr, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brant, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverberg, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassopoulos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kistner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtha, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regueiro, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumm, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhart, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targan, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libioulle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lathrop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belaiche, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laukens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gossum, A. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelenika, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franchimont, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hugot, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onnie, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumpstead, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwilliam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremelling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deloukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satsangi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span> </span><span class="NLM_article-title">Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fng.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18587394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFSqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=955-962&author=J.+C.+Barrettauthor=S.+Hansoulauthor=D.+L.+Nicolaeauthor=J.+H.+Choauthor=R.+H.+Duerrauthor=J.+D.+Riouxauthor=S.+R.+Brantauthor=M.+K.+Silverbergauthor=K.+D.+Taylorauthor=M.+M.+Barmadaauthor=A.+Bittonauthor=T.+Dassopoulosauthor=L.+W.+Dattaauthor=T.+Greenauthor=A.+M.+Griffithsauthor=E.+O.+Kistnerauthor=M.+T.+Murthaauthor=M.+D.+Regueiroauthor=J.+T.+Rotterauthor=L.+P.+Schummauthor=A.+H.+Steinhartauthor=S.+T.+Targanauthor=R.+J.+Xavierauthor=C.+Libioulleauthor=C.+Sandorauthor=M.+Lathropauthor=J.+Belaicheauthor=O.+Dewitauthor=I.+Gutauthor=S.+Heathauthor=D.+Laukensauthor=M.+Mniauthor=P.+Rutgeertsauthor=A.+v.+Gossumauthor=D.+Zelenikaauthor=D.+Franchimontauthor=J.-P.+Hugotauthor=M.+de+Vosauthor=S.+Vermeireauthor=E.+Louisauthor=L.+R.+Cardonauthor=C.+A.+Andersonauthor=H.+Drummondauthor=E.+Nimmoauthor=T.+Ahmadauthor=N.+J.+Prescottauthor=C.+M.+Onnieauthor=S.+A.+Fisherauthor=J.+Marchiniauthor=J.+Ghoriauthor=S.+Bumpsteadauthor=R.+Gwilliamauthor=M.+Tremellingauthor=P.+Deloukasauthor=J.+Mansfieldauthor=D.+Jewelauthor=J.+Satsangiauthor=C.+G.+Mathewauthor=M.+Parkesauthor=M.+Georgesauthor=M.+J.+Daly&title=Genome-wide+association+defines+more+than+30+distinct+susceptibility+loci+for+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease</span></div><div class="casAuthors">Barrett, Jeffrey C.; Hansoul, Sarah; Nicolae, Dan L.; Cho, Judy H.; Duerr, Richard H.; Rioux, John D.; Brant, Steven R.; Silverberg, Mark S.; Taylor, Kent D.; Barmada, M. Michael; Bitton, Alain; Dassopoulos, Themistocles; Datta, Lisa Wu; Green, Todd; Griffiths, Anne M.; Kistner, Emily O.; Murtha, Michael T.; Regueiro, Miguel D.; Rotter, Jerome I.; Schumm, L. Philip; Steinhart, A. Hillary; Targan, Stephan R.; Xavier, Ramnik J.; Libioulle, Cecile; Sandor, Cynthia; Lathrop, Mark; Belaiche, Jacques; Dewit, Olivier; Gut, Ivo; Heath, Simon; Laukens, Debby; Mni, Myriam; Rutgeerts, Paul; Van Gossum, Andre; Zelenika, Diana; Franchimont, Denis; Hugot, Jean-Pierre; de Vos, Martine; Vermeire, Severine; Louis, Edouard; Cardon, Lon R.; Anderson, Carl A.; Drummond, Hazel; Nimmo, Elaine; Ahmad, Tariq; Prescott, Natalie J.; Onnie, Clive M.; Fisher, Sheila A.; Marchini, Jonathan; Ghori, Jilur; Bumpstead, Suzannah; Gwilliam, Rhian; Tremelling, Mark; Deloukas, Panos; Mansfield, John; Jewell, Derek; Satsangi, Jack; Mathew, Christopher G.; Parkes, Miles; Georges, Michel; Daly, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">955-962</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mark Daly and colleagues present results of a combined anal. of data from three recent genome-wide assocn. studies for Crohn's disease, followed by replication in a large independent sample collection.  Their results confirm 11 previously reported risk loci and provide genome-wide significant evidence for 21 new loci assocd. with the disease.  Mark Daly and colleagues present results of a combined anal. of data from three recent genome-wide assocn. studies for Crohn's disease, followed by replication in a large independent sample collection.  Their results confirm 11 previously reported risk loci and provide genome-wide significant evidence for 21 new loci assocd. with the disease.  Several risk factors for Crohn's disease have been identified in recent genome-wide assocn. studies.  To advance gene discovery further, we combined data from three studies on Crohn's disease (a total of 3,230 cases and 4,829 controls) and carried out replication in 3,664 independent cases with a mixt. of population-based and family-based controls.  The results strongly confirm 11 previously reported loci and provide genome-wide significant evidence for 21 addnl. loci, including the regions contg. STAT3, JAK2, ICOSLG, CDKAL1 and ITLN1.  The expanded mol. understanding of the basis of this disease offers promise for informed therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXvOZmM6KfrLVg90H21EOLACvtfcHk0ljMwbCr5JOOBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFSqs7k%253D&md5=c2f2805316b115765c02aa1dc503626b</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1038%2Fng.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.175%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DJ.%2BC.%26aulast%3DHansoul%26aufirst%3DS.%26aulast%3DNicolae%26aufirst%3DD.%2BL.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DDuerr%26aufirst%3DR.%2BH.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DBrant%26aufirst%3DS.%2BR.%26aulast%3DSilverberg%26aufirst%3DM.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%2BD.%26aulast%3DBarmada%26aufirst%3DM.%2BM.%26aulast%3DBitton%26aufirst%3DA.%26aulast%3DDassopoulos%26aufirst%3DT.%26aulast%3DDatta%26aufirst%3DL.%2BW.%26aulast%3DGreen%26aufirst%3DT.%26aulast%3DGriffiths%26aufirst%3DA.%2BM.%26aulast%3DKistner%26aufirst%3DE.%2BO.%26aulast%3DMurtha%26aufirst%3DM.%2BT.%26aulast%3DRegueiro%26aufirst%3DM.%2BD.%26aulast%3DRotter%26aufirst%3DJ.%2BT.%26aulast%3DSchumm%26aufirst%3DL.%2BP.%26aulast%3DSteinhart%26aufirst%3DA.%2BH.%26aulast%3DTargan%26aufirst%3DS.%2BT.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3DLibioulle%26aufirst%3DC.%26aulast%3DSandor%26aufirst%3DC.%26aulast%3DLathrop%26aufirst%3DM.%26aulast%3DBelaiche%26aufirst%3DJ.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DGut%26aufirst%3DI.%26aulast%3DHeath%26aufirst%3DS.%26aulast%3DLaukens%26aufirst%3DD.%26aulast%3DMni%26aufirst%3DM.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DGossum%26aufirst%3DA.%2Bv.%26aulast%3DZelenika%26aufirst%3DD.%26aulast%3DFranchimont%26aufirst%3DD.%26aulast%3DHugot%26aufirst%3DJ.-P.%26aulast%3Dde%2BVos%26aufirst%3DM.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DLouis%26aufirst%3DE.%26aulast%3DCardon%26aufirst%3DL.%2BR.%26aulast%3DAnderson%26aufirst%3DC.%2BA.%26aulast%3DDrummond%26aufirst%3DH.%26aulast%3DNimmo%26aufirst%3DE.%26aulast%3DAhmad%26aufirst%3DT.%26aulast%3DPrescott%26aufirst%3DN.%2BJ.%26aulast%3DOnnie%26aufirst%3DC.%2BM.%26aulast%3DFisher%26aufirst%3DS.%2BA.%26aulast%3DMarchini%26aufirst%3DJ.%26aulast%3DGhori%26aufirst%3DJ.%26aulast%3DBumpstead%26aufirst%3DS.%26aulast%3DGwilliam%26aufirst%3DR.%26aulast%3DTremelling%26aufirst%3DM.%26aulast%3DDeloukas%26aufirst%3DP.%26aulast%3DMansfield%26aufirst%3DJ.%26aulast%3DJewel%26aufirst%3DD.%26aulast%3DSatsangi%26aufirst%3DJ.%26aulast%3DMathew%26aufirst%3DC.%2BG.%26aulast%3DParkes%26aufirst%3DM.%26aulast%3DGeorges%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26atitle%3DGenome-wide%2520association%2520defines%2520more%2520than%252030%2520distinct%2520susceptibility%2520loci%2520for%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2008%26volume%3D40%26spage%3D955%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Duerr, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brant, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverberg, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhart, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regueiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassopoulos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Targan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Datta, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kistner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumm, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregersen, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmada, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotter, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolae, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. H.</span><span> </span><span class="NLM_article-title">A genome-wide association study identifies IL23R as an inflammatory bowel disease gene</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=1461-1463&author=R.+H.+Duerrauthor=K.+D.+Taylorauthor=S.+R.+Brantauthor=J.+D.+Riouxauthor=M.+S.+Silverbergauthor=M.+J.+Dalyauthor=A.+H.+Steinhartauthor=C.+Abrahamauthor=M.+Regueiroauthor=A.+Griffithsauthor=T.+Dassopoulosauthor=A.+Bittonauthor=H.+Yangauthor=S.+Targanauthor=L.+W.+Dattaauthor=E.+O.+Kistnerauthor=L.+P.+Schummauthor=A.+T.+Leeauthor=P.+K.+Gregersenauthor=M.+M.+Barmadaauthor=J.+I.+Rotterauthor=D.+L.+Nicolaeauthor=J.+H.+Cho&title=A+genome-wide+association+study+identifies+IL23R+as+an+inflammatory+bowel+disease+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuerr%26aufirst%3DR.%2BH.%26aulast%3DTaylor%26aufirst%3DK.%2BD.%26aulast%3DBrant%26aufirst%3DS.%2BR.%26aulast%3DRioux%26aufirst%3DJ.%2BD.%26aulast%3DSilverberg%26aufirst%3DM.%2BS.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DSteinhart%26aufirst%3DA.%2BH.%26aulast%3DAbraham%26aufirst%3DC.%26aulast%3DRegueiro%26aufirst%3DM.%26aulast%3DGriffiths%26aufirst%3DA.%26aulast%3DDassopoulos%26aufirst%3DT.%26aulast%3DBitton%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DTargan%26aufirst%3DS.%26aulast%3DDatta%26aufirst%3DL.%2BW.%26aulast%3DKistner%26aufirst%3DE.%2BO.%26aulast%3DSchumm%26aufirst%3DL.%2BP.%26aulast%3DLee%26aufirst%3DA.%2BT.%26aulast%3DGregersen%26aufirst%3DP.%2BK.%26aulast%3DBarmada%26aufirst%3DM.%2BM.%26aulast%3DRotter%26aufirst%3DJ.%2BI.%26aulast%3DNicolae%26aufirst%3DD.%2BL.%26aulast%3DCho%26aufirst%3DJ.%2BH.%26atitle%3DA%2520genome-wide%2520association%2520study%2520identifies%2520IL23R%2520as%2520an%2520inflammatory%2520bowel%2520disease%2520gene%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D1461%26epage%3D1463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahern, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bounocore, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kullberg, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cua, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pwrie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloy, K. J.</span><span> </span><span class="NLM_article-title">Interleukin-23 drives innate and T cell-mediated intestinal inflammation</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">2473</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2473-2483&author=S.+Hueauthor=P.+Ahernauthor=S.+Bounocoreauthor=M.+C.+Kullbergauthor=D.+J.+Cuaauthor=B.+S.+McKenzieauthor=F.+Pwrieauthor=K.+J.+Maloy&title=Interleukin-23+drives+innate+and+T+cell-mediated+intestinal+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHue%26aufirst%3DS.%26aulast%3DAhern%26aufirst%3DP.%26aulast%3DBounocore%26aufirst%3DS.%26aulast%3DKullberg%26aufirst%3DM.%2BC.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DPwrie%26aufirst%3DF.%26aulast%3DMaloy%26aufirst%3DK.%2BJ.%26atitle%3DInterleukin-23%2520drives%2520innate%2520and%2520T%2520cell-mediated%2520intestinal%2520inflammation%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2473%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kullberg, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorelick, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cua, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powrie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheever, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloy, K, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sher, A.</span><span> </span><span class="NLM_article-title">IL-23 plays a key role in <i>Helicobacter hepaticus</i>-induced T cell-dependent colitis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">–</span> <span class="NLM_lpage">2494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2485-2494&author=M.+C.+Kullbergauthor=D.+Jankovicauthor=C.+G.+Fengauthor=S.+Hueauthor=P.+L.+Gorelickauthor=B.+S.+McKenzieauthor=D.+J.+Cuaauthor=F.+Powrieauthor=A.+W.+Cheeverauthor=K%2C+J.+Maloyauthor=A.+Sher&title=IL-23+plays+a+key+role+in+Helicobacter+hepaticus-induced+T+cell-dependent+colitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKullberg%26aufirst%3DM.%2BC.%26aulast%3DJankovic%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DC.%2BG.%26aulast%3DHue%26aufirst%3DS.%26aulast%3DGorelick%26aufirst%3DP.%2BL.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DPowrie%26aufirst%3DF.%26aulast%3DCheever%26aufirst%3DA.%2BW.%26aulast%3DMaloy%26aufirst%3DK%252C%2BJ.%26aulast%3DSher%26aufirst%3DA.%26atitle%3DIL-23%2520plays%2520a%2520key%2520role%2520in%2520Helicobacter%2520hepaticus-induced%2520T%2520cell-dependent%2520colitis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2485%26epage%3D2494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sandborn, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorak, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisher, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanns, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blank, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span> </span><span class="NLM_article-title">A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1130</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=1130-1141&author=W.+J.+Sandbornauthor=B.+Feaganauthor=R.+N.+Fedorakauthor=E.+Scherlauthor=M.+R.+Fleisherauthor=S.+Katzauthor=J.+Johannsauthor=M.+Blankauthor=P.+Rutgeerts&title=A+randomized+trial+of+ustekinumab%2C+a+human+interleukin-12%2F23+monoclonal+antibody%2C+in+patients+with+moderate-to-severe+Crohn%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandborn%26aufirst%3DW.%2BJ.%26aulast%3DFeagan%26aufirst%3DB.%26aulast%3DFedorak%26aufirst%3DR.%2BN.%26aulast%3DScherl%26aufirst%3DE.%26aulast%3DFleisher%26aufirst%3DM.%2BR.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DJohanns%26aufirst%3DJ.%26aulast%3DBlank%26aufirst%3DM.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DA%2520randomized%2520trial%2520of%2520ustekinumab%252C%2520a%2520human%2520interleukin-12%252F23%2520monoclonal%2520antibody%252C%2520in%2520patients%2520with%2520moderate-to-severe%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DGastroenterology%26date%3D2008%26volume%3D135%26spage%3D1130%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kralovics, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passamonti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiedt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passweg, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tichelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoda, R.</span><span> </span><span class="NLM_article-title">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1779</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa051113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15858187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1779-1790&author=R.+Kralovicsauthor=F.+Passamontiauthor=A.+S.+Buserauthor=S.-S.+Teoauthor=R.+Tiedtauthor=J.+R.+Passwegauthor=A.+Tichelliauthor=M.+Cazzolaauthor=R.+Skoda&title=A+gain-of-function+mutation+of+JAK2+in+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">A gain-of-function mutation of JAK2 in myeloproliferative disorders</span></div><div class="casAuthors">Kralovics, Robert; Passamonti, Francesco; Buser, Andreas S.; Teo, Soon-Siong; Tiedt, Ralph; Passweg, Jakob R.; Tichelli, Andre; Cazzola, Mario; Skoda, Radek C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1779-1790</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multi-potent progenitor.  The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases.  METHODS We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis).  RESULTS Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene.  In patients with 9pLOH, JAK2 had a homozygous G→T transversion, causing phenylalanine to be substituted for valine at position 617 of JAK2 (V617F).  All 51 patients with 9pLOH had the V617F mutation.  Of 193 patients without 9pLOH, 66 were heterozygous for V617F and 127 did not have the mutation.  The frequency of V617F was 65 % among patients with polycythemia vera (83 of 128), 57 % among patients with idiopathic myelofibrosis (13 of 23), and 23 % among patients with essential thrombocythemia (21 of 93).  V617F is a somatic mutation present in hematopoietic cells.  Mitotic recombination probably causes both 9pLOH and the transition from heterozygosity to homozygosity for V617F.  Genetic evidence and in vitro functional studies indicate that V617F gives hematopoietic precursors proliferative and survival advantages.  Patients with the V617F mutation had a significantly longer duration of disease and a higher rate of complications (fibrosis, hemorrhage, and thrombosis) and treatment with cytoreductive therapy than patients with wild-type JAK2.  CONCLUSIONS A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqTe7EsB_527Vg90H21EOLACvtfcHk0lheiPRowvsXBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFyhsLw%253D&md5=5dd4bc090ded1c812b61923cad36e77e</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa051113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa051113%26sid%3Dliteratum%253Aachs%26aulast%3DKralovics%26aufirst%3DR.%26aulast%3DPassamonti%26aufirst%3DF.%26aulast%3DBuser%26aufirst%3DA.%2BS.%26aulast%3DTeo%26aufirst%3DS.-S.%26aulast%3DTiedt%26aufirst%3DR.%26aulast%3DPassweg%26aufirst%3DJ.%2BR.%26aulast%3DTichelli%26aufirst%3DA.%26aulast%3DCazzola%26aufirst%3DM.%26aulast%3DSkoda%26aufirst%3DR.%26atitle%3DA%2520gain-of-function%2520mutation%2520of%2520JAK2%2520in%2520myeloproliferative%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1779%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">James, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couedic, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staerk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delhommeau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raslova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaceur-Griscelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villeval, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casadevall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vainchenker, W.</span><span> </span><span class="NLM_article-title">A unique clonal JAK2 mutation leading to constitutive signaling causes polytheamia vera</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">434</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2005&pages=1144-1148&author=C.+Jamesauthor=V.+Ugoauthor=J.-P.+Couedicauthor=J.+Staerkauthor=F.+Delhommeauauthor=C.+Lacoutauthor=L.+Garconauthor=H.+Raslovaauthor=R.+Bergerauthor=A.+Bennaceur-Griscelliauthor=J.+L.+Villevalauthor=S.+N.+Constantinescuauthor=N.+Casadevallauthor=W.+Vainchenker&title=A+unique+clonal+JAK2+mutation+leading+to+constitutive+signaling+causes+polytheamia+vera"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DC.%26aulast%3DUgo%26aufirst%3DV.%26aulast%3DCouedic%26aufirst%3DJ.-P.%26aulast%3DStaerk%26aufirst%3DJ.%26aulast%3DDelhommeau%26aufirst%3DF.%26aulast%3DLacout%26aufirst%3DC.%26aulast%3DGarcon%26aufirst%3DL.%26aulast%3DRaslova%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DBennaceur-Griscelli%26aufirst%3DA.%26aulast%3DVilleval%26aufirst%3DJ.%2BL.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DCasadevall%26aufirst%3DN.%26aulast%3DVainchenker%26aufirst%3DW.%26atitle%3DA%2520unique%2520clonal%2520JAK2%2520mutation%2520leading%2520to%2520constitutive%2520signaling%2520causes%2520polytheamia%2520vera%26jtitle%3DNature%26date%3D2005%26volume%3D434%26spage%3D1144%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Parganas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stravopodis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanin, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colamonici, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deursen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosveld, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 is essential for signaling through a variety of cytokine receptors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=385-395&author=E.+Parganasauthor=D.+Wangauthor=D.+Stravopodisauthor=D.+J.+Tophamauthor=J.+C.+Marineauthor=S.+Teglundauthor=E.+F.+Vaninauthor=S.+Bodnerauthor=O.+R.+Colamoniciauthor=J.+M.+van+Deursenauthor=G.+Grosveldauthor=J.+N.+Ihle&title=JAK2+is+essential+for+signaling+through+a+variety+of+cytokine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParganas%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DStravopodis%26aufirst%3DD.%26aulast%3DTopham%26aufirst%3DD.%2BJ.%26aulast%3DMarine%26aufirst%3DJ.%2BC.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DVanin%26aufirst%3DE.%2BF.%26aulast%3DBodner%26aufirst%3DS.%26aulast%3DColamonici%26aufirst%3DO.%2BR.%26aulast%3Dvan%2BDeursen%26aufirst%3DJ.%2BM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520is%2520essential%2520for%2520signaling%2520through%2520a%2520variety%2520of%2520cytokine%2520receptors%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Neubauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffstadt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeffer, K.</span><span> </span><span class="NLM_article-title">JAK2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=397-409&author=H.+Neubauerauthor=A.+Cumanoauthor=M.+Mullerauthor=H.+Wuauthor=U.+Huffstadtauthor=K.+Pfeffer&title=JAK2+deficiency+defines+an+essential+developmental+checkpoint+in+definitive+hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%26aulast%3DCumano%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHuffstadt%26aufirst%3DU.%26aulast%3DPfeffer%26aufirst%3DK.%26atitle%3DJAK2%2520deficiency%2520defines%2520an%2520essential%2520developmental%2520checkpoint%2520in%2520definitive%2520hematopoiesis%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">2721</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=2721-2730&author=A.+Tefferi&title=JAK+inhibitors+for+myeloproliferative+neoplasms%3A+clarifying+facts+from+myths"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DJAK%2520inhibitors%2520for%2520myeloproliferative%2520neoplasms%253A%2520clarifying%2520facts%2520from%2520myths%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D2721%26epage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1200%2FJCO.2010.32.8021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21220608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=789-796&author=A.+Pardananiauthor=J.+Gotlibauthor=C.+Jamiesonauthor=J.+E.+Cortesauthor=M.+Talpazauthor=R.+M.+Stoneauthor=M.+H.+Silvermanauthor=D.+G.+Gillilandauthor=J.+Shorrauthor=A.+Tefferi&title=Safety+and+efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Pardanani, Animesh; Gotlib, Jason R.; Jamieson, Catriona; Cortes, Jorge E.; Talpaz, Moshe; Stone, Richard M.; Silverman, Michael H.; Gilliland, D. Gary; Shorr, Jolene; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">789-796</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Myelofibrosis is a myeloid malignancy assocd. with anemia, splenomegaly, and constitutional symptoms.  Patients frequently harbor JAK-STAT activating mutations that are sensitive to TG101348, a selective small-mol. Janus kinase 2 (JAK2) inhibitor.  Patients and Methods In a multicenter phase I trial, oral TG101348 was administered once a day to patients with high- or intermediate-risk primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.  Results Fifty-nine patients were treated, including 28 in the dose-escalation phase.  The max.-tolerated dose was 680 mg/d, and dose-limiting toxicity was a reversible and asymptomatic increase in the serum amylase level.  Forty-three patients (73%) continued treatment beyond six cycles; the median cumulative exposure to TG101348 was 380 days.  Adverse events included nausea, vomiting, diarrhea, anemia, and thrombocytopenia; corresponding grades 3 to 4 incidence rates were 3%, 3%, 10%, 35%, and 24%.  TG101348 treatment had modest effect on serum cytokine levels, but greater than half of the patients with early satiety, night sweats, fatigue, pruritus, and cough achieved rapid and durable improvement in these symptoms.  By six and 12 cycles of treatment, 39% and 47% of patients, resp., had achieved a spleen response per International Working Group criteria.  The majority of patients with leukocytosis or thrombocytosis at baseline (n = 28 and n = 10, resp.) achieved normalization of blood counts after six (57% and 90%, resp.) and 12 (56% and 88%, resp.) cycles.  A significant decrease in JAK2 V617F allele burden was obsd. at 6 mo in mutation-pos. patients (n = 51; P = .04), particularly in the subgroup with allele burden greater than 20% (n = 23; P < .01); the decrease was durable at 12 mo.  Conclusion TG101348 is well tolerated and produces significant redn. in disease burden and durable clin. benefit in patients with myelofibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4BD7RVGmfLVg90H21EOLACvtfcHk0lj-4X21D5gWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D&md5=8b69a31d9dcf09b3b121e477f98d103b</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.32.8021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.32.8021%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DShorr%26aufirst%3DJ.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520myelofibrosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D789%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Verstovsek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1056%2FNEJMoa1002028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20843246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1117-1127&author=S.+Verstovsekauthor=H.+Kantarjianauthor=R.+A.+Mesaauthor=A.+Pardananiauthor=J.+Cortes-Francoauthor=D.+A.+Thomasauthor=Z.+Estrovauthor=J.+S.+Fridmanauthor=E.+C.+Bradleyauthor=S.+Erickson-Viitanenauthor=K.+Vaddiauthor=R.+Levyauthor=A.+Tefferi&title=Safety+and+efficacy+of+INCB018424%2C+a+JAK1+and+JAK2+inhibitor%2C+in+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30cR"><div class="casContent"><span class="casTitleNuber">30c</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Verstovsek, Srdan; Kantarjian, Hagop; Mesa, Ruben A.; Pardanani, Animesh D.; Cortes-Franco, Jorge; Thomas, Deborah A.; Estrov, Zeev; Fridman, Jordan S.; Bradley, Edward C.; Erickson-Viitanen, Susan; Vaddi, Kris; Levy, Richard; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1117-1127</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Myelofibrosis is a Philadelphia chromosome-neg. myeloproliferative neoplasm assocd. with cytopenias, splenomegaly, poor quality of life, and shortened survival.  About half of patients with myelofibrosis carry a gain-of-function mutation in the Janus kinase 2 gene (JAK2 V617F) that contributes to the pathophysiol. of the disease.  INCB018424 is a potent and selective Janus kinase 1 (JAK1) and JAK2 inhibitor.  Methods: We conducted a phase 1-2 trial of INCB018424 in patients with JAK2 V617F-pos. or JAK2 V617F-neg. primary myelofibrosis, post-essential thrombocythemia myelofibrosis, or post-polycythemia vera myelofibrosis.  Results: A total of 153 patients received INCB018424 for a median duration of more than 14.7 mo.  The initial dose-escalation phase established 25 mg twice daily or 100 mg once daily as max. tolerated doses, on the basis of reversible thrombocytopenia.  A dose-dependent suppression of phosphorylated signal transducer and activator of transcription 3 (STAT3), a marker of JAK signaling, was demonstrated in patients with wild-type JAK2 and in patients with the JAK2 V617F mutation.  We studied addnl. doses and established that a 15-mg twice-daily starting dose, followed by individualized dose titrn., was the most effective and safest dosing regimen.  At this dose, 17 of 33 patients (52%) had a rapid objective response (>50% redn. of splenomegaly) lasting for 12 mo or more, and this therapy was assocd. with grade 3 or grade 4 adverse events (mainly myelosuppression) in less than 10% of patients.  Patients with debilitating symptoms, including wt. loss, fatigue, night sweats, and pruritus, had rapid improvement.  Clin. benefits were assocd. with a marked diminution of levels of circulating inflammatory cytokines that are commonly elevated in myelofibrosis.  Conclusions: INCB018424 was assocd. with marked and durable clin. benefits in patients with myelofibrosis for whom no approved therapies existed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUi05ApP1FLrVg90H21EOLACvtfcHk0lj-4X21D5gWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOltrjJ&md5=ba6fe766323a10a1508c686fdb3720b1</span></div><a href="/servlet/linkout?suffix=cit30c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1002028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1002028%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DCortes-Franco%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DEstrov%26aufirst%3DZ.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DBradley%26aufirst%3DE.%2BC.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520INCB018424%252C%2520a%2520JAK1%2520and%2520JAK2%2520inhibitor%252C%2520in%2520myelofibrosis%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1117%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Ishizaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muromoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohshira, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekine, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oritani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span> </span><span class="NLM_article-title">Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2011&pages=181-89&author=M.+Ishizakiauthor=T.+Akimotoauthor=R.+Muromotoauthor=M.+Yokoyamaauthor=Y.+Ohshiraauthor=Y.+Sekineauthor=H.+Maedaauthor=K.+Shimodaauthor=K.+Oritaniauthor=T.+Matsuda&title=Involvement+of+tyrosine+kinase-2+in+both+the+IL-12%2FTh1+and+IL-23%2FTh17+axes+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshizaki%26aufirst%3DM.%26aulast%3DAkimoto%26aufirst%3DT.%26aulast%3DMuromoto%26aufirst%3DR.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DOhshira%26aufirst%3DY.%26aulast%3DSekine%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DShimoda%26aufirst%3DK.%26aulast%3DOritani%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26atitle%3DInvolvement%2520of%2520tyrosine%2520kinase-2%2520in%2520both%2520the%2520IL-12%252FTh1%2520and%2520IL-23%252FTh17%2520axes%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D187%26spage%3D181%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Minegishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agematsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yachie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujieda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abinun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochs, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belohradsky, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasuyama, H.</span><span> </span><span class="NLM_article-title">Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.immuni.2006.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=17088085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=745-755&author=Y.+Minegishiauthor=M.+Saitoauthor=T.+Morioauthor=K.+Watanabeauthor=K.+Agematsuauthor=S.+Tsuchiyaauthor=H.+Takadaauthor=T.+Haraauthor=N.+Kawamuraauthor=T.+Arigaauthor=H.+Kanekoauthor=N.+Kondoauthor=I.+Tsugeauthor=A.+Yachieauthor=Y.+Sakiyamaauthor=T.+Iwataauthor=F.+Besshoauthor=T.+Ohishiauthor=K.+Johauthor=K.+Imaiauthor=K.+Kogawaauthor=M.+Shinoharaauthor=M.+Fujiedaauthor=H.+Wakiguchiauthor=S.+Pasicauthor=M.+Abinunauthor=H.+D.+Ochsauthor=E.+D.+Rennerauthor=A.+Janssonauthor=B.+H.+Belohradskyauthor=A.+Melinauthor=N.+Shimizuauthor=S.+Mizutaniauthor=T.+Miyawakiauthor=S.+Nonoyamaauthor=H.+Karasuyama&title=Human+tyrosine+kinase+2+deficiency+reveals+its+requisite+roles+in+multiple+cytokine+signals+involved+in+innate+and+acquired+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</span></div><div class="casAuthors">Minegishi, Yoshiyuki; Saito, Masako; Morio, Tomohiro; Watanabe, Ken; Agematsu, Kazunaga; Tsuchiya, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Kaneko, Hideo; Kondo, Naomi; Tsuge, Ikuya; Yachie, Akihiro; Sakiyama, Yukio; Iwata, Tsutomu; Bessho, Fumio; Ohishi, Tsutomu; Joh, Kosuke; Imai, Kohsuke; Kogawa, Kazuhiro; Shinohara, Miwa; Fujieda, Mikiya; Wakiguchi, Hiroshi; Pasic, Srdjan; Abinun, Mario; Ochs, Hans D.; Renner, Eleonore D.; Jansson, Annette; Belohradsky, Bernd H.; Metin, Ayse; Shimizu, Norio; Mizutani, Shuki; Miyawaki, Toshio; Nonoyama, Shigeaki; Karasuyama, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family.  Here we identified a homozygous Tyk2 mutation in a patient who had been clin. diagnosed with hyper-IgE syndrome.  This patient showed unusual susceptibility to various microorganisms including virus, fungi, and mycobacteria and suffered from atopic dermatitis with elevated serum IgE.  The patient's cells displayed defects in multiple cytokine signaling pathways including those for type I interferon (IFN), interleukin (IL)-6, IL-10, IL-12, and IL-23.  The cytokine signals were successfully restored by transducing the intact Tyk2 gene.  Thus, the Tyk2 deficiency is likely to account for the patient's complex clin. manifestations, including the phenotype of impaired T helper 1 (Th1) differentiation and accelerated Th2 differentiation.  This study identifies human Tyk2 deficiency and demonstrates that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially from Tyk2 function in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TTbAIzXM-bVg90H21EOLACvtfcHk0liHue52j699aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI&md5=debec30b44a7e1dc111d7cfb1c92f7dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DMorio%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DAgematsu%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DN.%26aulast%3DAriga%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DN.%26aulast%3DTsuge%26aufirst%3DI.%26aulast%3DYachie%26aufirst%3DA.%26aulast%3DSakiyama%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DBessho%26aufirst%3DF.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DJoh%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DKogawa%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DM.%26aulast%3DFujieda%26aufirst%3DM.%26aulast%3DWakiguchi%26aufirst%3DH.%26aulast%3DPasic%26aufirst%3DS.%26aulast%3DAbinun%26aufirst%3DM.%26aulast%3DOchs%26aufirst%3DH.%2BD.%26aulast%3DRenner%26aufirst%3DE.%2BD.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DBelohradsky%26aufirst%3DB.%2BH.%26aulast%3DMelin%26aufirst%3DA.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DMiyawaki%26aufirst%3DT.%26aulast%3DNonoyama%26aufirst%3DS.%26aulast%3DKarasuyama%26aufirst%3DH.%26atitle%3DHuman%2520tyrosine%2520kinase%25202%2520deficiency%2520reveals%2520its%2520requisite%2520roles%2520in%2520multiple%2520cytokine%2520signals%2520involved%2520in%2520innate%2520and%2520acquired%2520immunity%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D745%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sohn, S. J.; Barrett, K.; van Abbema, A.; Chang, C.; Kohli, P. B.; Kanda, H.; Smith, J.; Lai, Y.; Zhou, A.; Williams, K.; Macleod, C.; Hurley, C. A.; Kulagowski, J. K.; Lewis-Koh, N.; Johnson, A. R.; Ghilardi, N.; Zak, M.; Liang, J.; Blair, W. S.; Magnuson, S.; Wu, L. C.</span><span> </span><span class="NLM_article-title">A restricted role for TYK2 catalytic activity in human cytokine response</span>. J. Immunol., submitted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sohn%2C+S.+J.%3B+Barrett%2C+K.%3B+van+Abbema%2C+A.%3B+Chang%2C+C.%3B+Kohli%2C+P.+B.%3B+Kanda%2C+H.%3B+Smith%2C+J.%3B+Lai%2C+Y.%3B+Zhou%2C+A.%3B+Williams%2C+K.%3B+Macleod%2C+C.%3B+Hurley%2C+C.+A.%3B+Kulagowski%2C+J.+K.%3B+Lewis-Koh%2C+N.%3B+Johnson%2C+A.+R.%3B+Ghilardi%2C+N.%3B+Zak%2C+M.%3B+Liang%2C+J.%3B+Blair%2C+W.+S.%3B+Magnuson%2C+S.%3B+Wu%2C+L.+C.+A+restricted+role+for+TYK2+catalytic+activity+in+human+cytokine+response.+J.+Immunol.%2C+submitted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSohn%26aufirst%3DS.%2BJ.%26atitle%3DA%2520restricted%2520role%2520for%2520TYK2%2520catalytic%2520activity%2520in%2520human%2520cytokine%2520response%26jtitle%3DJ.%2520Immunol." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span> </span><span class="NLM_article-title">Immunotherapeutic implication of IL-6 blockade</span> <span class="citation_source-journal">Immunotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=87-105&author=T.+Tanakaauthor=T.+Kishimoto&title=Immunotherapeutic+implication+of+IL-6+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DImmunotherapeutic%2520implication%2520of%2520IL-6%2520blockade%26jtitle%3DImmunotherapy%26date%3D2012%26volume%3D4%26spage%3D87%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the JAK1 gene demonstrates obligatory and nonredundant roles of the JAKs in cytokine-induced biologic response</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+A.+Arthurauthor=K.+L.+Kingauthor=K.+C.+F.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+JAK1+gene+demonstrates+obligatory+and+nonredundant+roles+of+the+JAKs+in+cytokine-induced+biologic+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BA.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%2BF.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520JAK1%2520gene%2520demonstrates%2520obligatory%2520and%2520nonredundant%2520roles%2520of%2520the%2520JAKs%2520in%2520cytokine-induced%2520biologic%2520response%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Comejo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercher, T.</span><span> </span><span class="NLM_article-title">JAK3: a two-faced player in hematological disorders</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2376</span><span class="NLM_x">–</span> <span class="NLM_lpage">2379</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.biocel.2009.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=19747563" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=2376-2379&author=M.+G.+Comejoauthor=T.+J.+Boggonauthor=T.+Mercher&title=JAK3%3A+a+two-faced+player+in+hematological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2009.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2009.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DComejo%26aufirst%3DM.%2BG.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DMercher%26aufirst%3DT.%26atitle%3DJAK3%253A%2520a%2520two-faced%2520player%2520in%2520hematological%2520disorders%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D2376%26epage%3D2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">JAK3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1111%2Fj.0105-2896.2005.00220.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15661026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2005&pages=127-142&author=M.+Pesuauthor=F.+Candottiauthor=M.+Husaauthor=S.+R.+Hofmannauthor=L.+D.+Notarangeloauthor=J.+J.+O%E2%80%99Shea&title=JAK3%2C+severe+combined+immunodeficiency%2C+and+a+new+class+of+immunosuppressive+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs</span></div><div class="casAuthors">Pesu, Marko; Candotti, Fabio; Husa, Matthew; Hofmann, Sigrun R.; Notarangelo, Luigi D.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent elucidation of the multiple mol. mechanisms underlying severe combined immunodeficiency (SCID) is an impressive example of the power of mol. medicine.  Anal. of patients and the concomitant generation of animal models mimicking these disorders have quickly provided great insights into the pathophysiol. of these potentially devastating illnesses.  Here, the authors summarize the discoveries that led to the understanding of the role of cytokine receptors and a specific tyrosine kinase, Janus kinase 3 (Jak3), in the pathogenesis of SCID.  The authors discuss how the identification of mutations of Jak3 in autosomal recessive SCID has facilitated the diagnosis of these disorders, offered new insights into the biol. of this kinase, permitted new avenues for therapy, and provided the rationale for a generation of a new class of immunosuppressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYir7OTbMwFbVg90H21EOLACvtfcHk0livfzfXMINYpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvFyns7o%253D&md5=038b25b97798eda4b6aa1818238e45ba</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1111%2Fj.0105-2896.2005.00220.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.0105-2896.2005.00220.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DHusa%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DS.%2BR.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJAK3%252C%2520severe%2520combined%2520immunodeficiency%252C%2520and%2520a%2520new%2520class%2520of%2520immunosuppressive%2520drugs%26jtitle%3DImmunol.%2520Rev.%26date%3D2005%26volume%3D203%26spage%3D127%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugazio, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badolato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaese, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span> </span><span class="NLM_article-title">Structural and functional basis for JAK3-deficient severe combined immunodeficiency</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">3996</span><span class="NLM_x">–</span> <span class="NLM_lpage">4003</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=3996-4003&author=F.+Candottiauthor=S.+A.+Oakesauthor=J.+A.+Johnsonauthor=S.+Gilianiauthor=R.+F.+Schumacherauthor=P.+Mellaauthor=M.+Fioiniauthor=A.+G.+Ugazioauthor=R.+Badolatoauthor=L.+D.+Notarangeloauthor=F.+Bozziauthor=P.+Macchiauthor=D.+Strinaauthor=P.+Vezzoniauthor=R.+M.+Blaeseauthor=J.+J.+O%E2%80%99Sheaauthor=A.+Villa&title=Structural+and+functional+basis+for+JAK3-deficient+severe+combined+immunodeficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DOakes%26aufirst%3DS.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DGiliani%26aufirst%3DS.%26aulast%3DSchumacher%26aufirst%3DR.%2BF.%26aulast%3DMella%26aufirst%3DP.%26aulast%3DFioini%26aufirst%3DM.%26aulast%3DUgazio%26aufirst%3DA.%2BG.%26aulast%3DBadolato%26aufirst%3DR.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DBozzi%26aufirst%3DF.%26aulast%3DMacchi%26aufirst%3DP.%26aulast%3DStrina%26aufirst%3DD.%26aulast%3DVezzoni%26aufirst%3DP.%26aulast%3DBlaese%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DVilla%26aufirst%3DA.%26atitle%3DStructural%2520and%2520functional%2520basis%2520for%2520JAK3-deficient%2520severe%2520combined%2520immunodeficiency%26jtitle%3DBlood%26date%3D1997%26volume%3D90%26spage%3D3996%26epage%3D4003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Russell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedy, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migone, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Mutation of JAK3 in a patient with SCID: essential role of JAK3 in lymphoid development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=797-800&author=S.+M.+Russellauthor=N.+Tayebiauthor=H.+Nakajimaauthor=M.+C.+Riedyauthor=J.+Robertsauthor=M.+J.+Amanauthor=T.-S.+Migoneauthor=M.+Noguchiauthor=M.+L.+Markertauthor=R.+H.+Buckleyauthor=J.+J.+O%E2%80%99Sheaauthor=W.+J.+Leonard&title=Mutation+of+JAK3+in+a+patient+with+SCID%3A+essential+role+of+JAK3+in+lymphoid+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%2BM.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DAman%26aufirst%3DM.%2BJ.%26aulast%3DMigone%26aufirst%3DT.-S.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DMarkert%26aufirst%3DM.%2BL.%26aulast%3DBuckley%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DMutation%2520of%2520JAK3%2520in%2520a%2520patient%2520with%2520SCID%253A%2520essential%2520role%2520of%2520JAK3%2520in%2520lymphoid%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D797%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8468</span><span class="NLM_x">–</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Littieauthor=K.+S.+Magnussonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+a+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lh8UOZ-NdsAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLittie%26aufirst%3DB.%2BM.%26aulast%3DMagnusson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520a%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarijian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1182%2Fblood-2009-04-214957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20130243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quintas-Cardamaauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarijianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+characterization+of+the+selective+JAK1%2F2+inhibitor+INCB018424%3A+therapeutic+implications+for+the+treatment+of+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms</span></div><div class="casAuthors">Quintas-Cardama, Alfonso; Vaddi, Kris; Liu, Phillip; Manshouri, Taghi; Li, Jun; Scherle, Peggy A.; Caulder, Eian; Wen, Xiaoming; Li, Yanlong; Waeltz, Paul; Rupar, Mark; Burn, Timothy; Lo, Yvonne; Kelley, Jennifer; Covington, Maryanne; Shepard, Stacey; Rodgers, James D.; Haley, Patrick; Kantarjian, Hagop; Fridman, Jordan S.; Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3109-3117</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Constitutive JAK2 activation in hematopoietic cells by the JAK2V617F mutation recapitulates myeloproliferative neoplasm (MPN) phenotypes in mice, establishing JAK2 inhibition as a potential therapeutic strategy.  Although most polycythemia vera patients carry the JAK2V617F mutation, half of those with essential thrombocythemia or primary myelofibrosis do not, suggesting alternative mechanisms for constitutive JAK-STAT signaling in MPNs.  Most patients with primary myelofibrosis have elevated levels of JAK-dependent proinflammatory cytokines (eg, interleukin-6) consistent with our observation of JAK1 hyperactivation.  Accordingly, we evaluated the effectiveness of selective JAK1/2 inhibition in exptl. models relevant to MPNs and report on the effects of INCB018424, the first potent, selective, oral JAK1/JAK2 inhibitor to enter the clinic.  INCB018424 inhibited interleukin-6 signaling (50% inhibitory concn. [IC50] = 281nM), and proliferation of JAK2V617F+ Ba/F3 cells (IC50 = 127nM).  In primary cultures, INCB018424 preferentially suppressed erythroid progenitor colony formation from JAK2V617F+ polycythemia vera patients (IC50 = 67nM) vs. healthy donors (IC50 > 400nM).  In a mouse model of JAK2V617F+ MPN, oral INCB018424 markedly reduced splenomegaly and circulating levels of inflammatory cytokines, and preferentially eliminated neoplastic cells, resulting in significantly prolonged survival without myelosuppressive or immunosuppressive effects.  Preliminary clin. results support these preclin. data and establish INCB018424 as a promising oral agent for the treatment of MPNs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKGz1l6Y-CbVg90H21EOLACvtfcHk0lh8UOZ-NdsAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWqsr8%253D&md5=cd52b7013d76ed00ca2df22444c45160</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-04-214957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-04-214957%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarijian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520selective%2520JAK1%252F2%2520inhibitor%2520INCB018424%253A%2520therapeutic%2520implications%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Alicea-Velazquez, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span> </span><span class="NLM_article-title">The use of structural biology in Janus kinase targeted drug discovery</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.2174%2F138945011794751528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21126226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=546-555&author=N.+L.+Alicea-Velazquezauthor=T.+J.+Boggon&title=The+use+of+structural+biology+in+Janus+kinase+targeted+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The use of structural biology in Janus kinase targeted drug discovery</span></div><div class="casAuthors">Alicea-Velazquez, Nilda L.; Boggon, Titus J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">546-555</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (or Jak kinases) mediate cytokine and growth factor signal transduction.  Acquired or inherited Jak mutations can result in dysregulation of Jak-mediated signal transduction and can be crit. to disease acquisition in neoplasias including acute myeloid, acute lymphoblastic and acute megakaryoblastic leukemias, and in rare X-linked severe combined immunodeficiency.  The discovery of an acquired Jak2 point mutation, V617F, in significant nos. of patients with classical myeloproliferative disorders has increased the interest in development of Jak2-specific tyrosine kinase inhibitors and consequently there are now over 20 publically available structures of Jak kinase domains that describe all four family members, Jak1, Jak2, Jak3, and Tyk2.  Here we review the recent advances in understanding the druggable structure and function of the Jak family, with a focus on the structural biol. of the Jak kinase domain.  We will discuss how these advances impact the development of Jak-targeted therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJwEtMK-lOu7Vg90H21EOLACvtfcHk0lh8UOZ-NdsAcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOkurg%253D&md5=5e76fc7eda3ffe580dc4e28044a88c2c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F138945011794751528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945011794751528%26sid%3Dliteratum%253Aachs%26aulast%3DAlicea-Velazquez%26aufirst%3DN.%2BL.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520use%2520of%2520structural%2520biology%2520in%2520Janus%2520kinase%2520targeted%2520drug%2520discovery%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2011%26volume%3D12%26spage%3D546%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40d"><span><span class="NLM_contrib-group">Goodacre, S. C.; Lai, Y.; Liang, J.; Magnuson, S. R.; Robarge, K. D.; Stanley, M. S.; Tsui, V.; Williams, K.; Zhang, B.; Zhou, A.</span><span> </span><span class="NLM_article-title">Janus Kinase Inhibitor Compounds and Methods</span>. WO2010142752,<span class="NLM_x"> </span><span class="NLM_year">2010</span>. The following patent applications describing TYK2 inhibitors were also published:</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+C.+Goodacre&author=Y.+Lai&author=J.+Liang&author=S.+R.+Magnuson&author=K.+D.+Robarge&author=M.+S.+Stanley&author=V.+Tsui&author=K.+Williams&author=B.+Zhang&author=A.+Zhou&title=Janus+Kinase+Inhibitor+Compounds+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26atitle%3DJanus%2520Kinase%2520Inhibitor%2520Compounds%2520and%2520Methods%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Buchmann, B.; Eis, K.; Bothe, U.; Bonin, A.; Bomer, U.</span>; <span> </span><span class="NLM_article-title">Carbonylamino-Substituierte Aniline-Pyromidinderivative als TYK-Inhibitoren, deren Herstellung und Verwendug als Arzneimittel</span>. DE2009001438,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Buchmann&author=K.+Eis&author=U.+Bothe&author=A.+Bonin&author=U.+Bomer&title=Carbonylamino-Substituierte+Aniline-Pyromidinderivative+als+TYK-Inhibitoren%2C+deren+Herstellung+und+Verwendug+als+Arzneimittel"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DCarbonylamino-Substituierte%2520Aniline-Pyromidinderivative%2520als%2520TYK-Inhibitoren%252C%2520deren%2520Herstellung%2520und%2520Verwendug%2520als%2520Arzneimittel%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Boys, M, L.; Burgess, L. E.; Groneberg, R. D.; Harvey, D. M.; Huang, L.; Kercher, T.; Kraser, C. F.; Laird, E.; Tarlton, E.; Zhao, Q.</span><span> </span><span class="NLM_article-title">5,7-Substituted-imidazo[1,2-<i>c</i>]pyrimidines as Inhibitors of JAK Kinases</span>. WO2011130146,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M%2C+L.+Boys&author=L.+E.+Burgess&author=R.+D.+Groneberg&author=D.+M.+Harvey&author=L.+Huang&author=T.+Kercher&author=C.+F.+Kraser&author=E.+Laird&author=E.+Tarlton&author=Q.+Zhao&title=5%2C7-Substituted-imidazo%5B1%2C2-c%5Dpyrimidines+as+Inhibitors+of+JAK+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoys%26aufirst%3DM%252C%2BL.%26atitle%3D5%252C7-Substituted-imidazo%255B1%252C2-c%255Dpyrimidines%2520as%2520Inhibitors%2520of%2520JAK%2520Kinases%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ellard, K.; Major, J.; Jones, A.; Lynch, R.; Ramsden, N.</span><span> </span><span class="NLM_article-title">Pyridine Compounds and Aza Analogs Thereof as TYK2 Inhibitors</span>. WO2012062704,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+Ellard&author=J.+Major&author=A.+Jones&author=R.+Lynch&author=N.+Ramsden&title=Pyridine+Compounds+and+Aza+Analogs+Thereof+as+TYK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEllard%26aufirst%3DK.%26atitle%3DPyridine%2520Compounds%2520and%2520Aza%2520Analogs%2520Thereof%2520as%2520TYK2%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Liang, J.; Tsui, V.; van Abbema, A.; Bao, L.; Barrett, K.; Beresini, M.; Berezhkovsky, B.; Blair, W.; Chang, C.; Driscoll, J.; Eigenbrot, C.; Ghilardi, N.; Gibbons, P.; Halladay, J.; Johnson, A.; Kohli, P. B.; Lai, Y.; Liimatta, M.; Mantik, P.; Menghrajani, K.; Murray, J.; Sambrone, A.; Shao, Y.; Shia, S.; Shin, Y.; Smith, J.; Sohn, S.; Stanley, M.; Ultsch, M.; Zhang, B.; Magnuson, S.</span><span> </span><span class="NLM_article-title">Lead identification of novel and selective TYK2 inhibitors</span>.  <span class="citation_source-journal">Eur. J. Med. Chem.</span>, accepted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liang%2C+J.%3B+Tsui%2C+V.%3B+van+Abbema%2C+A.%3B+Bao%2C+L.%3B+Barrett%2C+K.%3B+Beresini%2C+M.%3B+Berezhkovsky%2C+B.%3B+Blair%2C+W.%3B+Chang%2C+C.%3B+Driscoll%2C+J.%3B+Eigenbrot%2C+C.%3B+Ghilardi%2C+N.%3B+Gibbons%2C+P.%3B+Halladay%2C+J.%3B+Johnson%2C+A.%3B+Kohli%2C+P.+B.%3B+Lai%2C+Y.%3B+Liimatta%2C+M.%3B+Mantik%2C+P.%3B+Menghrajani%2C+K.%3B+Murray%2C+J.%3B+Sambrone%2C+A.%3B+Shao%2C+Y.%3B+Shia%2C+S.%3B+Shin%2C+Y.%3B+Smith%2C+J.%3B+Sohn%2C+S.%3B+Stanley%2C+M.%3B+Ultsch%2C+M.%3B+Zhang%2C+B.%3B+Magnuson%2C+S.+Lead+identification+of+novel+and+selective+TYK2+inhibitors.+Eur.+J.+Med.+Chem.%2C+accepted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26atitle%3DLead%2520identification%2520of%2520novel%2520and%2520selective%2520TYK2%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">Our compounds were found to be consistently much less active against the JAK3 enzyme than TYK2 (>50-fold difference between the JAK3 <i>K</i><sub>i</sub> and TYK2 <i>K</i><sub>i</sub>). JAK3 inhibitory activities were not reported for the majority of compounds described in this work except for compound <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and compounds <b>35</b>–<b>37</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Recent reports also suggested that JAK3 inhibition is not sufficient in blocking effects of type I cytokines and that JAK1 is the dominant kinase: </p></div><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovlering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rault, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">JAK1 has a dominant role over JAK3 in signal transduction through γc-containing cytokine receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rovleringauthor=F.+Raultauthor=M.+Kappauthor=P.+Druckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=JAK1+has+a+dominant+role+over+JAK3+in+signal+transduction+through+%CE%B3c-containing+cytokine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42aR"><div class="casContent"><span class="casTitleNuber">42a</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0lh73VmILI09jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRovlering%26aufirst%3DC.%26aulast%3DRault%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJAK1%2520has%2520a%2520dominant%2520role%2520over%2520JAK3%2520in%2520signal%2520transduction%2520through%2520%25CE%25B3c-containing%2520cytokine%2520receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchetto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangrevelinghe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+Janus+kinase+3+inhibitor+with+high+selectivity+within+the+Janus+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520Janus%2520kinase%25203%2520inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520Janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D284%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0liZgpzPBmClfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spingthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Spingthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43bR"><div class="casContent"><span class="casTitleNuber">43b</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liZgpzPBmClfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpingthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="note"><p class="first last">Kinase P-loop is known to be flexible: </p></div><div class="NLM_citation" id="rightTab-cit44a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornev, A. P.</span><span> </span><span class="NLM_article-title">Protein kinases: evolution of dynamic regulatory protein</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=65-77&author=S.+S.+Taylorauthor=A.+P.+Kornev&title=Protein+kinases%3A+evolution+of+dynamic+regulatory+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DKornev%26aufirst%3DA.%2BP.%26atitle%3DProtein%2520kinases%253A%2520evolution%2520of%2520dynamic%2520regulatory%2520protein%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2011%26volume%3D36%26spage%3D65%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit44b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Defining the conserved internal architecture of a protein kinase</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1804</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1804&publication_year=2010&pages=440-444&author=A.+P.+Kornevauthor=S.+S.+Taylor&title=Defining+the+conserved+internal+architecture+of+a+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DDefining%2520the%2520conserved%2520internal%2520architecture%2520of%2520a%2520protein%2520kinase%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1804%26spage%3D440%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Cruciani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosati, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Boeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, R.</span><span> </span><span class="NLM_article-title">Metasite: understanding metabolism in human cytochromes from the perspective of the chemist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6970</span><span class="NLM_x">–</span> <span class="NLM_lpage">6979</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050529c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6970-6979&author=G.+Crucianiauthor=E.+Carosatiauthor=B.+De+Boeckauthor=K.+Ethirajuluauthor=C.+Mackieauthor=T.+Howeauthor=R.+Vianello&title=Metasite%3A+understanding+metabolism+in+human+cytochromes+from+the+perspective+of+the+chemist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050529c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050529c%26sid%3Dliteratum%253Aachs%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DCarosati%26aufirst%3DE.%26aulast%3DDe%2BBoeck%26aufirst%3DB.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DVianello%26aufirst%3DR.%26atitle%3DMetasite%253A%2520understanding%2520metabolism%2520in%2520human%2520cytochromes%2520from%2520the%2520perspective%2520of%2520the%2520chemist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6970%26epage%3D6979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hill, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">648</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46aR"><div class="casContent"><span class="casTitleNuber">46a</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0lhI3xtdyAuxpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit46a&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D648%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit46b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Richie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability—Are too many aromatic rings a liability in drug design?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1011-1020&author=T.+J.+Richieauthor=S.+J.+F.+MacDonald&title=The+impact+of+aromatic+ring+count+on+compound+developability%E2%80%94Are+too+many+aromatic+rings+a+liability+in+drug+design%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichie%26aufirst%3DT.%2BJ.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%25E2%2580%2594Are%2520too%2520many%2520aromatic%2520rings%2520a%2520liability%2520in%2520drug%2520design%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1011%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Paulini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Orthogonal multipolar interactions in structural chemistry and biology</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1788</span><span class="NLM_x">–</span> <span class="NLM_lpage">1805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1002%2Fanie.200462213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=1788-1805&author=R.+Pauliniauthor=K.+M%C3%BCllerauthor=F.+Diederich&title=Orthogonal+multipolar+interactions+in+structural+chemistry+and+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Orthogonal multipolar interactions in structural chemistry and biology</span></div><div class="casAuthors">Paulini, Ralph; Mueller, Klaus; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1788-1805</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The past few decades of mol. recognition studies have greatly enhanced our knowledge on apolar, ion-dipole, and hydrogen-bonding interactions.  However, much less attention has been given to the role that multipolar interactions, in particular those with orthogonal dipolar alignment, play in organizing a crystal lattice or stabilizing complexes involving biol. receptors.  By using results from database mining, this review attempts to give an overview of types and structural features of these previously rather overlooked interactions.  A no. of illustrative examples of these interactions found in X-ray crystal structures of small mols. and protein-ligand complexes demonstrate their propensity and thus potential importance for both, chem. and biol. mol. recognition processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTGHoutIq12LVg90H21EOLACvtfcHk0lhI3xtdyAuxpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislWkt7s%253D&md5=6ad842547313b27fc1676e9c3a001909</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fanie.200462213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200462213%26sid%3Dliteratum%253Aachs%26aulast%3DPaulini%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DOrthogonal%2520multipolar%2520interactions%2520in%2520structural%2520chemistry%2520and%2520biology%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D1788%26epage%3D1805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reutlinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N. R.</span><span> </span><span class="NLM_article-title">Rationalizing tight ligand binding through cooperative interaction networks</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3180</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200319e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=3180-3198&author=B.+Kuhnauthor=J.+E.+Fuchsauthor=M.+Reutlingerauthor=M.+Stahlauthor=N.+R.+Taylor&title=Rationalizing+tight+ligand+binding+through+cooperative+interaction+networks"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rationalizing Tight Ligand Binding through Cooperative Interaction Networks</span></div><div class="casAuthors">Kuhn, Bernd; Fuchs, Julian E.; Reutlinger, Michael; Stahl, Martin; Taylor, Neil R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3180-3198</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small modifications of the mol. structure of a ligand sometimes cause strong gains in binding affinity to a protein target, rendering a weakly active chem. series suddenly attractive for further optimization.  Our goal in this study is to better rationalize and predict the occurrence of such interaction hot-spots in receptor binding sites.  To this end, we introduce two new concepts into the computational description of mol. recognition.  First, we take a broader view of noncovalent interactions and describe protein-ligand binding with a comprehensive set of favorable and unfavorable contact types, including for example halogen bonding and orthogonal multipolar interactions.  Second, we go beyond the commonly used pairwise additive treatment of at. interactions and use a small world network approach to describe how interactions are modulated by their environment.  This approach allows us to capture local cooperativity effects and considerably improves the performance of a newly derived empirical scoring function, Scorpions-core.  More importantly, however, we demonstrate how an intuitive visualization of key intermol. interactions, interaction networks, and binding hot-spots supports the identification and rationalization of tight ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCzUUIjVW8P7Vg90H21EOLACvtfcHk0lh9SRoy334OnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7rI&md5=e8e1bdc3bad1cfdfc11253de5837e4c6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fci200319e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200319e%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DFuchs%26aufirst%3DJ.%2BE.%26aulast%3DReutlinger%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DN.%2BR.%26atitle%3DRationalizing%2520tight%2520ligand%2520binding%2520through%2520cooperative%2520interaction%2520networks%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D3180%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starovasnik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span> </span><span class="NLM_article-title">A new regulatory switch in a JAK protein kinase</span> <span class="citation_source-journal">Proteins: Struct., Funct., Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=393-401&author=V.+Tsuiauthor=P.+Gibbonsauthor=M.+Ultschauthor=K.+Mortaraauthor=C.+Changauthor=W.+Blairauthor=R.+Pulkauthor=M.+Stanleyauthor=M.+Starovasnikauthor=D.+Williamsauthor=M.+Lamersauthor=P.+Leonardauthor=S.+Magnusonauthor=J.+Liangauthor=C.+Eigenbrot&title=A+new+regulatory+switch+in+a+JAK+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DStanley%26aufirst%3DM.%26aulast%3DStarovasnik%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26atitle%3DA%2520new%2520regulatory%2520switch%2520in%2520a%2520JAK%2520protein%2520kinase%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Bioinf.%26date%3D2011%26volume%3D79%26spage%3D393%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49bR"><div class="casContent"><span class="casTitleNuber">49b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lgFE7VtEP9KOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lgFE7VtEP9KOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Graczyk, P. P.</span><span> </span><span class="NLM_article-title">Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5773</span><span class="NLM_x">–</span> <span class="NLM_lpage">5779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070562u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5773-5779&author=P.+P.+Graczyk&title=Gini+coefficient%3A+a+new+way+to+express+selectivity+of+kinase+inhibitors+against+a+family+of+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Gini Coefficient: A New Way To Express Selectivity of Kinase Inhibitors against a Family of Kinases</span></div><div class="casAuthors">Graczyk, Piotr P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5773-5779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel application of the Gini coeff. for expressing selectivity of kinase inhibitors against a panel of kinases is proposed.  This has been illustrated using single-point inhibition data for 40 com. available kinase inhibitors screened against 85 kinases.  Nonselective inhibitors are characterized by Gini values close to zero (Staurosporine, Gini 0.150).  Highly selective compds. exhibit Gini values close to 1 (PD184352 Gini 0.905).  The relative selectivity of inhibitors does not depend on the ATP concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUHpmF-C9u7Vg90H21EOLACvtfcHk0lgFE7VtEP9KOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFyhu7rL&md5=51f4902e49196dfef8e135c4a09182d7</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm070562u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070562u%26sid%3Dliteratum%253Aachs%26aulast%3DGraczyk%26aufirst%3DP.%2BP.%26atitle%3DGini%2520coefficient%253A%2520a%2520new%2520way%2520to%2520express%2520selectivity%2520of%2520kinase%2520inhibitors%2520against%2520a%2520family%2520of%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5773%26epage%3D5779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Böhm, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obst-Sander, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52a&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.-J.+B%C3%B6hmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+M%C3%BCllerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52aR"><div class="casContent"><span class="casTitleNuber">52a</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2eaXAmLlFbFHGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit52a&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6hm%26aufirst%3DH.-J.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit52b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Purser, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouverneur, V.</span><span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1039%2FB610213C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=18197348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52b&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=320-330&author=S.+Purserauthor=P.+R.+Mooreauthor=S.+Swallowauthor=V.+Gouverneur&title=Fluorine+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52bR"><div class="casContent"><span class="casTitleNuber">52b</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Purser, Sophie; Moore, Peter R.; Swallow, Steve; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-330</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  It has become evident that fluorinated compds. have a remarkable record in medicinal chem. and will play a continuing role in providing lead compds. for therapeutic applications.  This tutorial review provides a sampling of renowned fluorinated drugs and their mode of action with a discussion clarifying the role and impact of fluorine substitution on drug potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKAqJ3UbgGbVg90H21EOLACvtfcHk0lhSVcZiTCyFgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D&md5=e6c9e3084e454c44a4ba245b98f7f1d7</span></div><a href="/servlet/linkout?suffix=cit52b&amp;dbid=16384&amp;doi=10.1039%2FB610213C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB610213C%26sid%3Dliteratum%253Aachs%26aulast%3DPurser%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DP.%2BR.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26spage%3D320%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit52c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hagmann, W. K.</span><span> </span><span class="NLM_article-title">The many roles for fluorine in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4359</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800219f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52c&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4359-4369&author=W.+K.+Hagmann&title=The+many+roles+for+fluorine+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52cR"><div class="casContent"><span class="casTitleNuber">52c</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles for Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Hagmann, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4359-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZV7sio8RhbVg90H21EOLACvtfcHk0lhSVcZiTCyFgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D&md5=821f8076bb0f632f687b1c90b05dd382</span></div><a href="/servlet/linkout?suffix=cit52c&amp;dbid=16384&amp;doi=10.1021%2Fjm800219f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800219f%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DThe%2520many%2520roles%2520for%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4359%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><div class="note"><p class="first last">The relatively small shift (4.4-fold) of potency between PBMC and human whole blood for compound <b>37</b> is likely due to its modest (86.6%) human plasma protein binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A nice review of “free drug principle” with many recent examples could be found:</p></div><span class="NLM_contrib-group">Trainor, G. L.</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm400266t&amp;key=10.1517%2F17460441.2.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm400266t&amp;key=23496037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400266t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+relatively+small+shift+%284.4-fold%29+of+potency+between+PBMC+and+human+whole+blood+for+compound+37+is+likely+due+to+its+modest+%2886.6%25%29+human+plasma+protein+binding+%28Table+4%29.+A+nice+review+of+%E2%80%9Cfree+drug+principle%E2%80%9D+with+many+recent+examples+could+be+found%3ATrainor%2C+G.+L.Expert+Opin.+Drug+Discovery+2007%2C+2%2C+51%E2%80%9364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of plasma protein binding in drug discovery</span></div><div class="casAuthors">Trainor, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Plasma protein binding of drugs is a well-recognized phenomena, but it is only recently that the implications for drug action in vivo have been fully appreciated.  Plasma proteins, by virtue of their high concn., control the free drug concn. in plasma and in compartments in equil. with plasma, thereby, effectively attenuating drug potency in vivo.  The historical background and thermodn. basis for the 'Free Drug Principle' is presented, along with special considerations for intracellular targets, deep compartments and α1-acid glycoprotein binding.  Real and apparent exceptions to the principle are discussed along with a survey of citations from the recent medicinal chem. literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyoyVEZ33iUbVg90H21EOLACvtfcHk0lhSVcZiTCyFgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Sitrw%253D&md5=06ed3a7f31e02588cf98e790abdc622f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1517%2F17460441.2.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D51%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="note"><p class="first last">Synthesis and chiral resolution of 2-fluorocyclopropanecarboxylic acid have been reported: </p></div><div class="NLM_citation" id="rightTab-cit54a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Akiba, T.; Ikeya, T.; Kawanishi, H.; Yukimoto, Y.; Kamihara, S.; Ebata, T.</span><span> </span><span class="NLM_article-title">Selective Dehalogenation Process</span>. U.S. Patent 5,780,669,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=T.+Akiba&author=T.+Ikeya&author=H.+Kawanishi&author=Y.+Yukimoto&author=S.+Kamihara&author=T.+Ebata&title=Selective+Dehalogenation+Process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAkiba%26aufirst%3DT.%26atitle%3DSelective%2520Dehalogenation%2520Process%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit54b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atarashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, I.</span><span> </span><span class="NLM_article-title">(Fluorocyclopropyl)quinolones. 2. Synthesis and stereochemical structure–activity relationship of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">3344</span><span class="NLM_x">–</span> <span class="NLM_lpage">3352</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00046a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=3344-3352&author=Y.+Kimuraauthor=S.+Atarashiauthor=K.+Kawakamiauthor=K.+Satoauthor=I.+Hayakawa&title=%28Fluorocyclopropyl%29quinolones.+2.+Synthesis+and+stereochemical+structure%E2%80%93activity+relationship+of+chiral+7-%287-amino-5-azaspiro%5B2.4%5Dheptan-5-yl%29-1-%282-fluorocyclopropyl%29quinolone+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54b&amp;dbid=16384&amp;doi=10.1021%2Fjm00046a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00046a019%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DAtarashi%26aufirst%3DS.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DHayakawa%26aufirst%3DI.%26atitle%3D%2528Fluorocyclopropyl%2529quinolones.%25202.%2520Synthesis%2520and%2520stereochemical%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520chiral%25207-%25287-amino-5-azaspiro%255B2.4%255Dheptan-5-yl%2529-1-%25282-fluorocyclopropyl%2529quinolone%2520antibacterial%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D3344%26epage%3D3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandretto, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span> </span><span class="NLM_article-title">Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2002&pages=567-576&author=A.+C.+Pierceauthor=K.+L.+Sandrettoauthor=G.+W.+Bemis&title=Kinase+inhibitors+and+the+case+for+CH...O+hydrogen+bonds+in+protein-ligand+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DSandretto%26aufirst%3DK.%2BL.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26atitle%3DKinase%2520inhibitors%2520and%2520the%2520case%2520for%2520CH...O%2520hydrogen%2520bonds%2520in%2520protein-ligand%2520binding%26jtitle%3DProteins%26date%3D2002%26volume%3D49%26spage%3D567%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GI1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GI1','PDB','4GI1'); return false;">PDB: 4GI1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ2','PDB','4GJ2'); return false;">PDB: 4GJ2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ3','PDB','4GJ3'); return false;">PDB: 4GJ3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm400266t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52312"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental procedures for different benzoic acids and the rest of compounds shown in this work; single X-ray crystal structures of compounds <b>23</b> and <b>32</b>; crystallographic methods and procedures for <b>19</b> in complex with TYK2, <b>23</b> in complex with TYK2, and <b>35</b> in complex with TYK2; time course of mouse IL-12 PK/PD experiment. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400266t/suppl_file/jm400266t_si_001.pdf">jm400266t_si_001.pdf (723.53 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400266t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm400266t%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400266t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667983953826d1d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
